cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
COAD	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.27	3.93	0.00011	Crohn's disease	
COAD	cis	1	rs10002541	chr4:56395011	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.55	8.37E-6	Personality dimensions	
COAD	cis	1	rs10005989	chr4:56405206	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.84	2.19E-6	Personality dimensions	
COAD	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.3	4.37	1.82E-5	Systolic blood pressure	
COAD	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.32	-4.47	1.18E-5	Longevity	
COAD	cis	1	rs1001373	chr1:171684506	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.29E-6	Hippocampal atrophy	
COAD	cis	1	rs10016506	chr4:56396674	SRD5A3	chr4:56212409-56237866:+	-0.26	-4.43	1.38E-5	Personality dimensions	
COAD	cis	1	rs10023907	chr4:88772535	SPP1	chr4:88896802-88904562:+	-0.28	-5.18	4.41E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs10029750	chr4:120172543	FABP2	chr4:120238406-120243316:-	0.37	5.63	4.62E-8	Corneal astigmatism	
COAD	cis	1	rs10034433	chr4:56421176	SRD5A3	chr4:56212409-56237866:+	-0.26	-4.65	5.22E-6	Personality dimensions	
COAD	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.32	-4.31	2.35E-5	Eye color traits	
COAD	cis	1	rs10041402	chr5:90738948	LOC100129716	chr5:90676164-90716531:+	0.34	4.11	5.37E-5	Smoking behavior	
COAD	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	1.01	13.2	8.08E-31	Type 2 diabetes	
COAD	cis	1	rs10059163	chr5:90742444	LOC100129716	chr5:90676164-90716531:+	0.34	4.11	5.37E-5	Smoking behavior	
COAD	cis	1	rs10073935	chr5:90742188	LOC100129716	chr5:90676164-90716531:+	0.34	4.11	5.37E-5	Smoking behavior	
COAD	cis	1	rs10076701	chr5:131596419	PDLIM4	chr5:131593351-131609145:+	-0.15	-4.21	3.59E-5	Blood metabolite levels	
COAD	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.36	4.42	1.45E-5	Fat distribution (HIV)	
COAD	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.29	4.78	2.9E-6	Height	
COAD	cis	1	rs10086778	chr8:10814140	SOX7	chr8:10581279-10697299:-	-0.25	-3.98	9.09E-5	Asthma and hay fever	
COAD	cis	1	rs10086872	chr8:10814210	SOX7	chr8:10581279-10697299:-	-0.25	-3.98	9.09E-5	Asthma and hay fever	
COAD	cis	1	rs10087376	chr8:10814617	SOX7	chr8:10581279-10697299:-	-0.25	-4.09	5.77E-5	Asthma and hay fever	
COAD	cis	1	rs10088439	chr8:8576699	FLJ10661	chr8:8086092-8102386:+	0.42	4.79	2.79E-6	Obesity-related traits	
COAD	cis	1	rs1008953	chr20:43980726	SYS1-DBNDD2	chr20:43991701-44039245:+	0.37	3.92	0.000115	Psoriasis	
COAD	cis	1	rs1009051	chr3:49521549	ARIH2	chr3:48956281-49022969:+	-0.3	-3.84	0.000153	Menarche (age at onset)	
COAD	cis	1	rs1009051	chr3:49521549	WDR6	chr3:49044637-49053386:+	-0.37	-5.51	8.63E-8	Menarche (age at onset)	
COAD	cis	1	rs10094684	chr8:10814888	SOX7	chr8:10581279-10697299:-	-0.25	-4.09	5.77E-5	Asthma and hay fever	
COAD	cis	1	rs10095261	chr8:10815377	SOX7	chr8:10581279-10697299:-	-0.26	-4.14	4.78E-5	Asthma and hay fever	
COAD	cis	1	rs10095390	chr8:10815515	SOX7	chr8:10581279-10697299:-	-0.26	-4.11	5.23E-5	Asthma and hay fever	
COAD	cis	1	rs10095733	chr8:8574646	FLJ10661	chr8:8086092-8102386:+	0.38	4.31	2.28E-5	Obesity-related traits	
COAD	cis	1	rs10095849	chr8:39408586	ADAM32	chr8:38965050-39142435:+	-0.35	-4.39	1.65E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
COAD	cis	1	rs10096350	chr8:124184470	FAM83A	chr8:124191287-124222317:+	-0.49	-4.34	2.01E-5	Urinary uromodulin levels	
COAD	cis	1	rs10096455	chr8:96041250	C8orf38	chr8:95908040-96088396:+	-0.29	-4.02	7.63E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs10096872	chr8:10814297	SOX7	chr8:10581279-10697299:-	-0.25	-4.04	6.99E-5	Asthma and hay fever	
COAD	cis	1	rs10097626	chr8:10814860	SOX7	chr8:10581279-10697299:-	0.25	4.1	5.52E-5	Asthma and hay fever	
COAD	cis	1	rs10098197	chr8:96042890	C8orf38	chr8:95908040-96088396:+	-0.29	-4.02	7.63E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs10098234	chr8:8576692	FLJ10661	chr8:8086092-8102386:+	0.42	4.79	2.79E-6	Obesity-related traits	
COAD	cis	1	rs10103769	chr8:8573036	FLJ10661	chr8:8086092-8102386:+	0.38	4.33	2.15E-5	Obesity-related traits	
COAD	cis	1	rs10106491	chr8:96038959	C8orf38	chr8:95908040-96088396:+	-0.29	-3.95	0.000101	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs1011054	chr4:120202387	FABP2	chr4:120238406-120243316:-	-0.36	-5.12	5.97E-7	Corneal astigmatism	
COAD	cis	1	rs10112230	chr8:96038072	C8orf38	chr8:95908040-96088396:+	-0.29	-3.95	0.000101	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.38	-5.59	5.83E-8	Rheumatoid arthritis	
COAD	cis	1	rs10120103	chr9:102695468	STX17	chr9:102668915-102736817:+	-0.28	-3.85	0.000146	Alopecia areata	
COAD	cis	1	rs10121601	chr9:102687445	STX17	chr9:102668915-102736817:+	-0.28	-3.91	0.000119	Alopecia areata	
COAD	cis	1	rs10123261	chr9:102695442	STX17	chr9:102668915-102736817:+	-0.28	-3.91	0.000119	Alopecia areata	
COAD	cis	1	rs10128711	chr11:18632984	SPTY2D1	chr11:18627949-18656020:-	-0.4	-6.46	5.23E-10	Cholesterol, total	
COAD	cis	1	rs1013338	chr22:38974154	CBY1	chr22:39052658-39069853:+	0.29	5.01	1.0E-6	Resting heart rate	
COAD	cis	1	rs10135	chr22:39082174	CBY1	chr22:39052658-39069853:+	-0.33	-5.73	2.79E-8	Resting heart rate	
COAD	cis	1	rs10136440	chr14:104397367	TDRD9	chr14:104394817-104519002:+	-0.33	-4.86	2.03E-6	Bipolar disorder	
COAD	cis	1	rs10136948	chr14:75511075	MLH3	chr14:75480467-75518235:-	0.25	4.27	2.73E-5	Height	
COAD	cis	1	rs10138183	chr14:75615227	MLH3	chr14:75480467-75518235:-	0.28	4.74	3.56E-6	Height	
COAD	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.4	-6.7	1.25E-10	Common traits (Other)	
COAD	cis	1	rs10140851	chr14:75512612	MLH3	chr14:75480467-75518235:-	0.27	4.57	7.4E-6	Height	
COAD	cis	1	rs10142626	chr14:75555636	MLH3	chr14:75480467-75518235:-	0.27	4.73	3.76E-6	Height	
COAD	cis	1	rs10142865	chr14:75555624	MLH3	chr14:75480467-75518235:-	0.27	4.73	3.76E-6	Height	
COAD	cis	1	rs10143132	chr14:75525850	MLH3	chr14:75480467-75518235:-	0.24	4.01	7.98E-5	Height	
COAD	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.4	-6.61	2.19E-10	Common traits (Other)	
COAD	cis	1	rs10146482	chr14:75574087	MLH3	chr14:75480467-75518235:-	0.26	4.63	5.75E-6	Height	
COAD	cis	1	rs10149651	chr14:104394440	TDRD9	chr14:104394817-104519002:+	-0.34	-5.1	6.52E-7	Bipolar disorder	
COAD	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.29	-4.99	1.08E-6	Height	
COAD	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.4	-6.65	1.72E-10	Common traits (Other)	
COAD	cis	1	rs10155014	chr3:49432321	WDR6	chr3:49044637-49053386:+	-0.35	-5.14	5.47E-7	Menarche (age at onset)	
COAD	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.63	-9.59	7.52E-19	Homocysteine levels	
COAD	cis	1	rs10158107	chr1:202394315	PPP1R12B	chr1:202317836-202557697:+	0.21	3.95	0.000102	Sex ratio	
COAD	cis	1	rs10174456	chr2:188198652	CALCRL	chr2:188207851-188313021:-	0.15	4.24	3.07E-5	Coronary heart disease	
COAD	cis	1	rs10174942	chr2:188143075	CALCRL	chr2:188207851-188313021:-	0.15	4.36	1.84E-5	Coronary heart disease	
COAD	cis	1	rs10175180	chr2:73673123	ALMS1	chr2:73612886-73837046:+	0.24	3.9	0.000124	Metabolite levels	
COAD	cis	1	rs1017697	chr2:219170462	GLB1L	chr2:220101505-220110131:-	0.44	3.92	0.000113	Smooth-surface caries	
COAD	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.57	8.51	1.35E-15	Response to antipsychotic treatment	
COAD	cis	1	rs10185178	chr2:171356274	MYO3B	chr2:171034655-171510983:+	-0.75	-4.77	3.06E-6	Coronary artery aneurysm in Kawasaki disease	
COAD	cis	1	rs10186501	chr2:73697844	ALMS1	chr2:73612886-73837046:+	0.24	3.91	0.000118	Metabolite levels	
COAD	cis	1	rs10191833	chr2:188171337	CALCRL	chr2:188207851-188313021:-	0.15	4.31	2.36E-5	Coronary heart disease	
COAD	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.71	-12.72	3.59E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs10198552	chr2:135599876	ACMSD	chr2:135596186-135659600:+	0.46	4.39	1.62E-5	Obesity-related traits	
COAD	cis	1	rs10204024	chr2:37732029	CDC42EP3	chr2:37870743-37899326:-	0.21	3.89	0.000126	Response to TNF-alpha inhibitors in rheumatoid arthritis	
COAD	cis	1	rs10205487	chr2:70151471	GMCL1	chr2:70056818-70106727:+	-0.22	-4.08	6.1E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.26	4.25	3.02E-5	Inflammatory skin disease	
COAD	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.27	4.58	7.32E-6	Inflammatory skin disease	
COAD	cis	1	rs10209928	chr2:108863898	SULT1C3	chr2:108863651-108881806:+	0.43	6.16	2.73E-9	Blood pressure	
COAD	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.74	11.39	1.14E-24	Diastolic blood pressure	
COAD	cis	1	rs10217337	chr9:102710396	STX17	chr9:102668915-102736817:+	-0.28	-3.93	0.000109	Alopecia areata	
COAD	cis	1	rs10217366	chr9:102710555	STX17	chr9:102668915-102736817:+	-0.28	-3.93	0.000109	Alopecia areata	
COAD	cis	1	rs10217692	chr9:102710431	STX17	chr9:102668915-102736817:+	-0.28	-3.96	9.73E-5	Alopecia areata	
COAD	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.9	7.01	2.07E-11	Coronary heart disease	
COAD	cis	1	rs10229552	chr7:99234899	CYP3A5	chr7:99245818-99332821:-	0.5	7.11	1.1E-11	Blood metabolite levels	
COAD	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.69	9.37	3.58E-18	Paget's disease	
COAD	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.83	-10.17	1.11E-20	Paget's disease	
COAD	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.3	4.9	1.69E-6	Longevity;Endometriosis	
COAD	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.38	4.76	3.15E-6	Atopic dermatitis	
COAD	cis	1	rs1029406	chr11:2309580	C11orf21	chr11:2317507-2323143:-	-0.33	-3.88	0.000131	Obesity-related traits	
COAD	cis	1	rs1029406	chr11:2309580	TSPAN32	chr11:2323243-2339430:+	-0.36	-3.85	0.000151	Obesity-related traits	
COAD	cis	1	rs1029407	chr11:2309582	C11orf21	chr11:2317507-2323143:-	-0.33	-3.88	0.000131	Obesity-related traits	
COAD	cis	1	rs1029407	chr11:2309582	TSPAN32	chr11:2323243-2339430:+	-0.36	-3.85	0.000151	Obesity-related traits	
COAD	cis	1	rs1029408	chr11:2309855	C11orf21	chr11:2317507-2323143:-	-0.34	-3.93	0.000107	Obesity-related traits	
COAD	cis	1	rs1029408	chr11:2309855	TSPAN32	chr11:2323243-2339430:+	-0.36	-3.89	0.000128	Obesity-related traits	
COAD	cis	1	rs1029740	chr7:22873586	TOMM7	chr7:22852254-22862421:-	-0.34	-5.15	5.13E-7	Fibrinogen	
COAD	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.34	-4.77	3.12E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1035476	chr5:90745976	LOC100129716	chr5:90676164-90716531:+	0.33	3.84	0.000152	Smoking behavior	
COAD	cis	1	rs1035477	chr5:90743325	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.34	-4.73	3.7E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs10405457	chr19:44296582	LYPD5	chr19:44300080-44324808:-	-0.25	-3.86	0.000143	Breast cancer	
COAD	cis	1	rs10409485	chr19:41920765	B3GNT8	chr19:41931265-41934635:-	0.32	5.23	3.48E-7	Height	
COAD	cis	1	rs10413735	chr19:41921071	B3GNT8	chr19:41931265-41934635:-	-0.33	-5.37	1.72E-7	Height	
COAD	cis	1	rs10417311	chr19:41902038	B3GNT8	chr19:41931265-41934635:-	-0.34	-5.54	7.23E-8	Height	
COAD	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.27	-4.61	6.27E-6	Gut microbiome composition (summer)	
COAD	cis	1	rs10417997	chr19:41902361	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.52	9.38E-6	Height	
COAD	cis	1	rs10422783	chr19:41906436	B3GNT8	chr19:41931265-41934635:-	-0.34	-5.57	6.36E-8	Height	
COAD	cis	1	rs10422956	chr19:41901261	B3GNT8	chr19:41931265-41934635:-	-0.34	-5.58	6.08E-8	Height	
COAD	cis	1	rs10429856	chr1:34001296	ADC	chr1:33546714-33586131:+	0.35	4.15	4.44E-5	Response to anti-TNF therapy in rheumatoid arthritis	
COAD	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.58	7.59	5.55E-13	Multiple sclerosis	
COAD	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.35	-5.79	2.02E-8	Multiple sclerosis	
COAD	cis	1	rs10431765	chr15:66044551	DENND4A	chr15:65952959-66084631:-	-0.2	-3.93	0.00011	Mean corpuscular hemoglobin	
COAD	cis	1	rs1043413	chr19:41939297	B3GNT8	chr19:41931265-41934635:-	0.27	4.43	1.37E-5	Height	
COAD	cis	1	rs1043441	chr22:39130964	CBY1	chr22:39052658-39069853:+	0.35	5.71	3.01E-8	Resting heart rate	
COAD	cis	1	rs1043674	chr14:75549370	MLH3	chr14:75480467-75518235:-	0.27	4.73	3.76E-6	Height	
COAD	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.63	-9.49	1.58E-18	Homocysteine levels	
COAD	cis	1	rs10454142	chr2:48646399	GTF2A1L	chr2:48844948-48960284:+	-0.33	-4.26	2.9E-5	Sex hormone-binding globulin levels	
COAD	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.58	-8.53	1.2E-15	Response to antipsychotic treatment	
COAD	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.62	-8.45	2.07E-15	Response to antipsychotic treatment	
COAD	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.63	-8.57	9.41E-16	Response to antipsychotic treatment	
COAD	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.58	-8.52	1.3E-15	Response to antipsychotic treatment	
COAD	cis	1	rs10455482	chr6:88902993	PM20D2	chr6:89855769-89875283:+	-0.26	-3.86	0.00014	Gut microbiota (functional units)	
COAD	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.53	9.33	4.73E-18	Folate pathway vitamin levels	
COAD	cis	1	rs10460009	chr18:2948029	SMCHD1	chr18:2655886-2805014:+	-0.26	-4.11	5.21E-5	Type 2 diabetes	
COAD	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.95	12.33	7.98E-28	Type 2 diabetes	
COAD	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.26	3.95	0.000101	Crohn's disease	
COAD	cis	1	rs10465591	chr1:202308344	PPP1R12B	chr1:202317836-202557697:+	0.2	3.84	0.000153	Sex ratio	
COAD	cis	1	rs1046701	chr14:59939804	C14orf149	chr14:59939406-59951126:-	0.41	4.28	2.67E-5	Schizophrenia	
COAD	cis	1	rs10468513	chr17:53062903	STXBP4	chr17:53046126-53241449:+	-0.28	-3.89	0.000125	Breast cancer	
COAD	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.44	6.15	2.97E-9	Glycated hemoglobin levels	
COAD	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.44	6.21	2.12E-9	Glycated hemoglobin levels	
COAD	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.46	6.39	7.7E-10	Glycated hemoglobin levels	
COAD	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.29	-4.72	3.77E-6	Longevity	
COAD	cis	1	rs1047418	chr14:75605792	MLH3	chr14:75480467-75518235:-	0.26	4.44	1.33E-5	Height	
COAD	cis	1	rs10474353	chr5:90732285	LOC100129716	chr5:90676164-90716531:+	0.35	4.21	3.53E-5	Smoking behavior	
COAD	cis	1	rs1047796	chr12:122628219	MLXIP	chr12:122516760-122628965:+	-0.22	-4.57	7.68E-6	Urate levels	
COAD	cis	1	rs1047813	chr12:122628516	MLXIP	chr12:122516760-122628965:+	0.22	4.43	1.4E-5	Urate levels	
COAD	cis	1	rs10484286	chr6:118956447	C6orf204	chr6:118786239-119031238:-	-0.27	-4.28	2.63E-5	Renal cell carcinoma	
COAD	cis	1	rs10485508	chr20:33605098	PROCR	chr20:33758727-33765164:+	-0.48	-4.06	6.61E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs10488821	chr11:30502175	MPPED2	chr11:30406040-30607930:-	0.26	4.35	1.99E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs10489249	chr1:171714521	VAMP4	chr1:171669298-171711214:-	0.32	4.53	8.95E-6	Hippocampal atrophy	
COAD	cis	1	rs10489251	chr1:171717534	VAMP4	chr1:171669298-171711214:-	0.31	4.25	2.98E-5	Hippocampal atrophy	
COAD	cis	1	rs10496191	chr2:73673798	ALMS1	chr2:73612886-73837046:+	0.24	3.9	0.000124	Metabolite levels	
COAD	cis	1	rs10496193	chr2:73773503	ALMS1	chr2:73612886-73837046:+	0.25	4.03	7.21E-5	Metabolite levels	
COAD	cis	1	rs10498633	chr14:92926952	ATXN3	chr14:92524897-92572965:-	-0.28	-3.86	0.00014	Alzheimer's disease in APOE e4- carriers;Alzheimer's disease (late onset)	
COAD	cis	1	rs10498633	chr14:92926952	CPSF2	chr14:92588329-92630543:+	-0.29	-4.04	6.93E-5	Alzheimer's disease in APOE e4- carriers;Alzheimer's disease (late onset)	
COAD	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.63	8.58	8.62E-16	Response to antipsychotic treatment	
COAD	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.94	5.51	8.69E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs10504857	chr8:89582625	MMP16	chr8:89049462-89339717:-	-0.19	-4.25	3.03E-5	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs1050779	chr16:58080215	MMP15	chr16:58059282-58080802:+	0.3	3.86	0.000145	Pulmonary function;Pulmonary function (interaction)	
COAD	cis	1	rs10510761	chr3:52965255	SFMBT1	chr3:52938628-53080070:-	0.57	5.02	9.78E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.44	-3.91	0.000116	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.27	4.07	6.22E-5	Blood metabolite levels;Blood metabolite ratios	
COAD	cis	1	rs1052676	chr1:171673054	VAMP4	chr1:171669298-171711214:-	0.34	4.64	5.57E-6	Hippocampal atrophy	
COAD	cis	1	rs10540	chr11:494662	PTDSS2	chr11:450280-491386:+	-0.48	-4.59	6.82E-6	Body mass index	
COAD	cis	1	rs1056610	chr22:39080078	CBY1	chr22:39052658-39069853:+	-0.34	-5.89	1.19E-8	Resting heart rate	
COAD	cis	1	rs1056964	chr22:51017476	CPT1B	chr22:51007291-51017096:-	-0.47	-4.69	4.38E-6	Narcolepsy	
COAD	cis	1	rs1065201	chr22:39069510	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs1065201	chr22:39069510	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.37	5.62	4.98E-8	Pancreatic cancer	
COAD	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.47	7.03	1.8E-11	Homocysteine levels	
COAD	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.35	-4.72	3.8E-6	Hematology traits	
COAD	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.29	-4.43	1.39E-5	Pancreatic cancer	
COAD	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.33	5.02	9.41E-7	Pancreatic cancer	
COAD	cis	1	rs10744335	chr12:122612146	MLXIP	chr12:122516760-122628965:+	-0.23	-4.54	8.55E-6	Urate levels	
COAD	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.54	6.8	7.13E-11	Multiple sclerosis	
COAD	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.38	-6.07	4.51E-9	Multiple sclerosis	
COAD	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.34	5.2	4.01E-7	Height	
COAD	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.41	-5.64	4.33E-8	Hematology traits	
COAD	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.39	-5.76	2.33E-8	Rheumatoid arthritis	
COAD	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.38	-5.41	1.41E-7	Rheumatoid arthritis	
COAD	cis	1	rs10760706	chr9:102723692	STX17	chr9:102668915-102736817:+	-0.28	-3.88	0.00013	Alopecia areata	
COAD	cis	1	rs10773037	chr12:122607916	MLXIP	chr12:122516760-122628965:+	0.24	4.92	1.57E-6	Urate levels	
COAD	cis	1	rs10783594	chr12:54067135	ATP5G2	chr12:54058945-54070512:-	0.27	5.08	7.2E-7	Height	
COAD	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.58	7.59	5.55E-13	Multiple sclerosis	
COAD	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.35	-5.79	2.02E-8	Multiple sclerosis	
COAD	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.58	7.59	5.55E-13	Multiple sclerosis	
COAD	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.35	-5.79	2.02E-8	Multiple sclerosis	
COAD	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.17	-3.81	0.000171	Palmitoleic acid (16:1n-7) plasma levels	
COAD	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.27	-4.02	7.58E-5	Height	
COAD	cis	1	rs10789823	chr11:111172403	C11orf93	chr11:111169976-111179353:+	0.31	4.36	1.9E-5	Colorectal cancer	
COAD	cis	1	rs10795917	chr10:12051816	CAMK1D	chr10:12391583-12871731:+	-0.26	-4.1	5.52E-5	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs10800830	chr1:202323296	PPP1R12B	chr1:202317836-202557697:+	0.2	3.82	0.000167	Sex ratio	
COAD	cis	1	rs10800833	chr1:202330653	PPP1R12B	chr1:202317836-202557697:+	0.2	3.89	0.000129	Sex ratio	
COAD	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.37	-5.45	1.18E-7	Rheumatoid arthritis	
COAD	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.31	4.75	3.33E-6	Pancreatic cancer	
COAD	cis	1	rs10832956	chr11:18645668	SPTY2D1	chr11:18627949-18656020:-	-0.36	-5.89	1.19E-8	Cholesterol, total	
COAD	cis	1	rs10832962	chr11:18656271	SPTY2D1	chr11:18627949-18656020:-	-0.4	-6.35	9.36E-10	Cholesterol, total	
COAD	cis	1	rs10832963	chr11:18664241	SPTY2D1	chr11:18627949-18656020:-	-0.35	-5.38	1.68E-7	Cholesterol, total	
COAD	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.44	-6.07	4.5E-9	Subjective well-being	
COAD	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.42	-5.71	3.0E-8	Subjective well-being	
COAD	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.42	-5.77	2.26E-8	Subjective well-being	
COAD	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.33	2.18E-7	Subjective well-being	
COAD	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.27	-4.12	5.16E-5	Lung cancer	
COAD	cis	1	rs10853751	chr19:41903220	B3GNT8	chr19:41931265-41934635:-	-0.34	-5.54	7.23E-8	Height	
COAD	cis	1	rs10859106	chr12:91476568	KERA	chr12:91444273-91452131:-	0.28	4.62	6.06E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs10865956	chr3:49581559	WDR6	chr3:49044637-49053386:+	-0.31	-4.23	3.17E-5	Menarche (age at onset)	
COAD	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.28	4.5	1.01E-5	Height	
COAD	cis	1	rs10873275	chr14:75531460	MLH3	chr14:75480467-75518235:-	0.25	4.32	2.21E-5	Height	
COAD	cis	1	rs10876480	chr12:54066271	ATP5G2	chr12:54058945-54070512:-	0.27	5.03	9.3E-7	Height	
COAD	cis	1	rs10876481	chr12:54066743	ATP5G2	chr12:54058945-54070512:-	0.27	5.05	8.22E-7	Height	
COAD	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.55	6.74	1.03E-10	Multiple sclerosis	
COAD	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.38	-5.92	9.97E-9	Multiple sclerosis	
COAD	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.58	7.66	3.76E-13	Multiple sclerosis	
COAD	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.34	-5.7	3.23E-8	Multiple sclerosis	
COAD	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.55	7.32	3.13E-12	Multiple sclerosis	
COAD	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.35	-5.75	2.5E-8	Multiple sclerosis	
COAD	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.56	7.08	1.32E-11	Multiple sclerosis	
COAD	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.36	-5.78	2.12E-8	Multiple sclerosis	
COAD	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.55	-6.89	4.18E-11	Multiple sclerosis	
COAD	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.36	5.63	4.56E-8	Multiple sclerosis	
COAD	cis	1	rs10881608	chr10:91374649	PANK1	chr10:91342749-91405215:-	0.31	3.85	0.000149	Metabolic traits	
COAD	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.17	4.1	5.43E-5	Blood metabolite levels	
COAD	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.19	-4.12	5.17E-5	Palmitoleic acid (16:1n-7) plasma levels	
COAD	cis	1	rs10885997	chr10:118397971	PNLIPRP2	chr10:118380465-118404654:+	0.46	6.95	2.95E-11	Phospholipid levels (plasma)	
COAD	cis	1	rs10887226	chr10:81713074	LOC219347	chr10:81805991-81838949:-	0.7	4.17	4.22E-5	Rheumatoid arthritis	
COAD	cis	1	rs10887586	chr10:88113521	GRID1	chr10:87359312-88126250:-	-0.18	-3.93	0.000111	Barrett's esophagus	
COAD	cis	1	rs10899467	chr11:78014057	USP35	chr11:77899858-77925753:+	0.35	4.04	7.02E-5	Testicular germ cell tumor	
COAD	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.32	-4.63	5.79E-6	Visceral fat	
COAD	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.32	-4.63	5.79E-6	Visceral fat	
COAD	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.34	-4.91	1.63E-6	Visceral fat	
COAD	cis	1	rs10903	chr1:171673236	VAMP4	chr1:171669298-171711214:-	0.34	4.66	5.02E-6	Hippocampal atrophy	
COAD	cis	1	rs10909625	chr14:25101629	GZMB	chr14:25100161-25103432:-	-0.35	-4.79	2.85E-6	Vitiligo	
COAD	cis	1	rs10913511	chr1:171668951	VAMP4	chr1:171669298-171711214:-	0.37	5.35	1.88E-7	Hippocampal atrophy	
COAD	cis	1	rs10913514	chr1:171670823	VAMP4	chr1:171669298-171711214:-	0.33	4.46	1.2E-5	Hippocampal atrophy	
COAD	cis	1	rs10913529	chr1:171679465	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.29E-6	Hippocampal atrophy	
COAD	cis	1	rs10913565	chr1:171706706	VAMP4	chr1:171669298-171711214:-	0.34	4.64	5.41E-6	Hippocampal atrophy	
COAD	cis	1	rs10913582	chr1:171715585	VAMP4	chr1:171669298-171711214:-	0.31	4.36	1.88E-5	Hippocampal atrophy	
COAD	cis	1	rs10916661	chr1:20201779	NBL1	chr1:19923467-19984945:+	0.21	4.04	7.14E-5	Warfarin maintenance dose	
COAD	cis	1	rs10916661	chr1:20201779	UBR4	chr1:19398604-19536746:-	0.21	4.47	1.17E-5	Warfarin maintenance dose	
COAD	cis	1	rs10916814	chr1:20892931	CDA	chr1:20915444-20945398:+	0.27	4.17	4.22E-5	Age-related hearing impairment (interaction)	
COAD	cis	1	rs10920409	chr1:202443663	PPP1R12B	chr1:202317836-202557697:+	0.2	3.91	0.000116	Sex ratio	
COAD	cis	1	rs10920410	chr1:202445856	PPP1R12B	chr1:202317836-202557697:+	-0.2	-3.95	0.000102	Sex ratio	
COAD	cis	1	rs10934254	chr3:113841634	QTRTD1	chr3:113775611-113807266:+	0.23	4.2	3.63E-5	Personality dimensions	
COAD	cis	1	rs10934255	chr3:113842444	QTRTD1	chr3:113775611-113807266:+	0.21	3.83	0.000161	Personality dimensions	
COAD	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.6	-8.96	6.14E-17	Height	
COAD	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.32	-4.4	1.56E-5	Height	
COAD	cis	1	rs10935186	chr3:136346206	PCCB	chr3:135969167-136056737:+	0.27	4.59	7.0E-6	Schizophrenia	
COAD	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.58	-8.44	2.23E-15	Response to antipsychotic treatment	
COAD	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.62	-8.41	2.72E-15	Response to antipsychotic treatment	
COAD	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.58	-8.36	3.7E-15	Response to antipsychotic treatment	
COAD	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.58	-8.52	1.3E-15	Response to antipsychotic treatment	
COAD	cis	1	rs1094677	chr3:195129744	C3orf21	chr3:194789015-194991895:-	-0.35	-4.74	3.45E-6	Body mass index	
COAD	cis	1	rs10971721	chr9:33827694	PRSS3	chr9:33750515-33799228:+	-0.44	-4.41	1.52E-5	Body mass index	
COAD	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.24	4.21	3.47E-5	Blood metabolite levels	
COAD	cis	1	rs11024739	chr11:18645843	SPTY2D1	chr11:18627949-18656020:-	0.39	6.36	8.78E-10	Cholesterol, total	
COAD	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.38	-5.23	3.53E-7	Subjective well-being	
COAD	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.38	-5.2	4.01E-7	Subjective well-being	
COAD	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.22	3.61E-7	Subjective well-being	
COAD	cis	1	rs11057654	chr12:122608636	MLXIP	chr12:122516760-122628965:+	0.24	4.84	2.23E-6	Urate levels	
COAD	cis	1	rs11057905	chr12:122609131	MLXIP	chr12:122516760-122628965:+	0.21	4.06	6.43E-5	Urate levels	
COAD	cis	1	rs11059094	chr12:122606837	MLXIP	chr12:122516760-122628965:+	0.23	4.67	4.91E-6	Urate levels	
COAD	cis	1	rs11061602	chr12:122615964	MLXIP	chr12:122516760-122628965:+	-0.22	-4.52	9.47E-6	Urate levels	
COAD	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.57	6.5	4.02E-10	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs11071846	chr15:65792839	DENND4A	chr15:65952959-66084631:-	0.23	4.35	1.95E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs11079034	chr17:40288890	DHX58	chr17:40253422-40264751:-	-0.32	-4.89	1.74E-6	Fibrinogen levels	
COAD	cis	1	rs11079511	chr17:61858537	FTSJ3	chr17:61896795-61905031:-	0.31	4.17	4.19E-5	Body mass index	
COAD	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.29	-4.8	2.67E-6	Longevity	
COAD	cis	1	rs1109619	chr8:8571616	FLJ10661	chr8:8086092-8102386:+	0.37	4.26	2.84E-5	Obesity-related traits	
COAD	cis	1	rs11098499	chr4:120187611	FABP2	chr4:120238406-120243316:-	0.4	5.94	9.14E-9	Corneal astigmatism	
COAD	cis	1	rs11098500	chr4:120219239	FABP2	chr4:120238406-120243316:-	0.4	6.06	4.68E-9	Corneal astigmatism	
COAD	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.53	5.94	9.29E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs11105972	chr12:91471955	KERA	chr12:91444273-91452131:-	0.29	4.65	5.23E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11105973	chr12:91472347	KERA	chr12:91444273-91452131:-	0.29	4.65	5.23E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11105974	chr12:91476481	KERA	chr12:91444273-91452131:-	0.28	4.62	6.06E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11105983	chr12:91480976	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11105988	chr12:91498299	KERA	chr12:91444273-91452131:-	0.27	4.3	2.42E-5	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.63	-8.32	5.04E-15	Renal function-related traits (BUN)	
COAD	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.52	-6.76	8.85E-11	Renal function-related traits (BUN)	
COAD	cis	1	rs111237243	chr14:59991030	C14orf149	chr14:59939406-59951126:-	-0.46	-4.15	4.45E-5	Schizophrenia	
COAD	cis	1	rs11126251	chr2:70163434	GMCL1	chr2:70056818-70106727:+	0.22	4.21	3.58E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs11127188	chr2:28972852	PPP1CB	chr2:28974612-29025805:+	0.29	4.86	2.01E-6	Body mass index	
COAD	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.36	-5.9	1.14E-8	Body mass index	
COAD	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.28	-4.66	5.09E-6	Longevity	
COAD	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.29	-4.84	2.22E-6	Longevity	
COAD	cis	1	rs11130190	chr3:49402137	WDR6	chr3:49044637-49053386:+	-0.31	-4.29	2.47E-5	Menarche (age at onset)	
COAD	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.27	-4.08	6.1E-5	Height	
COAD	cis	1	rs11132254	chr4:185611592	CCDC111	chr4:185570767-185616112:+	0.3	3.89	0.000127	Kawasaki disease	
COAD	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.47	-9.07	2.86E-17	Kawasaki disease	
COAD	cis	1	rs111355947	chr14:59911985	C14orf149	chr14:59939406-59951126:-	-0.49	-4.16	4.31E-5	Schizophrenia	
COAD	cis	1	rs111355947	chr14:59911985	JKAMP	chr14:59951161-59972080:+	0.46	3.92	0.000115	Schizophrenia	
COAD	cis	1	rs111476301	chr14:59920191	C14orf149	chr14:59939406-59951126:-	-0.46	-4.12	5.09E-5	Schizophrenia	
COAD	cis	1	rs111489600	chr14:59993021	C14orf149	chr14:59939406-59951126:-	-0.46	-4.15	4.45E-5	Schizophrenia	
COAD	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.34	4.51	9.95E-6	Atopic dermatitis	
COAD	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.41	6.75	9.39E-11	Common traits (Other)	
COAD	cis	1	rs11159117	chr14:75584867	MLH3	chr14:75480467-75518235:-	0.26	4.54	8.63E-6	Height	
COAD	cis	1	rs11167254	chr20:33654584	EDEM2	chr20:33703160-33865928:-	0.34	4.01	8.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.28	4.12	5.1E-5	Crohn's disease	
COAD	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.5	6.66	1.61E-10	Crohn's disease	
COAD	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.55	6.86	5.11E-11	Multiple sclerosis	
COAD	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.36	-5.68	3.62E-8	Multiple sclerosis	
COAD	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.54	6.8	6.95E-11	Multiple sclerosis	
COAD	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.36	-5.69	3.34E-8	Multiple sclerosis	
COAD	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.55	6.83	5.81E-11	Multiple sclerosis	
COAD	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.36	-5.79	1.98E-8	Multiple sclerosis	
COAD	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.55	6.83	5.81E-11	Multiple sclerosis	
COAD	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.36	-5.79	1.98E-8	Multiple sclerosis	
COAD	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.58	7.59	5.55E-13	Multiple sclerosis	
COAD	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.35	-5.79	2.02E-8	Multiple sclerosis	
COAD	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.54	6.73	1.06E-10	Multiple sclerosis	
COAD	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.35	-5.54	7.5E-8	Multiple sclerosis	
COAD	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.55	6.83	6.02E-11	Multiple sclerosis	
COAD	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.34	-5.38	1.64E-7	Multiple sclerosis	
COAD	cis	1	rs11174437	chr12:62744626	FAM19A2	chr12:62102043-62653925:-	0.33	3.9	0.000124	Pyoderma gangrenosum in inflammatory bowel disease	
COAD	cis	1	rs111745772	chr14:60011260	C14orf149	chr14:59939406-59951126:-	-0.54	-4.42	1.47E-5	Schizophrenia	
COAD	cis	1	rs111745772	chr14:60011260	JKAMP	chr14:59951161-59972080:+	0.51	4.23	3.28E-5	Schizophrenia	
COAD	cis	1	rs111803315	chr14:59965293	C14orf149	chr14:59939406-59951126:-	-0.52	-4.46	1.24E-5	Schizophrenia	
COAD	cis	1	rs111803315	chr14:59965293	JKAMP	chr14:59951161-59972080:+	0.45	3.83	0.000159	Schizophrenia	
COAD	cis	1	rs11185760	chr10:91331304	PANK1	chr10:91342749-91405215:-	0.36	4.14	4.76E-5	Metabolic traits	
COAD	cis	1	rs11185773	chr10:91349331	PANK1	chr10:91342749-91405215:-	0.4	4.76	3.25E-6	Metabolic traits	
COAD	cis	1	rs11185780	chr10:91363624	PANK1	chr10:91342749-91405215:-	-0.41	-4.72	3.85E-6	Metabolic traits	
COAD	cis	1	rs11185790	chr10:91372533	PANK1	chr10:91342749-91405215:-	-0.33	-4.12	5.07E-5	Metabolic traits	
COAD	cis	1	rs111882043	chr14:59899356	C14orf149	chr14:59939406-59951126:-	-0.48	-4.17	4.15E-5	Schizophrenia	
COAD	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.18	4.23	3.2E-5	Blood metabolite levels	
COAD	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.18	4.34	2.07E-5	Blood metabolite levels	
COAD	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.18	4.33	2.09E-5	Blood metabolite levels	
COAD	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.17	4.1	5.43E-5	Blood metabolite levels	
COAD	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.17	4.1	5.43E-5	Blood metabolite levels	
COAD	cis	1	rs11188411	chr10:97397344	ENTPD1	chr10:97471536-97637022:+	0.17	4	8.24E-5	Blood metabolite levels	
COAD	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.18	-4.21	3.49E-5	Blood metabolite levels	
COAD	cis	1	rs111899361	chr7:1112348	GPER	chr7:1121844-1133451:+	0.48	4.08	6.09E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs111899361	chr7:1112348	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.67	4.74E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs111901203	chr11:58297542	CNTF	chr11:58390146-58393203:+	0.4	3.87	0.00014	Lymphoma	
COAD	cis	1	rs11190130	chr10:101275206	NKX2-3	chr10:101292690-101296278:+	-0.22	-4.69	4.41E-6	Dental caries	
COAD	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.93	5.52	8.25E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.35	-4.51	9.91E-6	Schizophrenia	
COAD	cis	1	rs111957218	chr19:10839089	RAVER1	chr19:10426891-10444314:-	0.46	4.08	5.94E-5	LDL cholesterol	
COAD	cis	1	rs11201298	chr10:81793751	LOC219347	chr10:81805991-81838949:-	0.64	5.2	4.09E-7	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	0.79	5.91	1.04E-8	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.56	-4.63	5.75E-6	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.66	-5.13	5.69E-7	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs11201991	chr10:88117122	GRID1	chr10:87359312-88126250:-	-0.19	-4.23	3.3E-5	Barrett's esophagus	
COAD	cis	1	rs11209026	chr1:67705958	WDR78	chr1:67278574-67390570:-	0.59	4.13	4.81E-5	Ankylosing spondylitis;Crohn's disease;Inflammatory skin disease;Ulcerative colitis;Psoriasis;Inflammatory bowel disease	
COAD	cis	1	rs11210359	chr1:74339167	LRRIQ3	chr1:74491704-74663871:-	0.31	4.27	2.76E-5	Bipolar disorder and schizophrenia	
COAD	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.63	-9.59	7.52E-19	Homocysteine levels	
COAD	cis	1	rs11211481	chr1:47694167	TAL1	chr1:47681963-47779819:-	0.17	4.03	7.36E-5	Body mass index	
COAD	cis	1	rs112261101	chr14:59917544	C14orf149	chr14:59939406-59951126:-	-0.49	-4.16	4.31E-5	Schizophrenia	
COAD	cis	1	rs112261101	chr14:59917544	JKAMP	chr14:59951161-59972080:+	0.46	3.92	0.000115	Schizophrenia	
COAD	cis	1	rs112293138	chr1:171714002	VAMP4	chr1:171669298-171711214:-	0.38	5.41	1.43E-7	Hippocampal atrophy	
COAD	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.27	4.06	6.62E-5	Height	
COAD	cis	1	rs112476368	chr14:59991452	C14orf149	chr14:59939406-59951126:-	-0.46	-4.15	4.45E-5	Schizophrenia	
COAD	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.41	-5.28	2.73E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs112555934	chr14:59977232	C14orf149	chr14:59939406-59951126:-	-0.49	-4.42	1.46E-5	Schizophrenia	
COAD	cis	1	rs11264203	chr1:36239234	C1orf216	chr1:36179477-36184790:-	-0.42	-5.54	7.33E-8	Schizophrenia	
COAD	cis	1	rs11264211	chr1:36270607	C1orf216	chr1:36179477-36184790:-	-0.4	-5.38	1.63E-7	Schizophrenia	
COAD	cis	1	rs11264213	chr1:36283954	C1orf216	chr1:36179477-36184790:-	-0.4	-5.51	8.49E-8	Schizophrenia	
COAD	cis	1	rs112661971	chr14:59901054	C14orf149	chr14:59939406-59951126:-	-0.48	-4.17	4.15E-5	Schizophrenia	
COAD	cis	1	rs1127489	chr6:170107702	C6orf70	chr6:170151721-170181617:+	0.4	4.56	7.77E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs112819780	chr14:60001564	C14orf149	chr14:59939406-59951126:-	-0.54	-4.42	1.47E-5	Schizophrenia	
COAD	cis	1	rs112819780	chr14:60001564	JKAMP	chr14:59951161-59972080:+	0.51	4.23	3.28E-5	Schizophrenia	
COAD	cis	1	rs112879614	chr14:60001681	C14orf149	chr14:59939406-59951126:-	-0.52	-4.35	1.96E-5	Schizophrenia	
COAD	cis	1	rs112879614	chr14:60001681	JKAMP	chr14:59951161-59972080:+	0.51	4.35	1.92E-5	Schizophrenia	
COAD	cis	1	rs112952088	chr14:60027907	C14orf149	chr14:59939406-59951126:-	-0.54	-4.39	1.67E-5	Schizophrenia	
COAD	cis	1	rs112952088	chr14:60027907	JKAMP	chr14:59951161-59972080:+	0.48	3.95	0.0001	Schizophrenia	
COAD	cis	1	rs113066613	chr7:1094128	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.69	4.42E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs113097743	chr14:60018216	C14orf149	chr14:59939406-59951126:-	-0.54	-4.39	1.67E-5	Schizophrenia	
COAD	cis	1	rs113097743	chr14:60018216	JKAMP	chr14:59951161-59972080:+	0.48	3.95	0.0001	Schizophrenia	
COAD	cis	1	rs113112586	chr14:59969142	C14orf149	chr14:59939406-59951126:-	-0.48	-4.4	1.58E-5	Schizophrenia	
COAD	cis	1	rs113146460	chr7:1105164	GPER	chr7:1121844-1133451:+	0.47	3.99	8.53E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.69	4.43E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs113172694	chr14:59998219	C14orf149	chr14:59939406-59951126:-	-0.5	-4.2	3.72E-5	Schizophrenia	
COAD	cis	1	rs113284747	chr14:59955937	C14orf149	chr14:59939406-59951126:-	-0.51	-4.29	2.51E-5	Schizophrenia	
COAD	cis	1	rs113284747	chr14:59955937	JKAMP	chr14:59951161-59972080:+	0.48	4.06	6.44E-5	Schizophrenia	
COAD	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.45	-5.71	3.01E-8	Esophageal cancer (squamous cell)	
COAD	cis	1	rs113337957	chr14:59967329	C14orf149	chr14:59939406-59951126:-	-0.48	-4.4	1.58E-5	Schizophrenia	
COAD	cis	1	rs1133483	chr4:100023923	ADH4	chr4:100044835-100065449:-	-0.46	-6.71	1.23E-10	HDL cholesterol	
COAD	cis	1	rs113482756	chr14:59948622	C14orf149	chr14:59939406-59951126:-	-0.44	-3.97	9.33E-5	Schizophrenia	
COAD	cis	1	rs113558975	chr14:59998385	C14orf149	chr14:59939406-59951126:-	-0.5	-4.2	3.72E-5	Schizophrenia	
COAD	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.02	7.76E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs113613442	chr14:59972563	C14orf149	chr14:59939406-59951126:-	-0.48	-4.4	1.58E-5	Schizophrenia	
COAD	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.59	8.52	1.31E-15	Height	
COAD	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.29	3.85	0.000146	Height	
COAD	cis	1	rs113858334	chr7:1073476	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs113869004	chr14:59918731	C14orf149	chr14:59939406-59951126:-	-0.49	-4.16	4.31E-5	Schizophrenia	
COAD	cis	1	rs113869004	chr14:59918731	JKAMP	chr14:59951161-59972080:+	0.46	3.92	0.000115	Schizophrenia	
COAD	cis	1	rs113878281	chr14:59917494	C14orf149	chr14:59939406-59951126:-	-0.49	-4.16	4.31E-5	Schizophrenia	
COAD	cis	1	rs113878281	chr14:59917494	JKAMP	chr14:59951161-59972080:+	0.46	3.92	0.000115	Schizophrenia	
COAD	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.37	5.68	3.58E-8	Pancreatic cancer	
COAD	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.52	8.89	1.02E-16	Folate pathway vitamin levels	
COAD	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.39	4.83	2.38E-6	Atopic dermatitis	
COAD	cis	1	rs114562844	chr3:52991584	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.08	4.25E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs114604770	chr8:89587010	MMP16	chr8:89049462-89339717:-	0.17	3.84	0.000154	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs114799538	chr8:10815827	SOX7	chr8:10581279-10697299:-	-0.26	-4.15	4.45E-5	Asthma and hay fever	
COAD	cis	1	rs1148000	chr12:75936301	GLIPR1L2	chr12:75784889-75825591:+	-0.3	-4.08	5.9E-5	Polycystic ovary syndrome	
COAD	cis	1	rs114827034	chr12:91480042	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11513751	chr12:91482180	KERA	chr12:91444273-91452131:-	0.28	4.57	7.47E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11513752	chr12:91482198	KERA	chr12:91444273-91452131:-	0.28	4.57	7.47E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11513822	chr12:91482005	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11513823	chr12:91482359	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs11519665	chr12:91482036	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs115264161	chr8:10815829	SOX7	chr8:10581279-10697299:-	-0.26	-4.21	3.58E-5	Asthma and hay fever	
COAD	cis	1	rs11541642	chr15:40683702	C15orf23	chr15:40674922-40686488:+	0.34	3.84	0.000156	Heschl's gyrus morphology	
COAD	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.72	-12.94	6.48E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs11560576	chr9:117604514	AMBP	chr9:116822410-116840752:-	0.51	4.11	5.31E-5	Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs11577073	chr1:171716724	VAMP4	chr1:171669298-171711214:-	-0.28	-3.9	0.000124	Hippocampal atrophy	
COAD	cis	1	rs11577745	chr1:171720909	VAMP4	chr1:171669298-171711214:-	0.33	4.73	3.65E-6	Hippocampal atrophy	
COAD	cis	1	rs11578699	chr1:171719769	VAMP4	chr1:171669298-171711214:-	0.31	4.25	2.98E-5	Hippocampal atrophy	
COAD	cis	1	rs11580522	chr1:171720978	VAMP4	chr1:171669298-171711214:-	-0.38	-5.41	1.43E-7	Hippocampal atrophy	
COAD	cis	1	rs11583920	chr1:171683611	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.29E-6	Hippocampal atrophy	
COAD	cis	1	rs11590680	chr1:171716574	VAMP4	chr1:171669298-171711214:-	0.3	4.19	3.79E-5	Hippocampal atrophy	
COAD	cis	1	rs11590714	chr1:171716779	VAMP4	chr1:171669298-171711214:-	0.33	4.69	4.45E-6	Hippocampal atrophy	
COAD	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.18	4.28	2.58E-5	Blood metabolite levels	
COAD	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.81	7.54	7.99E-13	Amyotrophic lateral sclerosis	
COAD	cis	1	rs11602622	chr11:78010830	USP35	chr11:77899858-77925753:+	0.28	3.84	0.000157	Testicular germ cell tumor	
COAD	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.4	-5.31	2.38E-7	Subjective well-being	
COAD	cis	1	rs11608788	chr12:122608155	MLXIP	chr12:122516760-122628965:+	0.24	4.92	1.57E-6	Urate levels	
COAD	cis	1	rs11608792	chr12:122608209	MLXIP	chr12:122516760-122628965:+	0.21	4.27	2.76E-5	Urate levels	
COAD	cis	1	rs11609875	chr12:122608502	MLXIP	chr12:122516760-122628965:+	0.24	4.9	1.67E-6	Urate levels	
COAD	cis	1	rs116101630	chr11:506826	PTDSS2	chr11:450280-491386:+	-0.5	-4.86	2.05E-6	Body mass index	
COAD	cis	1	rs116139393	chr7:6771660	PMS2CL	chr7:6749757-6793492:+	-0.34	-4.41	1.49E-5	Alzheimer's disease (APOE e4 interaction)	
COAD	cis	1	rs11622475	chr14:104509076	TDRD9	chr14:104394817-104519002:+	0.34	4.52	9.42E-6	Bipolar disorder	
COAD	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.26	-4.52	9.2E-6	Height	
COAD	cis	1	rs11625697	chr14:104464800	TDRD9	chr14:104394817-104519002:+	0.33	4.95	1.31E-6	Bipolar disorder	
COAD	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.39	6.52	3.54E-10	Common traits (Other)	
COAD	cis	1	rs11632310	chr15:65882326	DENND4A	chr15:65952959-66084631:-	-0.23	-4.36	1.88E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs11636148	chr15:65796880	DENND4A	chr15:65952959-66084631:-	0.21	4.06	6.55E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs11637431	chr15:65882251	DENND4A	chr15:65952959-66084631:-	-0.23	-4.36	1.88E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.32	-4.58	7.36E-6	Schizophrenia	
COAD	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.33	-4.7	4.13E-6	Schizophrenia	
COAD	cis	1	rs11640439	chr16:57303194	PLLP	chr16:57290009-57318571:-	0.35	4.54	8.54E-6	Sleep duration	
COAD	cis	1	rs11641566	chr16:58835180	GOT2	chr16:58741035-58768246:-	-0.33	-5.37	1.7E-7	Blood metabolite ratios	
COAD	cis	1	rs11641836	chr16:58832047	GOT2	chr16:58741035-58768246:-	-0.29	-4.84	2.18E-6	Blood metabolite ratios	
COAD	cis	1	rs11644891	chr16:58833825	GOT2	chr16:58741035-58768246:-	-0.33	-5.37	1.7E-7	Blood metabolite ratios	
COAD	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.44	5.22	3.7E-7	Urinary metabolites	
COAD	cis	1	rs11648514	chr16:58832080	GOT2	chr16:58741035-58768246:-	-0.32	-5.23	3.47E-7	Blood metabolite ratios	
COAD	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.5	8.85	1.34E-16	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.54	-8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.54	8.44	2.15E-15	Eye color traits	
COAD	cis	1	rs1165668	chr12:104317996	C12orf73	chr12:104343981-104359473:-	0.23	3.96	9.53E-5	Coronary heart disease	
COAD	cis	1	rs1165669	chr12:104318172	C12orf73	chr12:104343981-104359473:-	-0.24	-4.08	5.91E-5	Coronary heart disease	
COAD	cis	1	rs1165670	chr12:104318406	C12orf73	chr12:104343981-104359473:-	0.23	3.96	9.53E-5	Coronary heart disease	
COAD	cis	1	rs11657081	chr17:61792339	FTSJ3	chr17:61896795-61905031:-	0.28	4.08	5.98E-5	Body mass index	
COAD	cis	1	rs11657306	chr17:61704822	FTSJ3	chr17:61896795-61905031:-	0.27	3.84	0.000153	Body mass index	
COAD	cis	1	rs11658168	chr17:7406134	CHRNB1	chr17:7348406-7360931:+	0.3	4.09	5.7E-5	Height	
COAD	cis	1	rs11658329	chr17:61763031	FTSJ3	chr17:61896795-61905031:-	-0.3	-4.39	1.65E-5	Body mass index	
COAD	cis	1	rs11660468	chr18:47209143	ACAA2	chr18:47309875-47340283:-	-0.26	-3.88	0.000131	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs116648076	chr2:99882347	REV1	chr2:100016939-100106480:-	0.36	4.73	3.61E-6	IgG glycosylation	
COAD	cis	1	rs11666377	chr19:17118433	ANO8	chr19:17434032-17445638:-	-0.33	-4.01	7.84E-5	Brain lesion load	
COAD	cis	1	rs11666415	chr19:24228512	ZNF254	chr19:24216247-24312652:+	0.33	4.08	6.02E-5	Response to taxane treatment (placlitaxel)	
COAD	cis	1	rs11669253	chr19:10836329	RAVER1	chr19:10426891-10444314:-	0.48	3.97	9.34E-5	LDL cholesterol	
COAD	cis	1	rs11670668	chr19:41920454	B3GNT8	chr19:41931265-41934635:-	-0.33	-5.5	9.23E-8	Height	
COAD	cis	1	rs11670757	chr19:41913431	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.62	6.1E-6	Height	
COAD	cis	1	rs11671653	chr19:10838486	RAVER1	chr19:10426891-10444314:-	-0.48	-4.36	1.88E-5	LDL cholesterol	
COAD	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.42	-8.44	2.15E-15	Body mass index	
COAD	cis	1	rs11681497	chr2:242344333	SEPT2	chr2:242254723-242293439:+	0.56	5.46	1.13E-7	Chronic lymphocytic leukemia	
COAD	cis	1	rs116876680	chr11:517473	PTDSS2	chr11:450280-491386:+	-0.49	-4.69	4.39E-6	Body mass index	
COAD	cis	1	rs11688116	chr2:188149415	CALCRL	chr2:188207851-188313021:-	0.15	4.35	1.96E-5	Coronary heart disease	
COAD	cis	1	rs11688129	chr2:28952581	PPP1CB	chr2:28974612-29025805:+	-0.29	-4.71	4.05E-6	Body mass index	
COAD	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.34	5.42	1.32E-7	Body mass index	
COAD	cis	1	rs11690423	chr2:28951537	PPP1CB	chr2:28974612-29025805:+	-0.28	-4.67	4.83E-6	Body mass index	
COAD	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.34	5.49	9.51E-8	Body mass index	
COAD	cis	1	rs11698834	chr20:23832595	CST2	chr20:23804404-23807312:-	0.29	4.06	6.38E-5	Response to TNF antagonist treatment	
COAD	cis	1	rs11699452	chr20:23837189	CST2	chr20:23804404-23807312:-	-0.27	-3.83	0.000159	Response to TNF antagonist treatment	
COAD	cis	1	rs11699520	chr20:23837634	CST2	chr20:23804404-23807312:-	-0.27	-3.83	0.000159	Response to TNF antagonist treatment	
COAD	cis	1	rs11700	chr16:67232684	LRRC29	chr16:67241043-67260901:-	0.44	5.41	1.41E-7	HDL cholesterol	
COAD	cis	1	rs11701004	chr21:40292102	ETS2	chr21:40177231-40196876:+	0.39	6.07	4.5E-9	Body mass index;Crohn's disease	
COAD	cis	1	rs11701004	chr21:40292102	PSMG1	chr21:40547390-40555440:-	0.24	4.19	3.84E-5	Body mass index;Crohn's disease	
COAD	cis	1	rs11701117	chr21:40292512	ETS2	chr21:40177231-40196876:+	0.38	5.83	1.64E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs11701117	chr21:40292512	PSMG1	chr21:40547390-40555440:-	0.23	3.98	8.84E-5	Body mass index;Crohn's disease	
COAD	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.28	-4.81	2.58E-6	Gut microbiome composition (summer)	
COAD	cis	1	rs11704021	chr22:39074716	CBY1	chr22:39052658-39069853:+	0.4	6.74	9.96E-11	Resting heart rate	
COAD	cis	1	rs11704021	chr22:39074716	JOSD1	chr22:39081549-39096459:-	-0.25	-4.04	7.14E-5	Resting heart rate	
COAD	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.54	-4.37	1.8E-5	Cholesterol, total;LDL cholesterol	
COAD	cis	1	rs11706035	chr3:53011868	SFMBT1	chr3:52938628-53080070:-	-0.62	-5.6	5.44E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.64	9.25	8.63E-18	Height	
COAD	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.34	4.49	1.09E-5	Height	
COAD	cis	1	rs11707780	chr3:53084326	SFMBT1	chr3:52938628-53080070:-	0.51	5.06	7.83E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11707780	chr3:53084326	TMEM110	chr3:52867139-52931547:-	-0.42	-4.27	2.72E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs11710292	chr3:53117798	SFMBT1	chr3:52938628-53080070:-	-0.59	-4.73	3.71E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11710292	chr3:53117798	TMEM110	chr3:52867139-52931547:-	0.48	3.95	0.000101	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11710707	chr3:52975916	SFMBT1	chr3:52938628-53080070:-	-0.63	-5.08	7.11E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11710707	chr3:52975916	TMEM110	chr3:52867139-52931547:-	0.54	4.39	1.68E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.28	-4.68	4.69E-6	Longevity	
COAD	cis	1	rs11712653	chr3:53070875	SFMBT1	chr3:52938628-53080070:-	0.61	5.4	1.53E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11713206	chr3:52999243	SFMBT1	chr3:52938628-53080070:-	-0.7	-5.52	8.05E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11713206	chr3:52999243	TMEM110	chr3:52867139-52931547:-	0.54	4.31	2.31E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11713290	chr3:52971579	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.04	5.29E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11713859	chr3:53042080	SFMBT1	chr3:52938628-53080070:-	-0.6	-4.86	2.07E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11713859	chr3:53042080	TMEM110	chr3:52867139-52931547:-	0.5	4.1	5.53E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.33	5.02	9.52E-7	Cognitive performance	
COAD	cis	1	rs11714876	chr3:53101640	SFMBT1	chr3:52938628-53080070:-	0.6	4.95	1.36E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11714876	chr3:53101640	TMEM110	chr3:52867139-52931547:-	-0.52	-4.38	1.75E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs117173094	chr10:81714191	LOC219347	chr10:81805991-81838949:-	0.7	4.17	4.22E-5	Rheumatoid arthritis	
COAD	cis	1	rs11717619	chr3:53003179	SFMBT1	chr3:52938628-53080070:-	-0.59	-5.69	3.38E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.42	4.01	7.83E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11718538	chr3:52975987	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.04	5.29E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11718834	chr3:52963668	SFMBT1	chr3:52938628-53080070:-	-0.64	-5.76	2.3E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.33	4.93	1.44E-6	Cognitive performance	
COAD	cis	1	rs11719762	chr3:49409002	WDR6	chr3:49044637-49053386:+	-0.35	-5.14	5.47E-7	Menarche (age at onset)	
COAD	cis	1	rs11720191	chr3:53013839	SFMBT1	chr3:52938628-53080070:-	-0.68	-6.15	2.82E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.36	5.34	2.01E-7	Cognitive performance	
COAD	cis	1	rs11723803	chr4:292369	ZNF876P	chr4:206389-249771:+	-0.45	-4.89	1.74E-6	Immune response to smallpox vaccine (IL-6)	
COAD	cis	1	rs11726229	chr4:120211580	FABP2	chr4:120238406-120243316:-	0.39	5.92	1.02E-8	Corneal astigmatism	
COAD	cis	1	rs11726609	chr4:56400869	SRD5A3	chr4:56212409-56237866:+	0.3	4.77	3.07E-6	Personality dimensions	
COAD	cis	1	rs11729657	chr4:1737585	FAM53A	chr4:1641609-1685854:-	-0.36	-5.23	3.55E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs11732213	chr4:1704244	FAM53A	chr4:1641609-1685854:-	0.43	5.6	5.37E-8	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs11733864	chr4:56321530	SRD5A3	chr4:56212409-56237866:+	0.27	4.66	5.04E-6	Personality dimensions	
COAD	cis	1	rs117339389	chr11:505025	PTDSS2	chr11:450280-491386:+	-0.5	-4.78	2.99E-6	Body mass index	
COAD	cis	1	rs11735092	chr4:88226231	MAPK10	chr4:86937633-87515263:-	0.18	4.29	2.5E-5	Platelet count	
COAD	cis	1	rs11737950	chr5:156436211	HAVCR1	chr5:156456531-156486130:-	-0.35	-4.4	1.61E-5	Hypertriglyceridemia	
COAD	cis	1	rs11737950	chr5:156436211	TIMD4	chr5:156346293-156390266:-	-0.32	-4.31	2.36E-5	Hypertriglyceridemia	
COAD	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.99	12.91	7.95E-30	Type 2 diabetes	
COAD	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.52	7.2	6.42E-12	Crohn's disease	
COAD	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.46	6.55	2.99E-10	Crohn's disease	
COAD	cis	1	rs11740496	chr5:156435402	HAVCR1	chr5:156456531-156486130:-	0.38	4.74	3.59E-6	Hypertriglyceridemia	
COAD	cis	1	rs11740496	chr5:156435402	TIMD4	chr5:156346293-156390266:-	0.35	4.62	5.96E-6	Hypertriglyceridemia	
COAD	cis	1	rs11740499	chr5:156431741	HAVCR1	chr5:156456531-156486130:-	-0.37	-4.67	4.88E-6	Hypertriglyceridemia	
COAD	cis	1	rs11740499	chr5:156431741	TIMD4	chr5:156346293-156390266:-	-0.34	-4.53	9.13E-6	Hypertriglyceridemia	
COAD	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.49	-5.86	1.42E-8	Crohn's disease	
COAD	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.4	4.83	2.36E-6	Crohn's disease	
COAD	cis	1	rs11746128	chr5:156421250	HAVCR1	chr5:156456531-156486130:-	-0.28	-3.87	0.000139	Hypertriglyceridemia	
COAD	cis	1	rs11746560	chr5:150185925	LOC134466	chr5:150310000-150326146:-	0.49	5.88	1.22E-8	Crohn's disease	
COAD	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.45	6.35	9.28E-10	Crohn's disease	
COAD	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.46	6.52	3.55E-10	Crohn's disease	
COAD	cis	1	rs11748553	chr5:150184553	LOC134466	chr5:150310000-150326146:-	0.49	5.88	1.22E-8	Crohn's disease	
COAD	cis	1	rs11752297	chr6:33735154	HLA-DOB	chr6:32780541-32784825:-	0.26	4.69	4.39E-6	Crohn's disease	
COAD	cis	1	rs11754744	chr6:26202605	HIST1H2AE	chr6:26217148-26217711:+	-0.43	-4.01	8.07E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs11755210	chr6:26202768	HIST1H2AE	chr6:26217148-26217711:+	-0.43	-4.01	8.07E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs11758152	chr6:42496494	PRPH2	chr6:42664334-42690358:-	0.21	3.93	0.000107	Obesity-related traits	
COAD	cis	1	rs11758351	chr6:26203910	HIST1H2AE	chr6:26217148-26217711:+	-0.45	-4.5	1.0E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.55	-7.27	4.3E-12	Response to antipsychotic treatment	
COAD	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.63	-8.81	1.83E-16	Response to antipsychotic treatment	
COAD	cis	1	rs11761941	chr7:1097183	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.74	3.45E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11763020	chr7:1060288	ZFAND2A	chr7:1192544-1199855:-	-0.39	-4.15	4.59E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11763793	chr7:1094342	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.69	4.42E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11763835	chr7:1094513	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.68	4.72E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.74	3.45E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11767527	chr7:1097394	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.74	3.45E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11768761	chr7:1069807	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.11	5.21E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.33	-4.38	1.74E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs11781040	chr8:96041746	C8orf38	chr8:95908040-96088396:+	-0.29	-4.02	7.63E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.84	-8.27	6.73E-15	Epithelial ovarian cancer;Ovarian cancer	
COAD	cis	1	rs11783935	chr8:10816117	SOX7	chr8:10581279-10697299:-	-0.26	-4.21	3.58E-5	Asthma and hay fever	
COAD	cis	1	rs11786878	chr8:96033292	C8orf38	chr8:95908040-96088396:+	-0.31	-3.92	0.000114	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.64	-10.01	3.7E-20	Response to antipsychotic treatment	
COAD	cis	1	rs11801846	chr1:171674241	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.27E-6	Hippocampal atrophy	
COAD	cis	1	rs11803174	chr1:171674338	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.27E-6	Hippocampal atrophy	
COAD	cis	1	rs118059236	chr7:1073202	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	0.77	6.25	1.7E-9	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs11845639	chr14:75570293	MLH3	chr14:75480467-75518235:-	0.25	4.26	2.81E-5	Height	
COAD	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.52	-5.37	1.78E-7	Tumor biomarkers	
COAD	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.43	-5.46	1.12E-7	Tumor biomarkers	
COAD	cis	1	rs11861787	chr16:8517745	ABAT	chr16:8768444-8878431:+	-0.23	-3.84	0.000153	Epilepsy (remission after treatment)	
COAD	cis	1	rs11865847	chr16:8518052	ABAT	chr16:8768444-8878431:+	-0.23	-3.82	0.000166	Epilepsy (remission after treatment)	
COAD	cis	1	rs11869069	chr17:40287101	DHX58	chr17:40253422-40264751:-	-0.32	-4.9	1.71E-6	Fibrinogen levels	
COAD	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.53	-9.49	1.53E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs11874381	chr18:47203408	ACAA2	chr18:47309875-47340283:-	-0.26	-3.91	0.00012	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs1187446	chr14:104409896	TDRD9	chr14:104394817-104519002:+	0.34	5.1	6.51E-7	Bipolar disorder	
COAD	cis	1	rs1187448	chr14:104406627	TDRD9	chr14:104394817-104519002:+	0.35	5.51	8.55E-8	Bipolar disorder	
COAD	cis	1	rs11875097	chr18:47214838	ACAA2	chr18:47309875-47340283:-	-0.29	-4.62	6.14E-6	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs11880539	chr19:41918949	B3GNT8	chr19:41931265-41934635:-	0.25	4.01	7.85E-5	Height	
COAD	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.61	9.3	5.92E-18	Schizophrenia	
COAD	cis	1	rs11883104	chr19:41923799	B3GNT8	chr19:41931265-41934635:-	-0.33	-5.37	1.72E-7	Height	
COAD	cis	1	rs11887056	chr2:99243861	UNC50	chr2:99225042-99234975:+	-0.34	-4.21	3.51E-5	Bipolar disorder	
COAD	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.29	4.18	4.03E-5	Urinary metabolites	
COAD	cis	1	rs11893500	chr2:70154187	GMCL1	chr2:70056818-70106727:+	0.21	3.95	0.000101	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.73	-6.21	2.06E-9	Plasma clusterin levels	
COAD	cis	1	rs11899408	chr2:243014630	THAP4	chr2:242523821-242576655:-	0.31	4.23	3.19E-5	Obesity-related traits	
COAD	cis	1	rs11901272	chr2:73720444	ALMS1	chr2:73612886-73837046:+	0.24	3.96	9.82E-5	Metabolite levels	
COAD	cis	1	rs11902198	chr2:70144596	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs11905354	chr20:33677164	EDEM2	chr20:33703160-33865928:-	0.35	4.09	5.75E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs11907438	chr20:33641220	EDEM2	chr20:33703160-33865928:-	0.33	3.84	0.000156	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs11907438	chr20:33641220	PROCR	chr20:33758727-33765164:+	-0.38	-3.85	0.000146	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs11907594	chr20:33673843	EDEM2	chr20:33703160-33865928:-	0.34	4.01	8.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.98	5.36E-17	Height	
COAD	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.34	-4.5	1.02E-5	Height	
COAD	cis	1	rs11920570	chr3:122090102	WDR5B	chr3:122130700-122134882:-	0.26	4.09	5.78E-5	Resting heart rate	
COAD	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.63	8.97	5.98E-17	Diastolic blood pressure	
COAD	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs11928090	chr3:49604904	WDR6	chr3:49044637-49053386:+	-0.36	-5.37	1.74E-7	Menarche (age at onset)	
COAD	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.04	3.75E-17	Height	
COAD	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.35	-4.54	8.6E-6	Height	
COAD	cis	1	rs11931061	chr4:56338793	SRD5A3	chr4:56212409-56237866:+	0.28	4.92	1.51E-6	Personality dimensions	
COAD	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.29	-4.34	2.01E-5	Crohn's disease	
COAD	cis	1	rs11961560	chr6:170130121	C6orf70	chr6:170151721-170181617:+	0.38	4.46	1.21E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.56	7.84E-6	Obesity-related traits	
COAD	cis	1	rs11975942	chr7:143740580	OR2A7	chr7:143955790-143974852:-	0.3	3.9	0.000121	Obesity-related traits	
COAD	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.92	14.39	5.89E-35	Educational attainment (years of education)	
COAD	cis	1	rs11988157	chr8:124194740	FAM83A	chr8:124191287-124222317:+	0.52	5.09	6.8E-7	Urinary uromodulin levels	
COAD	cis	1	rs1199095	chr10:59950760	IPMK	chr10:59955618-60027694:-	0.24	4.11	5.32E-5	Inflammatory bowel disease	
COAD	cis	1	rs1199099	chr10:59948335	IPMK	chr10:59955618-60027694:-	0.24	4.08	5.9E-5	Inflammatory bowel disease	
COAD	cis	1	rs1199100	chr10:59948044	IPMK	chr10:59955618-60027694:-	0.24	4.08	5.9E-5	Inflammatory bowel disease	
COAD	cis	1	rs1199101	chr10:59947901	IPMK	chr10:59955618-60027694:-	0.24	4.08	5.99E-5	Inflammatory bowel disease	
COAD	cis	1	rs1199103	chr10:59947231	IPMK	chr10:59955618-60027694:-	-0.23	-3.85	0.00015	Inflammatory bowel disease	
COAD	cis	1	rs1199104	chr10:59946781	IPMK	chr10:59955618-60027694:-	0.25	4.16	4.32E-5	Inflammatory bowel disease	
COAD	cis	1	rs1199107	chr10:59943709	IPMK	chr10:59955618-60027694:-	0.25	4.25	3.04E-5	Inflammatory bowel disease	
COAD	cis	1	rs1199108	chr10:59942324	IPMK	chr10:59955618-60027694:-	0.25	4.23	3.29E-5	Inflammatory bowel disease	
COAD	cis	1	rs11995572	chr8:89592083	MMP16	chr8:89049462-89339717:-	0.17	4.05	6.74E-5	Schizophrenia	
COAD	cis	1	rs12029926	chr1:183640149	APOBEC4	chr1:183615418-183622448:-	0.56	3.88	0.00013	Systemic lupus erythematosus	
COAD	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.56	5.87	1.34E-8	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.56	5.87	1.34E-8	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs12036501	chr1:202336996	PPP1R12B	chr1:202317836-202557697:+	0.2	3.89	0.000129	Sex ratio	
COAD	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.56	5.99	6.85E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs12042669	chr1:202453928	PPP1R12B	chr1:202317836-202557697:+	0.2	3.81	0.00017	Sex ratio	
COAD	cis	1	rs12051145	chr16:67239676	LRRC29	chr16:67241043-67260901:-	-0.44	-5.43	1.28E-7	HDL cholesterol	
COAD	cis	1	rs12051247	chr16:67241282	LRRC29	chr16:67241043-67260901:-	-0.45	-5.46	1.11E-7	HDL cholesterol	
COAD	cis	1	rs12051249	chr16:67241427	LRRC29	chr16:67241043-67260901:-	-0.44	-5.8	1.89E-8	HDL cholesterol	
COAD	cis	1	rs12053519	chr2:99875018	REV1	chr2:100016939-100106480:-	0.32	4.36	1.88E-5	IgG glycosylation	
COAD	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.26	3.87	0.000135	Crohn's disease	
COAD	cis	1	rs12083902	chr1:36275112	C1orf216	chr1:36179477-36184790:-	-0.4	-5.42	1.34E-7	Schizophrenia	
COAD	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.89	-7	2.12E-11	Coronary heart disease	
COAD	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.56	6.13	3.26E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.55	5.69	3.33E-8	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs12128536	chr1:171674607	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.29E-6	Hippocampal atrophy	
COAD	cis	1	rs12130075	chr1:247218491	ZNF670	chr1:247200087-247242069:-	-0.32	-3.94	0.000104	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.41	6.88	4.54E-11	Inflammatory skin disease	
COAD	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.57	6.1	3.73E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs12132221	chr1:171685694	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.29E-6	Hippocampal atrophy	
COAD	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.53	5.94	9.29E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs12145310	chr1:20901064	CDA	chr1:20915444-20945398:+	-0.28	-4.11	5.27E-5	Age-related hearing impairment (interaction)	
COAD	cis	1	rs12145351	chr1:20901181	CDA	chr1:20915444-20945398:+	-0.28	-4.1	5.51E-5	Age-related hearing impairment (interaction)	
COAD	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.58	-8.44	2.23E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12155623	chr8:49812201	EFCAB1	chr8:49623351-49647870:-	0.27	4.02	7.57E-5	Sudden cardiac arrest	
COAD	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.35	4.41	1.54E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.61	-8.72	3.29E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.61	-8.71	3.52E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12192208	chr6:124693764	NKAIN2	chr6:124125069-125146784:+	0.48	6.16	2.79E-9	Neuroticism	
COAD	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.63	-8.78	2.27E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.61	-8.25	7.8E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.62	-8.33	4.59E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.54	9.54	1.09E-18	Folate pathway vitamin levels	
COAD	cis	1	rs12197114	chr6:109735498	AKD1	chr6:109814059-110012415:-	-0.3	-5.1	6.52E-7	Height	
COAD	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.38	6.12	3.4E-9	Height	
COAD	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.63	-9.28	7.01E-18	Response to antipsychotic treatment	
COAD	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.61	-9.18	1.4E-17	Response to antipsychotic treatment	
COAD	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.62	-8.8	1.87E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.63	-8.81	1.83E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.59	-8.55	1.09E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.57	-8.46	1.99E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.58	-8.44	2.23E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.53	9.22	1.06E-17	Folate pathway vitamin levels	
COAD	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.62	-8.66	4.84E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.62	-8.66	4.84E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.63	-9.74	2.5E-19	Response to antipsychotic treatment	
COAD	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.58	-8.38	3.3E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12204812	chr6:124681503	NKAIN2	chr6:124125069-125146784:+	0.47	6.37	8.73E-10	Neuroticism	
COAD	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.62	-8.65	5.35E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.63	-8.49	1.55E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.61	-9.18	1.4E-17	Response to antipsychotic treatment	
COAD	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.57	-8.5	1.49E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.62	-8.8	1.87E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.62	-8.65	5.35E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.62	-8.72	3.26E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.62	-8.8	1.87E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.57	-8.5	1.49E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.62	-8.41	2.72E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.58	-8.53	1.24E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.63	-8.89	1.03E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.62	-8.72	3.26E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12218540	chr10:81736361	LOC219347	chr10:81805991-81838949:-	0.67	4.13	4.85E-5	Rheumatoid arthritis	
COAD	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.65	-5.52	8.2E-8	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs12237931	chr9:117607618	AMBP	chr9:116822410-116840752:-	0.52	4.27	2.72E-5	Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs12260159	chr10:100702737	HPSE2	chr10:100218877-100995619:-	0.29	3.88	0.000132	Migraine	
COAD	cis	1	rs12286198	chr11:30503194	MPPED2	chr11:30406040-30607930:-	0.26	4.35	1.99E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs12286337	chr11:30503297	MPPED2	chr11:30406040-30607930:-	0.26	4.35	1.99E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.39	5.96	8.08E-9	Pancreatic cancer	
COAD	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.35	-5.01	9.98E-7	Educational attainment;Height;Head circumference (infant)	
COAD	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.41	-4.37	1.81E-5	Colorectal cancer	
COAD	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.39	-4.17	4.14E-5	Colorectal cancer	
COAD	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.34	4.34	2.08E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs12329875	chr21:30137796	N6AMT1	chr21:30244513-30257693:-	-0.42	-5.07	7.44E-7	Cognitive test performance	
COAD	cis	1	rs12333080	chr6:118845410	C6orf204	chr6:118786239-119031238:-	-0.28	-4.78	2.89E-6	Renal cell carcinoma	
COAD	cis	1	rs12358144	chr10:88114486	GRID1	chr10:87359312-88126250:-	-0.19	-4.21	3.5E-5	Barrett's esophagus	
COAD	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.43	-5.89	1.18E-8	Subjective well-being	
COAD	cis	1	rs12366611	chr12:122607487	MLXIP	chr12:122516760-122628965:+	0.24	4.92	1.57E-6	Urate levels	
COAD	cis	1	rs12372754	chr12:91481578	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs12414891	chr10:81690385	PLAC9	chr10:81892258-81904784:+	-0.38	-5.01	1.01E-6	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.52	-6.3	1.27E-9	Arsenic metabolism	
COAD	cis	1	rs12417570	chr11:462684	PTDSS2	chr11:450280-491386:+	-0.49	-4.48	1.12E-5	Body mass index	
COAD	cis	1	rs12418639	chr11:473300	PTDSS2	chr11:450280-491386:+	0.48	4.74	3.49E-6	Body mass index	
COAD	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.22	3.61E-7	Subjective well-being	
COAD	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.42	5.9	1.13E-8	Subjective well-being	
COAD	cis	1	rs12419716	chr11:503385	PTDSS2	chr11:450280-491386:+	-0.5	-4.78	2.99E-6	Body mass index	
COAD	cis	1	rs12419766	chr11:503710	PTDSS2	chr11:450280-491386:+	-0.5	-4.78	2.99E-6	Body mass index	
COAD	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs12421457	chr11:505780	PTDSS2	chr11:450280-491386:+	-0.5	-4.78	2.99E-6	Body mass index	
COAD	cis	1	rs12422267	chr12:132601596	EP400NL	chr12:132568828-132600084:+;chr12	-0.49	-4.09	5.72E-5	Plasma amyloid beta peptide concentrations (ABx-40)	
COAD	cis	1	rs12425790	chr12:121452504	OASL	chr12:121458095-121476780:-	0.3	4.05	6.65E-5	Type 2 diabetes	
COAD	cis	1	rs12435391	chr14:75601737	MLH3	chr14:75480467-75518235:-	0.24	4.03	7.38E-5	Height	
COAD	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.58	-5.83	1.59E-8	Tumor biomarkers	
COAD	cis	1	rs12443102	chr15:43932103	CATSPER2	chr15:43922774-43959900:-	-0.33	-3.97	9.24E-5	Tumor biomarkers	
COAD	cis	1	rs12443102	chr15:43932103	LCMT2	chr15:43619976-43622891:-	-0.39	-4	8.34E-5	Tumor biomarkers	
COAD	cis	1	rs12447804	chr16:58075282	MMP15	chr16:58059282-58080802:+	0.31	3.99	8.73E-5	Pulmonary function;Pulmonary function (interaction)	
COAD	cis	1	rs12460161	chr19:44293986	LYPD5	chr19:44300080-44324808:-	-0.25	-3.89	0.000129	Breast cancer	
COAD	cis	1	rs12470450	chr2:232113888	ARMC9	chr2:232063342-232238606:+	0.28	4.41	1.51E-5	Food antigen IgG levels	
COAD	cis	1	rs12472278	chr2:108873433	SULT1C3	chr2:108863651-108881806:+	-0.43	-6.13	3.17E-9	Blood pressure	
COAD	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.79	-6.9	3.93E-11	Plasma clusterin levels	
COAD	cis	1	rs12475412	chr2:70167197	GMCL1	chr2:70056818-70106727:+	0.24	4.5	1.03E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs12477202	chr2:108867112	SULT1C3	chr2:108863651-108881806:+	0.45	6.24	1.71E-9	Blood pressure	
COAD	cis	1	rs12478744	chr2:23947589	C2orf84	chr2:24397531-24414566:+	-0.28	-4.46	1.24E-5	Obesity-related traits	
COAD	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs12488768	chr3:53086234	SFMBT1	chr3:52938628-53080070:-	0.32	5.01	1.01E-6	Ulcerative colitis	
COAD	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.59	8.85	1.35E-16	Height	
COAD	cis	1	rs12506395	chr4:120185094	FABP2	chr4:120238406-120243316:-	0.37	5.54	7.52E-8	Corneal astigmatism	
COAD	cis	1	rs12515328	chr5:39019550	OSMR	chr5:38846128-38934402:+	-0.12	-4	8.42E-5	Obesity-related traits	
COAD	cis	1	rs12515585	chr5:156430150	HAVCR1	chr5:156456531-156486130:-	-0.35	-4.36	1.88E-5	Hypertriglyceridemia	
COAD	cis	1	rs12515585	chr5:156430150	TIMD4	chr5:156346293-156390266:-	-0.35	-4.56	8.03E-6	Hypertriglyceridemia	
COAD	cis	1	rs12524768	chr6:33760478	LEMD2	chr6:33738991-33756906:-	0.23	3.91	0.000115	Body mass index	
COAD	cis	1	rs1253099	chr14:59946830	C14orf149	chr14:59939406-59951126:-	-0.36	-4.11	5.37E-5	Schizophrenia	
COAD	cis	1	rs1253102	chr14:59947861	C14orf149	chr14:59939406-59951126:-	-0.36	-4.11	5.37E-5	Schizophrenia	
COAD	cis	1	rs1253107	chr14:59952947	C14orf149	chr14:59939406-59951126:-	-0.4	-4.19	3.8E-5	Schizophrenia	
COAD	cis	1	rs12545109	chr8:57313906	PENK	chr8:57353513-57359282:-	-0.26	-4.67	4.93E-6	Obesity-related traits	
COAD	cis	1	rs12545771	chr8:8567977	FLJ10661	chr8:8086092-8102386:+	0.4	4.5	1.03E-5	Obesity-related traits	
COAD	cis	1	rs12547721	chr8:8570671	FLJ10661	chr8:8086092-8102386:+	0.36	4.21	3.58E-5	Obesity-related traits	
COAD	cis	1	rs12550458	chr8:8567832	FLJ10661	chr8:8086092-8102386:+	0.4	4.5	1.03E-5	Obesity-related traits	
COAD	cis	1	rs12550762	chr8:8576535	FLJ10661	chr8:8086092-8102386:+	0.34	3.93	0.000107	Obesity-related traits	
COAD	cis	1	rs12567136	chr1:11883731	CLCN6	chr1:11866207-11907674:+	-0.26	-4.14	4.78E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs12570188	chr10:100855702	COX15	chr10:101468507-101492423:-	-0.56	-3.82	0.000168	Asthma (childhood onset)	
COAD	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.54	-8.35	3.97E-15	Forced vital capacity	
COAD	cis	1	rs12583	chr3:49571462	WDR6	chr3:49044637-49053386:+	0.3	4.15	4.45E-5	Menarche (age at onset)	
COAD	cis	1	rs12587007	chr14:97098734	BDKRB1	chr14:96722559-96735303:+	-0.37	-3.87	0.000136	Tanning	
COAD	cis	1	rs12588240	chr14:75612083	MLH3	chr14:75480467-75518235:-	0.28	4.8	2.67E-6	Height	
COAD	cis	1	rs12589376	chr14:75561152	MLH3	chr14:75480467-75518235:-	0.25	4.31	2.28E-5	Height	
COAD	cis	1	rs12589815	chr14:75544101	MLH3	chr14:75480467-75518235:-	0.26	4.44	1.33E-5	Height	
COAD	cis	1	rs12589876	chr14:75544189	MLH3	chr14:75480467-75518235:-	0.24	4.05	6.69E-5	Height	
COAD	cis	1	rs12590452	chr14:75548756	MLH3	chr14:75480467-75518235:-	0.27	4.73	3.76E-6	Height	
COAD	cis	1	rs12594061	chr15:66046429	DENND4A	chr15:65952959-66084631:-	-0.2	-3.91	0.000117	Mean corpuscular hemoglobin	
COAD	cis	1	rs12599931	chr16:58826531	GOT2	chr16:58741035-58768246:-	-0.29	-4.85	2.11E-6	Blood metabolite ratios	
COAD	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.27	3.86	0.00014	Coffee consumption (cups per day)	
COAD	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.29	4.02	7.51E-5	Coffee consumption (cups per day)	
COAD	cis	1	rs12603327	chr17:40290552	DHX58	chr17:40253422-40264751:-	-0.31	-4.75	3.32E-6	Fibrinogen levels	
COAD	cis	1	rs12603330	chr17:40290589	DHX58	chr17:40253422-40264751:-	-0.31	-4.75	3.32E-6	Fibrinogen levels	
COAD	cis	1	rs12613947	chr2:70161342	GMCL1	chr2:70056818-70106727:+	0.22	4.27	2.71E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs12616140	chr2:108867728	SULT1C3	chr2:108863651-108881806:+	0.44	6.2	2.25E-9	Blood pressure	
COAD	cis	1	rs12617717	chr2:86342303	LOC90784	chr2:86247339-86250991:-	-0.7	-5.47	1.04E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs12617717	chr2:86342303	MAT2A	chr2:85766288-85772401:+	-0.54	-4.03	7.28E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs12618769	chr2:99239931	UNC50	chr2:99225042-99234975:+	0.33	4.23	3.27E-5	Bipolar disorder	
COAD	cis	1	rs12620810	chr2:86391481	LOC90784	chr2:86247339-86250991:-	-0.69	-5.63	4.66E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs12621280	chr2:232132984	ARMC9	chr2:232063342-232238606:+	0.39	5.87	1.3E-8	Food antigen IgG levels	
COAD	cis	1	rs12621280	chr2:232132984	C2orf72	chr2:231902281-231914425:+	0.28	3.87	0.000139	Food antigen IgG levels	
COAD	cis	1	rs12621567	chr2:232118813	ARMC9	chr2:232063342-232238606:+	0.3	4.7	4.2E-6	Food antigen IgG levels	
COAD	cis	1	rs12623494	chr2:99245917	UNC50	chr2:99225042-99234975:+	-0.34	-4.23	3.3E-5	Bipolar disorder	
COAD	cis	1	rs12636133	chr3:113839724	QTRTD1	chr3:113775611-113807266:+	0.21	3.85	0.000151	Personality dimensions	
COAD	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.66	9.57	8.72E-19	Diastolic blood pressure	
COAD	cis	1	rs12643926	chr4:56310621	SRD5A3	chr4:56212409-56237866:+	0.27	4.65	5.32E-6	Personality dimensions	
COAD	cis	1	rs12646078	chr4:56368204	SRD5A3	chr4:56212409-56237866:+	0.25	4.1	5.47E-5	Personality dimensions	
COAD	cis	1	rs12651840	chr5:90729592	LOC100129716	chr5:90676164-90716531:+	0.35	4.21	3.53E-5	Smoking behavior	
COAD	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.27	3.84	0.000157	Crohn's disease	
COAD	cis	1	rs12655973	chr5:90736537	LOC100129716	chr5:90676164-90716531:+	0.35	4.28	2.64E-5	Smoking behavior	
COAD	cis	1	rs12656350	chr5:90751343	LOC100129716	chr5:90676164-90716531:+	0.32	3.83	0.000162	Smoking behavior	
COAD	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.33	4.37	1.78E-5	Crohn's disease	
COAD	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.46	6.55	2.99E-10	Crohn's disease	
COAD	cis	1	rs12658259	chr5:81173250	ATP6AP1L	chr5:81575281-81614146:+	-0.33	-3.91	0.000119	Cognitive function	
COAD	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.53	7.14	9.0E-12	Crohn's disease	
COAD	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.62	-8.43	2.35E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.58	-8.38	3.3E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.57	8.27	6.76E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.61	8.69	4.1E-16	Response to antipsychotic treatment	
COAD	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.63	-8.49	1.55E-15	Response to antipsychotic treatment	
COAD	cis	1	rs12675542	chr8:29986454	MBOAT4	chr8:29989188-30002200:-	-0.36	-4.02	7.54E-5	Migraine	
COAD	cis	1	rs12708980	chr16:57012379	GPR97	chr16:57702157-57723288:+	0.21	3.83	0.000159	HDL cholesterol	
COAD	cis	1	rs12709013	chr16:58829790	GOT2	chr16:58741035-58768246:-	0.28	4.8	2.7E-6	Blood metabolite ratios	
COAD	cis	1	rs12709364	chr17:37933823	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs12709812	chr19:37794850	ZFP30	chr19:38123389-38146368:-	0.3	3.95	0.000102	Coronary artery calcification	
COAD	cis	1	rs12710437	chr21:37808771	CLDN14	chr21:37832920-37948867:-	-0.4	-4.83	2.36E-6	Myopia (pathological)	
COAD	cis	1	rs1273153	chr14:59946459	C14orf149	chr14:59939406-59951126:-	0.38	4.52	9.3E-6	Schizophrenia	
COAD	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.4	6.83	6.03E-11	Inflammatory skin disease	
COAD	cis	1	rs12744221	chr1:145645606	NUDT17	chr1:145586494-145590461:-	0.3	4.15	4.43E-5	Epilepsy (remission after treatment)	
COAD	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.33	-4.48	1.14E-5	Polycystic ovary syndrome	
COAD	cis	1	rs1275469	chr12:75935230	GLIPR1L2	chr12:75784889-75825591:+	-0.3	-4.03	7.34E-5	Polycystic ovary syndrome	
COAD	cis	1	rs12760759	chr1:27158344	PIGV	chr1:27114455-27124886:+	0.49	4.27	2.78E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
COAD	cis	1	rs12774378	chr10:91331621	PANK1	chr10:91342749-91405215:-	0.37	4.28	2.67E-5	Metabolic traits	
COAD	cis	1	rs12777097	chr10:88115638	GRID1	chr10:87359312-88126250:-	-0.19	-4.21	3.5E-5	Barrett's esophagus	
COAD	cis	1	rs12777243	chr10:91336117	PANK1	chr10:91342749-91405215:-	0.4	4.71	3.96E-6	Metabolic traits	
COAD	cis	1	rs1278493	chr3:135814009	PCCB	chr3:135969167-136056737:+	-0.27	-4.6	6.46E-6	Gestational age at birth (child effect)	
COAD	cis	1	rs12786555	chr11:506229	PTDSS2	chr11:450280-491386:+	-0.5	-4.78	2.99E-6	Body mass index	
COAD	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.22	3.61E-7	Subjective well-being	
COAD	cis	1	rs12787909	chr11:117546482	ATP5L	chr11:118272104-118280561:+	0.47	4.62	6.08E-6	Lipoprotein (a) - cholesterol levels	
COAD	cis	1	rs12788729	chr11:502371	PTDSS2	chr11:450280-491386:+	-0.5	-4.78	2.99E-6	Body mass index	
COAD	cis	1	rs12794284	chr11:477623	PTDSS2	chr11:450280-491386:+	-0.47	-4.67	4.85E-6	Body mass index	
COAD	cis	1	rs1279831	chr3:135933264	PCCB	chr3:135969167-136056737:+	0.27	4.82	2.41E-6	Gestational age at birth (child effect)	
COAD	cis	1	rs12800378	chr11:87865942	RAB38	chr11:87846431-87908599:-	0.39	4.94	1.38E-6	Frontotemporal dementia	
COAD	cis	1	rs12801148	chr11:511707	PTDSS2	chr11:450280-491386:+	-0.49	-4.71	4.1E-6	Body mass index	
COAD	cis	1	rs12801271	chr11:508720	PTDSS2	chr11:450280-491386:+	-0.49	-4.71	4.1E-6	Body mass index	
COAD	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.3	4.36	1.85E-5	IgG glycosylation	
COAD	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.3	-4.42	1.43E-5	IgG glycosylation	
COAD	cis	1	rs12879542	chr14:75507525	MLH3	chr14:75480467-75518235:-	0.25	4.31	2.29E-5	Height	
COAD	cis	1	rs12881735	chr14:92932828	CPSF2	chr14:92588329-92630543:+	-0.31	-4.32	2.21E-5	Alzheimer's disease in APOE e4- carriers;Alzheimer's disease (late onset)	
COAD	cis	1	rs12889168	chr14:104481957	TDRD9	chr14:104394817-104519002:+	0.35	5.25	3.14E-7	Bipolar disorder	
COAD	cis	1	rs12889309	chr14:75593902	MLH3	chr14:75480467-75518235:-	0.28	4.74	3.47E-6	Height	
COAD	cis	1	rs12889472	chr14:75543979	MLH3	chr14:75480467-75518235:-	0.25	4.22	3.42E-5	Height	
COAD	cis	1	rs12897094	chr14:75579416	MLH3	chr14:75480467-75518235:-	0.25	4.19	3.88E-5	Height	
COAD	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.35	4.56	8.03E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.35	4.56	8.03E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.32	-4.48	1.13E-5	Schizophrenia	
COAD	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.35	4.56	8.03E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.32	-4.48	1.13E-5	Schizophrenia	
COAD	cis	1	rs12906196	chr15:65884888	DENND4A	chr15:65952959-66084631:-	-0.23	-4.34	2.04E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.35	4.35	1.93E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.31	-4.32	2.2E-5	Schizophrenia	
COAD	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.32	-4.62	5.92E-6	Schizophrenia	
COAD	cis	1	rs12924215	chr16:58071092	MMP15	chr16:58059282-58080802:+	0.31	4.15	4.59E-5	Pulmonary function;Pulmonary function (interaction)	
COAD	cis	1	rs12926993	chr16:58823122	GOT2	chr16:58741035-58768246:-	-0.31	-5.07	7.5E-7	Blood metabolite ratios	
COAD	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.52	7.91	7.18E-14	Eye color traits	
COAD	cis	1	rs12952146	chr17:37970903	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs12968867	chr18:60850310	TNFRSF11A	chr18:59992548-60053502:+	0.23	3.98	8.98E-5	Cardiac Troponin-T levels	
COAD	cis	1	rs12969657	chr18:67536496	CD226	chr18:67530195-67624232:-	0.15	4.07	6.14E-5	Type 1 diabetes;Type 1 diabetes autoantibodies	
COAD	cis	1	rs12999430	chr2:70306785	FAM136A	chr2:70523109-70529220:-	-0.32	-4.17	4.12E-5	Obesity-related traits	
COAD	cis	1	rs13000817	chr2:70273707	FAM136A	chr2:70523109-70529220:-	-0.32	-4.18	3.93E-5	Obesity-related traits	
COAD	cis	1	rs13003464	chr2:61186829	AHSA2	chr2:61404553-61414058:+	-0.15	-3.91	0.000115	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.28	5.43	1.27E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs13008738	chr2:61078921	C2orf74	chr2:61372243-61391964:+	0.28	4.44	1.32E-5	Inflammatory skin disease	
COAD	cis	1	rs13013355	chr2:188177314	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs13014235	chr2:202215492	PPIL3	chr2:201735680-201753999:-	-0.24	-3.87	0.00014	Basal cell carcinoma	
COAD	cis	1	rs13015457	chr2:70125763	GMCL1	chr2:70056818-70106727:+	0.2	3.87	0.00014	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs13016703	chr2:169155595	STK39	chr2:168810531-169104105:-	-0.38	-4.1	5.44E-5	Parkinson's disease	
COAD	cis	1	rs13031901	chr2:188192019	CALCRL	chr2:188207851-188313021:-	-0.14	-4.31	2.35E-5	Coronary heart disease	
COAD	cis	1	rs13033143	chr2:61161095	C2orf74	chr2:61372243-61391964:+	0.26	4.38	1.76E-5	Inflammatory skin disease	
COAD	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.27	-4.49	1.09E-5	Gut microbiome composition (summer)	
COAD	cis	1	rs13058817	chr3:53024139	SFMBT1	chr3:52938628-53080070:-	-0.57	-4.41	1.51E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13058817	chr3:53024139	TMEM110	chr3:52867139-52931547:-	0.49	3.89	0.000129	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.06	3.12E-17	Height	
COAD	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.35	-4.57	7.7E-6	Height	
COAD	cis	1	rs13059843	chr3:195028183	C3orf21	chr3:194789015-194991895:-	0.35	4.9	1.66E-6	Body mass index	
COAD	cis	1	rs13062518	chr3:195038287	C3orf21	chr3:194789015-194991895:-	0.35	4.88	1.84E-6	Body mass index	
COAD	cis	1	rs13069006	chr3:52973305	SFMBT1	chr3:52938628-53080070:-	-0.63	-5.08	7.11E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13069006	chr3:52973305	TMEM110	chr3:52867139-52931547:-	0.54	4.39	1.68E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.29	-4.96	1.29E-6	Longevity	
COAD	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.85	1.35E-16	Height	
COAD	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.35	-4.52	9.2E-6	Height	
COAD	cis	1	rs13072395	chr3:52980573	SFMBT1	chr3:52938628-53080070:-	-0.7	-5.52	8.05E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.54	4.31	2.31E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13072457	chr3:53102389	SFMBT1	chr3:52938628-53080070:-	-0.6	-4.78	2.87E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13072457	chr3:53102389	TMEM110	chr3:52867139-52931547:-	0.47	3.85	0.000149	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13072818	chr3:53074263	SFMBT1	chr3:52938628-53080070:-	-0.61	-5.33	2.17E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13072826	chr3:195064755	C3orf21	chr3:194789015-194991895:-	0.37	5.05	8.11E-7	Body mass index	
COAD	cis	1	rs13074524	chr3:52974184	SFMBT1	chr3:52938628-53080070:-	-0.61	-5.49	9.68E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13076033	chr3:52898427	SFMBT1	chr3:52938628-53080070:-	-0.71	-5.61	5.09E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13076033	chr3:52898427	TMEM110	chr3:52867139-52931547:-	0.55	4.39	1.63E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.29	-4.93	1.45E-6	Longevity	
COAD	cis	1	rs13078971	chr3:53103645	SFMBT1	chr3:52938628-53080070:-	-0.6	-4.82	2.44E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13078971	chr3:53103645	TMEM110	chr3:52867139-52931547:-	0.49	3.98	8.92E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.97	6.01E-17	Height	
COAD	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.35	-4.56	7.75E-6	Height	
COAD	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.06	3.12E-17	Height	
COAD	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.35	-4.57	7.7E-6	Height	
COAD	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.36	5.34	2.01E-7	Cognitive performance	
COAD	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.34	5.13	5.79E-7	Cognitive performance	
COAD	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs13088281	chr3:53147576	SFMBT1	chr3:52938628-53080070:-	0.53	4.22	3.4E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13088455	chr3:53087482	SFMBT1	chr3:52938628-53080070:-	0.32	5.01	1.01E-6	Ulcerative colitis	
COAD	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.85	1.35E-16	Height	
COAD	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.35	-4.52	9.2E-6	Height	
COAD	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.3	-4.87	1.94E-6	Longevity	
COAD	cis	1	rs13091844	chr3:53010271	SFMBT1	chr3:52938628-53080070:-	-0.62	-5.6	5.44E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13091924	chr3:195051136	C3orf21	chr3:194789015-194991895:-	0.36	5.08	7.23E-7	Body mass index	
COAD	cis	1	rs13092352	chr3:52969697	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.04	5.29E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs13096474	chr3:49443081	WDR6	chr3:49044637-49053386:+	0.33	4.89	1.73E-6	Menarche (age at onset)	
COAD	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.06	3.12E-17	Height	
COAD	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.35	-4.57	7.7E-6	Height	
COAD	cis	1	rs13096715	chr3:195074488	C3orf21	chr3:194789015-194991895:-	0.36	4.95	1.32E-6	Body mass index	
COAD	cis	1	rs13099	chr14:75599155	MLH3	chr14:75480467-75518235:-	-0.3	-5.08	7.28E-7	Height	
COAD	cis	1	rs13102385	chr4:56345255	SRD5A3	chr4:56212409-56237866:+	0.28	4.91	1.59E-6	Personality dimensions	
COAD	cis	1	rs13116504	chr4:120209412	FABP2	chr4:120238406-120243316:-	0.37	5.64	4.34E-8	Corneal astigmatism	
COAD	cis	1	rs13118159	chr4:1365127	TMEM129	chr4:1717680-1723084:-	0.29	3.89	0.000128	Longevity	
COAD	cis	1	rs13121235	chr4:56311947	SRD5A3	chr4:56212409-56237866:+	0.27	4.68	4.58E-6	Personality dimensions	
COAD	cis	1	rs13122400	chr4:39713743	RPL9	chr4:39455747-39460568:-	-0.37	-5.04	8.86E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
COAD	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.34	-4.73	3.7E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs13153099	chr5:156436195	HAVCR1	chr5:156456531-156486130:-	-0.35	-4.4	1.61E-5	Hypertriglyceridemia	
COAD	cis	1	rs13153099	chr5:156436195	TIMD4	chr5:156346293-156390266:-	-0.32	-4.31	2.36E-5	Hypertriglyceridemia	
COAD	cis	1	rs13165709	chr5:38971865	OSMR	chr5:38846128-38934402:+	-0.12	-3.93	0.000109	Obesity-related traits	
COAD	cis	1	rs13168670	chr5:140146899	WDR55	chr5:140044384-140050551:+	-0.33	-5.44	1.21E-7	Schizophrenia	
COAD	cis	1	rs13168867	chr5:38975458	OSMR	chr5:38846128-38934402:+	-0.12	-3.9	0.000123	Obesity-related traits	
COAD	cis	1	rs13169155	chr5:156426663	HAVCR1	chr5:156456531-156486130:-	-0.34	-4.24	3.05E-5	Hypertriglyceridemia	
COAD	cis	1	rs13169155	chr5:156426663	TIMD4	chr5:156346293-156390266:-	-0.33	-4.44	1.35E-5	Hypertriglyceridemia	
COAD	cis	1	rs13169465	chr5:156426916	HAVCR1	chr5:156456531-156486130:-	-0.32	-3.95	0.000101	Hypertriglyceridemia	
COAD	cis	1	rs13169465	chr5:156426916	TIMD4	chr5:156346293-156390266:-	-0.32	-4.21	3.46E-5	Hypertriglyceridemia	
COAD	cis	1	rs13169621	chr5:156426974	HAVCR1	chr5:156456531-156486130:-	-0.33	-3.98	9.03E-5	Hypertriglyceridemia	
COAD	cis	1	rs13169621	chr5:156426974	TIMD4	chr5:156346293-156390266:-	-0.34	-4.31	2.34E-5	Hypertriglyceridemia	
COAD	cis	1	rs13171123	chr5:39060643	OSMR	chr5:38846128-38934402:+	-0.12	-4.12	5.06E-5	Obesity-related traits	
COAD	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.42	-5.79	2.01E-8	Subjective well-being	
COAD	cis	1	rs13177882	chr5:39021493	OSMR	chr5:38846128-38934402:+	-0.12	-3.98	8.77E-5	Obesity-related traits	
COAD	cis	1	rs131801	chr22:50966634	TYMP	chr22:50964184-50968514:-	0.15	4.33	2.1E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs13181803	chr5:156429177	HAVCR1	chr5:156456531-156486130:-	-0.34	-4.17	4.13E-5	Hypertriglyceridemia	
COAD	cis	1	rs13181803	chr5:156429177	TIMD4	chr5:156346293-156390266:-	-0.34	-4.45	1.27E-5	Hypertriglyceridemia	
COAD	cis	1	rs13182402	chr5:125918148	ALDH7A1	chr5:125878918-125931082:-	-0.38	-4.06	6.39E-5	Osteoporosis	
COAD	cis	1	rs13190742	chr6:163008758	PACRG	chr6:163148164-163736523:+	0.49	5.31	2.39E-7	Body mass index	
COAD	cis	1	rs13191362	chr6:163033350	PACRG	chr6:163148164-163736523:+	0.55	5.64	4.37E-8	Body mass index	
COAD	cis	1	rs13192894	chr6:163052444	PACRG	chr6:163148164-163736523:+	0.52	5.03	9.0E-7	Body mass index	
COAD	cis	1	rs13193282	chr6:163015442	PACRG	chr6:163148164-163736523:+	0.52	5.59	5.77E-8	Body mass index	
COAD	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.63	-8.81	1.83E-16	Response to antipsychotic treatment	
COAD	cis	1	rs13195226	chr6:163006421	PACRG	chr6:163148164-163736523:+	0.38	4.32	2.25E-5	Body mass index	
COAD	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.62	-8.47	1.78E-15	Response to antipsychotic treatment	
COAD	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.64	-9.86	1.1E-19	Response to antipsychotic treatment	
COAD	cis	1	rs13199223	chr6:163001083	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs1319987	chr6:118782236	C6orf204	chr6:118786239-119031238:-	-0.26	-4.33	2.12E-5	Renal cell carcinoma	
COAD	cis	1	rs1319988	chr6:118782379	C6orf204	chr6:118786239-119031238:-	-0.26	-4.33	2.12E-5	Renal cell carcinoma	
COAD	cis	1	rs13200329	chr6:163004418	PACRG	chr6:163148164-163736523:+	0.38	4.32	2.25E-5	Body mass index	
COAD	cis	1	rs13201023	chr6:162981381	PACRG	chr6:163148164-163736523:+	0.46	4.95	1.3E-6	Body mass index	
COAD	cis	1	rs13202339	chr6:163081812	PACRG	chr6:163148164-163736523:+	0.52	5.2	3.98E-7	Body mass index	
COAD	cis	1	rs13204013	chr6:163002480	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs13204439	chr6:163015358	PACRG	chr6:163148164-163736523:+	-0.37	-4.15	4.5E-5	Body mass index	
COAD	cis	1	rs13206253	chr6:163166902	PACRG	chr6:163148164-163736523:+	0.47	5.39	1.56E-7	Body mass index	
COAD	cis	1	rs13207239	chr6:163008772	PACRG	chr6:163148164-163736523:+	0.48	5.2	4.12E-7	Body mass index	
COAD	cis	1	rs13207671	chr6:162979056	PACRG	chr6:163148164-163736523:+	0.51	5.49	9.47E-8	Body mass index	
COAD	cis	1	rs1320893	chr7:143752112	OR2A7	chr7:143955790-143974852:-	0.29	3.85	0.00015	Obesity-related traits	
COAD	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.28	-3.91	0.00012	Obesity-related traits	
COAD	cis	1	rs1320894	chr7:143751802	OR2A7	chr7:143955790-143974852:-	0.28	3.9	0.000122	Obesity-related traits	
COAD	cis	1	rs13209100	chr6:163159350	PACRG	chr6:163148164-163736523:+	0.38	4.58	7.21E-6	Body mass index	
COAD	cis	1	rs13209728	chr6:162997533	PACRG	chr6:163148164-163736523:+	0.38	4.29	2.48E-5	Body mass index	
COAD	cis	1	rs13210412	chr6:163019478	PACRG	chr6:163148164-163736523:+	0.41	4.61	6.2E-6	Body mass index	
COAD	cis	1	rs13210756	chr6:163009030	PACRG	chr6:163148164-163736523:+	0.38	4.36	1.91E-5	Body mass index	
COAD	cis	1	rs13212608	chr6:163032128	PACRG	chr6:163148164-163736523:+	0.48	5.18	4.36E-7	Body mass index	
COAD	cis	1	rs13213408	chr6:162998049	PACRG	chr6:163148164-163736523:+	0.5	5.43	1.31E-7	Body mass index	
COAD	cis	1	rs13214516	chr6:163121583	PACRG	chr6:163148164-163736523:+	0.52	5.04	8.62E-7	Body mass index	
COAD	cis	1	rs13215491	chr6:163010325	PACRG	chr6:163148164-163736523:+	0.49	5.31	2.39E-7	Body mass index	
COAD	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.61	-9.24	8.8E-18	Response to antipsychotic treatment	
COAD	cis	1	rs13218900	chr6:163081638	PACRG	chr6:163148164-163736523:+	0.49	4.97	1.21E-6	Body mass index	
COAD	cis	1	rs13220048	chr6:163004325	PACRG	chr6:163148164-163736523:+	0.49	5.27	2.88E-7	Body mass index	
COAD	cis	1	rs13220181	chr6:163004401	PACRG	chr6:163148164-163736523:+	0.38	4.32	2.25E-5	Body mass index	
COAD	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.29	-5.54	7.56E-8	Menarche (age at onset)	
COAD	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.29	-3.97	9.19E-5	Obesity-related traits	
COAD	cis	1	rs13226728	chr7:143746578	OR2A7	chr7:143955790-143974852:-	0.3	4.13	4.8E-5	Obesity-related traits	
COAD	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.28	-3.89	0.000127	Obesity-related traits	
COAD	cis	1	rs13243677	chr7:143746572	OR2A7	chr7:143955790-143974852:-	0.29	4.04	7.14E-5	Obesity-related traits	
COAD	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.74	15.44	1.15E-38	Bone mineral density	
COAD	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.74	15.3	3.64E-38	Bone mineral density	
COAD	cis	1	rs13256369	chr8:8577379	FLJ10661	chr8:8086092-8102386:+	0.4	4.71	3.95E-6	Obesity-related traits	
COAD	cis	1	rs13256903	chr8:89596159	MMP16	chr8:89049462-89339717:-	0.17	3.82	0.000167	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs13266699	chr8:8570313	FLJ10661	chr8:8086092-8102386:+	-0.41	-4.81	2.59E-6	Obesity-related traits	
COAD	cis	1	rs13267501	chr8:8574058	FLJ10661	chr8:8086092-8102386:+	0.37	4.21	3.55E-5	Obesity-related traits	
COAD	cis	1	rs13267565	chr8:89596182	MMP16	chr8:89049462-89339717:-	0.17	3.92	0.000114	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs13268482	chr8:89596484	MMP16	chr8:89049462-89339717:-	0.17	3.89	0.000125	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs13271966	chr8:8575472	FLJ10661	chr8:8086092-8102386:+	0.37	4.28	2.59E-5	Obesity-related traits	
COAD	cis	1	rs13282915	chr8:8570891	FLJ10661	chr8:8086092-8102386:+	0.35	4.05	6.82E-5	Obesity-related traits	
COAD	cis	1	rs13313564	chr17:37955555	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs13313573	chr17:37955818	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.28	4.59	6.76E-6	Longevity	
COAD	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs13322887	chr3:49555583	WDR6	chr3:49044637-49053386:+	0.31	4.28	2.6E-5	Menarche (age at onset)	
COAD	cis	1	rs13324903	chr3:195086647	C3orf21	chr3:194789015-194991895:-	-0.34	-4.67	4.79E-6	Body mass index	
COAD	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.59	7.99	4.24E-14	Diastolic blood pressure	
COAD	cis	1	rs13334403	chr16:67222676	LRRC29	chr16:67241043-67260901:-	-0.5	-5.03	8.94E-7	HDL cholesterol	
COAD	cis	1	rs13338688	chr16:67248831	LRRC29	chr16:67241043-67260901:-	-0.44	-5.46	1.09E-7	HDL cholesterol	
COAD	cis	1	rs13338846	chr16:67247444	LRRC29	chr16:67241043-67260901:-	-0.47	-4.81	2.51E-6	HDL cholesterol	
COAD	cis	1	rs13339140	chr16:67213923	LRRC29	chr16:67241043-67260901:-	-0.47	-5.59	5.68E-8	HDL cholesterol	
COAD	cis	1	rs1333963	chr6:163192571	PACRG	chr6:163148164-163736523:+	0.55	5.49	9.33E-8	Body mass index	
COAD	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.29	4.43	1.41E-5	Crohn's disease	
COAD	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.57	-8.46	2.0E-15	Response to antipsychotic treatment	
COAD	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.62	-8.65	5.35E-16	Response to antipsychotic treatment	
COAD	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.57	-6.49	4.35E-10	Prostate cancer	
COAD	cis	1	rs13390389	chr2:188112487	CALCRL	chr2:188207851-188313021:-	0.15	4.43	1.36E-5	Coronary heart disease	
COAD	cis	1	rs1339580	chr10:60027122	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs1339582	chr10:59937183	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1339583	chr10:59937003	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1339584	chr10:59936857	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1339585	chr10:59936841	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.21E-5	Inflammatory bowel disease	
COAD	cis	1	rs1339586	chr10:60017646	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs1339588	chr10:59998210	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.47	4.3	2.42E-5	Rheumatoid arthritis	
COAD	cis	1	rs13404250	chr2:188116196	CALCRL	chr2:188207851-188313021:-	0.15	4.33	2.12E-5	Coronary heart disease	
COAD	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.51	-5.7	3.25E-8	Rheumatoid arthritis	
COAD	cis	1	rs13409829	chr2:188182661	CALCRL	chr2:188207851-188313021:-	0.15	4.31	2.36E-5	Coronary heart disease	
COAD	cis	1	rs13415839	chr2:232126534	ARMC9	chr2:232063342-232238606:+	0.26	4.05	6.76E-5	Food antigen IgG levels	
COAD	cis	1	rs13418561	chr2:188150214	CALCRL	chr2:188207851-188313021:-	0.15	4.35	1.96E-5	Coronary heart disease	
COAD	cis	1	rs13427277	chr2:188075497	CALCRL	chr2:188207851-188313021:-	0.15	4.4	1.57E-5	Coronary heart disease	
COAD	cis	1	rs13430665	chr2:188229007	CALCRL	chr2:188207851-188313021:-	0.14	3.97	9.21E-5	Coronary heart disease	
COAD	cis	1	rs13435802	chr4:120177960	FABP2	chr4:120238406-120243316:-	-0.37	-5.59	5.8E-8	Corneal astigmatism	
COAD	cis	1	rs13437605	chr6:118899014	C6orf204	chr6:118786239-119031238:-	-0.27	-4.47	1.18E-5	Renal cell carcinoma	
COAD	cis	1	rs1346719	chr3:53077372	SFMBT1	chr3:52938628-53080070:-	-0.53	-6.05	5.1E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.33	-5.26	3.01E-7	Cognitive function	
COAD	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.33	-5.17	4.69E-7	Cognitive function	
COAD	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.33	-5.24	3.33E-7	Cognitive function	
COAD	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.35	-5.7	3.22E-8	Cognitive function	
COAD	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.35	-5.8	1.9E-8	Cognitive function	
COAD	cis	1	rs1355412	chr8:29985683	MBOAT4	chr8:29989188-30002200:-	0.39	4.32	2.19E-5	Migraine	
COAD	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.58	8.67	4.75E-16	Height	
COAD	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.3	4.04	7.16E-5	Height	
COAD	cis	1	rs1359781	chr6:33762104	HLA-DOB	chr6:32780541-32784825:-	0.21	3.95	9.92E-5	Crohn's disease	
COAD	cis	1	rs1361353	chr10:59938091	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.44	-5.1	6.44E-7	Type 2 diabetes	
COAD	cis	1	rs1371867	chr8:101330209	RNF19A	chr8:101269288-101322327:-	-0.24	-3.99	8.57E-5	Atrioventricular conduction	
COAD	cis	1	rs1374469	chr4:1724799	FAM53A	chr4:1641609-1685854:-	-0.45	-6.41	6.83E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs138209	chr22:50539413	MAPK12	chr22:50688492-50700089:-	-0.22	-4.14	4.61E-5	Gestational age at birth in labor-initiated deliveries (child effect)	
COAD	cis	1	rs138244	chr22:50565367	MLC1	chr22:50497820-50524358:-	-0.28	-4.46	1.22E-5	Gestational age at birth in labor-initiated deliveries (child effect)	
COAD	cis	1	rs138249	chr22:50569790	MLC1	chr22:50497820-50524358:-	-0.29	-4.52	9.47E-6	Gestational age at birth in labor-initiated deliveries (child effect)	
COAD	cis	1	rs138250	chr22:50570361	MLC1	chr22:50497820-50524358:-	-0.28	-4.46	1.22E-5	Gestational age at birth in labor-initiated deliveries (child effect)	
COAD	cis	1	rs138252	chr22:50570873	MLC1	chr22:50497820-50524358:-	-0.28	-4.46	1.22E-5	Gestational age at birth in labor-initiated deliveries (child effect)	
COAD	cis	1	rs138702	chr22:39132601	CBY1	chr22:39052658-39069853:+	-0.33	-5.71	3.08E-8	Resting heart rate	
COAD	cis	1	rs138702	chr22:39132601	JOSD1	chr22:39081549-39096459:-	0.26	4.46	1.21E-5	Resting heart rate	
COAD	cis	1	rs138705	chr22:39133803	CBY1	chr22:39052658-39069853:+	0.35	5.74	2.66E-8	Resting heart rate	
COAD	cis	1	rs138706	chr22:39137834	CBY1	chr22:39052658-39069853:+	0.31	5.18	4.45E-7	Resting heart rate	
COAD	cis	1	rs138712	chr22:39141600	CBY1	chr22:39052658-39069853:+	0.38	6.1	3.76E-9	Resting heart rate	
COAD	cis	1	rs138713	chr22:39142615	CBY1	chr22:39052658-39069853:+	0.34	5.58	5.98E-8	Resting heart rate	
COAD	cis	1	rs138716	chr22:39146527	CBY1	chr22:39052658-39069853:+	0.32	5.03	9.01E-7	Resting heart rate	
COAD	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.42	-4.2	3.73E-5	Response to cytadine analogues (cytosine arabinoside)	
COAD	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.21	4.01	7.99E-5	Height	
COAD	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.62	-8.66	4.84E-16	Response to antipsychotic treatment	
COAD	cis	1	rs1416763	chr10:60029163	IPMK	chr10:59955618-60027694:-	0.23	3.86	0.000141	Inflammatory bowel disease	
COAD	cis	1	rs1416766	chr10:59978237	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs142039564	chr1:119056258	WARS2	chr1:119573841-119683295:-	-0.27	-4.03	7.33E-5	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
COAD	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.83	10.13	1.5E-20	Type 2 diabetes	
COAD	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.83	10.19	9.51E-21	Type 2 diabetes	
COAD	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.3	-5.69	3.42E-8	Menarche (age at onset)	
COAD	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.3	-5.69	3.42E-8	Menarche (age at onset)	
COAD	cis	1	rs1458726	chr11:30505879	MPPED2	chr11:30406040-30607930:-	0.26	4.35	1.99E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.28	4.75	3.31E-6	Longevity	
COAD	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.25	-4.15	4.59E-5	Menarche (age at onset)	
COAD	cis	1	rs1464569	chr3:49460350	WDR6	chr3:49044637-49053386:+	-0.36	-5.33	2.11E-7	Menarche (age at onset)	
COAD	cis	1	rs1466211	chr2:108856412	SULT1C3	chr2:108863651-108881806:+	0.44	6.15	2.92E-9	Blood pressure	
COAD	cis	1	rs1466212	chr2:108856532	SULT1C3	chr2:108863651-108881806:+	0.44	6.21	2.09E-9	Blood pressure	
COAD	cis	1	rs1466213	chr2:108856607	SULT1C3	chr2:108863651-108881806:+	0.44	6.24	1.8E-9	Blood pressure	
COAD	cis	1	rs1467609	chr9:98945338	FANCC	chr9:97861338-98079991:-	-0.59	-4.15	4.45E-5	Smoking initiation	
COAD	cis	1	rs1471399	chr4:88774073	SPP1	chr4:88896802-88904562:+	-0.28	-5.18	4.41E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs1471401	chr4:88774340	SPP1	chr4:88896802-88904562:+	-0.28	-5.13	5.75E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs1471403	chr4:88775243	SPP1	chr4:88896802-88904562:+	0.24	4.32	2.17E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs1473248	chr19:41923314	B3GNT8	chr19:41931265-41934635:-	0.33	5.37	1.72E-7	Height	
COAD	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.61	9.15	1.74E-17	Height	
COAD	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.32	4.36	1.87E-5	Height	
COAD	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.52	-8.29	6.11E-15	Ankylosing spondylitis	
COAD	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.43	5.64	4.4E-8	Ankylosing spondylitis	
COAD	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.36	-5.59	5.69E-8	Pancreatic cancer	
COAD	cis	1	rs1522106	chr4:56307214	SRD5A3	chr4:56212409-56237866:+	-0.25	-4.09	5.77E-5	Personality dimensions	
COAD	cis	1	rs1522108	chr4:56380733	SRD5A3	chr4:56212409-56237866:+	0.26	4.34	2.02E-5	Personality dimensions	
COAD	cis	1	rs1522110	chr4:56380283	SRD5A3	chr4:56212409-56237866:+	0.24	4.28	2.61E-5	Personality dimensions	
COAD	cis	1	rs1522111	chr4:56329563	SRD5A3	chr4:56212409-56237866:+	0.28	4.74	3.54E-6	Personality dimensions	
COAD	cis	1	rs1528229	chr2:188154489	CALCRL	chr2:188207851-188313021:-	-0.15	-4.43	1.4E-5	Coronary heart disease	
COAD	cis	1	rs1528233	chr2:188207245	CALCRL	chr2:188207851-188313021:-	-0.13	-3.97	9.29E-5	Coronary heart disease	
COAD	cis	1	rs1532306	chr1:33999599	ADC	chr1:33546714-33586131:+	0.33	3.89	0.000126	Response to anti-TNF therapy in rheumatoid arthritis	
COAD	cis	1	rs1532307	chr1:33999657	ADC	chr1:33546714-33586131:+	0.33	3.92	0.000115	Response to anti-TNF therapy in rheumatoid arthritis	
COAD	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.49	1.08E-5	Obesity-related traits	
COAD	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.34	-4.52	9.43E-6	Obesity-related traits	
COAD	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.49	1.08E-5	Obesity-related traits	
COAD	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.61	-8.65	5.22E-16	Height	
COAD	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.34	-4.4	1.59E-5	Height	
COAD	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.6	8.81	1.83E-16	Height	
COAD	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.29	3.84	0.000156	Height	
COAD	cis	1	rs1538767	chr3:195007852	C3orf21	chr3:194789015-194991895:-	0.36	5.09	6.75E-7	Body mass index	
COAD	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.34	-4.54	8.67E-6	Obesity-related traits	
COAD	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.2	3.95	0.000101	Height	
COAD	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.18	3.87	0.00014	Height	
COAD	cis	1	rs1548226	chr20:43983777	SYS1-DBNDD2	chr20:43991701-44039245:+	0.42	4.29	2.49E-5	Psoriasis	
COAD	cis	1	rs1550773	chr10:60044441	IPMK	chr10:59955618-60027694:-	0.23	3.83	0.000158	Inflammatory bowel disease	
COAD	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.4	6.83	6.03E-11	Inflammatory skin disease	
COAD	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.48	-6.22	1.99E-9	Esophageal cancer (squamous cell)	
COAD	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.83	10.18	1.01E-20	Type 2 diabetes	
COAD	cis	1	rs1560706	chr19:10838004	RAVER1	chr19:10426891-10444314:-	0.52	4.72	3.81E-6	LDL cholesterol	
COAD	cis	1	rs1560734	chr19:10841049	RAVER1	chr19:10426891-10444314:-	-0.45	-4.27	2.79E-5	LDL cholesterol	
COAD	cis	1	rs1561289	chr2:25369040	POMC	chr2:25383722-25391559:-	-0.23	-4.02	7.7E-5	Body mass index	
COAD	cis	1	rs1561328	chr2:86272758	LOC90784	chr2:86247339-86250991:-	-0.7	-7.55	7.44E-13	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs15637	chr17:61772050	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.66	9.61	6.66E-19	Diastolic blood pressure	
COAD	cis	1	rs15655	chr1:171673272	VAMP4	chr1:171669298-171711214:-	0.34	4.64	5.6E-6	Hippocampal atrophy	
COAD	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.28	-4.76	3.19E-6	Blood metabolite levels	
COAD	cis	1	rs1569716	chr22:38998519	CBY1	chr22:39052658-39069853:+	0.28	4.73	3.73E-6	Resting heart rate	
COAD	cis	1	rs1569716	chr22:38998519	JOSD1	chr22:39081549-39096459:-	-0.23	-3.95	9.95E-5	Resting heart rate	
COAD	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.22	4.26	2.85E-5	Height	
COAD	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.19	4.08	6.1E-5	Height	
COAD	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.61	-8.15	1.51E-14	Response to antipsychotic treatment	
COAD	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.62	-8.66	4.84E-16	Response to antipsychotic treatment	
COAD	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.29	-5.58	6.09E-8	Menarche (age at onset)	
COAD	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.25	5.34	2.04E-7	Menarche (age at onset)	
COAD	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.55	6.83	5.81E-11	Multiple sclerosis	
COAD	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.36	-5.79	1.98E-8	Multiple sclerosis	
COAD	cis	1	rs1609268	chr2:188205598	CALCRL	chr2:188207851-188313021:-	-0.14	-4.57	7.52E-6	Coronary heart disease	
COAD	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.38	-5.48	1.02E-7	Rheumatoid arthritis	
COAD	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.72	-10.63	3.63E-22	Diastolic blood pressure	
COAD	cis	1	rs1618814	chr10:59963477	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1623294	chr10:59939025	IPMK	chr10:59955618-60027694:-	0.24	4.04	7.07E-5	Inflammatory bowel disease	
COAD	cis	1	rs1630731	chr10:59959530	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1632282	chr2:188208012	CALCRL	chr2:188207851-188313021:-	-0.15	-4.63	5.81E-6	Coronary heart disease	
COAD	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.4	-5.52	8.32E-8	Rheumatoid arthritis	
COAD	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.26	4.6	6.72E-6	Rheumatoid arthritis	
COAD	cis	1	rs1655841	chr15:65721043	DENND4A	chr15:65952959-66084631:-	-0.22	-4.16	4.35E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs1655843	chr15:65721261	DENND4A	chr15:65952959-66084631:-	-0.22	-4.17	4.2E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs1665362	chr4:1726367	FAM53A	chr4:1641609-1685854:-	-0.37	-5.49	9.68E-8	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs1665364	chr4:1727206	FAM53A	chr4:1641609-1685854:-	0.37	5.38	1.69E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs1665366	chr4:1728381	FAM53A	chr4:1641609-1685854:-	0.48	6.71	1.19E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs166870	chr15:80069762	MTHFS	chr15:80137320-80189370:-	0.35	5.07	7.45E-7	Disease-free survival in breast cancer	
COAD	cis	1	rs166925	chr19:41926098	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.02E-7	Height	
COAD	cis	1	rs1679709	chr6:28228342	ZSCAN23	chr6:28393287-28411279:-	-0.38	-4.08	6.09E-5	Depression	
COAD	cis	1	rs1680790	chr3:128625853	ACAD9	chr3:128598333-128634910:+	-0.33	-4.06	6.57E-5	IgG glycosylation	
COAD	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.44	-4.55	8.36E-6	Bone mineral density	
COAD	cis	1	rs16830002	chr3:119290708	CD80	chr3:119243142-119278481:-	-0.18	-4.02	7.48E-5	Vitiligo	
COAD	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.54	5.42	1.35E-7	Rheumatoid arthritis	
COAD	cis	1	rs1683776	chr3:128622760	ACAD9	chr3:128598333-128634910:+	-0.33	-4	8.27E-5	IgG glycosylation	
COAD	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.66	-10.33	3.52E-21	Response to antipsychotic treatment	
COAD	cis	1	rs16884476	chr8:89584486	MMP16	chr8:89049462-89339717:-	0.17	3.89	0.000128	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs16891378	chr6:26188864	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.01	8.01E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs16891397	chr6:26200256	HIST1H2AE	chr6:26217148-26217711:+	-0.43	-4.12	4.99E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs16891401	chr6:26202337	HIST1H2AE	chr6:26217148-26217711:+	-0.45	-4.26	2.81E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs16891405	chr6:26204506	HIST1H2AE	chr6:26217148-26217711:+	-0.45	-4.47	1.17E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs16898097	chr8:124195034	FAM83A	chr8:124191287-124222317:+	-0.47	-4.11	5.31E-5	Urinary uromodulin levels	
COAD	cis	1	rs16899276	chr5:81165704	ATG10	chr5:81267844-81551211:+	0.32	4.07	6.26E-5	Cognitive function	
COAD	cis	1	rs16899276	chr5:81165704	ATP6AP1L	chr5:81575281-81614146:+	0.36	4.34	2.08E-5	Cognitive function	
COAD	cis	1	rs16917224	chr8:96030110	C8orf38	chr8:95908040-96088396:+	-0.3	-4.04	7.1E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs16917233	chr8:96044967	C8orf38	chr8:95908040-96088396:+	0.31	4.21	3.59E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs16920793	chr11:30507095	MPPED2	chr11:30406040-30607930:-	-0.26	-4.27	2.79E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.59	-7.51	9.5E-13	Bilirubin levels	
COAD	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.45	-6.26	1.58E-9	Esophageal cancer (squamous cell)	
COAD	cis	1	rs16955471	chr17:53058807	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs1698392	chr10:59967089	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1698395	chr10:59938724	IPMK	chr10:59955618-60027694:-	0.24	4.04	7.07E-5	Inflammatory bowel disease	
COAD	cis	1	rs1698396	chr10:59937308	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1698402	chr10:59936444	IPMK	chr10:59955618-60027694:-	0.25	4.1	5.46E-5	Inflammatory bowel disease	
COAD	cis	1	rs1698468	chr10:59961590	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.33	-4.36	1.9E-5	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.34	-4.73	3.7E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.31	-4.18	4.04E-5	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.34	-4.62	6.05E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs17018691	chr12:91473900	KERA	chr12:91444273-91452131:-	0.29	4.65	5.23E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs17018694	chr12:91474052	KERA	chr12:91444273-91452131:-	0.29	4.65	5.23E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs17018731	chr12:91499367	KERA	chr12:91444273-91452131:-	0.26	4.16	4.35E-5	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs17024276	chr2:39962578	TMEM178	chr2:39893093-39945101:+	0.46	4.42	1.43E-5	Erectile dysfunction and prostate cancer treatment	
COAD	cis	1	rs17027011	chr2:86406556	LOC90784	chr2:86247339-86250991:-	-0.7	-5.85	1.48E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.56	5.99	6.85E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.52	5.56	6.55E-8	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs17037427	chr1:11873416	CLCN6	chr1:11866207-11907674:+	0.23	3.93	0.000109	QRS complex (12-leadsum)	
COAD	cis	1	rs17037429	chr1:11873787	CLCN6	chr1:11866207-11907674:+	-0.23	-4.06	6.39E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs17037452	chr1:11895675	CLCN6	chr1:11866207-11907674:+	0.22	3.9	0.000123	QRS complex (12-leadsum)	
COAD	cis	1	rs17052727	chr3:53070914	SFMBT1	chr3:52938628-53080070:-	-0.63	-5.66	4.03E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.73	11.21	4.39E-24	Diastolic blood pressure	
COAD	cis	1	rs1706249	chr2:188153718	CALCRL	chr2:188207851-188313021:-	-0.15	-4.43	1.4E-5	Coronary heart disease	
COAD	cis	1	rs1706252	chr2:188156578	CALCRL	chr2:188207851-188313021:-	0.13	4.14	4.64E-5	Coronary heart disease	
COAD	cis	1	rs1706261	chr2:188204916	CALCRL	chr2:188207851-188313021:-	-0.14	-4.57	7.52E-6	Coronary heart disease	
COAD	cis	1	rs1706262	chr2:188203848	CALCRL	chr2:188207851-188313021:-	-0.14	-4.31	2.32E-5	Coronary heart disease	
COAD	cis	1	rs1706276	chr2:188206664	CALCRL	chr2:188207851-188313021:-	-0.14	-4.11	5.27E-5	Coronary heart disease	
COAD	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.67	9.64	5.2E-19	Diastolic blood pressure	
COAD	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.66	9.57	8.72E-19	Diastolic blood pressure	
COAD	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.66	9.61	6.66E-19	Diastolic blood pressure	
COAD	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.27	-4.48	1.14E-5	Height	
COAD	cis	1	rs17080292	chr6:118850266	C6orf204	chr6:118786239-119031238:-	-0.28	-4.76	3.23E-6	Renal cell carcinoma	
COAD	cis	1	rs17080302	chr6:118854037	C6orf204	chr6:118786239-119031238:-	-0.28	-4.78	2.89E-6	Renal cell carcinoma	
COAD	cis	1	rs17085889	chr4:56402115	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.69	4.4E-6	Personality dimensions	
COAD	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.43	7.11	1.14E-11	Common traits (Other)	
COAD	cis	1	rs17115231	chr12:75933675	GLIPR1L2	chr12:75784889-75825591:+	-0.28	-3.84	0.000152	Polycystic ovary syndrome	
COAD	cis	1	rs1715218	chr15:65721328	DENND4A	chr15:65952959-66084631:-	-0.23	-4.25	2.92E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs17161692	chr7:98953863	CYP3A5	chr7:99245818-99332821:-	-0.59	-7.21	5.89E-12	Blood metabolite levels	
COAD	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.54	7.17	7.54E-12	Age-related hearing impairment (interaction)	
COAD	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.72	-10.63	3.63E-22	Diastolic blood pressure	
COAD	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.68	-9.96	4.97E-20	Diastolic blood pressure	
COAD	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.72	-10.72	1.87E-22	Diastolic blood pressure	
COAD	cis	1	rs17207042	chr18:67537351	CD226	chr18:67530195-67624232:-	0.14	3.95	0.000102	Type 1 diabetes;Type 1 diabetes autoantibodies	
COAD	cis	1	rs17214386	chr14:97094416	BDKRB1	chr14:96722559-96735303:+	-0.38	-3.98	8.9E-5	Tanning	
COAD	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.4	-4.36	1.89E-5	Colorectal cancer	
COAD	cis	1	rs17239287	chr19:52022033	FPR2	chr19:52264453-52273777:+	0.37	3.84	0.000154	Carotid intima media thickness	
COAD	cis	1	rs17245674	chr4:171884710	MFAP3L	chr4:170907750-170947429:-	0.31	3.87	0.000138	Lupus nephritis in systemic lupus erythematosus	
COAD	cis	1	rs1728667	chr2:188153421	CALCRL	chr2:188207851-188313021:-	-0.13	-4.21	3.5E-5	Coronary heart disease	
COAD	cis	1	rs1728668	chr2:188153662	CALCRL	chr2:188207851-188313021:-	-0.13	-4.21	3.5E-5	Coronary heart disease	
COAD	cis	1	rs1728669	chr2:188153875	CALCRL	chr2:188207851-188313021:-	-0.13	-4.21	3.5E-5	Coronary heart disease	
COAD	cis	1	rs1728670	chr2:188154357	CALCRL	chr2:188207851-188313021:-	-0.15	-4.43	1.4E-5	Coronary heart disease	
COAD	cis	1	rs1728673	chr2:188156452	CALCRL	chr2:188207851-188313021:-	-0.14	-4.4	1.58E-5	Coronary heart disease	
COAD	cis	1	rs1728680	chr2:188193463	CALCRL	chr2:188207851-188313021:-	-0.14	-4.46	1.23E-5	Coronary heart disease	
COAD	cis	1	rs1728690	chr2:188206953	CALCRL	chr2:188207851-188313021:-	-0.14	-4.57	7.52E-6	Coronary heart disease	
COAD	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.79	-5.35	1.88E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs17317888	chr20:33594959	PROCR	chr20:33758727-33765164:+	-0.48	-4.06	6.61E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs17318666	chr19:41940342	B3GNT8	chr19:41931265-41934635:-	0.33	5.22	3.63E-7	Height	
COAD	cis	1	rs17323510	chr8:124186089	FAM83A	chr8:124191287-124222317:+	0.49	4.46	1.2E-5	Urinary uromodulin levels	
COAD	cis	1	rs17396440	chr2:48270256	FOXN2	chr2:48541795-48606434:+	0.37	3.95	0.000101	Schizophrenia	
COAD	cis	1	rs17424234	chr6:118808521	C6orf204	chr6:118786239-119031238:-	-0.27	-4.51	9.74E-6	Renal cell carcinoma	
COAD	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.96	19.65	2.19E-53	Carotid intima media thickness	
COAD	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.27	-5.78	2.16E-8	Menarche (age at onset)	
COAD	cis	1	rs174551	chr11:61573684	FADS2	chr11:61583728-61634825:+	0.4	5.33	2.17E-7	LDL cholesterol	
COAD	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.59	8.19	1.15E-14	Sex hormone-binding globulin levels	
COAD	cis	1	rs17513621	chr2:99246559	UNC50	chr2:99225042-99234975:+	-0.39	-4.79	2.78E-6	Bipolar disorder	
COAD	cis	1	rs1752435	chr14:59946094	C14orf149	chr14:59939406-59951126:-	-0.37	-4.22	3.38E-5	Schizophrenia	
COAD	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.24	-4.01	8.0E-5	Inflammatory skin disease	
COAD	cis	1	rs175425	chr14:75626131	MLH3	chr14:75480467-75518235:-	-0.28	-4.71	4.01E-6	Height	
COAD	cis	1	rs175426	chr14:75624134	MLH3	chr14:75480467-75518235:-	-0.3	-5.17	4.74E-7	Height	
COAD	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.31	-5.31	2.33E-7	Height	
COAD	cis	1	rs175442	chr14:75603564	MLH3	chr14:75480467-75518235:-	-0.3	-5.14	5.3E-7	Height	
COAD	cis	1	rs175443	chr14:75601963	MLH3	chr14:75480467-75518235:-	-0.31	-5.14	5.38E-7	Height	
COAD	cis	1	rs175449	chr14:75590846	MLH3	chr14:75480467-75518235:-	-0.3	-5.14	5.31E-7	Height	
COAD	cis	1	rs175492	chr14:75545220	MLH3	chr14:75480467-75518235:-	0.3	5.33	2.08E-7	Height	
COAD	cis	1	rs175512	chr14:75523382	MLH3	chr14:75480467-75518235:-	-0.29	-4.9	1.65E-6	Height	
COAD	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.33	4.61	6.44E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.33	-4.68	4.57E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.34	-4.73	3.7E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.32	-4.3	2.41E-5	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.34	-4.73	3.7E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs17584578	chr2:86307624	LOC90784	chr2:86247339-86250991:-	0.7	5.83	1.65E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.56	-9.01	4.45E-17	Forced vital capacity	
COAD	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.93	5.69	3.47E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.5	-8.09	2.3E-14	Temperament	
COAD	cis	1	rs17649068	chr1:171713893	VAMP4	chr1:171669298-171711214:-	0.32	4.53	8.95E-6	Hippocampal atrophy	
COAD	cis	1	rs17649250	chr1:171720586	VAMP4	chr1:171669298-171711214:-	0.38	5.43	1.29E-7	Hippocampal atrophy	
COAD	cis	1	rs17656948	chr18:47209971	ACAA2	chr18:47309875-47340283:-	0.27	4.18	3.96E-5	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.88	-5.54	7.42E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	0.33	3.83	0.000163	Heschl's gyrus morphology	
COAD	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.3	-5.66	3.91E-8	Menarche (age at onset)	
COAD	cis	1	rs1769003	chr10:59937590	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769005	chr10:59935940	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769006	chr10:59935547	IPMK	chr10:59955618-60027694:-	0.24	4.05	6.63E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769040	chr10:59954081	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769042	chr10:59956734	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769044	chr10:59958956	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769045	chr10:59960522	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769046	chr10:59960630	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs1769047	chr10:59963046	IPMK	chr10:59955618-60027694:-	0.26	4.33	2.13E-5	Inflammatory bowel disease	
COAD	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.34	5.19	4.29E-7	Cognitive performance	
COAD	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs17707196	chr2:188201216	CALCRL	chr2:188207851-188313021:-	0.15	4.23	3.28E-5	Coronary heart disease	
COAD	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.73	-13.12	1.54E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.71	-13.08	2.16E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.71	-13.23	6.5E-31	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs17724311	chr7:22876793	TOMM7	chr7:22852254-22862421:-	-0.31	-4.66	5.06E-6	Fibrinogen	
COAD	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.46	5.28	2.69E-7	Crohn's disease	
COAD	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.33	5.01	9.91E-7	Prostate cancer	
COAD	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.3	-5.63	4.53E-8	Menarche (age at onset)	
COAD	cis	1	rs17756804	chr2:188163250	CALCRL	chr2:188207851-188313021:-	0.15	4.31	2.35E-5	Coronary heart disease	
COAD	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.44	5.97	7.56E-9	Esophageal cancer (squamous cell)	
COAD	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.45	-6.09	4.01E-9	Esophageal cancer (squamous cell)	
COAD	cis	1	rs1778508	chr6:28229881	ZSCAN23	chr6:28393287-28411279:-	-0.35	-3.95	9.9E-5	Depression	
COAD	cis	1	rs1778511	chr6:28229411	ZSCAN23	chr6:28393287-28411279:-	-0.36	-3.95	0.000101	Depression	
COAD	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.43	6.22	2.0E-9	Crohn's disease	
COAD	cis	1	rs17809330	chr15:65889250	DENND4A	chr15:65952959-66084631:-	0.23	4.33	2.13E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.45	-5.71	3.01E-8	Esophageal cancer (squamous cell)	
COAD	cis	1	rs17860606	chr6:170099561	C6orf70	chr6:170151721-170181617:+	0.39	4.37	1.82E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs1788103	chr18:67538824	CD226	chr18:67530195-67624232:-	-0.14	-3.98	8.82E-5	Type 1 diabetes;Type 1 diabetes autoantibodies	
COAD	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.33	-4.55	8.37E-6	Polycystic ovary syndrome	
COAD	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.35	4.86	2.02E-6	Glomerular filtration rate (creatinine)	
COAD	cis	1	rs1800774	chr16:57015545	GPR97	chr16:57702157-57723288:+	-0.26	-4.46	1.2E-5	HDL cholesterol	
COAD	cis	1	rs180515	chr17:58024275	DHX40P1	chr17:58053385-58096336:-	0.3	4.29	2.55E-5	Multiple sclerosis	
COAD	cis	1	rs1810563	chr1:12054030	MFN2	chr1:12040238-12073571:+	0.3	4.88	1.85E-6	Platelet count	
COAD	cis	1	rs181394970	chr2:86776235	VPS24	chr2:86730554-86948245:-	0.31	4.36	1.88E-5	Glomerular filtration rate in chronic kidney disease	
COAD	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.63	9.57	8.42E-19	Height	
COAD	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.3	4.01	7.81E-5	Height	
COAD	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.62	9.6	6.83E-19	Height	
COAD	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.31	4.28	2.63E-5	Height	
COAD	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.26	3.89	0.000126	Crohn's disease	
COAD	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.33	-4.68	4.57E-6	Schizophrenia	
COAD	cis	1	rs1832556	chr10:60028248	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.83	10.18	1.01E-20	Type 2 diabetes	
COAD	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.32	4.75	3.37E-6	IgG glycosylation	
COAD	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.31	-4.32	2.2E-5	Schizophrenia	
COAD	cis	1	rs1856564	chr10:60017452	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.63	-8.81	1.83E-16	Response to antipsychotic treatment	
COAD	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.58	-8.44	2.23E-15	Response to antipsychotic treatment	
COAD	cis	1	rs1859690	chr7:99227172	CYP3A5	chr7:99245818-99332821:-	0.51	7.37	2.22E-12	Blood metabolite levels	
COAD	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.83	10.18	1.01E-20	Type 2 diabetes	
COAD	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.6	9.08	2.76E-17	Height	
COAD	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.33	4.53	8.98E-6	Height	
COAD	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.26	-3.85	0.000147	Height	
COAD	cis	1	rs1865761	chr18:67539392	CD226	chr18:67530195-67624232:-	0.14	3.93	0.000107	Type 1 diabetes;Type 1 diabetes autoantibodies	
COAD	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.37	4.58	7.2E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs1867571	chr10:60038850	IPMK	chr10:59955618-60027694:-	0.25	4.2	3.72E-5	Inflammatory bowel disease	
COAD	cis	1	rs1867572	chr10:60038940	IPMK	chr10:59955618-60027694:-	0.25	4.2	3.72E-5	Inflammatory bowel disease	
COAD	cis	1	rs1867573	chr10:60042972	IPMK	chr10:59955618-60027694:-	-0.25	-4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.62	9.4	2.86E-18	Height	
COAD	cis	1	rs1874883	chr3:134205071	CEP63	chr3:134204575-134293852:+	0.29	3.9	0.000124	Height	
COAD	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.55	6.83	5.81E-11	Multiple sclerosis	
COAD	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.36	-5.79	1.98E-8	Multiple sclerosis	
COAD	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.02	7.76E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs1881284	chr2:188157329	CALCRL	chr2:188207851-188313021:-	-0.13	-3.99	8.5E-5	Coronary heart disease	
COAD	cis	1	rs1881285	chr2:188157332	CALCRL	chr2:188207851-188313021:-	-0.14	-4.3	2.46E-5	Coronary heart disease	
COAD	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.33	5.17	4.76E-7	Systolic blood pressure	
COAD	cis	1	rs1882140	chr12:91479826	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.46	-5.89	1.16E-8	Esophageal cancer (squamous cell)	
COAD	cis	1	rs189339	chr12:66252294	HELB	chr12:66696356-66731992:+	-0.29	-4.01	8.05E-5	Type 2 diabetes	
COAD	cis	1	rs1895448	chr5:90743854	LOC100129716	chr5:90676164-90716531:+	0.35	4.19	3.78E-5	Smoking behavior	
COAD	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.26	3.84	0.000156	Crohn's disease	
COAD	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.28	5.49	9.38E-8	Menarche (age at onset)	
COAD	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.99	12.9	9.01E-30	Type 2 diabetes	
COAD	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.3	-4.26	2.89E-5	Schizophrenia	
COAD	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.64	-9.86	1.1E-19	Response to antipsychotic treatment	
COAD	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.57	-8.43	2.37E-15	Response to antipsychotic treatment	
COAD	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.29	5.94E-15	Height	
COAD	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.33	-4.27	2.77E-5	Height	
COAD	cis	1	rs1918902	chr2:188091511	CALCRL	chr2:188207851-188313021:-	0.15	4.25	2.95E-5	Coronary heart disease	
COAD	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.39	1.63E-5	Obesity-related traits	
COAD	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.32	-4.38	1.73E-5	Obesity-related traits	
COAD	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.45	1.28E-5	Obesity-related traits	
COAD	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.45	1.26E-5	Obesity-related traits	
COAD	cis	1	rs1919951	chr7:143768891	OR2A7	chr7:143955790-143974852:-	0.31	4.14	4.61E-5	Obesity-related traits	
COAD	cis	1	rs1920790	chr12:91492788	KERA	chr12:91444273-91452131:-	0.28	4.47	1.15E-5	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.28	4.25	2.92E-5	Pulse pressure	
COAD	cis	1	rs1941746	chr11:65502413	CFL1	chr11:65622287-65626886:-	0.27	3.85	0.000149	Atopic dermatitis	
COAD	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.38	-5.61	5.26E-8	Rheumatoid arthritis	
COAD	cis	1	rs1961779	chr12:91483139	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs1962131	chr8:133434644	LRRC6	chr8:133584448-133687813:-	-0.33	-3.98	9.1E-5	LDL peak particle diameter (total fat intake interaction)	
COAD	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.65	-9.23	9.71E-18	Response to antipsychotic treatment	
COAD	cis	1	rs1964292	chr5:90743608	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs1969253	chr3:183876512	ABCF3	chr3:183903863-183911795:+	0.36	5.14	5.48E-7	Major depressive disorder	
COAD	cis	1	rs1971762	chr12:54058238	ATP5G2	chr12:54058945-54070512:-	0.27	4.97	1.23E-6	Height	
COAD	cis	1	rs1975284	chr8:57314663	PENK	chr8:57353513-57359282:-	-0.23	-4.39	1.67E-5	Obesity-related traits	
COAD	cis	1	rs1979214	chr2:70137498	GMCL1	chr2:70056818-70106727:+	0.21	3.95	0.000101	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-1	-10.38	2.42E-21	Schizophrenia	
COAD	cis	1	rs1982861	chr3:49577665	WDR6	chr3:49044637-49053386:+	-0.31	-4.23	3.17E-5	Menarche (age at onset)	
COAD	cis	1	rs1990674	chr17:53061075	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.62	8.28	6.28E-15	Diastolic blood pressure	
COAD	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.57	-8.43	2.37E-15	Response to antipsychotic treatment	
COAD	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.38	-3.97	9.2E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.63	-9.28	7.01E-18	Response to antipsychotic treatment	
COAD	cis	1	rs1999997	chr10:59996969	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.53	-8.45	2.08E-15	Forced vital capacity	
COAD	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.37	4.83	2.34E-6	Atopic dermatitis	
COAD	cis	1	rs2011331	chr1:152286002	FLG	chr1:152274651-152297679:-	0.24	4.03	7.34E-5	Atopic dermatitis	
COAD	cis	1	rs2014521	chr17:40283413	DHX58	chr17:40253422-40264751:-	-0.32	-4.84	2.2E-6	Fibrinogen levels	
COAD	cis	1	rs2016366	chr1:2513678	MMEL1	chr1:2522081-2564481:-	-0.29	-3.81	0.000171	Ulcerative colitis	
COAD	cis	1	rs2017962	chr19:22208751	ZNF208	chr19:22115760-22193745:-	0.21	3.85	0.000151	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2017962	chr19:22208751	ZNF257	chr19:22235266-22273901:+	0.39	4.92	1.52E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2019022	chr10:60024052	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.5	-5.57	6.21E-8	Rheumatoid arthritis	
COAD	cis	1	rs2031035	chr9:102711698	STX17	chr9:102668915-102736817:+	-0.28	-3.93	0.000109	Alopecia areata	
COAD	cis	1	rs2036402	chr5:156464242	HAVCR1	chr5:156456531-156486130:-	-0.37	-4.56	7.72E-6	Hypertriglyceridemia	
COAD	cis	1	rs2036402	chr5:156464242	TIMD4	chr5:156346293-156390266:-	-0.36	-4.71	3.96E-6	Hypertriglyceridemia	
COAD	cis	1	rs2045241	chr11:114428783	FAM55A	chr11:114392438-114430580:-	-0.23	-3.91	0.000116	Ulcerative colitis	
COAD	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.26	4.22	3.33E-5	Longevity	
COAD	cis	1	rs2049693	chr2:188112036	CALCRL	chr2:188207851-188313021:-	0.15	4.46	1.22E-5	Coronary heart disease	
COAD	cis	1	rs2050265	chr1:11879699	CLCN6	chr1:11866207-11907674:+	0.23	4.05	6.67E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs2052553	chr5:90729906	LOC100129716	chr5:90676164-90716531:+	0.35	4.21	3.53E-5	Smoking behavior	
COAD	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.59	8.74	2.96E-16	Height	
COAD	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.31	4.12	5.19E-5	Height	
COAD	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs2056938	chr20:44022672	SYS1-DBNDD2	chr20:43991701-44039245:+	0.38	4.25	2.95E-5	Psoriasis	
COAD	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.37	5.68	3.58E-8	Pancreatic cancer	
COAD	cis	1	rs2064088	chr22:39053382	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs2064088	chr22:39053382	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs2068737	chr10:59999575	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.55	-6.72	1.14E-10	Multiple sclerosis	
COAD	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.34	5.27	2.81E-7	Multiple sclerosis	
COAD	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.33	-5.09	6.83E-7	Cognitive performance	
COAD	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.55	6.64	1.77E-10	Multiple sclerosis	
COAD	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.34	-5.26	3.0E-7	Multiple sclerosis	
COAD	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.43	7.21	6.18E-12	Common traits (Other)	
COAD	cis	1	rs2072794	chr22:39150543	CBY1	chr22:39052658-39069853:+	0.35	5.55	7.05E-8	Resting heart rate	
COAD	cis	1	rs2072794	chr22:39150543	JOSD1	chr22:39081549-39096459:-	-0.26	-4.18	3.98E-5	Resting heart rate	
COAD	cis	1	rs2072795	chr22:39064209	CBY1	chr22:39052658-39069853:+	-0.36	-6.1	3.8E-9	Resting heart rate	
COAD	cis	1	rs2072795	chr22:39064209	JOSD1	chr22:39081549-39096459:-	0.29	4.85	2.1E-6	Resting heart rate	
COAD	cis	1	rs2072796	chr22:39064230	CBY1	chr22:39052658-39069853:+	0.37	6.32	1.14E-9	Resting heart rate	
COAD	cis	1	rs2072796	chr22:39064230	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.23E-6	Resting heart rate	
COAD	cis	1	rs2072798	chr22:39148483	CBY1	chr22:39052658-39069853:+	0.33	5.41	1.42E-7	Resting heart rate	
COAD	cis	1	rs2072798	chr22:39148483	JOSD1	chr22:39081549-39096459:-	-0.27	-4.31	2.33E-5	Resting heart rate	
COAD	cis	1	rs2074018	chr11:2309634	C11orf21	chr11:2317507-2323143:-	0.33	3.85	0.000147	Obesity-related traits	
COAD	cis	1	rs2074771	chr2:242350944	SEPT2	chr2:242254723-242293439:+	0.57	5.5	9.06E-8	Chronic lymphocytic leukemia	
COAD	cis	1	rs2076028	chr22:39150450	CBY1	chr22:39052658-39069853:+	0.33	5.35	1.97E-7	Resting heart rate	
COAD	cis	1	rs2076028	chr22:39150450	JOSD1	chr22:39081549-39096459:-	-0.27	-4.29	2.49E-5	Resting heart rate	
COAD	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.63	-9.59	7.52E-19	Homocysteine levels	
COAD	cis	1	rs2078089	chr19:22209753	ZNF208	chr19:22115760-22193745:-	0.21	3.85	0.000151	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2078089	chr19:22209753	ZNF257	chr19:22235266-22273901:+	0.39	4.92	1.52E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2080303	chr2:202165206	PPIL3	chr2:201735680-201753999:-	-0.28	-3.85	0.000147	Basal cell carcinoma	
COAD	cis	1	rs2081302	chr2:23945355	C2orf84	chr2:24397531-24414566:+	-0.28	-4.14	4.74E-5	Obesity-related traits	
COAD	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.33	4.21	3.45E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs2084220	chr11:18656932	SPTY2D1	chr11:18627949-18656020:-	-0.4	-6.35	9.36E-10	Cholesterol, total	
COAD	cis	1	rs2087017	chr3:113842013	QTRTD1	chr3:113775611-113807266:+	-0.21	-3.82	0.000169	Personality dimensions	
COAD	cis	1	rs2095892	chr10:60023719	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2095893	chr10:59969551	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2095894	chr10:59968671	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.29	-5.13	5.79E-7	Height	
COAD	cis	1	rs2105220	chr10:59969064	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.99	12.94	6.26E-30	Type 2 diabetes	
COAD	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	1.02	13.83	5.24E-33	Type 2 diabetes	
COAD	cis	1	rs2113422	chr2:23939007	C2orf84	chr2:24397531-24414566:+	-0.26	-4.08	6.01E-5	Obesity-related traits	
COAD	cis	1	rs2113423	chr2:23942287	C2orf84	chr2:24397531-24414566:+	-0.26	-4.12	5.03E-5	Obesity-related traits	
COAD	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.27	4.01	7.95E-5	Crohn's disease	
COAD	cis	1	rs2118404	chr2:25377329	POMC	chr2:25383722-25391559:-	0.23	4.01	7.87E-5	Body mass index	
COAD	cis	1	rs2120019	chr15:75334184	SCAMP5	chr15:75287901-75313836:+	0.36	4.42	1.43E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs2123694	chr2:108857505	SULT1C3	chr2:108863651-108881806:+	0.44	6.15	2.92E-9	Blood pressure	
COAD	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.72	-12.76	2.57E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.65	9.42	2.51E-18	Diastolic blood pressure	
COAD	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.66	9.54	1.04E-18	Diastolic blood pressure	
COAD	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.59	-12.17	2.75E-27	Kawasaki disease	
COAD	cis	1	rs2131877	chr3:194858374	C3orf21	chr3:194789015-194991895:-	-0.4	-4.02	7.54E-5	Non-small cell lung cancer	
COAD	cis	1	rs2140270	chr3:49439440	WDR6	chr3:49044637-49053386:+	0.31	4.29	2.47E-5	Menarche (age at onset)	
COAD	cis	1	rs2143346	chr6:26198449	HIST1H2AE	chr6:26217148-26217711:+	0.42	3.94	0.000104	Renal underexcretion gout;Gout	
COAD	cis	1	rs2143347	chr6:26198494	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-3.94	0.000104	Renal underexcretion gout;Gout	
COAD	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.39	4.74	3.55E-6	Atopic dermatitis	
COAD	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.17	4.07	6.33E-5	Blood metabolite levels	
COAD	cis	1	rs2153281	chr10:59972453	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2153282	chr10:59972416	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2153283	chr10:59972299	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.31	-4.31	2.36E-5	Eye color traits	
COAD	cis	1	rs2156257	chr6:163100710	PACRG	chr6:163148164-163736523:+	0.53	5.23	3.4E-7	Body mass index	
COAD	cis	1	rs2166580	chr4:1743169	FAM53A	chr4:1641609-1685854:-	-0.45	-6.41	6.59E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.63	-9.82	1.45E-19	Response to antipsychotic treatment	
COAD	cis	1	rs2169748	chr2:28957753	PPP1CB	chr2:28974612-29025805:+	-0.29	-4.69	4.44E-6	Body mass index	
COAD	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.35	5.46	1.08E-7	Body mass index	
COAD	cis	1	rs2169751	chr2:28966758	PPP1CB	chr2:28974612-29025805:+	0.29	4.82	2.42E-6	Body mass index	
COAD	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.52	8.09E-8	Body mass index	
COAD	cis	1	rs2170850	chr2:179675051	FKBP7	chr2:179328393-179343355:-	0.28	3.86	0.000143	Resting heart rate	
COAD	cis	1	rs2175366	chr19:22128279	ZNF208	chr19:22115760-22193745:-	0.22	3.94	0.000105	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2175366	chr19:22128279	ZNF257	chr19:22235266-22273901:+	0.39	4.93	1.46E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2177129	chr4:56365414	SRD5A3	chr4:56212409-56237866:+	0.27	4.81	2.61E-6	Personality dimensions	
COAD	cis	1	rs2177268	chr3:49439725	WDR6	chr3:49044637-49053386:+	0.31	4.29	2.47E-5	Menarche (age at onset)	
COAD	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs2181203	chr10:81716105	LOC219347	chr10:81805991-81838949:-	0.7	4.17	4.22E-5	Rheumatoid arthritis	
COAD	cis	1	rs218697	chr17:6594014	DVL2	chr17:7128661-7137863:-	0.36	3.97	9.25E-5	Blood metabolite levels	
COAD	cis	1	rs218698	chr17:6594700	TMEM102	chr17:7338762-7340998:+	0.36	3.83	0.000161	Blood metabolite levels	
COAD	cis	1	rs2198463	chr2:108875093	SULT1C3	chr2:108863651-108881806:+	0.46	6.43	6.2E-10	Blood pressure	
COAD	cis	1	rs2200578	chr2:99876244	REV1	chr2:100016939-100106480:-	0.34	4.22	3.35E-5	IgG glycosylation	
COAD	cis	1	rs2205802	chr22:39046327	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs2205802	chr22:39046327	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.2	4.33	2.14E-5	Type 1 diabetes autoantibodies	
COAD	cis	1	rs2217957	chr8:57313360	PENK	chr8:57353513-57359282:-	-0.27	-4.85	2.09E-6	Obesity-related traits	
COAD	cis	1	rs2219078	chr2:108875198	SULT1C3	chr2:108863651-108881806:+	0.46	6.27	1.53E-9	Blood pressure	
COAD	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.41	7.69	3.08E-13	Homocysteine levels	
COAD	cis	1	rs223116	chr14:23977010	C14orf167	chr14:24407940-24424298:-	0.25	4.04	7.13E-5	Resting heart rate	
COAD	cis	1	rs2231626	chr20:44002665	SYS1-DBNDD2	chr20:43991701-44039245:+	0.4	4.2	3.62E-5	Psoriasis	
COAD	cis	1	rs2231940	chr19:41944237	B3GNT8	chr19:41931265-41934635:-	0.32	5.09	6.94E-7	Height	
COAD	cis	1	rs2235230	chr22:39124467	CBY1	chr22:39052658-39069853:+	-0.37	-5.98	7.3E-9	Resting heart rate	
COAD	cis	1	rs2235230	chr22:39124467	JOSD1	chr22:39081549-39096459:-	0.25	3.94	0.000105	Resting heart rate	
COAD	cis	1	rs2235962	chr14:68248281	MPP5	chr14:67708021-67802535:+	0.2	3.84	0.000157	Amyotrophic lateral sclerosis (sporadic)	
COAD	cis	1	rs2236107	chr20:3285821	C20orf194	chr20:3229948-3388587:-	0.14	3.86	0.000145	IFN-related cytopenia	
COAD	cis	1	rs2236246	chr14:104379206	TDRD9	chr14:104394817-104519002:+	-0.32	-4.56	8.0E-6	Bipolar disorder	
COAD	cis	1	rs2236247	chr14:104378087	TDRD9	chr14:104394817-104519002:+	0.28	4.45	1.26E-5	Bipolar disorder	
COAD	cis	1	rs2236786	chr4:1719294	FAM53A	chr4:1641609-1685854:-	0.44	5.73	2.72E-8	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.43	7.11	1.14E-11	Common traits (Other)	
COAD	cis	1	rs2240009	chr17:40283142	DHX58	chr17:40253422-40264751:-	-0.32	-4.84	2.2E-6	Fibrinogen levels	
COAD	cis	1	rs2240010	chr17:40278081	DHX58	chr17:40253422-40264751:-	-0.32	-4.84	2.2E-6	Fibrinogen levels	
COAD	cis	1	rs2241435	chr2:86360916	LOC90784	chr2:86247339-86250991:-	-0.63	-5.49	9.65E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs2241706	chr19:41912807	B3GNT8	chr19:41931265-41934635:-	-0.34	-5.66	4.04E-8	Height	
COAD	cis	1	rs2241708	chr19:41912270	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.62	5.97E-6	Height	
COAD	cis	1	rs2241709	chr19:41912250	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.62	6.1E-6	Height	
COAD	cis	1	rs2241710	chr19:41912092	B3GNT8	chr19:41931265-41934635:-	-0.34	-5.66	4.04E-8	Height	
COAD	cis	1	rs2241711	chr19:41911980	B3GNT8	chr19:41931265-41934635:-	-0.34	-5.66	4.04E-8	Height	
COAD	cis	1	rs2241774	chr16:58072153	MMP15	chr16:58059282-58080802:+	0.3	4.06	6.62E-5	Pulmonary function;Pulmonary function (interaction)	
COAD	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.29	4.89	1.74E-6	Longevity	
COAD	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.31	4.38	1.69E-5	Longevity	
COAD	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.31	4.38	1.69E-5	Longevity	
COAD	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.31	4.38	1.69E-5	Longevity	
COAD	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.21	-3.97	9.22E-5	Height	
COAD	cis	1	rs2245717	chr20:43995880	SYS1-DBNDD2	chr20:43991701-44039245:+	0.39	4.19	3.76E-5	Psoriasis	
COAD	cis	1	rs2247037	chr20:44031295	SYS1-DBNDD2	chr20:43991701-44039245:+	0.37	4.03	7.42E-5	Psoriasis	
COAD	cis	1	rs2248637	chr20:43997240	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.4	-4.08	6.0E-5	Psoriasis	
COAD	cis	1	rs2251039	chr10:60028894	IPMK	chr10:59955618-60027694:-	0.25	4.19	3.79E-5	Inflammatory bowel disease	
COAD	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.36	-6.78	8.17E-11	Homocysteine levels	
COAD	cis	1	rs2253105	chr20:44011301	SYS1-DBNDD2	chr20:43991701-44039245:+	0.4	4.45	1.27E-5	Psoriasis	
COAD	cis	1	rs2253192	chr10:59999323	IPMK	chr10:59955618-60027694:-	-0.25	-4.15	4.52E-5	Inflammatory bowel disease	
COAD	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.28	-4.07	6.27E-5	Height	
COAD	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.29	-4.33	2.16E-5	Height	
COAD	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.27	-4.08	6.1E-5	Height	
COAD	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.27	-4.08	6.1E-5	Height	
COAD	cis	1	rs2254775	chr10:60036815	IPMK	chr10:59955618-60027694:-	0.25	4.2	3.72E-5	Inflammatory bowel disease	
COAD	cis	1	rs2256686	chr20:44017331	SYS1-DBNDD2	chr20:43991701-44039245:+	0.38	4.15	4.41E-5	Psoriasis	
COAD	cis	1	rs2263759	chr20:44011502	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	4.04	7.14E-5	Psoriasis	
COAD	cis	1	rs2263764	chr20:44025815	SYS1-DBNDD2	chr20:43991701-44039245:+	0.39	4.38	1.71E-5	Psoriasis	
COAD	cis	1	rs2263768	chr20:44031241	SYS1-DBNDD2	chr20:43991701-44039245:+	0.37	4.03	7.42E-5	Psoriasis	
COAD	cis	1	rs2267393	chr22:39101619	CBY1	chr22:39052658-39069853:+	0.33	5.75	2.52E-8	Resting heart rate	
COAD	cis	1	rs2267394	chr22:39101633	CBY1	chr22:39052658-39069853:+	0.33	5.75	2.52E-8	Resting heart rate	
COAD	cis	1	rs2267395	chr22:39113903	CBY1	chr22:39052658-39069853:+	0.34	5.79	2.05E-8	Resting heart rate	
COAD	cis	1	rs2268617	chr14:75608728	MLH3	chr14:75480467-75518235:-	0.25	4.14	4.63E-5	Height	
COAD	cis	1	rs2269186	chr14:104379912	TDRD9	chr14:104394817-104519002:+	0.32	4.62	6.14E-6	Bipolar disorder	
COAD	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.4	5.62	4.78E-8	Height	
COAD	cis	1	rs227163	chr1:7961206	UTS2	chr1:7903144-7973294:-	-0.32	-4.94	1.39E-6	Rheumatoid arthritis	
COAD	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.81	-12.71	3.81E-29	Diastolic blood pressure	
COAD	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.59	-4.98	1.16E-6	Rheumatoid arthritis	
COAD	cis	1	rs2273610	chr14:104387642	TDRD9	chr14:104394817-104519002:+	0.33	4.8	2.67E-6	Bipolar disorder	
COAD	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.3	4.24	3.1E-5	Longevity	
COAD	cis	1	rs2276547	chr2:28975107	PPP1CB	chr2:28974612-29025805:+	0.27	4.29	2.53E-5	Body mass index	
COAD	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.35	-5.51	8.59E-8	Body mass index	
COAD	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.46	-7.27	4.08E-12	Cholesterol, total	
COAD	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.43	-4.57	7.49E-6	Colorectal cancer	
COAD	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.29	-4.84	2.18E-6	Longevity	
COAD	cis	1	rs2281019	chr22:39064378	CBY1	chr22:39052658-39069853:+	0.37	6.32	1.14E-9	Resting heart rate	
COAD	cis	1	rs2281019	chr22:39064378	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.23E-6	Resting heart rate	
COAD	cis	1	rs2281020	chr22:39064406	CBY1	chr22:39052658-39069853:+	0.37	6.32	1.14E-9	Resting heart rate	
COAD	cis	1	rs2281020	chr22:39064406	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.23E-6	Resting heart rate	
COAD	cis	1	rs2281021	chr22:39064667	CBY1	chr22:39052658-39069853:+	0.37	6.32	1.14E-9	Resting heart rate	
COAD	cis	1	rs2281021	chr22:39064667	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.23E-6	Resting heart rate	
COAD	cis	1	rs2284073	chr22:39105948	CBY1	chr22:39052658-39069853:+	0.34	5.88	1.25E-8	Resting heart rate	
COAD	cis	1	rs2285087	chr4:3088211	RGS12	chr4:3294755-3441638:+	0.31	4.4	1.61E-5	Parental longevity (mother's age at death)	
COAD	cis	1	rs2285657	chr17:40272594	DHX58	chr17:40253422-40264751:-	-0.3	-4.61	6.43E-6	Fibrinogen levels	
COAD	cis	1	rs2286498	chr7:22857504	TOMM7	chr7:22852254-22862421:-	0.35	5.24	3.26E-7	Fibrinogen	
COAD	cis	1	rs2286499	chr7:22857477	TOMM7	chr7:22852254-22862421:-	-0.34	-5.11	6.25E-7	Fibrinogen	
COAD	cis	1	rs2286501	chr7:22856785	TOMM7	chr7:22852254-22862421:-	-0.36	-5.36	1.86E-7	Fibrinogen	
COAD	cis	1	rs2286503	chr7:22856606	TOMM7	chr7:22852254-22862421:-	-0.34	-4.9	1.7E-6	Fibrinogen	
COAD	cis	1	rs2286809	chr11:22851455	SVIP	chr11:22843600-22851382:-	0.28	3.93	0.000109	Dialysis-related mortality	
COAD	cis	1	rs2288344	chr15:56122347	PRTG	chr15:55903748-56035177:-	0.21	3.95	0.0001	Keloid	
COAD	cis	1	rs2288871	chr19:41917868	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.56	7.97E-6	Height	
COAD	cis	1	rs2289329	chr15:40705159	DISP2	chr15:40650434-40663256:+	0.3	4.48	1.11E-5	Blood metabolite levels;Blood metabolite ratios	
COAD	cis	1	rs2289681	chr17:42989088	ACBD4	chr17:43209967-43221541:+	0.41	4.05	6.69E-5	Cognitive function	
COAD	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.29	-4.93	1.45E-6	Longevity	
COAD	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.72	-12.72	3.77E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.68	10.24	6.82E-21	Cognitive function	
COAD	cis	1	rs2292986	chr19:21776332	ZNF738	chr19:21541735-21571383:+	-0.28	-3.83	0.000159	Colorectal or endometrial cancer	
COAD	cis	1	rs2293551	chr1:202408594	PPP1R12B	chr1:202317836-202557697:+	0.21	3.96	9.64E-5	Sex ratio	
COAD	cis	1	rs2293552	chr1:202408751	PPP1R12B	chr1:202317836-202557697:+	0.21	3.96	9.64E-5	Sex ratio	
COAD	cis	1	rs2294296	chr22:39053049	CBY1	chr22:39052658-39069853:+	0.36	6.06	4.67E-9	Resting heart rate	
COAD	cis	1	rs2294296	chr22:39053049	JOSD1	chr22:39081549-39096459:-	-0.28	-4.73	3.75E-6	Resting heart rate	
COAD	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.18	4.23	3.2E-5	Blood metabolite levels	
COAD	cis	1	rs2296747	chr6:33744882	HLA-DOB	chr6:32780541-32784825:-	0.22	4.27	2.73E-5	Crohn's disease	
COAD	cis	1	rs2296747	chr6:33744882	LEMD2	chr6:33738991-33756906:-	-0.21	-3.9	0.000123	Crohn's disease	
COAD	cis	1	rs2296748	chr6:33745071	HLA-DOB	chr6:32780541-32784825:-	0.22	4.21	3.51E-5	Crohn's disease	
COAD	cis	1	rs2298914	chr1:171710405	VAMP4	chr1:171669298-171711214:-	0.37	5.1	6.52E-7	Hippocampal atrophy	
COAD	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.29	4.79	2.86E-6	Height	
COAD	cis	1	rs2301889	chr7:98931105	CYP3A5	chr7:99245818-99332821:-	0.63	7.8	1.45E-13	Blood metabolite levels	
COAD	cis	1	rs2303339	chr2:86346180	LOC90784	chr2:86247339-86250991:-	0.7	5.49	9.67E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs2303339	chr2:86346180	MAT2A	chr2:85766288-85772401:+	0.52	3.82	0.000165	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs2303340	chr2:86333193	LOC90784	chr2:86247339-86250991:-	-0.6	-4.77	3.11E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs2304242	chr19:41944616	B3GNT8	chr19:41931265-41934635:-	0.32	5.17	4.63E-7	Height	
COAD	cis	1	rs2304641	chr1:85513398	MCOLN2	chr1:85391267-85462796:-	-0.5	-5.19	4.14E-7	Serum sulfate level	
COAD	cis	1	rs2305188	chr4:1739592	FAM53A	chr4:1641609-1685854:-	-0.37	-5.3	2.41E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.53	5.13	5.8E-7	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.54	5.99	6.76E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs2315281	chr19:19480099	HAPLN4	chr19:19366453-19384074:-	-0.26	-3.94	0.000106	Schizophrenia	
COAD	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.63	-8.51	1.42E-15	Response to antipsychotic treatment	
COAD	cis	1	rs2336540	chr3:52974589	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.04	5.29E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs2336541	chr3:52974630	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.04	5.29E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs2346676	chr16:67223803	LRRC29	chr16:67241043-67260901:-	-0.47	-6.11	3.69E-9	HDL cholesterol	
COAD	cis	1	rs2356501	chr6:118942371	C6orf204	chr6:118786239-119031238:-	-0.28	-4.58	7.27E-6	Renal cell carcinoma	
COAD	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.55	-8.33	4.51E-15	Homocysteine levels	
COAD	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.48	-7.17	7.56E-12	Homocysteine levels	
COAD	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.39	-6.64	1.82E-10	Common traits (Other)	
COAD	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.41	-7.1	1.22E-11	Common traits (Other)	
COAD	cis	1	rs2359821	chr19:22208314	ZNF208	chr19:22115760-22193745:-	0.21	3.85	0.000151	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2359821	chr19:22208314	ZNF257	chr19:22235266-22273901:+	0.39	4.92	1.52E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs2361453	chr1:202336314	PPP1R12B	chr1:202317836-202557697:+	0.2	3.89	0.000129	Sex ratio	
COAD	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.28	-4.57	7.65E-6	Longevity	
COAD	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.26	4.4	1.57E-5	Longevity	
COAD	cis	1	rs2363286	chr7:1091625	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.45	1.27E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.76	-6.62	2.09E-10	Plasma clusterin levels	
COAD	cis	1	rs2367526	chr5:90740525	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs2368984	chr14:104372055	TDRD9	chr14:104394817-104519002:+	0.32	4.77	3.1E-6	Bipolar disorder	
COAD	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.65	9.64	5.03E-19	Height	
COAD	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.36	4.81	2.59E-6	Height	
COAD	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.59	8.85	1.35E-16	Height	
COAD	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.43	1.36E-5	Obesity-related traits	
COAD	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.45	1.29E-5	Obesity-related traits	
COAD	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.39	1.63E-5	Obesity-related traits	
COAD	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.85	1.35E-16	Height	
COAD	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.35	-4.52	9.2E-6	Height	
COAD	cis	1	rs2395449	chr6:33728755	HLA-DOB	chr6:32780541-32784825:-	0.24	4.33	2.13E-5	Crohn's disease	
COAD	cis	1	rs2403083	chr8:86108149	LRRCC1	chr8:86019377-86058312:+	0.29	4.48	1.12E-5	Plasma amyloid beta peptide concentrations (ABx-40)	
COAD	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.25	-3.96	9.49E-5	Blood metabolite levels	
COAD	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.25	-3.96	9.49E-5	Blood metabolite levels	
COAD	cis	1	rs2413544	chr22:39059404	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs2413544	chr22:39059404	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs2413545	chr22:39092524	CBY1	chr22:39052658-39069853:+	0.41	6.53	3.5E-10	Resting heart rate	
COAD	cis	1	rs2413546	chr22:39107001	CBY1	chr22:39052658-39069853:+	0.38	6.41	6.79E-10	Resting heart rate	
COAD	cis	1	rs2413546	chr22:39107001	JOSD1	chr22:39081549-39096459:-	-0.26	-4.32	2.2E-5	Resting heart rate	
COAD	cis	1	rs2413547	chr22:39107338	CBY1	chr22:39052658-39069853:+	0.38	6.41	6.79E-10	Resting heart rate	
COAD	cis	1	rs2413547	chr22:39107338	JOSD1	chr22:39081549-39096459:-	-0.26	-4.32	2.2E-5	Resting heart rate	
COAD	cis	1	rs2414885	chr15:66034624	DENND4A	chr15:65952959-66084631:-	-0.21	-4.01	8.01E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.37	4.78	2.91E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs2415255	chr15:75332412	SCAMP5	chr15:75287901-75313836:+	0.36	4.41	1.51E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs2416937	chr9:102680637	STX17	chr9:102668915-102736817:+	-0.28	-3.91	0.000119	Alopecia areata	
COAD	cis	1	rs2416942	chr9:102706489	STX17	chr9:102668915-102736817:+	-0.28	-3.93	0.000109	Alopecia areata	
COAD	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.21	-4.04	6.96E-5	Height	
COAD	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.2	-3.92	0.000112	Height	
COAD	cis	1	rs2425697	chr20:44025175	SYS1-DBNDD2	chr20:43991701-44039245:+	0.4	4.44	1.35E-5	Psoriasis	
COAD	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.94	12.14	3.56E-27	Type 2 diabetes	
COAD	cis	1	rs2440845	chr10:59971884	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2440846	chr10:59974293	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2440847	chr10:59996176	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2440848	chr10:59996403	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2440849	chr10:60002164	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.23E-5	Inflammatory bowel disease	
COAD	cis	1	rs2440850	chr10:60011731	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2440855	chr10:59964744	IPMK	chr10:59955618-60027694:-	0.25	4.16	4.24E-5	Inflammatory bowel disease	
COAD	cis	1	rs2440856	chr10:60030789	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs244299	chr17:53240266	STXBP4	chr17:53046126-53241449:+	0.26	3.99	8.43E-5	Menarche (age at onset)	
COAD	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.59	6.31	1.21E-9	Tumor biomarkers	
COAD	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.45	5.74	2.68E-8	Tumor biomarkers	
COAD	cis	1	rs2447196	chr15:43893818	LCMT2	chr15:43619976-43622891:-	0.41	4.43	1.38E-5	Tumor biomarkers	
COAD	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.55	-5.75	2.54E-8	Tumor biomarkers	
COAD	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.46	-5.81	1.8E-8	Tumor biomarkers	
COAD	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.56	-5.76	2.37E-8	Tumor biomarkers	
COAD	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.46	-5.8	1.96E-8	Tumor biomarkers	
COAD	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.37	6.72	1.17E-10	Homocysteine levels	
COAD	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.55	-9.62	5.95E-19	Folate pathway vitamin levels	
COAD	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.53	-8.39	3.04E-15	Ankylosing spondylitis	
COAD	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.43	5.6	5.37E-8	Ankylosing spondylitis	
COAD	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.59	6.01	6.13E-9	Tumor biomarkers	
COAD	cis	1	rs2470134	chr15:43849886	LCMT2	chr15:43619976-43622891:-	0.43	4.4	1.58E-5	Tumor biomarkers	
COAD	cis	1	rs2486483	chr10:60003000	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.23E-5	Inflammatory bowel disease	
COAD	cis	1	rs2486486	chr10:60046654	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.53	-9.16	1.54E-17	Folate pathway vitamin levels	
COAD	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.54	-9.32	5.01E-18	Folate pathway vitamin levels	
COAD	cis	1	rs2502757	chr9:136586954	SARDH	chr9:136528686-136605077:-	-0.31	-5.07	7.64E-7	Asthma	
COAD	cis	1	rs2511155	chr11:77969223	USP35	chr11:77899858-77925753:+	0.3	3.85	0.000151	Testicular germ cell tumor	
COAD	cis	1	rs2511168	chr11:77965081	USP35	chr11:77899858-77925753:+	0.3	4	8.12E-5	Testicular germ cell tumor	
COAD	cis	1	rs2512532	chr11:77968641	USP35	chr11:77899858-77925753:+	0.3	3.85	0.000151	Testicular germ cell tumor	
COAD	cis	1	rs2521263	chr11:2308762	C11orf21	chr11:2317507-2323143:-	-0.39	-4.41	1.54E-5	Obesity-related traits	
COAD	cis	1	rs2521263	chr11:2308762	TSPAN32	chr11:2323243-2339430:+	-0.37	-3.85	0.00015	Obesity-related traits	
COAD	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.33	-4.42	1.44E-5	Bipolar disorder and schizophrenia	
COAD	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.58	6.95	2.84E-11	Bipolar disorder and schizophrenia	
COAD	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	1.01	12.86	1.18E-29	Type 2 diabetes	
COAD	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.99	12.77	2.37E-29	Type 2 diabetes	
COAD	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.99	12.95	5.99E-30	Type 2 diabetes	
COAD	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.97	12.85	1.34E-29	Type 2 diabetes	
COAD	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.97	12.47	2.52E-28	Type 2 diabetes	
COAD	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	1.04	13.19	8.63E-31	Type 2 diabetes	
COAD	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.94	-12.39	4.84E-28	Type 2 diabetes	
COAD	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.95	12.61	8.65E-29	Type 2 diabetes	
COAD	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.98	12.96	5.47E-30	Type 2 diabetes	
COAD	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.97	12.89	9.56E-30	Type 2 diabetes	
COAD	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.97	12.89	9.56E-30	Type 2 diabetes	
COAD	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.99	13.28	4.41E-31	Type 2 diabetes	
COAD	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.99	13.28	4.41E-31	Type 2 diabetes	
COAD	cis	1	rs2564926	chr3:53094730	SFMBT1	chr3:52938628-53080070:-	0.48	4.38	1.7E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs2564926	chr3:53094730	TMEM110	chr3:52867139-52931547:-	-0.5	-4.71	4.05E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.3	-4.3	2.4E-5	Height	
COAD	cis	1	rs2564956	chr3:53070462	SFMBT1	chr3:52938628-53080070:-	-0.32	-5.07	7.56E-7	Ulcerative colitis	
COAD	cis	1	rs2569754	chr19:41936734	B3GNT8	chr19:41931265-41934635:-	-0.33	-5.22	3.63E-7	Height	
COAD	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.27	-4.02	7.58E-5	Height	
COAD	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.27	-4.02	7.58E-5	Height	
COAD	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.26	-3.86	0.000145	Height	
COAD	cis	1	rs2581817	chr3:53071797	SFMBT1	chr3:52938628-53080070:-	-0.31	-4.94	1.39E-6	Ulcerative colitis	
COAD	cis	1	rs2583282	chr12:104313579	C12orf73	chr12:104343981-104359473:-	0.24	4.02	7.59E-5	Coronary heart disease	
COAD	cis	1	rs2590299	chr10:59969000	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590305	chr10:59973844	IPMK	chr10:59955618-60027694:-	0.25	4.11	5.3E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590306	chr10:59976966	IPMK	chr10:59955618-60027694:-	0.23	3.88	0.000135	Inflammatory bowel disease	
COAD	cis	1	rs2590307	chr10:59977161	IPMK	chr10:59955618-60027694:-	0.24	4.09	5.77E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590308	chr10:59977569	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590311	chr10:59983565	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590313	chr10:59986383	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590315	chr10:59986492	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590317	chr10:59987658	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590321	chr10:59996693	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590323	chr10:60000781	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.23E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590330	chr10:60008219	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.23E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590335	chr10:60009389	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.23E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590336	chr10:60010497	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.23E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590339	chr10:60012231	IPMK	chr10:59955618-60027694:-	0.26	4.34	2.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590340	chr10:60012271	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590344	chr10:60013067	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590348	chr10:60014595	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590349	chr10:60014646	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590356	chr10:60019047	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590357	chr10:60019964	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590358	chr10:60020982	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590359	chr10:60021247	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590364	chr10:60038406	IPMK	chr10:59955618-60027694:-	0.25	4.2	3.72E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590367	chr10:60041574	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590368	chr10:60043482	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590370	chr10:60049020	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.15E-5	Inflammatory bowel disease	
COAD	cis	1	rs2590371	chr10:60054487	IPMK	chr10:59955618-60027694:-	0.24	4.09	5.67E-5	Inflammatory bowel disease	
COAD	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.43	4.5	1.03E-5	Response to cytadine analogues (cytosine arabinoside)	
COAD	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.46	-4.5	1.02E-5	Response to cytadine analogues (cytosine arabinoside)	
COAD	cis	1	rs2597328	chr8:133436380	LRRC6	chr8:133584448-133687813:-	-0.31	-3.85	0.00015	LDL peak particle diameter (total fat intake interaction)	
COAD	cis	1	rs2602836	chr4:100014805	ADH4	chr4:100044835-100065449:-	0.46	6.71	1.22E-10	HDL cholesterol	
COAD	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.51	-5.24	3.27E-7	Tumor biomarkers	
COAD	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.43	-5.45	1.16E-7	Tumor biomarkers	
COAD	cis	1	rs2630252	chr3:128624772	ACAD9	chr3:128598333-128634910:+	-0.33	-4	8.27E-5	IgG glycosylation	
COAD	cis	1	rs2637678	chr6:116787378	FAM26F	chr6:116782556-116784933:+	0.2	4.44	1.35E-5	Ulcerative colitis	
COAD	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.46	-4.5	1.02E-5	Response to cytadine analogues (cytosine arabinoside)	
COAD	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.44	-4.36	1.87E-5	Response to cytadine analogues (cytosine arabinoside)	
COAD	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.5	-7.99	4.32E-14	Ankylosing spondylitis	
COAD	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.44	5.77	2.25E-8	Ankylosing spondylitis	
COAD	cis	1	rs2651829	chr11:2308304	C11orf21	chr11:2317507-2323143:-	0.3	3.99	8.65E-5	Obesity-related traits	
COAD	cis	1	rs2653503	chr10:59964034	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2653504	chr10:59964042	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2653505	chr10:59964142	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.34	-4.68	4.7E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs2659915	chr7:66153101	NCRNA00174	chr7:65841032-65865395:-	0.19	3.91	0.000116	Aortic root size	
COAD	cis	1	rs26965	chr5:112739017	REEP5	chr5:112212081-112258031:-	0.41	4.61	6.21E-6	F-cell distribution	
COAD	cis	1	rs2723620	chr11:6523657	OLFML1	chr11:7506755-7532561:+	0.11	3.93	0.000108	DNA methylation (variation)	
COAD	cis	1	rs2727099	chr15:66063428	DENND4A	chr15:65952959-66084631:-	-0.2	-3.94	0.000105	Mean corpuscular hemoglobin	
COAD	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.32	-4.27	2.8E-5	Information processing speed	
COAD	cis	1	rs2741432	chr20:43989514	SYS1-DBNDD2	chr20:43991701-44039245:+	0.38	4.07	6.28E-5	Psoriasis	
COAD	cis	1	rs2741435	chr20:43988198	SYS1-DBNDD2	chr20:43991701-44039245:+	0.38	4.27	2.68E-5	Psoriasis	
COAD	cis	1	rs2741611	chr20:44020809	SYS1-DBNDD2	chr20:43991701-44039245:+	0.38	4.25	2.95E-5	Psoriasis	
COAD	cis	1	rs2741612	chr20:44019972	SYS1-DBNDD2	chr20:43991701-44039245:+	0.38	4.25	2.95E-5	Psoriasis	
COAD	cis	1	rs2741639	chr20:44008432	SYS1-DBNDD2	chr20:43991701-44039245:+	0.41	4.48	1.14E-5	Psoriasis	
COAD	cis	1	rs2741640	chr20:44008408	SYS1-DBNDD2	chr20:43991701-44039245:+	0.41	4.48	1.14E-5	Psoriasis	
COAD	cis	1	rs2743237	chr20:44026618	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	4.01	8.08E-5	Psoriasis	
COAD	cis	1	rs2743414	chr20:43991566	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	3.9	0.000124	Psoriasis	
COAD	cis	1	rs2743419	chr20:43992645	SYS1-DBNDD2	chr20:43991701-44039245:+	0.37	4.05	6.86E-5	Psoriasis	
COAD	cis	1	rs2743423	chr20:43993539	SYS1-DBNDD2	chr20:43991701-44039245:+	0.37	4.05	6.86E-5	Psoriasis	
COAD	cis	1	rs2743424	chr20:43993934	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	3.9	0.000124	Psoriasis	
COAD	cis	1	rs2743439	chr20:43999636	SYS1-DBNDD2	chr20:43991701-44039245:+	0.39	4.16	4.37E-5	Psoriasis	
COAD	cis	1	rs27529	chr5:96126308	ELL2	chr5:95220804-95297775:-	0.22	3.81	0.00017	Ankylosing spondylitis	
COAD	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.47	-7.44	1.47E-12	Ankylosing spondylitis	
COAD	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.44	5.76	2.32E-8	Ankylosing spondylitis	
COAD	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.49	7.83	1.25E-13	Ankylosing spondylitis	
COAD	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.45	-6	6.46E-9	Ankylosing spondylitis	
COAD	cis	1	rs2790145	chr10:59976277	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790146	chr10:59975743	IPMK	chr10:59955618-60027694:-	0.23	3.84	0.000153	Inflammatory bowel disease	
COAD	cis	1	rs2790157	chr10:59973396	IPMK	chr10:59955618-60027694:-	0.25	4.19	3.75E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790159	chr10:60018794	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790161	chr10:59968090	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790167	chr10:60024470	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790168	chr10:60025448	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790169	chr10:60025654	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790170	chr10:60028507	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790172	chr10:60008464	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.23E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790173	chr10:60031575	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790174	chr10:60031931	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790178	chr10:60034083	IPMK	chr10:59955618-60027694:-	0.24	4	8.2E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790179	chr10:60035372	IPMK	chr10:59955618-60027694:-	-0.24	-4	8.14E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790185	chr10:60041840	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790188	chr10:60042186	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790191	chr10:60045091	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790193	chr10:60046226	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790212	chr10:60013138	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790214	chr10:60013404	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790216	chr10:59997926	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790217	chr10:59997644	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790218	chr10:59997301	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790219	chr10:60013849	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790222	chr10:59995438	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790228	chr10:60014325	IPMK	chr10:59955618-60027694:-	0.25	4.18	3.93E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790230	chr10:59989772	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790231	chr10:59989010	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790235	chr10:59985274	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790238	chr10:59983573	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790240	chr10:59982139	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs2790241	chr10:60015313	IPMK	chr10:59955618-60027694:-	0.23	3.81	0.00017	Inflammatory bowel disease	
COAD	cis	1	rs2790242	chr10:59980652	IPMK	chr10:59955618-60027694:-	-0.23	-3.84	0.000155	Inflammatory bowel disease	
COAD	cis	1	rs2791603	chr3:195142939	C3orf21	chr3:194789015-194991895:-	-0.34	-4.69	4.38E-6	Body mass index	
COAD	cis	1	rs2799077	chr6:28234597	ZSCAN23	chr6:28393287-28411279:-	0.36	3.95	0.000101	Depression	
COAD	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.64	-9.93	6.32E-20	Response to antipsychotic treatment	
COAD	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.64	-9.93	6.32E-20	Response to antipsychotic treatment	
COAD	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.64	-9.93	6.32E-20	Response to antipsychotic treatment	
COAD	cis	1	rs2821117	chr1:197328594	DENND1B	chr1:197479509-197744623:-	-0.28	-4.8	2.69E-6	Asthma	
COAD	cis	1	rs282802	chr15:80072820	MTHFS	chr15:80137320-80189370:-	0.28	4.33	2.11E-5	Disease-free survival in breast cancer	
COAD	cis	1	rs282804	chr15:80071108	MTHFS	chr15:80137320-80189370:-	-0.32	-4.94	1.42E-6	Disease-free survival in breast cancer	
COAD	cis	1	rs2832065	chr21:30135362	N6AMT1	chr21:30244513-30257693:-	-0.4	-4.72	3.8E-6	Cognitive test performance	
COAD	cis	1	rs2832077	chr21:30141021	CCT8	chr21:30428650-30446010:-	-0.28	-3.9	0.000122	Cognitive test performance	
COAD	cis	1	rs2832077	chr21:30141021	N6AMT1	chr21:30244513-30257693:-	-0.47	-5.78	2.11E-8	Cognitive test performance	
COAD	cis	1	rs2832183	chr21:30482150	N6AMT1	chr21:30244513-30257693:-	-0.31	-4.52	9.4E-6	Dental caries	
COAD	cis	1	rs2832184	chr21:30483265	N6AMT1	chr21:30244513-30257693:-	-0.32	-4.63	5.66E-6	Dental caries	
COAD	cis	1	rs2832185	chr21:30483761	N6AMT1	chr21:30244513-30257693:-	-0.31	-4.57	7.6E-6	Dental caries	
COAD	cis	1	rs2832189	chr21:30487414	N6AMT1	chr21:30244513-30257693:-	-0.32	-4.63	5.66E-6	Dental caries	
COAD	cis	1	rs2832190	chr21:30488226	N6AMT1	chr21:30244513-30257693:-	-0.32	-4.63	5.82E-6	Dental caries	
COAD	cis	1	rs2832191	chr21:30489300	N6AMT1	chr21:30244513-30257693:-	-0.33	-4.9	1.66E-6	Dental caries	
COAD	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.32	-4.4	1.57E-5	Eye color traits	
COAD	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.31	-4.29	2.5E-5	Eye color traits	
COAD	cis	1	rs28360546	chr6:163210973	PACRG	chr6:163148164-163736523:+	0.5	5.01	1.01E-6	Body mass index	
COAD	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.41	5	1.06E-6	Atopic dermatitis	
COAD	cis	1	rs2836751	chr21:40290959	ETS2	chr21:40177231-40196876:+	0.37	5.87	1.3E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs2836751	chr21:40290959	PSMG1	chr21:40547390-40555440:-	0.23	3.89	0.000127	Body mass index;Crohn's disease	
COAD	cis	1	rs2836753	chr21:40291187	ETS2	chr21:40177231-40196876:+	0.37	5.82	1.72E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs2836754	chr21:40291740	ETS2	chr21:40177231-40196876:+	-0.4	-6.17	2.61E-9	Body mass index;Crohn's disease	
COAD	cis	1	rs2836754	chr21:40291740	PSMG1	chr21:40547390-40555440:-	-0.24	-4.14	4.75E-5	Body mass index;Crohn's disease	
COAD	cis	1	rs2836755	chr21:40292704	ETS2	chr21:40177231-40196876:+	0.36	5.58	5.94E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs2836756	chr21:40293081	ETS2	chr21:40177231-40196876:+	0.36	5.58	5.94E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs2836758	chr21:40295162	ETS2	chr21:40177231-40196876:+	0.35	5.35	1.95E-7	Body mass index;Crohn's disease	
COAD	cis	1	rs28374715	chr15:41563950	INO80	chr15:41271081-41408340:-	0.31	4.48	1.13E-5	Ulcerative colitis	
COAD	cis	1	rs28374891	chr4:120183550	FABP2	chr4:120238406-120243316:-	0.37	5.63	4.62E-8	Corneal astigmatism	
COAD	cis	1	rs28379681	chr7:1070539	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs2838517	chr21:45613825	ICOSLG	chr21:45646724-45660834:-	0.28	3.81	0.000171	Inflammatory bowel disease	
COAD	cis	1	rs28385906	chr12:122599361	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.43	-6.15	2.91E-9	Testicular germ cell tumor	
COAD	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.48	-7.02	1.92E-11	Testicular germ cell tumor	
COAD	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.29	3.92	0.000113	Atopic dermatitis	
COAD	cis	1	rs28399710	chr7:1070631	ZFAND2A	chr7:1192544-1199855:-	-0.38	-3.96	9.84E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs28406132	chr8:96030377	C8orf38	chr8:95908040-96088396:+	-0.3	-4	8.31E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs28414202	chr12:122590563	MLXIP	chr12:122516760-122628965:+	0.22	4.45	1.28E-5	Urate levels	
COAD	cis	1	rs28419773	chr4:120211061	FABP2	chr4:120238406-120243316:-	0.39	5.92	1.02E-8	Corneal astigmatism	
COAD	cis	1	rs28430881	chr12:122602899	MLXIP	chr12:122516760-122628965:+	0.2	3.9	0.000122	Urate levels	
COAD	cis	1	rs28444423	chr15:65982141	DENND4A	chr15:65952959-66084631:-	-0.21	-4.06	6.49E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs28448438	chr4:56416665	SRD5A3	chr4:56212409-56237866:+	-0.26	-4.31	2.28E-5	Personality dimensions	
COAD	cis	1	rs28450064	chr12:122598941	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs28463311	chr17:61919643	FTSJ3	chr17:61896795-61905031:-	0.3	3.96	9.68E-5	Body mass index	
COAD	cis	1	rs28463765	chr4:56412434	SRD5A3	chr4:56212409-56237866:+	-0.25	-4.11	5.34E-5	Personality dimensions	
COAD	cis	1	rs28464252	chr12:122599856	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs284648	chr19:41926790	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.02E-7	Height	
COAD	cis	1	rs284649	chr19:41926838	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.02E-7	Height	
COAD	cis	1	rs284650	chr19:41927129	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.02E-7	Height	
COAD	cis	1	rs284651	chr19:41928336	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.09E-7	Height	
COAD	cis	1	rs284652	chr19:41928652	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.09E-7	Height	
COAD	cis	1	rs284654	chr19:41928724	B3GNT8	chr19:41931265-41934635:-	-0.29	-4.75	3.33E-6	Height	
COAD	cis	1	rs284655	chr19:41928765	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.09E-7	Height	
COAD	cis	1	rs284656	chr19:41929251	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.09E-7	Height	
COAD	cis	1	rs284657	chr19:41929915	B3GNT8	chr19:41931265-41934635:-	-0.26	-4.37	1.83E-5	Height	
COAD	cis	1	rs284658	chr19:41929988	B3GNT8	chr19:41931265-41934635:-	-0.26	-4.34	2.08E-5	Height	
COAD	cis	1	rs284663	chr19:41932612	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.12	5.8E-7	Height	
COAD	cis	1	rs28468623	chr7:98922812	CYP3A5	chr7:99245818-99332821:-	0.59	7.35	2.6E-12	Blood metabolite levels	
COAD	cis	1	rs28478366	chr12:122606662	MLXIP	chr12:122516760-122628965:+	0.24	4.77	3.07E-6	Urate levels	
COAD	cis	1	rs28478717	chr12:122602939	MLXIP	chr12:122516760-122628965:+	0.23	4.51	9.75E-6	Urate levels	
COAD	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.46	-6.39	7.38E-10	Glycated hemoglobin levels	
COAD	cis	1	rs28513831	chr8:124189208	FAM83A	chr8:124191287-124222317:+	-0.44	-3.93	0.000111	Urinary uromodulin levels	
COAD	cis	1	rs28514423	chr4:56429239	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.86	2.0E-6	Personality dimensions	
COAD	cis	1	rs28528096	chr7:1070912	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs28529535	chr12:122600803	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs28537152	chr8:124189071	FAM83A	chr8:124191287-124222317:+	-0.44	-3.93	0.000111	Urinary uromodulin levels	
COAD	cis	1	rs2854218	chr17:61942940	FTSJ3	chr17:61896795-61905031:-	0.37	4.95	1.31E-6	Body mass index	
COAD	cis	1	rs2854219	chr17:61942682	FTSJ3	chr17:61896795-61905031:-	0.31	4.12	4.99E-5	Body mass index	
COAD	cis	1	rs2854223	chr17:61939014	FTSJ3	chr17:61896795-61905031:-	0.28	4.05	6.79E-5	Body mass index	
COAD	cis	1	rs28548845	chr12:122594249	MLXIP	chr12:122516760-122628965:+	0.22	4.45	1.28E-5	Urate levels	
COAD	cis	1	rs28556680	chr15:66023799	DENND4A	chr15:65952959-66084631:-	-0.21	-4.01	8.01E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs28558726	chr17:53058676	STXBP4	chr17:53046126-53241449:+	-0.29	-4.03	7.23E-5	Breast cancer	
COAD	cis	1	rs28569273	chr12:122593042	MLXIP	chr12:122516760-122628965:+	0.21	4.12	5.16E-5	Urate levels	
COAD	cis	1	rs28572116	chr4:56424344	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.49	1.08E-5	Personality dimensions	
COAD	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.44	-4.39	1.67E-5	Response to cytadine analogues (cytosine arabinoside)	
COAD	cis	1	rs28580691	chr17:37965567	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs28582059	chr4:56408404	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.83	2.28E-6	Personality dimensions	
COAD	cis	1	rs28600861	chr8:124189063	FAM83A	chr8:124191287-124222317:+	-0.44	-3.93	0.000111	Urinary uromodulin levels	
COAD	cis	1	rs28605425	chr12:122596148	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs28605789	chr6:118889952	C6orf204	chr6:118786239-119031238:-	-0.27	-4.46	1.22E-5	Renal cell carcinoma	
COAD	cis	1	rs28626045	chr14:75589195	MLH3	chr14:75480467-75518235:-	0.28	4.87	1.93E-6	Height	
COAD	cis	1	rs28626850	chr12:122600968	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.55	8.7	3.92E-16	Forced vital capacity	
COAD	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.55	8.61	7.14E-16	Forced vital capacity	
COAD	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.55	-8.83	1.56E-16	Forced vital capacity	
COAD	cis	1	rs28639626	chr12:122599042	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs28649184	chr12:122599259	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs28651964	chr8:96026781	C8orf38	chr8:95908040-96088396:+	-0.28	-3.82	0.000167	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.44	-4.62	5.91E-6	Bone mineral density	
COAD	cis	1	rs28670674	chr4:56407103	SRD5A3	chr4:56212409-56237866:+	-0.26	-4.18	3.95E-5	Personality dimensions	
COAD	cis	1	rs28670850	chr8:124189125	FAM83A	chr8:124191287-124222317:+	-0.44	-3.93	0.000111	Urinary uromodulin levels	
COAD	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.35	-5.25	3.17E-7	Educational attainment;Height;Head circumference (infant)	
COAD	cis	1	rs28694222	chr8:124195017	FAM83A	chr8:124191287-124222317:+	-0.46	-4.07	6.36E-5	Urinary uromodulin levels	
COAD	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.62	8.28	6.28E-15	Diastolic blood pressure	
COAD	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.66	9.61	6.66E-19	Diastolic blood pressure	
COAD	cis	1	rs28737311	chr12:122601289	MLXIP	chr12:122516760-122628965:+	0.22	4.45	1.28E-5	Urate levels	
COAD	cis	1	rs28739522	chr12:122599834	MLXIP	chr12:122516760-122628965:+	0.24	4.71	4.06E-6	Urate levels	
COAD	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.42	-4.7	4.21E-6	Bone mineral density	
COAD	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.41	-4.59	6.79E-6	Bone mineral density	
COAD	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.57	7.51	9.38E-13	Diastolic blood pressure	
COAD	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.26	4.38	1.75E-5	Longevity	
COAD	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.64	9.65	4.81E-19	Height	
COAD	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.3	4.09	5.66E-5	Height	
COAD	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.25	-3.9	0.000124	Blood metabolite levels	
COAD	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.55	-5.59	5.57E-8	Tumor biomarkers	
COAD	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.46	-5.73	2.81E-8	Tumor biomarkers	
COAD	cis	1	rs2924584	chr4:99988208	ADH4	chr4:100044835-100065449:-	-0.43	-6.35	9.27E-10	HDL cholesterol	
COAD	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.52	-5.37	1.78E-7	Tumor biomarkers	
COAD	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.43	-5.46	1.12E-7	Tumor biomarkers	
COAD	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.33	4.42	1.47E-5	Obesity-related traits	
COAD	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.32	-4.32	2.17E-5	Obesity-related traits	
COAD	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.39	1.63E-5	Obesity-related traits	
COAD	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.34	-4.46	1.21E-5	Obesity-related traits	
COAD	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.02	7.68E-5	Obesity-related traits	
COAD	cis	1	rs2951363	chr7:143754724	OR2A7	chr7:143955790-143974852:-	0.29	3.97	9.17E-5	Obesity-related traits	
COAD	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.28	-3.91	0.00012	Obesity-related traits	
COAD	cis	1	rs2951364	chr7:143754483	OR2A7	chr7:143955790-143974852:-	0.28	3.9	0.000122	Obesity-related traits	
COAD	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.02	7.68E-5	Obesity-related traits	
COAD	cis	1	rs2951368	chr7:143752821	OR2A7	chr7:143955790-143974852:-	0.29	3.97	9.17E-5	Obesity-related traits	
COAD	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.28	-3.91	0.00012	Obesity-related traits	
COAD	cis	1	rs2951369	chr7:143752638	OR2A7	chr7:143955790-143974852:-	0.28	3.9	0.000122	Obesity-related traits	
COAD	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.02	7.68E-5	Obesity-related traits	
COAD	cis	1	rs2951372	chr7:143749503	OR2A7	chr7:143955790-143974852:-	0.29	3.97	9.17E-5	Obesity-related traits	
COAD	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.02	7.68E-5	Obesity-related traits	
COAD	cis	1	rs2961115	chr7:143753371	OR2A7	chr7:143955790-143974852:-	0.29	3.97	9.17E-5	Obesity-related traits	
COAD	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.32	-4.29	2.57E-5	Obesity-related traits	
COAD	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.32	-4.3	2.38E-5	Obesity-related traits	
COAD	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.19	3.88E-5	Obesity-related traits	
COAD	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.34	-4.46	1.21E-5	Obesity-related traits	
COAD	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.39	1.63E-5	Obesity-related traits	
COAD	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.39	1.63E-5	Obesity-related traits	
COAD	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.39	1.63E-5	Obesity-related traits	
COAD	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.44	1.3E-5	Obesity-related traits	
COAD	cis	1	rs2961134	chr7:143771062	OR2A7	chr7:143955790-143974852:-	0.32	4.47	1.18E-5	Obesity-related traits	
COAD	cis	1	rs2961144	chr7:143747870	OR2A7	chr7:143955790-143974852:-	-0.31	-4.25	2.97E-5	Obesity-related traits	
COAD	cis	1	rs2965198	chr19:19473030	HAPLN4	chr19:19366453-19384074:-	-0.27	-3.92	0.000112	Schizophrenia	
COAD	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.3	5.16	4.96E-7	Schizophrenia	
COAD	cis	1	rs2985697	chr14:50092902	RPL36AL	chr14:50085407-50087349:-	0.19	4.1	5.58E-5	Carotid intima media thickness	
COAD	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.63	-9.57	8.71E-19	Homocysteine levels	
COAD	cis	1	rs2993834	chr10:59971616	IPMK	chr10:59955618-60027694:-	0.25	4.17	4.22E-5	Inflammatory bowel disease	
COAD	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.5	-8.02	3.59E-14	Ankylosing spondylitis	
COAD	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.43	5.67	3.84E-8	Ankylosing spondylitis	
COAD	cis	1	rs302604	chr6:39731420	DAAM2	chr6:39760142-39872640:+	0.12	3.88	0.000133	Hypospadias	
COAD	cis	1	rs302660	chr11:87885448	RAB38	chr11:87846431-87908599:-	0.4	4.99	1.12E-6	Frontotemporal dementia	
COAD	cis	1	rs302662	chr11:87881236	RAB38	chr11:87846431-87908599:-	0.39	4.89	1.78E-6	Frontotemporal dementia	
COAD	cis	1	rs302663	chr11:87880759	RAB38	chr11:87846431-87908599:-	0.39	4.93	1.48E-6	Frontotemporal dementia	
COAD	cis	1	rs302668	chr11:87876911	RAB38	chr11:87846431-87908599:-	0.38	4.76	3.18E-6	Frontotemporal dementia	
COAD	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.53	-8.43	2.39E-15	Ankylosing spondylitis	
COAD	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.44	5.59	5.85E-8	Ankylosing spondylitis	
COAD	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.53	-8.43	2.39E-15	Ankylosing spondylitis	
COAD	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.44	5.59	5.85E-8	Ankylosing spondylitis	
COAD	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.53	-8.43	2.39E-15	Ankylosing spondylitis	
COAD	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.44	5.59	5.85E-8	Ankylosing spondylitis	
COAD	cis	1	rs3092744	chr20:44025282	SYS1-DBNDD2	chr20:43991701-44039245:+	0.37	4.21	3.54E-5	Psoriasis	
COAD	cis	1	rs3097417	chr3:53088601	SFMBT1	chr3:52938628-53080070:-	0.5	4.67	4.72E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs3097417	chr3:53088601	TMEM110	chr3:52867139-52931547:-	-0.48	-4.65	5.21E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	1.01	13.25	5.32E-31	Type 2 diabetes	
COAD	cis	1	rs3099555	chr4:1725651	FAM53A	chr4:1641609-1685854:-	-0.37	-5.44	1.22E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.51	-5.28	2.78E-7	Tumor biomarkers	
COAD	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.43	-5.41	1.46E-7	Tumor biomarkers	
COAD	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.34	-4.73	3.7E-6	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs3106351	chr2:188202989	CALCRL	chr2:188207851-188313021:-	-0.14	-4.31	2.32E-5	Coronary heart disease	
COAD	cis	1	rs3106352	chr2:188202673	CALCRL	chr2:188207851-188313021:-	-0.14	-4.57	7.52E-6	Coronary heart disease	
COAD	cis	1	rs3120662	chr1:152302865	FLG	chr1:152274651-152297679:-	0.24	3.85	0.000149	Atopic dermatitis	
COAD	cis	1	rs3125579	chr6:98908958	SFRS18	chr6:99846535-99873207:-	0.28	4.9	1.69E-6	Brain imaging in schizophrenia (interaction)	
COAD	cis	1	rs3126085	chr1:152300817	FLG	chr1:152274651-152297679:-	0.24	3.85	0.000149	Atopic dermatitis	
COAD	cis	1	rs315135	chr12:69762987	YEATS4	chr12:69753532-69784575:+	0.63	5.2	4.06E-7	Response to diuretic therapy	
COAD	cis	1	rs316009	chr6:160675764	SLC22A1	chr6:160542863-160579748:+	-0.5	-3.9	0.000121	Blood metabolite ratios	
COAD	cis	1	rs316010	chr6:160674557	SLC22A1	chr6:160542863-160579748:+	-0.53	-4.28	2.58E-5	Blood metabolite ratios	
COAD	cis	1	rs3180872	chr22:51017394	CPT1B	chr22:51007291-51017096:-	-0.47	-4.69	4.38E-6	Narcolepsy	
COAD	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.76	-6.85	5.19E-11	Dental caries	
COAD	cis	1	rs3213446	chr22:51015674	CPT1B	chr22:51007291-51017096:-	-0.43	-4.32	2.21E-5	Narcolepsy	
COAD	cis	1	rs3213861	chr19:41919944	B3GNT8	chr19:41931265-41934635:-	-0.33	-5.5	9.23E-8	Height	
COAD	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.29	-4.66	5.0E-6	Longevity	
COAD	cis	1	rs332529	chr5:90789470	LOC100129716	chr5:90676164-90716531:+	0.36	4.46	1.24E-5	Smoking behavior	
COAD	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	1.01	12.86	1.18E-29	Type 2 diabetes	
COAD	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.98	12.97	4.84E-30	Type 2 diabetes	
COAD	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	1.01	13.35	2.51E-31	Type 2 diabetes	
COAD	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.36	5.34	2.01E-7	Cognitive performance	
COAD	cis	1	rs33999310	chr3:52883332	SFMBT1	chr3:52938628-53080070:-	-0.68	-5.41	1.39E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs33999310	chr3:52883332	TMEM110	chr3:52867139-52931547:-	0.56	4.56	7.92E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34052221	chr6:163160803	PACRG	chr6:163148164-163736523:+	0.5	5	1.04E-6	Body mass index	
COAD	cis	1	rs34066731	chr6:163011047	PACRG	chr6:163148164-163736523:+	0.49	5.31	2.39E-7	Body mass index	
COAD	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.34	5.2	3.99E-7	Cognitive performance	
COAD	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.57	-8.51	1.38E-15	Response to antipsychotic treatment	
COAD	cis	1	rs34117728	chr5:156433497	HAVCR1	chr5:156456531-156486130:-	-0.36	-4.43	1.42E-5	Hypertriglyceridemia	
COAD	cis	1	rs34117728	chr5:156433497	TIMD4	chr5:156346293-156390266:-	-0.36	-4.73	3.64E-6	Hypertriglyceridemia	
COAD	cis	1	rs34121720	chr3:53072167	SFMBT1	chr3:52938628-53080070:-	-0.61	-5.33	2.17E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.22	3.61E-7	Subjective well-being	
COAD	cis	1	rs34177053	chr6:163007772	PACRG	chr6:163148164-163736523:+	0.38	4.36	1.91E-5	Body mass index	
COAD	cis	1	rs34192365	chr6:163012382	PACRG	chr6:163148164-163736523:+	0.52	5.59	5.77E-8	Body mass index	
COAD	cis	1	rs34228197	chr6:163008232	PACRG	chr6:163148164-163736523:+	0.38	4.36	1.91E-5	Body mass index	
COAD	cis	1	rs34230359	chr5:156449561	HAVCR1	chr5:156456531-156486130:-	-0.34	-4.4	1.55E-5	Hypertriglyceridemia	
COAD	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.34	4.34	2.08E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs34244302	chr3:53102236	SFMBT1	chr3:52938628-53080070:-	-0.6	-4.78	2.87E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34244302	chr3:53102236	TMEM110	chr3:52867139-52931547:-	0.47	3.85	0.000149	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34246550	chr8:89585399	MMP16	chr8:89049462-89339717:-	0.17	3.84	0.000154	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.62	-8.72	3.26E-16	Response to antipsychotic treatment	
COAD	cis	1	rs34291217	chr17:37944411	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs34313969	chr3:52995166	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.08	4.25E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34319345	chr16:58820592	GOT2	chr16:58741035-58768246:-	-0.31	-5.1	6.42E-7	Blood metabolite ratios	
COAD	cis	1	rs34340609	chr3:53077276	SFMBT1	chr3:52938628-53080070:-	-0.53	-6.18	2.47E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34340609	chr3:53077276	TMEM110	chr3:52867139-52931547:-	0.33	3.84	0.000157	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34344906	chr6:162993378	PACRG	chr6:163148164-163736523:+	0.51	5.49	9.47E-8	Body mass index	
COAD	cis	1	rs34398656	chr6:162999612	PACRG	chr6:163148164-163736523:+	0.38	4.29	2.48E-5	Body mass index	
COAD	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.4	-4.68	4.69E-6	Bone mineral density	
COAD	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.4	-4.68	4.69E-6	Bone mineral density	
COAD	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.4	-4.68	4.69E-6	Bone mineral density	
COAD	cis	1	rs34409160	chr2:28943865	PPP1CB	chr2:28974612-29025805:+	-0.25	-4.03	7.36E-5	Body mass index	
COAD	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.34	5.23	3.49E-7	Body mass index	
COAD	cis	1	rs34409737	chr5:156457857	HAVCR1	chr5:156456531-156486130:-	-0.36	-4.41	1.49E-5	Hypertriglyceridemia	
COAD	cis	1	rs34409737	chr5:156457857	TIMD4	chr5:156346293-156390266:-	-0.34	-4.44	1.35E-5	Hypertriglyceridemia	
COAD	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.38	6.26	1.55E-9	Inflammatory skin disease	
COAD	cis	1	rs34443622	chr6:163208214	PACRG	chr6:163148164-163736523:+	0.55	5.56	6.64E-8	Body mass index	
COAD	cis	1	rs3448	chr3:49396751	WDR6	chr3:49044637-49053386:+	-0.31	-4.29	2.47E-5	Menarche (age at onset)	
COAD	cis	1	rs34530577	chr3:53103796	RFT1	chr3:53122503-53164470:-	-0.31	-4.48	1.14E-5	Height	
COAD	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.62	-8.72	3.26E-16	Response to antipsychotic treatment	
COAD	cis	1	rs34586537	chr2:70163316	GMCL1	chr2:70056818-70106727:+	-0.23	-4.47	1.19E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs34594856	chr6:163051845	PACRG	chr6:163148164-163736523:+	0.52	5.11	6.36E-7	Body mass index	
COAD	cis	1	rs34619021	chr6:163029767	PACRG	chr6:163148164-163736523:+	0.51	5.47	1.06E-7	Body mass index	
COAD	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.57	-8.43	2.37E-15	Response to antipsychotic treatment	
COAD	cis	1	rs34637087	chr6:163004064	PACRG	chr6:163148164-163736523:+	0.49	5.27	2.88E-7	Body mass index	
COAD	cis	1	rs34653853	chr6:163114362	PACRG	chr6:163148164-163736523:+	0.53	5.26	3.08E-7	Body mass index	
COAD	cis	1	rs34655790	chr6:163202739	PACRG	chr6:163148164-163736523:+	0.49	5.01	1.0E-6	Body mass index	
COAD	cis	1	rs34697913	chr6:163000187	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs34714518	chr6:163080778	PACRG	chr6:163148164-163736523:+	0.49	4.97	1.21E-6	Body mass index	
COAD	cis	1	rs34725898	chr6:163127302	PACRG	chr6:163148164-163736523:+	0.53	5.41	1.42E-7	Body mass index	
COAD	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.31	-4.32	2.2E-5	Schizophrenia	
COAD	cis	1	rs34773528	chr6:163088796	PACRG	chr6:163148164-163736523:+	0.53	5.27	2.89E-7	Body mass index	
COAD	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.31	-5.83	1.6E-8	Menarche (age at onset)	
COAD	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.53	5.94	9.29E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.56	-8.37	3.64E-15	Response to antipsychotic treatment	
COAD	cis	1	rs34865093	chr5:156424767	HAVCR1	chr5:156456531-156486130:-	-0.34	-4.24	3.16E-5	Hypertriglyceridemia	
COAD	cis	1	rs34865093	chr5:156424767	TIMD4	chr5:156346293-156390266:-	-0.34	-4.51	9.71E-6	Hypertriglyceridemia	
COAD	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.4	-5.29	2.64E-7	Subjective well-being	
COAD	cis	1	rs34918316	chr6:163005386	PACRG	chr6:163148164-163736523:+	0.49	5.27	2.88E-7	Body mass index	
COAD	cis	1	rs34931503	chr6:163003876	PACRG	chr6:163148164-163736523:+	0.49	5.27	2.88E-7	Body mass index	
COAD	cis	1	rs34933390	chr3:53006265	SFMBT1	chr3:52938628-53080070:-	-0.63	-5.71	3.09E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34943350	chr3:53012888	SFMBT1	chr3:52938628-53080070:-	-0.71	-5.69	3.46E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34943350	chr3:53012888	TMEM110	chr3:52867139-52931547:-	0.55	4.44	1.31E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.27	-4.61	6.31E-6	Gut microbiome composition (summer)	
COAD	cis	1	rs34964872	chr14:104448435	TDRD9	chr14:104394817-104519002:+	0.33	5.05	8.46E-7	Bipolar disorder	
COAD	cis	1	rs34979715	chr3:53048960	SFMBT1	chr3:52938628-53080070:-	-0.68	-5.5	9.22E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs34979715	chr3:53048960	TMEM110	chr3:52867139-52931547:-	0.48	3.86	0.000144	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35017019	chr6:162982581	PACRG	chr6:163148164-163736523:+	0.51	5.49	9.47E-8	Body mass index	
COAD	cis	1	rs35044651	chr6:163004142	PACRG	chr6:163148164-163736523:+	0.48	5.18	4.52E-7	Body mass index	
COAD	cis	1	rs35049594	chr18:47211067	ACAA2	chr18:47309875-47340283:-	-0.28	-4.19	3.88E-5	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs35056702	chr6:109736326	AKD1	chr6:109814059-110012415:-	-0.22	-3.89	0.000127	Height	
COAD	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.29	4.67	4.92E-6	Height	
COAD	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.57	-9.25	8.34E-18	Forced vital capacity	
COAD	cis	1	rs35068485	chr11:466032	PTDSS2	chr11:450280-491386:+	-0.46	-4.56	8.01E-6	Body mass index	
COAD	cis	1	rs35092540	chr6:163090778	PACRG	chr6:163148164-163736523:+	0.5	5.03	9.12E-7	Body mass index	
COAD	cis	1	rs35103567	chr6:163183400	PACRG	chr6:163148164-163736523:+	0.45	4.63	5.72E-6	Body mass index	
COAD	cis	1	rs35105110	chr17:37950422	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs35126854	chr6:163012443	PACRG	chr6:163148164-163736523:+	0.38	4.36	1.91E-5	Body mass index	
COAD	cis	1	rs35159031	chr5:156475430	HAVCR1	chr5:156456531-156486130:-	-0.4	-5.11	6.34E-7	Hypertriglyceridemia	
COAD	cis	1	rs35159031	chr5:156475430	TIMD4	chr5:156346293-156390266:-	-0.33	-4.46	1.21E-5	Hypertriglyceridemia	
COAD	cis	1	rs35163227	chr3:53127876	SFMBT1	chr3:52938628-53080070:-	-0.55	-4.39	1.61E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35174175	chr3:53041509	SFMBT1	chr3:52938628-53080070:-	-0.6	-4.86	2.07E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35174175	chr3:53041509	TMEM110	chr3:52867139-52931547:-	0.5	4.1	5.53E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35184688	chr17:40272406	DHX58	chr17:40253422-40264751:-	-0.31	-4.64	5.44E-6	Fibrinogen levels	
COAD	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.29	-5.8	1.96E-8	Menarche (age at onset)	
COAD	cis	1	rs35231079	chr11:515224	PTDSS2	chr11:450280-491386:+	-0.49	-4.71	4.1E-6	Body mass index	
COAD	cis	1	rs352476	chr15:65805389	DENND4A	chr15:65952959-66084631:-	0.21	4.07	6.36E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs352479	chr15:65803428	DENND4A	chr15:65952959-66084631:-	0.21	4.06	6.55E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs35255804	chr11:492617	PTDSS2	chr11:450280-491386:+	-0.49	-4.72	3.81E-6	Body mass index	
COAD	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.33	-4.69	4.5E-6	Schizophrenia	
COAD	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.26	-4.13	4.86E-5	Gut microbiome composition (summer)	
COAD	cis	1	rs35383933	chr6:163002869	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.63	-9.83	1.3E-19	Response to antipsychotic treatment	
COAD	cis	1	rs35398388	chr19:37740358	ZFP30	chr19:38123389-38146368:-	-0.34	-4.42	1.47E-5	Coronary artery calcification	
COAD	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.62	-8.72	3.26E-16	Response to antipsychotic treatment	
COAD	cis	1	rs35424047	chr6:163029715	PACRG	chr6:163148164-163736523:+	0.51	5.47	1.06E-7	Body mass index	
COAD	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.54	8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs35449999	chr6:163023465	PACRG	chr6:163148164-163736523:+	0.5	5.34	2.03E-7	Body mass index	
COAD	cis	1	rs35454259	chr6:27254475	C6orf41	chr6:26924772-26991752:+	0.51	5.3	2.44E-7	Schizophrenia	
COAD	cis	1	rs35454259	chr6:27254475	LOC100270746	chr6:26987146-26988085:-	0.46	4.52	9.26E-6	Schizophrenia	
COAD	cis	1	rs35506518	chr17:37938094	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs35507120	chr3:53053924	SFMBT1	chr3:52938628-53080070:-	-0.6	-4.79	2.81E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35507120	chr3:53053924	TMEM110	chr3:52867139-52931547:-	0.56	4.54	8.47E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35522482	chr22:39063015	CBY1	chr22:39052658-39069853:+	0.37	6.32	1.14E-9	Resting heart rate	
COAD	cis	1	rs35522482	chr22:39063015	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.23E-6	Resting heart rate	
COAD	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.27	-5.26	3.05E-7	Menarche (age at onset)	
COAD	cis	1	rs35565791	chr22:39063011	CBY1	chr22:39052658-39069853:+	0.37	6.32	1.14E-9	Resting heart rate	
COAD	cis	1	rs35565791	chr22:39063011	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.23E-6	Resting heart rate	
COAD	cis	1	rs35575481	chr6:163007746	PACRG	chr6:163148164-163736523:+	0.52	5.59	5.77E-8	Body mass index	
COAD	cis	1	rs35576914	chr3:53092270	SFMBT1	chr3:52938628-53080070:-	-0.54	-4.28	2.64E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35576914	chr3:53092270	TMEM110	chr3:52867139-52931547:-	0.52	4.26	2.88E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.37	4.55	8.25E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs35593345	chr6:163174981	PACRG	chr6:163148164-163736523:+	0.49	5.03	8.92E-7	Body mass index	
COAD	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.44	-6.13	3.17E-9	Subjective well-being	
COAD	cis	1	rs35632377	chr5:156436252	HAVCR1	chr5:156456531-156486130:-	-0.35	-4.4	1.61E-5	Hypertriglyceridemia	
COAD	cis	1	rs35632377	chr5:156436252	TIMD4	chr5:156346293-156390266:-	-0.32	-4.31	2.36E-5	Hypertriglyceridemia	
COAD	cis	1	rs35643470	chr4:120184948	FABP2	chr4:120238406-120243316:-	0.37	5.53	7.74E-8	Corneal astigmatism	
COAD	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.32	-4.45	1.26E-5	Schizophrenia	
COAD	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.33	-4.7	4.13E-6	Schizophrenia	
COAD	cis	1	rs35672725	chr8:89581838	MMP16	chr8:89049462-89339717:-	0.19	4.19	3.77E-5	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs35712350	chr5:90679519	LOC100129716	chr5:90676164-90716531:+	0.32	3.82	0.00017	Smoking behavior	
COAD	cis	1	rs35715471	chr8:89582284	MMP16	chr8:89049462-89339717:-	0.18	4.13	4.82E-5	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs35720014	chr3:52982110	SFMBT1	chr3:52938628-53080070:-	-0.64	-5.12	5.99E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35720014	chr3:52982110	TMEM110	chr3:52867139-52931547:-	0.53	4.36	1.87E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35723993	chr6:163008197	PACRG	chr6:163148164-163736523:+	0.49	5.31	2.39E-7	Body mass index	
COAD	cis	1	rs35734267	chr2:70281190	FAM136A	chr2:70523109-70529220:-	-0.3	-3.85	0.000151	Obesity-related traits	
COAD	cis	1	rs35736167	chr15:75332002	SCAMP5	chr15:75287901-75313836:+	0.36	4.48	1.12E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs35737577	chr3:53002557	SFMBT1	chr3:52938628-53080070:-	-0.68	-6.24	1.81E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35754151	chr6:163074867	PACRG	chr6:163148164-163736523:+	0.52	5.14	5.4E-7	Body mass index	
COAD	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.63	-9.83	1.3E-19	Response to antipsychotic treatment	
COAD	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.62	-8.35	4.04E-15	Response to antipsychotic treatment	
COAD	cis	1	rs35767091	chr4:56346723	SRD5A3	chr4:56212409-56237866:+	0.28	4.72	3.77E-6	Personality dimensions	
COAD	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.63	-9.28	7.01E-18	Response to antipsychotic treatment	
COAD	cis	1	rs35811812	chr11:498442	PTDSS2	chr11:450280-491386:+	-0.48	-5.08	7.2E-7	Body mass index	
COAD	cis	1	rs35818596	chr6:163001874	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs35820211	chr6:163046252	PACRG	chr6:163148164-163736523:+	0.54	5.17	4.58E-7	Body mass index	
COAD	cis	1	rs35831082	chr5:38963532	OSMR	chr5:38846128-38934402:+	-0.12	-3.87	0.000138	Obesity-related traits	
COAD	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.32	-4.61	6.41E-6	Visceral fat	
COAD	cis	1	rs35849389	chr3:53005235	SFMBT1	chr3:52938628-53080070:-	-0.68	-6.24	1.77E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs35868174	chr5:156425303	HAVCR1	chr5:156456531-156486130:-	-0.34	-4.24	3.16E-5	Hypertriglyceridemia	
COAD	cis	1	rs35868174	chr5:156425303	TIMD4	chr5:156346293-156390266:-	-0.34	-4.51	9.71E-6	Hypertriglyceridemia	
COAD	cis	1	rs35874808	chr11:506442	PTDSS2	chr11:450280-491386:+	-0.49	-4.71	4.1E-6	Body mass index	
COAD	cis	1	rs35898083	chr11:484469	PTDSS2	chr11:450280-491386:+	-0.51	-4.89	1.74E-6	Body mass index	
COAD	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs35911566	chr6:162994154	PACRG	chr6:163148164-163736523:+	0.51	5.49	9.47E-8	Body mass index	
COAD	cis	1	rs35938199	chr17:37950813	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.36	5.34	2.01E-7	Cognitive performance	
COAD	cis	1	rs35996687	chr11:458595	PTDSS2	chr11:450280-491386:+	-0.49	-4.48	1.11E-5	Body mass index	
COAD	cis	1	rs36007635	chr6:163009335	PACRG	chr6:163148164-163736523:+	0.49	5.31	2.39E-7	Body mass index	
COAD	cis	1	rs36035949	chr6:109736614	AKD1	chr6:109814059-110012415:-	-0.23	-3.98	8.97E-5	Height	
COAD	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.32	5.17	4.77E-7	Height	
COAD	cis	1	rs36042757	chr6:163004744	PACRG	chr6:163148164-163736523:+	0.38	4.32	2.25E-5	Body mass index	
COAD	cis	1	rs36053186	chr8:89583242	MMP16	chr8:89049462-89339717:-	0.18	3.99	8.75E-5	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs36089715	chr18:47213022	ACAA2	chr18:47309875-47340283:-	-0.29	-4.45	1.25E-5	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs36090694	chr3:53010742	SFMBT1	chr3:52938628-53080070:-	-0.65	-5.29	2.61E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs36090694	chr3:53010742	TMEM110	chr3:52867139-52931547:-	0.54	4.49	1.08E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.58	-8.38	3.3E-15	Response to antipsychotic treatment	
COAD	cis	1	rs36107456	chr6:162997399	PACRG	chr6:163148164-163736523:+	0.38	4.29	2.48E-5	Body mass index	
COAD	cis	1	rs36113695	chr6:163004733	PACRG	chr6:163148164-163736523:+	0.49	5.27	2.88E-7	Body mass index	
COAD	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.73	-13.47	9.39E-32	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs3729639	chr16:67225501	LRRC29	chr16:67241043-67260901:-	-0.44	-5.51	8.48E-8	HDL cholesterol	
COAD	cis	1	rs3730397	chr16:67228128	LRRC29	chr16:67241043-67260901:-	-0.49	-4.98	1.16E-6	HDL cholesterol	
COAD	cis	1	rs3730399	chr16:67229019	LRRC29	chr16:67241043-67260901:-	-0.45	-5.47	1.05E-7	HDL cholesterol	
COAD	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.42	5.53	7.71E-8	Trans fatty acid levels	
COAD	cis	1	rs3732276	chr2:242343404	SEPT2	chr2:242254723-242293439:+	0.57	5.51	8.63E-8	Chronic lymphocytic leukemia	
COAD	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.36	5.34	2.01E-7	Cognitive performance	
COAD	cis	1	rs3736544	chr4:56309992	SRD5A3	chr4:56212409-56237866:+	0.28	4.68	4.65E-6	Personality dimensions	
COAD	cis	1	rs3738848	chr2:73761881	ALMS1	chr2:73612886-73837046:+	0.24	3.85	0.000146	Metabolite levels	
COAD	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.31	4.75	3.33E-6	Pancreatic cancer	
COAD	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.46	-9.03	3.93E-17	IgG glycosylation	
COAD	cis	1	rs3742773	chr14:75579643	MLH3	chr14:75480467-75518235:-	0.23	3.85	0.000148	Height	
COAD	cis	1	rs3742778	chr14:75538217	MLH3	chr14:75480467-75518235:-	-0.26	-4.43	1.38E-5	Height	
COAD	cis	1	rs3742780	chr14:75505008	MLH3	chr14:75480467-75518235:-	0.24	4.01	8.07E-5	Height	
COAD	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.65	8.95	6.92E-17	Schizophrenia	
COAD	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.26	4.75	3.44E-6	Gut microbiome composition (summer)	
COAD	cis	1	rs3747170	chr22:39067331	CBY1	chr22:39052658-39069853:+	0.38	6.53	3.43E-10	Resting heart rate	
COAD	cis	1	rs3747170	chr22:39067331	JOSD1	chr22:39081549-39096459:-	-0.27	-4.56	7.86E-6	Resting heart rate	
COAD	cis	1	rs3747172	chr22:39067524	CBY1	chr22:39052658-39069853:+	0.37	6.3	1.28E-9	Resting heart rate	
COAD	cis	1	rs3747172	chr22:39067524	JOSD1	chr22:39081549-39096459:-	-0.26	-4.33	2.1E-5	Resting heart rate	
COAD	cis	1	rs3747174	chr22:39069181	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs3747174	chr22:39069181	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.53	5.94	9.29E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs3748682	chr1:38279987	FHL3	chr1:38462444-38471234:-	0.25	4.17	4.18E-5	Hypothyroidism	
COAD	cis	1	rs3749591	chr4:120214030	FABP2	chr4:120238406-120243316:-	0.39	5.74	2.61E-8	Corneal astigmatism	
COAD	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.33	4.43	1.39E-5	Fractional exhaled nitric oxide (childhood)	
COAD	cis	1	rs3752749	chr4:1737262	FAM53A	chr4:1641609-1685854:-	-0.44	-6.3	1.26E-9	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs3757135	chr6:26200707	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-3.86	0.000141	Renal underexcretion gout;Gout	
COAD	cis	1	rs3761430	chr22:31538002	INPP5J	chr22:31503961-31530682:+	0.43	3.83	0.000163	Age-related hearing impairment	
COAD	cis	1	rs3761454	chr22:39066820	CBY1	chr22:39052658-39069853:+	0.38	6.52	3.52E-10	Resting heart rate	
COAD	cis	1	rs3761454	chr22:39066820	JOSD1	chr22:39081549-39096459:-	-0.27	-4.58	7.25E-6	Resting heart rate	
COAD	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.28	6.32	1.12E-9	Type 1 diabetes autoantibodies	
COAD	cis	1	rs3767421	chr1:202432160	PPP1R12B	chr1:202317836-202557697:+	-0.2	-3.86	0.000141	Sex ratio	
COAD	cis	1	rs3767425	chr1:202413840	PPP1R12B	chr1:202317836-202557697:+	0.21	3.94	0.000104	Sex ratio	
COAD	cis	1	rs3769693	chr2:99259346	UNC50	chr2:99225042-99234975:+	-0.36	-4.3	2.45E-5	Bipolar disorder	
COAD	cis	1	rs3769694	chr2:99259239	UNC50	chr2:99225042-99234975:+	-0.39	-4.53	8.8E-6	Bipolar disorder	
COAD	cis	1	rs3769696	chr2:99258927	UNC50	chr2:99225042-99234975:+	-0.36	-4.55	8.33E-6	Bipolar disorder	
COAD	cis	1	rs3769697	chr2:99242580	UNC50	chr2:99225042-99234975:+	-0.33	-4.14	4.63E-5	Bipolar disorder	
COAD	cis	1	rs3770066	chr2:86392350	LOC90784	chr2:86247339-86250991:-	-0.65	-5.34	2.07E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs3771531	chr2:70164034	GMCL1	chr2:70056818-70106727:+	0.25	4.68	4.68E-6	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.34	5.26	3.07E-7	Cognitive performance	
COAD	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.34	5.19	4.29E-7	Cognitive performance	
COAD	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.58	7.89	8.07E-14	Diastolic blood pressure	
COAD	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.29	-4.84	2.18E-6	Longevity	
COAD	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.15	-4.21	3.56E-5	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs3778483	chr6:46627100	TDRD6	chr6:46655866-46670149:+	0.3	5.24	3.28E-7	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.33	-4.72	3.77E-6	Visceral fat	
COAD	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.55	6.86	4.89E-11	Multiple sclerosis	
COAD	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.36	-5.79	1.98E-8	Multiple sclerosis	
COAD	cis	1	rs3788544	chr22:39064966	CBY1	chr22:39052658-39069853:+	0.39	6.41	6.6E-10	Resting heart rate	
COAD	cis	1	rs3788545	chr22:39065172	CBY1	chr22:39052658-39069853:+	0.38	6.53	3.43E-10	Resting heart rate	
COAD	cis	1	rs3788545	chr22:39065172	JOSD1	chr22:39081549-39096459:-	-0.27	-4.47	1.15E-5	Resting heart rate	
COAD	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.73	-13.31	3.34E-31	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.73	-13.28	4.23E-31	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.72	-12.78	2.3E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.7	-12.68	4.97E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs3793079	chr6:33767788	HLA-DOB	chr6:32780541-32784825:-	0.22	4.27	2.74E-5	Crohn's disease	
COAD	cis	1	rs3793079	chr6:33767788	LEMD2	chr6:33738991-33756906:-	-0.21	-3.97	9.3E-5	Crohn's disease	
COAD	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.53	-5.86	1.39E-8	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs3796352	chr3:52913279	SFMBT1	chr3:52938628-53080070:-	-0.7	-5.49	9.52E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs3796352	chr3:52913279	TMEM110	chr3:52867139-52931547:-	0.54	4.31	2.33E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.49	-9.54	1.05E-18	Kawasaki disease	
COAD	cis	1	rs3800316	chr6:27256102	C6orf41	chr6:26924772-26991752:+	0.43	5.84	1.58E-8	Schizophrenia	
COAD	cis	1	rs3800316	chr6:27256102	LOC100270746	chr6:26987146-26988085:-	0.4	5.13	5.76E-7	Schizophrenia	
COAD	cis	1	rs3802840	chr11:111171646	C11orf53	chr11:111126707-111156970:+	-0.29	-3.91	0.000117	Colorectal cancer	
COAD	cis	1	rs3802840	chr11:111171646	C11orf93	chr11:111169976-111179353:+	-0.31	-4.36	1.9E-5	Colorectal cancer	
COAD	cis	1	rs3802841	chr11:111171672	C11orf53	chr11:111126707-111156970:+	0.3	4.05	6.78E-5	Colorectal cancer	
COAD	cis	1	rs3802841	chr11:111171672	C11orf93	chr11:111169976-111179353:+	0.31	4.45	1.25E-5	Colorectal cancer	
COAD	cis	1	rs3802842	chr11:111171709	C11orf53	chr11:111126707-111156970:+	0.3	4.05	6.78E-5	Colorectal cancer	
COAD	cis	1	rs3802842	chr11:111171709	C11orf93	chr11:111169976-111179353:+	0.31	4.45	1.25E-5	Colorectal cancer	
COAD	cis	1	rs3805152	chr4:56359658	SRD5A3	chr4:56212409-56237866:+	0.25	4.1	5.47E-5	Personality dimensions	
COAD	cis	1	rs3805154	chr4:56363927	SRD5A3	chr4:56212409-56237866:+	0.27	4.55	8.26E-6	Personality dimensions	
COAD	cis	1	rs3805157	chr4:56364103	SRD5A3	chr4:56212409-56237866:+	0.27	4.81	2.61E-6	Personality dimensions	
COAD	cis	1	rs3806108	chr6:33767579	HLA-DOB	chr6:32780541-32784825:-	0.22	4.21	3.53E-5	Crohn's disease	
COAD	cis	1	rs3806108	chr6:33767579	LEMD2	chr6:33738991-33756906:-	-0.21	-3.83	0.00016	Crohn's disease	
COAD	cis	1	rs3806692	chr3:53080987	SFMBT1	chr3:52938628-53080070:-	-0.53	-4.92	1.54E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs3806692	chr3:53080987	TMEM110	chr3:52867139-52931547:-	0.5	4.74	3.5E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.53	9.38	3.31E-18	Folate pathway vitamin levels	
COAD	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.53	-9.33	4.83E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs3810174	chr19:41904165	B3GNT8	chr19:41931265-41934635:-	-0.3	-5.04	8.75E-7	Height	
COAD	cis	1	rs3810175	chr19:41904396	B3GNT8	chr19:41931265-41934635:-	0.34	5.63	4.76E-8	Height	
COAD	cis	1	rs3816037	chr19:41918009	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.56	7.97E-6	Height	
COAD	cis	1	rs3816804	chr12:56680745	IKZF4	chr12:56411922-56432219:+	0.34	3.82	0.000169	Height	
COAD	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.53	9.33	4.69E-18	Folate pathway vitamin levels	
COAD	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.55	6.82	6.22E-11	Multiple sclerosis	
COAD	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.35	-5.43	1.3E-7	Multiple sclerosis	
COAD	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.65	-6.18	2.41E-9	Abdominal aortic aneurysm	
COAD	cis	1	rs3827357	chr22:39079413	CBY1	chr22:39052658-39069853:+	0.37	6.35	9.37E-10	Resting heart rate	
COAD	cis	1	rs3827357	chr22:39079413	JOSD1	chr22:39081549-39096459:-	-0.26	-4.4	1.61E-5	Resting heart rate	
COAD	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.71	-12.15	3.1E-27	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs3845800	chr2:203734365	ICA1L	chr2:203637873-203736371:-	-0.4	-4.11	5.32E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
COAD	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.63	9.52	1.22E-18	Height	
COAD	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.31	4.1	5.54E-5	Height	
COAD	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs3847669	chr12:75949158	GLIPR1L2	chr12:75784889-75825591:+	-0.32	-4.31	2.27E-5	Polycystic ovary syndrome	
COAD	cis	1	rs3850304	chr14:59895019	C14orf149	chr14:59939406-59951126:-	-0.46	-4.36	1.84E-5	Schizophrenia	
COAD	cis	1	rs3850304	chr14:59895019	JKAMP	chr14:59951161-59972080:+	0.45	4.24	3.04E-5	Schizophrenia	
COAD	cis	1	rs3866330	chr3:49582994	WDR6	chr3:49044637-49053386:+	-0.37	-5.41	1.43E-7	Menarche (age at onset)	
COAD	cis	1	rs3870339	chr3:49536863	ARIH2	chr3:48956281-49022969:+	-0.31	-3.95	9.94E-5	Menarche (age at onset)	
COAD	cis	1	rs3870339	chr3:49536863	WDR6	chr3:49044637-49053386:+	-0.38	-5.67	3.77E-8	Menarche (age at onset)	
COAD	cis	1	rs3870341	chr3:49584745	WDR6	chr3:49044637-49053386:+	-0.37	-5.41	1.43E-7	Menarche (age at onset)	
COAD	cis	1	rs3892761	chr12:54070445	ATP5G2	chr12:54058945-54070512:-	0.28	5.13	5.76E-7	Height	
COAD	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.27	-3.98	8.98E-5	Crohn's disease	
COAD	cis	1	rs3905330	chr3:49550774	WDR6	chr3:49044637-49053386:+	-0.37	-5.43	1.29E-7	Menarche (age at onset)	
COAD	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.3	-4.04	6.93E-5	Chronic obstructive pulmonary disease (moderate to severe)	
COAD	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.61	9.15	1.74E-17	Height	
COAD	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.32	4.36	1.87E-5	Height	
COAD	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.68	-9.96	4.97E-20	Diastolic blood pressure	
COAD	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.54	8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.45	-7.51	9.28E-13	Schizophrenia	
COAD	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.54	-7.01	2.03E-11	Inflammatory skin disease	
COAD	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.47	5.14	5.28E-7	Inflammatory skin disease	
COAD	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.17	3.98	9.09E-5	Blood metabolite levels	
COAD	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.92	0.000113	Coffee consumption (cups per day)	
COAD	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.55	-8.43	2.42E-15	Eye color traits	
COAD	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.54	-8.3	5.84E-15	Eye color traits	
COAD	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.95	0.000102	Coffee consumption (cups per day)	
COAD	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.56	-5.58	6.06E-8	Urate levels in lean individuals	
COAD	cis	1	rs41258374	chr6:160182265	PNLDC1	chr6:160221301-160241735:+	0.57	4.05	6.7E-5	Iron status biomarkers	
COAD	cis	1	rs41265383	chr6:170068025	C6orf70	chr6:170151721-170181617:+	0.35	3.94	0.000105	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs41266807	chr6:26199822	HIST1H2AE	chr6:26217148-26217711:+	-0.43	-4.08	6.06E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs41275472	chr1:11876300	CLCN6	chr1:11866207-11907674:+	0.22	3.86	0.000144	QRS complex (12-leadsum)	
COAD	cis	1	rs4130590	chr9:130107964	SLC2A8	chr9:130159465-130170161:+	0.26	4.91	1.63E-6	Bipolar disorder	
COAD	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.28	4.3	2.46E-5	Pulse pressure	
COAD	cis	1	rs4142995	chr7:17919258	SNX13	chr7:17830386-17980131:-	-0.21	-3.93	0.00011	HDL cholesterol	
COAD	cis	1	rs4144081	chr2:70155482	GMCL1	chr2:70056818-70106727:+	0.22	4.15	4.55E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.15	-4.22	3.38E-5	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs4144937	chr6:46628516	TDRD6	chr6:46655866-46670149:+	0.3	5.19	4.14E-7	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.33	5.01	1.02E-6	Pancreatic cancer	
COAD	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.33	5.02	9.41E-7	Pancreatic cancer	
COAD	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.39	5.96	8.08E-9	Pancreatic cancer	
COAD	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.37	5.59	5.58E-8	Pancreatic cancer	
COAD	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.36	5.56	6.7E-8	Pancreatic cancer	
COAD	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.32	-4.8	2.69E-6	Pancreatic cancer	
COAD	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.39	5.89	1.2E-8	Pancreatic cancer	
COAD	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.33	4.93	1.44E-6	Pancreatic cancer	
COAD	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.34	-5.27	2.92E-7	Pancreatic cancer	
COAD	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.38	5.81	1.82E-8	Pancreatic cancer	
COAD	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.36	5.51	8.52E-8	Pancreatic cancer	
COAD	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.32	4.96	1.3E-6	Pancreatic cancer	
COAD	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.32	4.96	1.3E-6	Pancreatic cancer	
COAD	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.35	-5.42	1.37E-7	Pancreatic cancer	
COAD	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.31	4.75	3.42E-6	Pancreatic cancer	
COAD	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.29	4.34	2.04E-5	Pancreatic cancer	
COAD	cis	1	rs417096	chr6:39727833	DAAM2	chr6:39760142-39872640:+	-0.12	-4	8.16E-5	Hypospadias	
COAD	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.39	-5.81	1.82E-8	Bipolar disorder	
COAD	cis	1	rs4234797	chr4:7219907	SORCS2	chr4:7194374-7744563:+	-0.2	-5.71	2.99E-8	Insulin-like growth factors	
COAD	cis	1	rs4234798	chr4:7219933	SORCS2	chr4:7194374-7744563:+	0.21	5.97	7.82E-9	Insulin-like growth factors	
COAD	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.56	8.68	4.37E-16	Forced vital capacity	
COAD	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.95	0.000102	Coffee consumption (cups per day)	
COAD	cis	1	rs4241407	chr3:49600319	WDR6	chr3:49044637-49053386:+	-0.29	-4.05	6.7E-5	Menarche (age at onset)	
COAD	cis	1	rs4245707	chr1:202391419	PPP1R12B	chr1:202317836-202557697:+	0.21	3.96	9.52E-5	Sex ratio	
COAD	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	0.38	5	1.05E-6	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
COAD	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.6	-5.96	8.08E-9	Cholesterol, total;LDL cholesterol	
COAD	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.54	-4.37	1.8E-5	Cholesterol, total;LDL cholesterol	
COAD	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.54	-5.45	1.19E-7	Urate levels in lean individuals	
COAD	cis	1	rs4262377	chr9:117589574	AMBP	chr9:116822410-116840752:-	-0.56	-4.67	4.72E-6	Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.39	-5.42	1.35E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
COAD	cis	1	rs42648	chr7:89977760	GTPBP10	chr7:89969690-90016650:+	0.26	4.11	5.29E-5	Homocysteine levels	
COAD	cis	1	rs42649	chr7:89977789	GTPBP10	chr7:89969690-90016650:+	0.26	4.02	7.76E-5	Homocysteine levels	
COAD	cis	1	rs42656	chr7:89981636	GTPBP10	chr7:89969690-90016650:+	0.25	3.97	9.39E-5	Homocysteine levels	
COAD	cis	1	rs42658	chr7:89981915	GTPBP10	chr7:89969690-90016650:+	0.26	4.19	3.84E-5	Homocysteine levels	
COAD	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.53	-8.96	6.15E-17	Folate pathway vitamin levels	
COAD	cis	1	rs4272382	chr8:8433488	ERI1	chr8:8860314-8890849:+	-0.51	-5.1	6.45E-7	Response to cytidine analogues (gemcitabine)	
COAD	cis	1	rs4272382	chr8:8433488	MFHAS1	chr8:8641999-8751131:-	-0.5	-4.89	1.81E-6	Response to cytidine analogues (gemcitabine)	
COAD	cis	1	rs4272382	chr8:8433488	TNKS	chr8:9413445-9639855:+	-0.45	-3.91	0.000116	Response to cytidine analogues (gemcitabine)	
COAD	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.35	-4.78	2.93E-6	Longevity	
COAD	cis	1	rs4282551	chr8:124185916	FAM83A	chr8:124191287-124222317:+	-0.5	-4.45	1.27E-5	Urinary uromodulin levels	
COAD	cis	1	rs4282626	chr9:102690180	STX17	chr9:102668915-102736817:+	-0.28	-3.91	0.000119	Alopecia areata	
COAD	cis	1	rs4285028	chr3:121660664	IQCB1	chr3:121488610-121553926:-	-0.29	-4.2	3.63E-5	Multiple sclerosis	
COAD	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.61	8.36	3.68E-15	Paget's disease	
COAD	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.71	-8.62	6.47E-16	Paget's disease	
COAD	cis	1	rs429657	chr15:65813764	DENND4A	chr15:65952959-66084631:-	0.21	4.02	7.67E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.58	8.45	2.06E-15	Height	
COAD	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.33	4.45	1.27E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	1.01	13.43	1.33E-31	Type 2 diabetes	
COAD	cis	1	rs4322591	chr14:75600697	MLH3	chr14:75480467-75518235:-	0.28	4.84	2.26E-6	Height	
COAD	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.38	-5.5	9.15E-8	Rheumatoid arthritis	
COAD	cis	1	rs4325101	chr1:183644070	APOBEC4	chr1:183615418-183622448:-	-0.56	-3.88	0.000131	Systemic lupus erythematosus	
COAD	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.89	0.000128	Coffee consumption (cups per day)	
COAD	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.46	7.63	4.47E-13	Schizophrenia	
COAD	cis	1	rs4342423	chr6:33732679	HLA-DOB	chr6:32780541-32784825:-	0.24	4.38	1.7E-5	Crohn's disease	
COAD	cis	1	rs4351999	chr15:65992380	DENND4A	chr15:65952959-66084631:-	-0.21	-3.98	8.94E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.37	5.65	4.1E-8	Pancreatic cancer	
COAD	cis	1	rs4356975	chr4:69972463	UGT2B7	chr4:69962193-69978704:+	0.31	4.36	1.9E-5	Obesity-related traits	
COAD	cis	1	rs436039	chr19:22214873	ZNF208	chr19:22115760-22193745:-	0.21	3.85	0.000151	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs436039	chr19:22214873	ZNF257	chr19:22235266-22273901:+	0.39	4.92	1.52E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.58	8.32	5.01E-15	Height	
COAD	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.85	1.35E-16	Height	
COAD	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.35	-4.52	9.2E-6	Height	
COAD	cis	1	rs4372836	chr2:28973883	PPP1CB	chr2:28974612-29025805:+	0.29	4.73	3.61E-6	Body mass index	
COAD	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.41	1.43E-7	Body mass index	
COAD	cis	1	rs4374747	chr5:156426239	HAVCR1	chr5:156456531-156486130:-	-0.34	-4.33	2.1E-5	Hypertriglyceridemia	
COAD	cis	1	rs4374747	chr5:156426239	TIMD4	chr5:156346293-156390266:-	-0.33	-4.5	1.03E-5	Hypertriglyceridemia	
COAD	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.5	8.84	1.5E-16	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs4377946	chr8:124185887	FAM83A	chr8:124191287-124222317:+	-0.5	-4.45	1.27E-5	Urinary uromodulin levels	
COAD	cis	1	rs4382199	chr5:90744228	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.4	-4.68	4.69E-6	Bone mineral density	
COAD	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.32	4.26	2.9E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
COAD	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.61	8.94	7.42E-17	Height	
COAD	cis	1	rs4423247	chr12:91476875	KERA	chr12:91444273-91452131:-	0.28	4.62	6.06E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.6	-8.51	1.41E-15	Height	
COAD	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.35	-4.6	6.52E-6	Height	
COAD	cis	1	rs4452862	chr9:102706745	STX17	chr9:102668915-102736817:+	-0.28	-3.93	0.000109	Alopecia areata	
COAD	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.89	0.00013	Coffee consumption (cups per day)	
COAD	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.28	3.88	0.000132	Coffee consumption (cups per day)	
COAD	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.55	9.5	1.44E-18	Folate pathway vitamin levels	
COAD	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.3	-4.95	1.31E-6	Longevity	
COAD	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.27	-5.78	2.16E-8	Menarche (age at onset)	
COAD	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.71	-13.34	2.67E-31	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.65	9.64	5.03E-19	Height	
COAD	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.36	4.81	2.59E-6	Height	
COAD	cis	1	rs4509126	chr6:170068058	C6orf70	chr6:170151721-170181617:+	0.35	3.94	0.000105	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs4510208	chr2:203734866	ALS2CR8	chr2:203776978-203851060:+	-0.28	-4.05	6.64E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
COAD	cis	1	rs4515105	chr3:190987891	UTS2D	chr3:190984945-191048325:-	-0.25	-3.89	0.00013	Age-related hearing impairment (interaction)	
COAD	cis	1	rs4520624	chr11:111172210	C11orf93	chr11:111169976-111179353:+	0.31	4.36	1.9E-5	Colorectal cancer	
COAD	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.28	3.89	0.000128	Coffee consumption (cups per day)	
COAD	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.61	-8.63	6.11E-16	Height	
COAD	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.33	-4.33	2.09E-5	Height	
COAD	cis	1	rs4549034	chr2:28972579	PPP1CB	chr2:28974612-29025805:+	0.29	4.73	3.61E-6	Body mass index	
COAD	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.41	1.43E-7	Body mass index	
COAD	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.36	4.73	3.75E-6	Hematology traits	
COAD	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.85	1.35E-16	Height	
COAD	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.35	-4.52	9.2E-6	Height	
COAD	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.95	0.000102	Coffee consumption (cups per day)	
COAD	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.39	4.77	3.08E-6	Crohn's disease	
COAD	cis	1	rs4580704	chr4:56326707	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.85	2.12E-6	Personality dimensions	
COAD	cis	1	rs4585797	chr9:102674147	STX17	chr9:102668915-102736817:+	-0.28	-3.91	0.000119	Alopecia areata	
COAD	cis	1	rs458588	chr6:118534293	ASF1A	chr6:119215241-119230333:+	0.52	4.03	7.21E-5	QT interval	
COAD	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.38	4.81	2.61E-6	Atopic dermatitis	
COAD	cis	1	rs4640348	chr2:28965479	PPP1CB	chr2:28974612-29025805:+	0.27	4.49	1.09E-5	Body mass index	
COAD	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.38	1.69E-7	Body mass index	
COAD	cis	1	rs4645525	chr8:10816174	SOX7	chr8:10581279-10697299:-	-0.26	-4.15	4.45E-5	Asthma and hay fever	
COAD	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.55	7.3	3.43E-12	Multiple sclerosis	
COAD	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.35	-5.98	7.26E-9	Multiple sclerosis	
COAD	cis	1	rs4654863	chr1:20902244	CDA	chr1:20915444-20945398:+	-0.28	-4.11	5.39E-5	Age-related hearing impairment (interaction)	
COAD	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.62	9.46	1.9E-18	Homocysteine levels	
COAD	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.45	-6.61	2.17E-10	Homocysteine levels	
COAD	cis	1	rs4665238	chr2:23942446	C2orf84	chr2:24397531-24414566:+	-0.26	-4.11	5.37E-5	Obesity-related traits	
COAD	cis	1	rs4665768	chr2:25372229	POMC	chr2:25383722-25391559:-	0.24	4.16	4.39E-5	Body mass index	
COAD	cis	1	rs4666118	chr2:28951698	PPP1CB	chr2:28974612-29025805:+	0.29	4.71	4.05E-6	Body mass index	
COAD	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.42	1.32E-7	Body mass index	
COAD	cis	1	rs4666119	chr2:28975690	PPP1CB	chr2:28974612-29025805:+	0.29	4.76	3.26E-6	Body mass index	
COAD	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.47	1.08E-7	Body mass index	
COAD	cis	1	rs4667160	chr2:188166881	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs4674	chr19:41930396	B3GNT8	chr19:41931265-41934635:-	-0.32	-5.2	4.09E-7	Height	
COAD	cis	1	rs4677834	chr3:195093631	C3orf21	chr3:194789015-194991895:-	-0.34	-4.67	4.79E-6	Body mass index	
COAD	cis	1	rs4687697	chr3:53090490	SFMBT1	chr3:52938628-53080070:-	0.33	5.23	3.53E-7	Ulcerative colitis	
COAD	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.31	4.62	6.15E-6	Height	
COAD	cis	1	rs4689088	chr4:7222253	SORCS2	chr4:7194374-7744563:+	-0.19	-5.49	9.44E-8	Insulin-like growth factors	
COAD	cis	1	rs4689653	chr4:7223319	SORCS2	chr4:7194374-7744563:+	-0.17	-4.92	1.56E-6	Insulin-like growth factors	
COAD	cis	1	rs4690071	chr4:3086753	RGS12	chr4:3294755-3441638:+	0.32	4.52	9.58E-6	Parental longevity (mother's age at death)	
COAD	cis	1	rs4693089	chr4:84373622	MRPS18C	chr4:84377118-84389352:+	-0.23	-4.21	3.59E-5	Menopause (age at onset)	
COAD	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.53	-8.43	2.39E-15	Ankylosing spondylitis	
COAD	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.44	5.59	5.85E-8	Ankylosing spondylitis	
COAD	cis	1	rs470119	chr22:50966914	TYMP	chr22:50964184-50968514:-	-0.14	-4.1	5.63E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs470360	chr11:65500530	CFL1	chr11:65622287-65626886:-	0.27	3.85	0.000149	Atopic dermatitis	
COAD	cis	1	rs4704729	chr5:156424516	HAVCR1	chr5:156456531-156486130:-	-0.34	-4.24	3.16E-5	Hypertriglyceridemia	
COAD	cis	1	rs4704729	chr5:156424516	TIMD4	chr5:156346293-156390266:-	-0.34	-4.51	9.71E-6	Hypertriglyceridemia	
COAD	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.63	-9.87	9.93E-20	Response to antipsychotic treatment	
COAD	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.64	-9.86	1.1E-19	Response to antipsychotic treatment	
COAD	cis	1	rs4711351	chr6:33754592	HLA-DOB	chr6:32780541-32784825:-	0.23	4.4	1.58E-5	Crohn's disease	
COAD	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.29	4.44	1.32E-5	Pulse pressure	
COAD	cis	1	rs4713682	chr6:33757047	HLA-DOB	chr6:32780541-32784825:-	0.21	4.02	7.76E-5	Crohn's disease	
COAD	cis	1	rs4713684	chr6:33766488	HLA-DOB	chr6:32780541-32784825:-	0.21	4.15	4.58E-5	Crohn's disease	
COAD	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.53	9.3	5.78E-18	Folate pathway vitamin levels	
COAD	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.53	9.07	3.02E-17	Folate pathway vitamin levels	
COAD	cis	1	rs4716375	chr6:170071218	C6orf70	chr6:170151721-170181617:+	0.35	3.94	0.000105	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs4716378	chr6:170086568	C6orf70	chr6:170151721-170181617:+	0.38	4.26	2.83E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs4716380	chr6:170090399	C6orf70	chr6:170151721-170181617:+	0.37	4.11	5.26E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.33	-4.43	1.36E-5	Obesity-related traits	
COAD	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.58	9.5	1.45E-18	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs473005	chr4:56288125	SRD5A3	chr4:56212409-56237866:+	0.23	4.01	7.93E-5	Personality dimensions	
COAD	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.32	4.08	6.09E-5	Response to temozolomide	
COAD	cis	1	rs4733384	chr8:29985381	MBOAT4	chr8:29989188-30002200:-	0.34	3.97	9.42E-5	Migraine	
COAD	cis	1	rs4742777	chr9:102679173	STX17	chr9:102668915-102736817:+	-0.28	-3.91	0.000119	Alopecia areata	
COAD	cis	1	rs4742778	chr9:102701967	STX17	chr9:102668915-102736817:+	-0.28	-3.93	0.000109	Alopecia areata	
COAD	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.32	-4.06	6.37E-5	Response to temozolomide	
COAD	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.42	-5.67	3.8E-8	Subjective well-being	
COAD	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.41	-5.64	4.43E-8	Subjective well-being	
COAD	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.43	-5.94	9.18E-9	Subjective well-being	
COAD	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.38	-5.12	6.0E-7	Subjective well-being	
COAD	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.54	-8.5	1.53E-15	Forced vital capacity	
COAD	cis	1	rs4757676	chr11:18640477	SPTY2D1	chr11:18627949-18656020:-	-0.39	-6.29	1.35E-9	Cholesterol, total	
COAD	cis	1	rs4758685	chr12:122626842	MLXIP	chr12:122516760-122628965:+	-0.21	-4.26	2.84E-5	Urate levels	
COAD	cis	1	rs4758687	chr12:122616286	MLXIP	chr12:122516760-122628965:+	-0.22	-4.49	1.05E-5	Urate levels	
COAD	cis	1	rs4758690	chr12:122610909	MLXIP	chr12:122516760-122628965:+	0.21	4.21	3.47E-5	Urate levels	
COAD	cis	1	rs4758691	chr12:122610019	MLXIP	chr12:122516760-122628965:+	0.22	4.31	2.28E-5	Urate levels	
COAD	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.65	-9.52	1.2E-18	Cognitive function	
COAD	cis	1	rs4759787	chr12:131290180	STX2	chr12:131274149-131323811:-	-0.54	-5.21	3.81E-7	Plasma plasminogen activator levels	
COAD	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.34	4.26	2.83E-5	Response to temozolomide	
COAD	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.52	-9.2	1.23E-17	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.51	9.16	1.62E-17	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.32	4.03	7.43E-5	Response to temozolomide	
COAD	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.95	0.000102	Coffee consumption (cups per day)	
COAD	cis	1	rs4801872	chr19:52025017	FPR2	chr19:52264453-52273777:+	0.35	3.85	0.000147	Carotid intima media thickness	
COAD	cis	1	rs4803463	chr19:41911040	B3GNT8	chr19:41931265-41934635:-	-0.31	-5.13	5.67E-7	Height	
COAD	cis	1	rs4803465	chr19:41918158	B3GNT8	chr19:41931265-41934635:-	0.27	4.56	7.72E-6	Height	
COAD	cis	1	rs4803468	chr19:41922352	B3GNT8	chr19:41931265-41934635:-	-0.33	-5.37	1.72E-7	Height	
COAD	cis	1	rs4803469	chr19:41922775	B3GNT8	chr19:41931265-41934635:-	-0.33	-5.37	1.72E-7	Height	
COAD	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.63	8.81	1.83E-16	Schizophrenia	
COAD	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.32	3.86	0.000144	Response to temozolomide	
COAD	cis	1	rs4808200	chr19:19554803	HAPLN4	chr19:19366453-19384074:-	0.27	3.92	0.000115	Schizophrenia	
COAD	cis	1	rs4809758	chr20:48440853	KCNB1	chr20:47988505-48100490:-	-0.19	-4.31	2.27E-5	Gut microbiota (beta diversity)	
COAD	cis	1	rs4809760	chr20:48454671	KCNB1	chr20:47988505-48100490:-	0.18	4.01	7.99E-5	Gut microbiota (beta diversity)	
COAD	cis	1	rs4810988	chr20:48465969	KCNB1	chr20:47988505-48100490:-	-0.18	-3.89	0.000129	Gut microbiota (beta diversity)	
COAD	cis	1	rs4812048	chr20:57587771	TH1L	chr20:57556311-57570186:+	-0.26	-4.11	5.21E-5	Mean platelet volume	
COAD	cis	1	rs4820345	chr22:39091151	CBY1	chr22:39052658-39069853:+	0.4	6.5	4.12E-10	Resting heart rate	
COAD	cis	1	rs4821798	chr22:39021165	CBY1	chr22:39052658-39069853:+	0.26	4.47	1.14E-5	Resting heart rate	
COAD	cis	1	rs4821798	chr22:39021165	JOSD1	chr22:39081549-39096459:-	-0.23	-3.94	0.000103	Resting heart rate	
COAD	cis	1	rs4821808	chr22:39065739	CBY1	chr22:39052658-39069853:+	0.39	6.61	2.1E-10	Resting heart rate	
COAD	cis	1	rs4821808	chr22:39065739	JOSD1	chr22:39081549-39096459:-	-0.26	-4.35	1.95E-5	Resting heart rate	
COAD	cis	1	rs4821809	chr22:39065743	CBY1	chr22:39052658-39069853:+	0.39	6.61	2.1E-10	Resting heart rate	
COAD	cis	1	rs4821809	chr22:39065743	JOSD1	chr22:39081549-39096459:-	-0.26	-4.35	1.95E-5	Resting heart rate	
COAD	cis	1	rs4821810	chr22:39072098	CBY1	chr22:39052658-39069853:+	0.33	5.78	2.09E-8	Resting heart rate	
COAD	cis	1	rs4821811	chr22:39075145	CBY1	chr22:39052658-39069853:+	0.38	6.48	4.55E-10	Resting heart rate	
COAD	cis	1	rs4821811	chr22:39075145	JOSD1	chr22:39081549-39096459:-	-0.25	-4.1	5.42E-5	Resting heart rate	
COAD	cis	1	rs4821812	chr22:39075235	CBY1	chr22:39052658-39069853:+	0.38	6.49	4.34E-10	Resting heart rate	
COAD	cis	1	rs4821812	chr22:39075235	JOSD1	chr22:39081549-39096459:-	-0.25	-4.23	3.28E-5	Resting heart rate	
COAD	cis	1	rs4821816	chr22:39113134	CBY1	chr22:39052658-39069853:+	0.33	5.69	3.37E-8	Resting heart rate	
COAD	cis	1	rs4823597	chr22:47531320	GRAMD4	chr22:47022658-47075687:+	-0.26	-3.86	0.000141	Longevity	
COAD	cis	1	rs4840352	chr8:8573508	FLJ10661	chr8:8086092-8102386:+	0.38	4.18	3.93E-5	Obesity-related traits	
COAD	cis	1	rs4841016	chr8:8572561	FLJ10661	chr8:8086092-8102386:+	0.37	4.19	3.81E-5	Obesity-related traits	
COAD	cis	1	rs4841017	chr8:8577093	FLJ10661	chr8:8086092-8102386:+	0.36	4.31	2.27E-5	Obesity-related traits	
COAD	cis	1	rs4852375	chr2:70125988	GMCL1	chr2:70056818-70106727:+	0.22	4.09	5.79E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.34	4.26	2.83E-5	Response to temozolomide	
COAD	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.28	4.64	5.57E-6	Longevity	
COAD	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.3	5.05	8.47E-7	Longevity	
COAD	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.29	4.04	6.95E-5	Longevity	
COAD	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.33	-4.55	8.05E-6	Longevity	
COAD	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.32	-4.48	1.1E-5	Longevity	
COAD	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.55	11.45	7.2E-25	Kawasaki disease	
COAD	cis	1	rs4864998	chr4:56332606	SRD5A3	chr4:56212409-56237866:+	0.26	4.23	3.21E-5	Personality dimensions	
COAD	cis	1	rs4865008	chr4:56410855	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.73	3.64E-6	Personality dimensions	
COAD	cis	1	rs4865010	chr4:56414962	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.61	6.22E-6	Personality dimensions	
COAD	cis	1	rs4865463	chr4:1742400	FAM53A	chr4:1641609-1685854:-	-0.37	-5.36	1.84E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs4865467	chr4:1745500	FAM53A	chr4:1641609-1685854:-	0.37	5.34	2.05E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.01	-19.86	4.28E-54	Pediatric autoimmune diseases	
COAD	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.29	-5.12	5.98E-7	Testicular germ cell tumor	
COAD	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.31	-5.32	2.22E-7	Testicular germ cell tumor	
COAD	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.31	-5.39	1.62E-7	Testicular germ cell tumor	
COAD	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.32	-5.5	9.14E-8	Testicular germ cell tumor	
COAD	cis	1	rs489319	chr1:44131794	ARTN	chr1:44398992-44402911:+	-0.29	-4.01	7.98E-5	Hypertension risk in short sleep duration	
COAD	cis	1	rs4899544	chr14:75546556	MLH3	chr14:75480467-75518235:-	0.26	4.38	1.71E-5	Height	
COAD	cis	1	rs4899546	chr14:75594946	MLH3	chr14:75480467-75518235:-	0.28	4.74	3.47E-6	Height	
COAD	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.4	-6.69	1.33E-10	Common traits (Other)	
COAD	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.4	-6.69	1.33E-10	Common traits (Other)	
COAD	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.4	-6.69	1.33E-10	Common traits (Other)	
COAD	cis	1	rs4903275	chr14:75512509	MLH3	chr14:75480467-75518235:-	0.25	4.31	2.29E-5	Height	
COAD	cis	1	rs4903279	chr14:75546583	MLH3	chr14:75480467-75518235:-	0.26	4.38	1.71E-5	Height	
COAD	cis	1	rs4903281	chr14:75554361	MLH3	chr14:75480467-75518235:-	0.24	3.97	9.3E-5	Height	
COAD	cis	1	rs4903284	chr14:75592483	MLH3	chr14:75480467-75518235:-	0.25	4.29	2.47E-5	Height	
COAD	cis	1	rs4903289	chr14:75623988	MLH3	chr14:75480467-75518235:-	-0.25	-4.19	3.83E-5	Height	
COAD	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.2	3.98	9.1E-5	Height	
COAD	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.22	4.22	3.33E-5	Height	
COAD	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.2	3.96	9.57E-5	Height	
COAD	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.2	3.94	0.000105	Height	
COAD	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.18	-3.88	0.00013	Height	
COAD	cis	1	rs4917385	chr10:105003721	C10orf32	chr10:104613967-104624718:+	-0.32	-4.03	7.42E-5	Systemic lupus erythematosus	
COAD	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.56	6.77	8.39E-11	Arsenic metabolism	
COAD	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.32	-3.94	0.000105	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.34	-3.95	9.91E-5	Type 2 diabetes	
COAD	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.42	-4.88	1.83E-6	Type 2 diabetes	
COAD	cis	1	rs4941187	chr18:60849216	TNFRSF11A	chr18:59992548-60053502:+	0.23	3.98	9.04E-5	Cardiac Troponin-T levels	
COAD	cis	1	rs4941188	chr18:60857029	TNFRSF11A	chr18:59992548-60053502:+	-0.23	-3.96	9.52E-5	Cardiac Troponin-T levels	
COAD	cis	1	rs494221	chr11:30492581	MPPED2	chr11:30406040-30607930:-	0.26	4.65	5.33E-6	Dental caries	
COAD	cis	1	rs4950848	chr1:202356174	PPP1R12B	chr1:202317836-202557697:+	0.21	3.97	9.2E-5	Sex ratio	
COAD	cis	1	rs4950849	chr1:202408518	PPP1R12B	chr1:202317836-202557697:+	0.21	3.96	9.64E-5	Sex ratio	
COAD	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.27	-4.04	7.08E-5	Menarche (age at onset)	
COAD	cis	1	rs4953023	chr2:44074000	LRPPRC	chr2:44113363-44223144:-	0.42	4.42	1.45E-5	Cholesterol, total	
COAD	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.6	8.81	1.83E-16	Height	
COAD	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.29	3.84	0.000156	Height	
COAD	cis	1	rs4958422	chr5:150186734	LOC134466	chr5:150310000-150326146:-	0.49	5.88	1.22E-8	Crohn's disease	
COAD	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.48	5.58	5.91E-8	Crohn's disease	
COAD	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.32	4.61	6.29E-6	Crohn's disease	
COAD	cis	1	rs4958852	chr5:150330631	LOC134466	chr5:150310000-150326146:-	0.52	6.8	6.91E-11	Crohn's disease	
COAD	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.52	-5.51	8.75E-8	Tumor biomarkers	
COAD	cis	1	rs4970948	chr1:151291243	PIP5K1A	chr1:151171021-151222006:+	-0.26	-4.05	6.76E-5	Gut microbiota (functional units)	
COAD	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.33	-4.1	5.59E-5	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.33	-4.1	5.59E-5	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs4973685	chr2:243019089	THAP4	chr2:242523821-242576655:-	0.37	4.79	2.82E-6	Obesity-related traits	
COAD	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.6	9.14	1.79E-17	Height	
COAD	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.31	4.22	3.43E-5	Height	
COAD	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.63	9.37	3.6E-18	Height	
COAD	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.33	4.38	1.73E-5	Height	
COAD	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.59	8.85	1.35E-16	Height	
COAD	cis	1	rs4974559	chr4:1380848	CRIPAK	chr4:1385340-1389782:+	-0.36	-5.53	7.79E-8	Systolic blood pressure	
COAD	cis	1	rs498872	chr11:118477367	TREH	chr11:118528942-118550381:-	0.33	4.11	5.4E-5	Glioma	
COAD	cis	1	rs499293	chr11:30504660	MPPED2	chr11:30406040-30607930:-	0.27	4.7	4.22E-6	Dental caries	
COAD	cis	1	rs5022636	chr1:151295061	PIP5K1A	chr1:151171021-151222006:+	-0.26	-3.88	0.000135	Gut microbiota (functional units)	
COAD	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.31	4.06	6.38E-5	Response to temozolomide	
COAD	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.31	3.86	0.000142	Response to temozolomide	
COAD	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.32	-4.08	5.92E-5	Response to temozolomide	
COAD	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.31	3.87	0.000137	Response to temozolomide	
COAD	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.34	4.38	1.7E-5	Response to temozolomide	
COAD	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.32	-4.08	6.09E-5	Response to temozolomide	
COAD	cis	1	rs524911	chr11:114401577	FAM55A	chr11:114392438-114430580:-	-0.23	-3.86	0.000143	Ulcerative colitis	
COAD	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.36	4.45	1.25E-5	Response to temozolomide	
COAD	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.32	-4.05	6.89E-5	Response to temozolomide	
COAD	cis	1	rs543725	chr11:57483039	TMX2	chr11:57480042-57508444:+	0.29	4.25	3.01E-5	Schizophrenia	
COAD	cis	1	rs545610	chr11:30508108	MPPED2	chr11:30406040-30607930:-	0.27	4.72	3.84E-6	Dental caries	
COAD	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.33	4.14	4.77E-5	Response to temozolomide	
COAD	cis	1	rs548756	chr11:114428866	FAM55A	chr11:114392438-114430580:-	-0.23	-3.88	0.000135	Ulcerative colitis	
COAD	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.33	4.21	3.45E-5	Response to temozolomide	
COAD	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.34	4.28	2.59E-5	Response to temozolomide	
COAD	cis	1	rs55670848	chr1:171697497	VAMP4	chr1:171669298-171711214:-	0.34	4.64	5.41E-6	Hippocampal atrophy	
COAD	cis	1	rs55697388	chr6:118891544	C6orf204	chr6:118786239-119031238:-	-0.27	-4.46	1.22E-5	Renal cell carcinoma	
COAD	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.71	-13.23	6.53E-31	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs557675	chr11:65566719	CTSW	chr11:65647284-65651212:+	-0.24	-4.89	1.76E-6	Urate levels	
COAD	cis	1	rs55777943	chr2:243040686	THAP4	chr2:242523821-242576655:-	0.37	4.54	8.56E-6	Obesity-related traits	
COAD	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.29	-5.82	1.74E-8	Menarche (age at onset)	
COAD	cis	1	rs55821258	chr8:96292041	C8orf37	chr8:96258235-96281437:-	0.47	4.2	3.62E-5	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
COAD	cis	1	rs55822577	chr6:163069710	PACRG	chr6:163148164-163736523:+	0.52	5.14	5.4E-7	Body mass index	
COAD	cis	1	rs55835850	chr2:28949296	PPP1CB	chr2:28974612-29025805:+	-0.29	-4.76	3.25E-6	Body mass index	
COAD	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.33	5.34	2.0E-7	Body mass index	
COAD	cis	1	rs55847707	chr6:163003414	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs55857306	chr1:11895795	CLCN6	chr1:11866207-11907674:+	0.28	4.37	1.76E-5	QRS complex (12-leadsum)	
COAD	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.31	-3.93	0.00011	Response to temozolomide	
COAD	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.51	-10.43	1.6E-21	Inflammatory skin disease	
COAD	cis	1	rs55899435	chr6:118812099	C6orf204	chr6:118786239-119031238:-	-0.28	-4.8	2.69E-6	Renal cell carcinoma	
COAD	cis	1	rs55905547	chr20:57589995	TH1L	chr20:57556311-57570186:+	-0.24	-3.89	0.000128	Mean platelet volume	
COAD	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.6	8.81	1.83E-16	Height	
COAD	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.29	3.84	0.000156	Height	
COAD	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.86	5.23	3.53E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs55934348	chr2:99246885	UNC50	chr2:99225042-99234975:+	-0.41	-4.77	3.09E-6	Bipolar disorder	
COAD	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.72	-13.12	1.48E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs55946144	chr20:33629610	EDEM2	chr20:33703160-33865928:-	0.33	3.83	0.000161	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs55946144	chr20:33629610	PROCR	chr20:33758727-33765164:+	-0.38	-3.87	0.000139	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.72	-13.12	1.48E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs55962025	chr4:3112109	RGS12	chr4:3294755-3441638:+	0.29	4.01	7.89E-5	Parental longevity (mother's age at death)	
COAD	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.29	-5.88	1.28E-8	Menarche (age at onset)	
COAD	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.47	-6.15	2.83E-9	Esophageal cancer (squamous cell)	
COAD	cis	1	rs56060232	chr14:104386165	TDRD9	chr14:104394817-104519002:+	0.35	5.13	5.55E-7	Bipolar disorder	
COAD	cis	1	rs56104203	chr2:86336256	LOC90784	chr2:86247339-86250991:-	-0.64	-5.17	4.59E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.59	8.06	2.71E-14	Diastolic blood pressure	
COAD	cis	1	rs56124423	chr3:119278163	CD80	chr3:119243142-119278481:-	0.2	4.06	6.48E-5	Vitiligo	
COAD	cis	1	rs56127630	chr3:49438036	WDR6	chr3:49044637-49053386:+	0.3	4.14	4.64E-5	Menarche (age at onset)	
COAD	cis	1	rs56153133	chr1:11885647	CLCN6	chr1:11866207-11907674:+	0.29	4.64	5.53E-6	QRS complex (12-leadsum)	
COAD	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.59	8.06	2.71E-14	Diastolic blood pressure	
COAD	cis	1	rs56160723	chr10:91373631	PANK1	chr10:91342749-91405215:-	0.31	3.87	0.000135	Metabolic traits	
COAD	cis	1	rs56162244	chr2:243018690	THAP4	chr2:242523821-242576655:-	0.3	3.9	0.000125	Obesity-related traits	
COAD	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.71	-12.78	2.27E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs56190030	chr1:11887382	CLCN6	chr1:11866207-11907674:+	0.22	3.94	0.000104	QRS complex (12-leadsum)	
COAD	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.64	7.96	5.27E-14	Diastolic blood pressure	
COAD	cis	1	rs56234712	chr16:67241754	LRRC29	chr16:67241043-67260901:-	-0.43	-5.82	1.72E-8	HDL cholesterol	
COAD	cis	1	rs56292923	chr2:243039986	THAP4	chr2:242523821-242576655:-	0.3	3.88	0.00013	Obesity-related traits	
COAD	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.2	3.85	0.00015	Height	
COAD	cis	1	rs563092	chr11:30501151	MPPED2	chr11:30406040-30607930:-	0.29	4.87	1.97E-6	Dental caries	
COAD	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.34	5.19	4.29E-7	Cognitive performance	
COAD	cis	1	rs56315277	chr6:160163213	PNLDC1	chr6:160221301-160241735:+	0.57	4.05	6.73E-5	Iron status biomarkers	
COAD	cis	1	rs56317427	chr10:81861934	PLAC9	chr10:81892258-81904784:+	-0.28	-4.04	7.08E-5	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.72	-13.51	6.88E-32	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.18	4.28	2.58E-5	Blood metabolite levels	
COAD	cis	1	rs56323081	chr2:243040807	THAP4	chr2:242523821-242576655:-	0.33	4.16	4.41E-5	Obesity-related traits	
COAD	cis	1	rs56348638	chr17:53064550	STXBP4	chr17:53046126-53241449:+	-0.28	-3.89	0.000125	Breast cancer	
COAD	cis	1	rs56383601	chr17:61929968	FTSJ3	chr17:61896795-61905031:-	0.31	4.11	5.32E-5	Body mass index	
COAD	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.34	4.28	2.59E-5	Response to temozolomide	
COAD	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.34	4.28	2.59E-5	Response to temozolomide	
COAD	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.66	9.6	6.79E-19	Diastolic blood pressure	
COAD	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.58	-11.88	2.71E-26	Crohn's disease	
COAD	cis	1	rs568617	chr11:65653242	FIBP	chr11:65651212-65656010:-	0.29	4.17	4.1E-5	Crohn's disease	
COAD	cis	1	rs56901035	chr8:96043188	C8orf38	chr8:95908040-96088396:+	-0.29	-4.02	7.63E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs570408	chr1:34174424	ZSCAN20	chr1:33938232-33961993:+	0.46	4.27	2.73E-5	Response to amphetamines	
COAD	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.39	4.74	3.55E-6	Atopic dermatitis	
COAD	cis	1	rs57165742	chr8:124184559	FAM83A	chr8:124191287-124222317:+	-0.49	-4.34	2.01E-5	Urinary uromodulin levels	
COAD	cis	1	rs57311533	chr8:89582889	MMP16	chr8:89049462-89339717:-	0.18	4.08	5.98E-5	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.28	3.89	0.000128	Coffee consumption (cups per day)	
COAD	cis	1	rs574653	chr11:30506207	MPPED2	chr11:30406040-30607930:-	0.28	4.84	2.19E-6	Dental caries	
COAD	cis	1	rs5750621	chr22:38956166	CBY1	chr22:39052658-39069853:+	0.39	6.25	1.63E-9	Resting heart rate	
COAD	cis	1	rs5750622	chr22:38956464	CBY1	chr22:39052658-39069853:+	0.36	5.83	1.65E-8	Resting heart rate	
COAD	cis	1	rs5750626	chr22:38977890	CBY1	chr22:39052658-39069853:+	0.39	6.22	1.98E-9	Resting heart rate	
COAD	cis	1	rs5750627	chr22:38982321	CBY1	chr22:39052658-39069853:+	0.31	5.31	2.32E-7	Resting heart rate	
COAD	cis	1	rs5750630	chr22:38985818	CBY1	chr22:39052658-39069853:+	0.38	5.99	6.93E-9	Resting heart rate	
COAD	cis	1	rs5750633	chr22:38993467	CBY1	chr22:39052658-39069853:+	0.28	4.83	2.32E-6	Resting heart rate	
COAD	cis	1	rs5750633	chr22:38993467	JOSD1	chr22:39081549-39096459:-	-0.22	-3.83	0.000163	Resting heart rate	
COAD	cis	1	rs5750649	chr22:39036769	CBY1	chr22:39052658-39069853:+	0.31	5.31	2.39E-7	Resting heart rate	
COAD	cis	1	rs5750652	chr22:39048316	CBY1	chr22:39052658-39069853:+	0.31	5.31	2.39E-7	Resting heart rate	
COAD	cis	1	rs5750659	chr22:39068789	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs5750659	chr22:39068789	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs5750662	chr22:39072472	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs5750662	chr22:39072472	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs5750664	chr22:39072769	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs5750664	chr22:39072769	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs5750668	chr22:39079964	CBY1	chr22:39052658-39069853:+	0.37	6.34	1.03E-9	Resting heart rate	
COAD	cis	1	rs5750668	chr22:39079964	JOSD1	chr22:39081549-39096459:-	-0.26	-4.38	1.75E-5	Resting heart rate	
COAD	cis	1	rs5750669	chr22:39080638	CBY1	chr22:39052658-39069853:+	0.41	6.84	5.65E-11	Resting heart rate	
COAD	cis	1	rs5750669	chr22:39080638	JOSD1	chr22:39081549-39096459:-	-0.25	-4.01	7.98E-5	Resting heart rate	
COAD	cis	1	rs5750671	chr22:39094619	CBY1	chr22:39052658-39069853:+	0.33	5.78	2.14E-8	Resting heart rate	
COAD	cis	1	rs5750672	chr22:39104168	CBY1	chr22:39052658-39069853:+	-0.34	-5.75	2.52E-8	Resting heart rate	
COAD	cis	1	rs5750672	chr22:39104168	JOSD1	chr22:39081549-39096459:-	0.26	4.32	2.24E-5	Resting heart rate	
COAD	cis	1	rs5750673	chr22:39110124	CBY1	chr22:39052658-39069853:+	0.37	6.2	2.17E-9	Resting heart rate	
COAD	cis	1	rs5750673	chr22:39110124	JOSD1	chr22:39081549-39096459:-	-0.27	-4.43	1.37E-5	Resting heart rate	
COAD	cis	1	rs5750677	chr22:39147715	CBY1	chr22:39052658-39069853:+	0.33	5.41	1.42E-7	Resting heart rate	
COAD	cis	1	rs5750677	chr22:39147715	JOSD1	chr22:39081549-39096459:-	-0.27	-4.31	2.33E-5	Resting heart rate	
COAD	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.34	-5.29	2.56E-7	Cognitive function	
COAD	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.69	-11.6	2.21E-25	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs5757141	chr22:38957483	CBY1	chr22:39052658-39069853:+	0.38	6.14	3.01E-9	Resting heart rate	
COAD	cis	1	rs5757162	chr22:38993370	CBY1	chr22:39052658-39069853:+	0.37	5.89	1.17E-8	Resting heart rate	
COAD	cis	1	rs5757166	chr22:38995385	CBY1	chr22:39052658-39069853:+	0.28	4.81	2.61E-6	Resting heart rate	
COAD	cis	1	rs5757166	chr22:38995385	JOSD1	chr22:39081549-39096459:-	-0.22	-3.84	0.000155	Resting heart rate	
COAD	cis	1	rs5757181	chr22:39013522	CBY1	chr22:39052658-39069853:+	0.36	5.78	2.16E-8	Resting heart rate	
COAD	cis	1	rs5757187	chr22:39021522	CBY1	chr22:39052658-39069853:+	-0.35	-6.05	4.93E-9	Resting heart rate	
COAD	cis	1	rs5757187	chr22:39021522	JOSD1	chr22:39081549-39096459:-	0.27	4.55	8.08E-6	Resting heart rate	
COAD	cis	1	rs5757193	chr22:39034867	CBY1	chr22:39052658-39069853:+	-0.4	-6.42	6.57E-10	Resting heart rate	
COAD	cis	1	rs5757196	chr22:39039855	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs5757196	chr22:39039855	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs5757200	chr22:39043491	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs5757200	chr22:39043491	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs5757203	chr22:39044152	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs5757203	chr22:39044152	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs5757204	chr22:39046700	CBY1	chr22:39052658-39069853:+	0.36	6.11	3.54E-9	Resting heart rate	
COAD	cis	1	rs5757204	chr22:39046700	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.24E-6	Resting heart rate	
COAD	cis	1	rs5757208	chr22:39049230	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs5757208	chr22:39049230	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs5757211	chr22:39051705	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs5757211	chr22:39051705	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs5757213	chr22:39053888	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs5757213	chr22:39053888	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs5757226	chr22:39070550	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs5757226	chr22:39070550	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs5757231	chr22:39071658	CBY1	chr22:39052658-39069853:+	-0.36	-6.07	4.39E-9	Resting heart rate	
COAD	cis	1	rs5757231	chr22:39071658	JOSD1	chr22:39081549-39096459:-	0.27	4.57	7.48E-6	Resting heart rate	
COAD	cis	1	rs5757232	chr22:39071677	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs5757232	chr22:39071677	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs5757234	chr22:39072686	CBY1	chr22:39052658-39069853:+	0.33	5.78	2.09E-8	Resting heart rate	
COAD	cis	1	rs5757253	chr22:39104320	CBY1	chr22:39052658-39069853:+	0.34	5.85	1.49E-8	Resting heart rate	
COAD	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.33	-5.05	8.14E-7	Cognitive function	
COAD	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.34	-5.33	2.09E-7	Cognitive function	
COAD	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.35	-5.48	1.02E-7	Cognitive function	
COAD	cis	1	rs5759598	chr22:23480962	GNAZ	chr22:23412669-23467221:+	-0.27	-3.91	0.000119	Bone mineral density	
COAD	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.72	6.88	4.3E-11	Amyotrophic lateral sclerosis	
COAD	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	0.77	7.19	6.83E-12	Amyotrophic lateral sclerosis	
COAD	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.83	7.66	3.61E-13	Amyotrophic lateral sclerosis	
COAD	cis	1	rs57603292	chr2:243028537	THAP4	chr2:242523821-242576655:-	0.39	4.84	2.19E-6	Obesity-related traits	
COAD	cis	1	rs576663	chr11:65498942	CFL1	chr11:65622287-65626886:-	0.27	3.85	0.000149	Atopic dermatitis	
COAD	cis	1	rs576779	chr4:56274307	SRD5A3	chr4:56212409-56237866:+	0.27	4.77	3.07E-6	Personality dimensions	
COAD	cis	1	rs57902736	chr8:124189893	FAM83A	chr8:124191287-124222317:+	-0.49	-4.22	3.32E-5	Urinary uromodulin levels	
COAD	cis	1	rs57925408	chr8:96062930	C8orf38	chr8:95908040-96088396:+	-0.36	-4.97	1.21E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs580705	chr11:114430047	FAM55A	chr11:114392438-114430580:-	-0.25	-4.21	3.47E-5	Ulcerative colitis	
COAD	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.33	4.22	3.36E-5	Response to temozolomide	
COAD	cis	1	rs58177772	chr8:124188067	FAM83A	chr8:124191287-124222317:+	-0.49	-4.22	3.41E-5	Urinary uromodulin levels	
COAD	cis	1	rs58189203	chr8:124184739	FAM83A	chr8:124191287-124222317:+	-0.49	-4.33	2.14E-5	Urinary uromodulin levels	
COAD	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.33	3.96	9.7E-5	Schizophrenia (negative symptoms)	
COAD	cis	1	rs58455759	chr1:171674987	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.27E-6	Hippocampal atrophy	
COAD	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.73	-13.47	9.39E-32	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs58601355	chr4:120186367	FABP2	chr4:120238406-120243316:-	0.39	5.94	9.15E-9	Corneal astigmatism	
COAD	cis	1	rs58603761	chr2:73726605	ALMS1	chr2:73612886-73837046:+	0.24	3.96	9.85E-5	Metabolite levels	
COAD	cis	1	rs58660500	chr3:53086573	SFMBT1	chr3:52938628-53080070:-	-0.54	-4.28	2.64E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs58660500	chr3:53086573	TMEM110	chr3:52867139-52931547:-	0.52	4.26	2.88E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.59	-5.68	3.62E-8	Abdominal aortic aneurysm	
COAD	cis	1	rs59036157	chr2:243040228	THAP4	chr2:242523821-242576655:-	0.33	4.16	4.41E-5	Obesity-related traits	
COAD	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.32	4.85	2.09E-6	Pancreatic cancer	
COAD	cis	1	rs59214302	chr19:10836062	RAVER1	chr19:10426891-10444314:-	0.48	3.97	9.34E-5	LDL cholesterol	
COAD	cis	1	rs59217052	chr3:158452456	RARRES1	chr3:158414899-158450275:-	0.51	7.03	1.78E-11	Tetralogy of Fallot	
COAD	cis	1	rs59233487	chr10:81729450	LOC219347	chr10:81805991-81838949:-	0.61	3.95	9.9E-5	Rheumatoid arthritis	
COAD	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.44	-4.55	8.36E-6	Bone mineral density	
COAD	cis	1	rs59274738	chr17:28437635	EFCAB5	chr17:28256874-28435469:+	0.27	3.87	0.000135	Coffee consumption (cups per day)	
COAD	cis	1	rs59313096	chr3:158452242	RARRES1	chr3:158414899-158450275:-	0.51	7.03	1.78E-11	Tetralogy of Fallot	
COAD	cis	1	rs59321715	chr5:150313480	LOC134466	chr5:150310000-150326146:-	0.6	7.04	1.71E-11	Crohn's disease	
COAD	cis	1	rs59517104	chr6:160158900	PNLDC1	chr6:160221301-160241735:+	0.53	3.83	0.00016	Iron status biomarkers	
COAD	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.33	4.4	1.58E-5	Crohn's disease	
COAD	cis	1	rs59715646	chr19:10839447	RAVER1	chr19:10426891-10444314:-	0.47	4.1	5.46E-5	LDL cholesterol	
COAD	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.49	5.86	1.37E-8	Crohn's disease	
COAD	cis	1	rs59804446	chr4:56429541	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.34	2.07E-5	Personality dimensions	
COAD	cis	1	rs59834873	chr8:124188824	FAM83A	chr8:124191287-124222317:+	-0.46	-4.12	5.16E-5	Urinary uromodulin levels	
COAD	cis	1	rs59918529	chr3:158452705	RARRES1	chr3:158414899-158450275:-	0.34	4.68	4.55E-6	Tetralogy of Fallot	
COAD	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.72	-13.53	5.89E-32	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs5995610	chr22:39064681	CBY1	chr22:39052658-39069853:+	0.37	6.32	1.14E-9	Resting heart rate	
COAD	cis	1	rs5995610	chr22:39064681	JOSD1	chr22:39081549-39096459:-	-0.29	-4.84	2.23E-6	Resting heart rate	
COAD	cis	1	rs6001173	chr22:39015302	CBY1	chr22:39052658-39069853:+	0.29	5.03	9.04E-7	Resting heart rate	
COAD	cis	1	rs6001175	chr22:39018334	CBY1	chr22:39052658-39069853:+	0.28	4.86	2.03E-6	Resting heart rate	
COAD	cis	1	rs6001175	chr22:39018334	JOSD1	chr22:39081549-39096459:-	-0.23	-3.93	0.000108	Resting heart rate	
COAD	cis	1	rs6001182	chr22:39047443	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs6001182	chr22:39047443	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs6001184	chr22:39052116	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs6001184	chr22:39052116	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs6001185	chr22:39052155	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs6001185	chr22:39052155	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs6001188	chr22:39062194	CBY1	chr22:39052658-39069853:+	0.37	6.28	1.42E-9	Resting heart rate	
COAD	cis	1	rs6001188	chr22:39062194	JOSD1	chr22:39081549-39096459:-	-0.27	-4.61	6.34E-6	Resting heart rate	
COAD	cis	1	rs6001191	chr22:39074452	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs6001191	chr22:39074452	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs6001204	chr22:39100239	CBY1	chr22:39052658-39069853:+	0.33	5.81	1.84E-8	Resting heart rate	
COAD	cis	1	rs6001214	chr22:39149155	CBY1	chr22:39052658-39069853:+	0.33	5.36	1.84E-7	Resting heart rate	
COAD	cis	1	rs6001214	chr22:39149155	JOSD1	chr22:39081549-39096459:-	-0.27	-4.41	1.49E-5	Resting heart rate	
COAD	cis	1	rs600193	chr15:65729409	DENND4A	chr15:65952959-66084631:-	0.22	4.27	2.8E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs60025964	chr2:99880577	REV1	chr2:100016939-100106480:-	0.34	4.22	3.35E-5	IgG glycosylation	
COAD	cis	1	rs6004667	chr22:25874464	CRYBB2	chr22:25615612-25627836:+	-0.8	-9.92	6.75E-20	Bipolar disorder with mood-incongruent psychosis	
COAD	cis	1	rs6004673	chr22:25885353	CRYBB2	chr22:25615612-25627836:+	0.7	8.81	1.81E-16	Bipolar disorder with mood-incongruent psychosis	
COAD	cis	1	rs601338	chr19:49206674	FUT2	chr19:49199228-49209190:+	-0.6	-11.17	6.25E-24	Blood metabolite levels;Blood metabolite ratios	
COAD	cis	1	rs601338	chr19:49206674	SEC1	chr19:49141296-49185501:+	-0.33	-4.79	2.74E-6	Blood metabolite levels;Blood metabolite ratios	
COAD	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.72	-12.79	2.14E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs6020091	chr20:48482670	KCNB1	chr20:47988505-48100490:-	-0.18	-3.9	0.000124	Gut microbiota (beta diversity)	
COAD	cis	1	rs6020092	chr20:48482934	KCNB1	chr20:47988505-48100490:-	-0.18	-3.9	0.000124	Gut microbiota (beta diversity)	
COAD	cis	1	rs60253563	chr6:170083019	C6orf70	chr6:170151721-170181617:+	0.38	4.24	3.16E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs6036630	chr20:24046233	NXT1	chr20:23331373-23335408:+	0.39	4.09	5.78E-5	Erectile dysfunction and prostate cancer treatment	
COAD	cis	1	rs60425110	chr15:75333000	SCAMP5	chr15:75287901-75313836:+	0.36	4.48	1.12E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.71	-12.31	8.9E-28	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs6051080	chr20:25975674	FAM182A	chr20:26035250-26067552:+	0.38	5.7	3.17E-8	Colorectal or endometrial cancer	
COAD	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.38	5.48	9.82E-8	Colorectal or endometrial cancer	
COAD	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.3	-4.95	1.31E-6	Longevity	
COAD	cis	1	rs60513756	chr5:90727692	LOC100129716	chr5:90676164-90716531:+	0.34	4.04	6.96E-5	Smoking behavior	
COAD	cis	1	rs60533128	chr2:243028088	THAP4	chr2:242523821-242576655:-	0.41	4.36	1.91E-5	Obesity-related traits	
COAD	cis	1	rs60622165	chr8:89599455	MMP16	chr8:89049462-89339717:-	0.17	3.89	0.000126	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.38	4.76	3.15E-6	Atopic dermatitis	
COAD	cis	1	rs6070692	chr20:57586374	TH1L	chr20:57556311-57570186:+	-0.27	-4.4	1.55E-5	Mean platelet volume	
COAD	cis	1	rs6070696	chr20:57597645	TH1L	chr20:57556311-57570186:+	-0.23	-4.15	4.43E-5	Mean platelet volume	
COAD	cis	1	rs6070697	chr20:57599402	TH1L	chr20:57556311-57570186:+	-0.27	-4.52	9.22E-6	Mean platelet volume	
COAD	cis	1	rs60719662	chr6:163006643	PACRG	chr6:163148164-163736523:+	0.38	4.32	2.25E-5	Body mass index	
COAD	cis	1	rs6075398	chr20:1921728	SNRPB	chr20:2442281-2451499:-	0.46	3.88	0.000133	Liver enzyme levels (alanine transaminase)	
COAD	cis	1	rs6075398	chr20:1921728	STK35	chr20:2082528-2129196:+	0.55	4.04	7.0E-5	Liver enzyme levels (alanine transaminase)	
COAD	cis	1	rs60755785	chr19:10839494	RAVER1	chr19:10426891-10444314:-	0.47	4.1	5.46E-5	LDL cholesterol	
COAD	cis	1	rs60827294	chr8:124187842	FAM83A	chr8:124191287-124222317:+	-0.5	-4.38	1.76E-5	Urinary uromodulin levels	
COAD	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.69	-12.52	1.78E-28	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.2	3.96	9.57E-5	Height	
COAD	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.21	4.05	6.69E-5	Height	
COAD	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.18	3.94	0.000106	Height	
COAD	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.21	4	8.32E-5	Height	
COAD	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.22	4.17	4.12E-5	Height	
COAD	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.2	3.89	0.000126	Height	
COAD	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.18	3.83	0.000159	Height	
COAD	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.21	4.02	7.68E-5	Height	
COAD	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.2	3.94	0.000105	Height	
COAD	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.2	3.94	0.000105	Height	
COAD	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.2	4.21	3.49E-5	Height	
COAD	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.21	4.11	5.26E-5	Height	
COAD	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.21	4.06	6.6E-5	Height	
COAD	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.19	3.97	9.43E-5	Height	
COAD	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.21	3.95	0.000102	Height	
COAD	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.21	3.95	0.000102	Height	
COAD	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.21	4.11	5.32E-5	Height	
COAD	cis	1	rs60942590	chr3:53016421	SFMBT1	chr3:52938628-53080070:-	-0.68	-6.15	2.82E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.54	9.51	1.33E-18	Folate pathway vitamin levels	
COAD	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.54	-8.57	9.14E-16	Forced vital capacity	
COAD	cis	1	rs61172708	chr3:52996052	SFMBT1	chr3:52938628-53080070:-	-0.67	-6.08	4.25E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.48	-7.73	2.26E-13	Triglycerides	
COAD	cis	1	rs612279	chr1:34173973	ZSCAN20	chr1:33938232-33961993:+	0.45	4.16	4.27E-5	Response to amphetamines	
COAD	cis	1	rs612602	chr18:8312191	ANKRD12	chr18:9136758-9285206:+	-0.27	-3.9	0.000124	Sitting height ratio	
COAD	cis	1	rs613089	chr1:147081187	ACP6	chr1:147119168-147142634:-	-0.37	-4.42	1.45E-5	Schizophrenia (negative symptoms)	
COAD	cis	1	rs6132677	chr20:23840242	CST2	chr20:23804404-23807312:-	-0.27	-3.83	0.000159	Response to TNF antagonist treatment	
COAD	cis	1	rs6132678	chr20:23842323	CST2	chr20:23804404-23807312:-	-0.27	-3.83	0.000159	Response to TNF antagonist treatment	
COAD	cis	1	rs6132679	chr20:23842400	CST2	chr20:23804404-23807312:-	-0.27	-3.83	0.000159	Response to TNF antagonist treatment	
COAD	cis	1	rs61366424	chr10:60004851	IPMK	chr10:59955618-60027694:-	0.24	3.98	8.78E-5	Inflammatory bowel disease	
COAD	cis	1	rs61369062	chr6:131611802	SAMD3	chr6:130465463-130686570:-	0.37	4.07	6.36E-5	Multiple myeloma (IgH translocation)	
COAD	cis	1	rs6138150	chr20:23847009	CST2	chr20:23804404-23807312:-	-0.28	-3.91	0.00012	Response to TNF antagonist treatment	
COAD	cis	1	rs6138151	chr20:23847180	CST2	chr20:23804404-23807312:-	-0.28	-3.86	0.000145	Response to TNF antagonist treatment	
COAD	cis	1	rs6140175	chr20:760863	RBCK1	chr20:388709-411608:+	0.53	4.11	5.37E-5	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	
COAD	cis	1	rs6140175	chr20:760863	TBC1D20	chr20:416126-443187:-	0.52	3.83	0.000161	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	
COAD	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.2	3.98	8.91E-5	Height	
COAD	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.2	3.94	0.000105	Height	
COAD	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.2	3.94	0.000105	Height	
COAD	cis	1	rs61422480	chr8:124188940	FAM83A	chr8:124191287-124222317:+	-0.44	-3.93	0.000111	Urinary uromodulin levels	
COAD	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.21	-4.13	4.89E-5	Height	
COAD	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.2	3.94	0.000105	Height	
COAD	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.18	3.84	0.000155	Height	
COAD	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.2	3.94	0.000105	Height	
COAD	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.21	4.06	6.6E-5	Height	
COAD	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.19	3.97	9.43E-5	Height	
COAD	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.21	3.95	0.000102	Height	
COAD	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.21	4.11	5.26E-5	Height	
COAD	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.22	4.17	4.12E-5	Height	
COAD	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-1.1	-10.25	6.11E-21	Blood metabolite levels	
COAD	cis	1	rs615199	chr6:117113653	FAM162B	chr6:117073360-117086886:-	0.26	4.06	6.38E-5	C-reactive protein levels	
COAD	cis	1	rs61524473	chr15:45646283	GATM	chr15:45653324-45670980:-	-0.47	-6.45	5.5E-10	Metabolite levels (small molecules and protein measures)	
COAD	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.31	4.23	3.18E-5	Crohn's disease	
COAD	cis	1	rs61558956	chr3:158452655	RARRES1	chr3:158414899-158450275:-	0.33	4.46	1.23E-5	Tetralogy of Fallot	
COAD	cis	1	rs61612071	chr5:90741470	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs617219	chr5:78429594	DMGDH	chr5:78293430-78365449:-	-0.26	-3.97	9.15E-5	Betaine levels in individuals undergoing cardiac evaluation	
COAD	cis	1	rs617219	chr5:78429594	JMY	chr5:78531954-78623036:+	-0.21	-3.85	0.00015	Betaine levels in individuals undergoing cardiac evaluation	
COAD	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.63	9.21	1.09E-17	Diastolic blood pressure	
COAD	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.63	9.21	1.09E-17	Diastolic blood pressure	
COAD	cis	1	rs61782665	chr1:47692035	TAL1	chr1:47681963-47779819:-	-0.17	-3.82	0.000167	Body mass index	
COAD	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.56	5.99	6.85E-9	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs61826828	chr1:174015261	RC3H1	chr1:173900354-173962210:-	-0.34	-4.29	2.57E-5	Schizophrenia	
COAD	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.4	4.93	1.49E-6	Schizophrenia	
COAD	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.33	-4.1	5.59E-5	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs61852637	chr1:247219636	ZNF670	chr1:247200087-247242069:-	-0.32	-3.94	0.000104	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.17	4.16	4.37E-5	Blood metabolite levels	
COAD	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.17	4.2	3.7E-5	Blood metabolite levels	
COAD	cis	1	rs61871793	chr10:97407738	ENTPD1	chr10:97471536-97637022:+	0.17	3.88	0.00013	Blood metabolite levels	
COAD	cis	1	rs61872688	chr10:101273546	NKX2-3	chr10:101292690-101296278:+	-0.21	-4.64	5.46E-6	Dental caries	
COAD	cis	1	rs61876323	chr11:462855	PTDSS2	chr11:450280-491386:+	-0.46	-4.56	8.01E-6	Body mass index	
COAD	cis	1	rs61876326	chr11:467368	PTDSS2	chr11:450280-491386:+	-0.46	-4.56	8.01E-6	Body mass index	
COAD	cis	1	rs61876332	chr11:487101	PTDSS2	chr11:450280-491386:+	-0.51	-4.85	2.12E-6	Body mass index	
COAD	cis	1	rs61876333	chr11:487136	PTDSS2	chr11:450280-491386:+	-0.5	-4.51	1.0E-5	Body mass index	
COAD	cis	1	rs61876334	chr11:487201	PTDSS2	chr11:450280-491386:+	-0.51	-4.85	2.12E-6	Body mass index	
COAD	cis	1	rs61876335	chr11:488878	PTDSS2	chr11:450280-491386:+	-0.49	-5.14	5.45E-7	Body mass index	
COAD	cis	1	rs61876336	chr11:489537	PTDSS2	chr11:450280-491386:+	-0.51	-4.85	2.12E-6	Body mass index	
COAD	cis	1	rs61876339	chr11:495283	PTDSS2	chr11:450280-491386:+	-0.48	-4.54	8.46E-6	Body mass index	
COAD	cis	1	rs61876340	chr11:495699	PTDSS2	chr11:450280-491386:+	-0.49	-4.72	3.81E-6	Body mass index	
COAD	cis	1	rs61876341	chr11:495892	PTDSS2	chr11:450280-491386:+	-0.49	-4.72	3.81E-6	Body mass index	
COAD	cis	1	rs61876342	chr11:496193	PTDSS2	chr11:450280-491386:+	-0.51	-4.87	1.9E-6	Body mass index	
COAD	cis	1	rs61877760	chr11:506596	PTDSS2	chr11:450280-491386:+	-0.49	-4.71	4.1E-6	Body mass index	
COAD	cis	1	rs61877775	chr11:521462	PTDSS2	chr11:450280-491386:+	-0.46	-4.18	4.05E-5	Body mass index	
COAD	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.33	-4.7	4.13E-6	Schizophrenia	
COAD	cis	1	rs62029093	chr16:49393549	N4BP1	chr16:48572639-48644120:-	0.33	3.98	8.81E-5	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs62029094	chr16:49393602	N4BP1	chr16:48572639-48644120:-	0.33	3.98	8.81E-5	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs62070270	chr17:28263980	EFCAB5	chr17:28256874-28435469:+	0.28	4.05	6.74E-5	Coffee consumption (cups per day)	
COAD	cis	1	rs62070312	chr17:28438877	EFCAB5	chr17:28256874-28435469:+	0.27	3.84	0.000153	Coffee consumption (cups per day)	
COAD	cis	1	rs62101776	chr18:47210074	ACAA2	chr18:47309875-47340283:-	-0.27	-4.15	4.59E-5	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs62101780	chr18:47211344	ACAA2	chr18:47309875-47340283:-	-0.27	-4.09	5.79E-5	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.71	-12.21	2.05E-27	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.72	-12.87	1.08E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.73	-13.12	1.48E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.72	-13.12	1.48E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.72	-12.57	1.22E-28	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs62114762	chr19:24233868	ZNF254	chr19:24216247-24312652:+	0.33	4.08	6.02E-5	Response to taxane treatment (placlitaxel)	
COAD	cis	1	rs62116204	chr19:52024375	FPR2	chr19:52264453-52273777:+	0.37	3.84	0.000154	Carotid intima media thickness	
COAD	cis	1	rs62117633	chr19:24219474	ZNF254	chr19:24216247-24312652:+	0.35	4.16	4.28E-5	Response to taxane treatment (placlitaxel)	
COAD	cis	1	rs62153845	chr2:99887162	REV1	chr2:100016939-100106480:-	0.34	4.22	3.35E-5	IgG glycosylation	
COAD	cis	1	rs62172508	chr2:188084469	CALCRL	chr2:188207851-188313021:-	0.13	4.05	6.86E-5	Coronary heart disease	
COAD	cis	1	rs62172509	chr2:188084535	CALCRL	chr2:188207851-188313021:-	0.15	4.25	2.95E-5	Coronary heart disease	
COAD	cis	1	rs62172510	chr2:188093671	CALCRL	chr2:188207851-188313021:-	0.15	4.26	2.82E-5	Coronary heart disease	
COAD	cis	1	rs62172533	chr2:188131585	CALCRL	chr2:188207851-188313021:-	0.15	4.24	3.11E-5	Coronary heart disease	
COAD	cis	1	rs62172550	chr2:188146887	CALCRL	chr2:188207851-188313021:-	0.15	4.35	1.96E-5	Coronary heart disease	
COAD	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.18	3.84	0.000155	Height	
COAD	cis	1	rs62259933	chr3:49469703	WDR6	chr3:49044637-49053386:+	0.33	4.6	6.54E-6	Menarche (age at onset)	
COAD	cis	1	rs62259944	chr3:49430883	WDR6	chr3:49044637-49053386:+	0.3	3.89	0.000129	Menarche (age at onset)	
COAD	cis	1	rs62259947	chr3:49439924	WDR6	chr3:49044637-49053386:+	0.31	4.1	5.41E-5	Menarche (age at onset)	
COAD	cis	1	rs62261249	chr3:49594060	WDR6	chr3:49044637-49053386:+	0.3	3.98	9.03E-5	Menarche (age at onset)	
COAD	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.33	5.02	9.52E-7	Cognitive performance	
COAD	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.6	-8.51	1.41E-15	Height	
COAD	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.35	-4.6	6.52E-6	Height	
COAD	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.6	-8.51	1.41E-15	Height	
COAD	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.35	-4.6	6.52E-6	Height	
COAD	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs62402013	chr6:26915000	C6orf41	chr6:26924772-26991752:+	-0.38	-5.51	8.5E-8	Schizophrenia	
COAD	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.39	-5.5	8.9E-8	Schizophrenia	
COAD	cis	1	rs62421536	chr6:118727972	C6orf204	chr6:118786239-119031238:-	-0.26	-4.28	2.61E-5	Renal cell carcinoma	
COAD	cis	1	rs62421539	chr6:118730559	C6orf204	chr6:118786239-119031238:-	-0.27	-4.58	7.25E-6	Renal cell carcinoma	
COAD	cis	1	rs62422189	chr6:118907053	C6orf204	chr6:118786239-119031238:-	-0.29	-4.6	6.63E-6	Renal cell carcinoma	
COAD	cis	1	rs62422220	chr6:118923731	C6orf204	chr6:118786239-119031238:-	-0.26	-4.32	2.26E-5	Renal cell carcinoma	
COAD	cis	1	rs62422221	chr6:118925581	C6orf204	chr6:118786239-119031238:-	-0.26	-4.11	5.25E-5	Renal cell carcinoma	
COAD	cis	1	rs62422224	chr6:118941116	C6orf204	chr6:118786239-119031238:-	-0.27	-4.28	2.63E-5	Renal cell carcinoma	
COAD	cis	1	rs62422227	chr6:118957200	C6orf204	chr6:118786239-119031238:-	-0.28	-4.58	7.27E-6	Renal cell carcinoma	
COAD	cis	1	rs62422228	chr6:118957276	C6orf204	chr6:118786239-119031238:-	-0.28	-4.58	7.27E-6	Renal cell carcinoma	
COAD	cis	1	rs62422229	chr6:118959288	C6orf204	chr6:118786239-119031238:-	-0.27	-4.47	1.17E-5	Renal cell carcinoma	
COAD	cis	1	rs62422235	chr6:118971913	C6orf204	chr6:118786239-119031238:-	-0.27	-4.18	3.91E-5	Renal cell carcinoma	
COAD	cis	1	rs62422236	chr6:118972633	C6orf204	chr6:118786239-119031238:-	-0.27	-4.18	3.91E-5	Renal cell carcinoma	
COAD	cis	1	rs62424172	chr6:118777533	C6orf204	chr6:118786239-119031238:-	-0.26	-4.33	2.12E-5	Renal cell carcinoma	
COAD	cis	1	rs62424175	chr6:118797381	C6orf204	chr6:118786239-119031238:-	-0.26	-4.22	3.38E-5	Renal cell carcinoma	
COAD	cis	1	rs62424195	chr6:118812108	C6orf204	chr6:118786239-119031238:-	-0.28	-4.8	2.69E-6	Renal cell carcinoma	
COAD	cis	1	rs62424198	chr6:118827247	C6orf204	chr6:118786239-119031238:-	-0.28	-4.78	2.89E-6	Renal cell carcinoma	
COAD	cis	1	rs62424199	chr6:118827252	C6orf204	chr6:118786239-119031238:-	-0.28	-4.78	2.89E-6	Renal cell carcinoma	
COAD	cis	1	rs62521826	chr8:124186668	FAM83A	chr8:124191287-124222317:+	-0.5	-4.45	1.27E-5	Urinary uromodulin levels	
COAD	cis	1	rs62663261	chr6:118900553	C6orf204	chr6:118786239-119031238:-	-0.29	-4.69	4.32E-6	Renal cell carcinoma	
COAD	cis	1	rs627804	chr15:65734040	DENND4A	chr15:65952959-66084631:-	-0.22	-4.24	3.1E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.58	-11.88	2.71E-26	Crohn's disease	
COAD	cis	1	rs641018	chr11:65655393	FIBP	chr11:65651212-65656010:-	0.29	4.17	4.1E-5	Crohn's disease	
COAD	cis	1	rs642803	chr11:65560620	CTSW	chr11:65647284-65651212:+	0.21	3.99	8.66E-5	Urate levels	
COAD	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.34	5.23	3.48E-7	Height	
COAD	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.63	-9.47	1.74E-18	Homocysteine levels	
COAD	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.47	-6.99	2.24E-11	Homocysteine levels	
COAD	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.58	8.45	2.06E-15	Height	
COAD	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs6439649	chr3:136371691	PCCB	chr3:135969167-136056737:+	-0.27	-4.59	7.0E-6	Schizophrenia	
COAD	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.43	-4.66	5.05E-6	Bone mineral density	
COAD	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.27	4.52	9.55E-6	Longevity	
COAD	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.29	-4.92	1.51E-6	Longevity	
COAD	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.29	-4.75	3.41E-6	Longevity	
COAD	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.3	-4.94	1.37E-6	Longevity	
COAD	cis	1	rs6445557	chr3:53083969	SFMBT1	chr3:52938628-53080070:-	0.5	5.89	1.16E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs6446262	chr3:49401153	WDR6	chr3:49044637-49053386:+	-0.31	-4.1	5.41E-5	Menarche (age at onset)	
COAD	cis	1	rs6446268	chr3:49445695	WDR6	chr3:49044637-49053386:+	0.31	4.26	2.83E-5	Menarche (age at onset)	
COAD	cis	1	rs6446275	chr3:49466871	WDR6	chr3:49044637-49053386:+	0.33	4.6	6.54E-6	Menarche (age at onset)	
COAD	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.99	12.91	8.25E-30	Type 2 diabetes	
COAD	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.83	10.14	1.34E-20	Type 2 diabetes	
COAD	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.62	9.66	4.67E-19	Response to antipsychotic treatment	
COAD	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.38	-7.05	1.63E-11	Homocysteine levels	
COAD	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.38	-7.17	7.55E-12	Homocysteine levels	
COAD	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.53	9.28	6.73E-18	Folate pathway vitamin levels	
COAD	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.55	9.62	5.95E-19	Folate pathway vitamin levels	
COAD	cis	1	rs6464573	chr7:143748098	OR2A7	chr7:143955790-143974852:-	-0.28	-3.85	0.000149	Obesity-related traits	
COAD	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.59	6.82E-6	Obesity-related traits	
COAD	cis	1	rs6468131	chr8:29981020	MBOAT4	chr8:29989188-30002200:-	-0.34	-3.88	0.000132	Migraine	
COAD	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.43	6.24	1.72E-9	Erythrocyte sedimentation rate	
COAD	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.46	-6.47	4.89E-10	Erythrocyte sedimentation rate	
COAD	cis	1	rs6477998	chr9:115997249	CDC26	chr9:116029290-116037869:-	0.39	5.27	2.8E-7	Hematology traits	
COAD	cis	1	rs6478111	chr9:117596180	AMBP	chr9:116822410-116840752:-	0.55	4.64	5.56E-6	Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.38	-5.52	8.21E-8	Rheumatoid arthritis	
COAD	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.4	-5.86	1.43E-8	Rheumatoid arthritis	
COAD	cis	1	rs6478987	chr9:102690883	STX17	chr9:102668915-102736817:+	-0.28	-3.91	0.000119	Alopecia areata	
COAD	cis	1	rs6483880	chr11:22852740	SVIP	chr11:22843600-22851382:-	0.28	3.93	0.000109	Dialysis-related mortality	
COAD	cis	1	rs648541	chr11:114429934	FAM55A	chr11:114392438-114430580:-	-0.25	-4.21	3.47E-5	Ulcerative colitis	
COAD	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.56	-9.08	2.81E-17	Forced vital capacity	
COAD	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.62	9.99	4.21E-20	Forced vital capacity	
COAD	cis	1	rs6489238	chr12:122612635	MLXIP	chr12:122516760-122628965:+	0.21	4.2	3.66E-5	Urate levels	
COAD	cis	1	rs6489242	chr12:122613278	MLXIP	chr12:122516760-122628965:+	0.21	4.21	3.58E-5	Urate levels	
COAD	cis	1	rs6494521	chr15:65739928	DENND4A	chr15:65952959-66084631:-	-0.22	-4.29	2.54E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs6494528	chr15:65865632	DENND4A	chr15:65952959-66084631:-	-0.22	-4.21	3.52E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs6494532	chr15:65975798	DENND4A	chr15:65952959-66084631:-	-0.21	-3.84	0.000154	Mean corpuscular hemoglobin	
COAD	cis	1	rs6494537	chr15:66051345	DENND4A	chr15:65952959-66084631:-	-0.2	-3.93	0.00011	Mean corpuscular hemoglobin	
COAD	cis	1	rs6499983	chr16:58843909	GOT2	chr16:58741035-58768246:-	-0.32	-5.27	2.81E-7	Blood metabolite ratios	
COAD	cis	1	rs6503877	chr17:56841948	RAD51C	chr17:56769963-56811690:+	0.3	4.71	4.02E-6	Cognitive test performance	
COAD	cis	1	rs6503882	chr17:56915761	RAD51C	chr17:56769963-56811690:+	0.29	4.47	1.17E-5	Cognitive test performance	
COAD	cis	1	rs6504173	chr17:61735056	FTSJ3	chr17:61896795-61905031:-	0.29	4.09	5.68E-5	Body mass index	
COAD	cis	1	rs6504182	chr17:61823672	FTSJ3	chr17:61896795-61905031:-	0.28	4.19	3.8E-5	Body mass index	
COAD	cis	1	rs6504948	chr17:53049987	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs6504949	chr17:53050133	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs6504950	chr17:53056471	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs6504951	chr17:53056975	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.95	0.000102	Coffee consumption (cups per day)	
COAD	cis	1	rs6505158	chr17:28403348	EFCAB5	chr17:28256874-28435469:+	-0.27	-3.83	0.000163	Coffee consumption (cups per day)	
COAD	cis	1	rs6508977	chr19:41909346	B3GNT8	chr19:41931265-41934635:-	-0.31	-5.13	5.67E-7	Height	
COAD	cis	1	rs6516891	chr21:30483070	N6AMT1	chr21:30244513-30257693:-	-0.32	-4.63	5.66E-6	Dental caries	
COAD	cis	1	rs6519119	chr22:38989007	CBY1	chr22:39052658-39069853:+	0.34	5.49	9.31E-8	Resting heart rate	
COAD	cis	1	rs6519120	chr22:38991393	CBY1	chr22:39052658-39069853:+	-0.34	-5.68	3.62E-8	Resting heart rate	
COAD	cis	1	rs6519120	chr22:38991393	JOSD1	chr22:39081549-39096459:-	0.28	4.6	6.61E-6	Resting heart rate	
COAD	cis	1	rs6519124	chr22:39045099	CBY1	chr22:39052658-39069853:+	0.31	5.31	2.39E-7	Resting heart rate	
COAD	cis	1	rs6532022	chr4:88773734	SPP1	chr4:88896802-88904562:+	-0.28	-5.18	4.41E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs6532023	chr4:88773849	SPP1	chr4:88896802-88904562:+	-0.28	-5.18	4.41E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.33	-4.48	1.14E-5	Longevity	
COAD	cis	1	rs653251	chr13:30894542	KATNAL1	chr13:30776768-30881584:-	0.32	4.01	8.01E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
COAD	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.21	-5.73	2.76E-8	Tuberculosis	
COAD	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.32	6.27	1.51E-9	Tuberculosis	
COAD	cis	1	rs6546553	chr2:70111711	GMCL1	chr2:70056818-70106727:+	0.22	4.15	4.54E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6546556	chr2:70139001	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6546558	chr2:70145717	GMCL1	chr2:70056818-70106727:+	0.21	4.05	6.8E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6546559	chr2:70145833	GMCL1	chr2:70056818-70106727:+	0.21	3.95	0.000101	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6546837	chr2:73677898	ALMS1	chr2:73612886-73837046:+	0.25	4.04	7.16E-5	Metabolite levels	
COAD	cis	1	rs6546838	chr2:73679280	ALMS1	chr2:73612886-73837046:+	0.24	3.9	0.000124	Metabolite levels	
COAD	cis	1	rs6546839	chr2:73680508	ALMS1	chr2:73612886-73837046:+	0.25	4.04	7.16E-5	Metabolite levels	
COAD	cis	1	rs6547872	chr2:28978074	PPP1CB	chr2:28974612-29025805:+	0.3	4.99	1.11E-6	Body mass index	
COAD	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.36	-5.86	1.36E-8	Body mass index	
COAD	cis	1	rs6554286	chr4:56400304	SRD5A3	chr4:56212409-56237866:+	-0.25	-4.21	3.57E-5	Personality dimensions	
COAD	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.58	-11.88	2.71E-26	Crohn's disease	
COAD	cis	1	rs656980	chr11:65656282	FIBP	chr11:65651212-65656010:-	0.29	4.17	4.1E-5	Crohn's disease	
COAD	cis	1	rs6570043	chr6:136134098	PDE7B	chr6:136172834-136516708:+	0.24	4.97	1.21E-6	Phosphorus levels	
COAD	cis	1	rs6573910	chr14:25100882	GZMB	chr14:25100161-25103432:-	0.36	5.06	8.0E-7	Vitiligo	
COAD	cis	1	rs6573911	chr14:25100933	GZMB	chr14:25100161-25103432:-	0.38	5.02	9.57E-7	Vitiligo	
COAD	cis	1	rs6579210	chr20:33605802	EDEM2	chr20:33703160-33865928:-	0.36	4.05	6.72E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs6579210	chr20:33605802	PROCR	chr20:33758727-33765164:+	-0.4	-3.92	0.000115	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs6579211	chr20:33605857	PROCR	chr20:33758727-33765164:+	-0.54	-4.37	1.76E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.21	4.06	6.6E-5	Height	
COAD	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.19	3.97	9.43E-5	Height	
COAD	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.49	-8.05	2.93E-14	Cholesterol, total	
COAD	cis	1	rs6580083	chr5:153865729	SAP30L	chr5:153825517-153840612:+	0.26	4.04	6.95E-5	QRS duration	
COAD	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.53	7.03	1.76E-11	Multiple sclerosis	
COAD	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.36	-6.06	4.75E-9	Multiple sclerosis	
COAD	cis	1	rs6584278	chr10:101278099	NKX2-3	chr10:101292690-101296278:+	-0.21	-4.6	6.62E-6	Dental caries	
COAD	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.75	-11.62	1.96E-25	Diastolic blood pressure	
COAD	cis	1	rs661054	chr11:114430410	FAM55A	chr11:114392438-114430580:-	-0.25	-4.24	3.08E-5	Ulcerative colitis	
COAD	cis	1	rs662099	chr15:65726693	DENND4A	chr15:65952959-66084631:-	-0.23	-4.5	1.02E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.33	-4.3	2.38E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs6651272	chr8:96047933	C8orf38	chr8:95908040-96088396:+	0.33	4.32	2.22E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs66529337	chr6:163005662	PACRG	chr6:163148164-163736523:+	0.38	4.32	2.25E-5	Body mass index	
COAD	cis	1	rs66534429	chr6:163003322	PACRG	chr6:163148164-163736523:+	0.38	4.29	2.48E-5	Body mass index	
COAD	cis	1	rs66594243	chr6:163169024	PACRG	chr6:163148164-163736523:+	0.48	4.89	1.78E-6	Body mass index	
COAD	cis	1	rs6661715	chr1:183622314	APOBEC4	chr1:183615418-183622448:-	-0.56	-3.83	0.000163	Systemic lupus erythematosus	
COAD	cis	1	rs6663499	chr1:183640764	APOBEC4	chr1:183615418-183622448:-	-0.56	-3.88	0.000131	Systemic lupus erythematosus	
COAD	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.64	-9.54	1.08E-18	Homocysteine levels	
COAD	cis	1	rs6669263	chr1:171692311	VAMP4	chr1:171669298-171711214:-	0.36	4.89	1.75E-6	Hippocampal atrophy	
COAD	cis	1	rs6669371	chr1:11882142	CLCN6	chr1:11866207-11907674:+	0.29	4.54	8.59E-6	QRS complex (12-leadsum)	
COAD	cis	1	rs6672267	chr1:12054911	MFN2	chr1:12040238-12073571:+	-0.25	-4.23	3.22E-5	Platelet count	
COAD	cis	1	rs66754062	chr20:23839051	CST2	chr20:23804404-23807312:-	-0.28	-3.87	0.00014	Response to TNF antagonist treatment	
COAD	cis	1	rs6676348	chr1:183640787	APOBEC4	chr1:183615418-183622448:-	-0.56	-3.88	0.000131	Systemic lupus erythematosus	
COAD	cis	1	rs6678890	chr1:171694566	VAMP4	chr1:171669298-171711214:-	0.34	4.64	5.41E-6	Hippocampal atrophy	
COAD	cis	1	rs66789102	chr6:163104432	PACRG	chr6:163148164-163736523:+	0.49	4.99	1.12E-6	Body mass index	
COAD	cis	1	rs6679354	chr1:171668002	VAMP4	chr1:171669298-171711214:-	0.29	4.22	3.31E-5	Hippocampal atrophy	
COAD	cis	1	rs6679552	chr1:202449586	PPP1R12B	chr1:202317836-202557697:+	0.2	3.92	0.000114	Sex ratio	
COAD	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.53	5.86	1.37E-8	Diastolic blood pressure;Blood pressure	
COAD	cis	1	rs6682784	chr1:202313978	PPP1R12B	chr1:202317836-202557697:+	0.2	3.84	0.000153	Sex ratio	
COAD	cis	1	rs6686643	chr1:165616588	MGST3	chr1:165600450-165624853:+	0.4	5.57	6.36E-8	Total ventricular volume	
COAD	cis	1	rs66918189	chr3:119292618	CD80	chr3:119243142-119278481:-	0.19	4.04	6.97E-5	Vitiligo	
COAD	cis	1	rs6692729	chr1:227018919	PSEN2	chr1:227058273-227083804:+	-0.32	-4.51	9.9E-6	Electrodermal activity	
COAD	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.36	-5.51	8.51E-8	Height	
COAD	cis	1	rs67025553	chr6:163011552	PACRG	chr6:163148164-163736523:+	0.52	5.59	5.77E-8	Body mass index	
COAD	cis	1	rs67042566	chr6:163006541	PACRG	chr6:163148164-163736523:+	0.49	5.27	2.88E-7	Body mass index	
COAD	cis	1	rs67046187	chr6:163068532	PACRG	chr6:163148164-163736523:+	0.52	5.14	5.4E-7	Body mass index	
COAD	cis	1	rs6704770	chr2:232109816	ARMC9	chr2:232063342-232238606:+	0.31	4.87	1.96E-6	Food antigen IgG levels	
COAD	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.32	4.26	2.9E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
COAD	cis	1	rs6707848	chr2:28988083	PPP1CB	chr2:28974612-29025805:+	0.3	4.87	1.97E-6	Body mass index	
COAD	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.38	-6	6.69E-9	Body mass index	
COAD	cis	1	rs67094146	chr6:163145412	PACRG	chr6:163148164-163736523:+	0.42	4.84	2.28E-6	Body mass index	
COAD	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.72	-12.8	1.86E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs6710959	chr2:28958603	PPP1CB	chr2:28974612-29025805:+	0.29	4.82	2.42E-6	Body mass index	
COAD	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.52	8.09E-8	Body mass index	
COAD	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.59	-5.09	6.71E-7	Rheumatoid arthritis	
COAD	cis	1	rs6711312	chr2:232122348	ARMC9	chr2:232063342-232238606:+	0.3	4.77	3.05E-6	Food antigen IgG levels	
COAD	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.55	-5.48	1.0E-7	Rheumatoid arthritis	
COAD	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.48	-5.3	2.45E-7	Rheumatoid arthritis	
COAD	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.57	-5.12	5.9E-7	Rheumatoid arthritis	
COAD	cis	1	rs6716937	chr2:70127229	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs67180937	chr1:222823743	HHIPL2	chr1:222695602-222721444:-	0.31	4.04	7.04E-5	Coronary artery disease	
COAD	cis	1	rs6718520	chr2:43325570	DYNC2LI1	chr2:44001182-44037147:+	0.29	4.35	1.94E-5	Multiple sclerosis	
COAD	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.75	-6.6	2.26E-10	Plasma clusterin levels	
COAD	cis	1	rs6721891	chr2:70146121	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.75	-6.64	1.82E-10	Plasma clusterin levels	
COAD	cis	1	rs67231414	chr9:117831717	TNC	chr9:117782806-117880486:-	-0.23	-4.15	4.55E-5	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs6724253	chr2:232121998	ARMC9	chr2:232063342-232238606:+	0.3	4.7	4.18E-6	Food antigen IgG levels	
COAD	cis	1	rs6724782	chr2:73679990	ALMS1	chr2:73612886-73837046:+	0.25	4.04	7.16E-5	Metabolite levels	
COAD	cis	1	rs6725425	chr2:70150674	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6729760	chr2:70161032	GMCL1	chr2:70056818-70106727:+	0.23	4.48	1.12E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6732020	chr2:135598067	ACMSD	chr2:135596186-135659600:+	0.46	4.38	1.75E-5	Obesity-related traits	
COAD	cis	1	rs6732595	chr2:243035338	THAP4	chr2:242523821-242576655:-	0.31	3.95	0.000102	Obesity-related traits	
COAD	cis	1	rs6734509	chr2:206324277	NRP2	chr2:206547224-206662856:+	0.22	4.4	1.6E-5	AIDS progression	
COAD	cis	1	rs6736408	chr2:70137774	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6739780	chr2:70138111	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6741449	chr2:70156589	GMCL1	chr2:70056818-70106727:+	0.22	4.29	2.57E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.21	-5.91	1.09E-8	Tuberculosis	
COAD	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.33	6.54	3.22E-10	Tuberculosis	
COAD	cis	1	rs6743297	chr2:243013814	THAP4	chr2:242523821-242576655:-	0.33	4.28	2.64E-5	Obesity-related traits	
COAD	cis	1	rs67487119	chr6:163102657	PACRG	chr6:163148164-163736523:+	0.49	5	1.07E-6	Body mass index	
COAD	cis	1	rs6750488	chr2:70146125	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.34	4.32	2.27E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs6754896	chr2:70138170	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs6756987	chr2:73687077	ALMS1	chr2:73612886-73837046:+	0.25	4.09	5.8E-5	Metabolite levels	
COAD	cis	1	rs6758089	chr2:188191834	CALCRL	chr2:188207851-188313021:-	-0.14	-4.31	2.35E-5	Coronary heart disease	
COAD	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.51	-6.72	1.16E-10	Triptolide cytotoxicity	
COAD	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.75	-9.97	4.79E-20	Triptolide cytotoxicity	
COAD	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.23	3.92	0.000113	Idiopathic membranous nephropathy	
COAD	cis	1	rs67605703	chr17:37938497	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs6761276	chr2:113832312	IL1F5	chr2:113816215-113822316:+	0.36	5.43	1.26E-7	Protein quantitative trait loci	
COAD	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.06	3.12E-17	Height	
COAD	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.35	-4.57	7.7E-6	Height	
COAD	cis	1	rs67646369	chr6:163003233	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.62	9.68	3.78E-19	Height	
COAD	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.3	4.14	4.67E-5	Height	
COAD	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.59	8.85	1.35E-16	Height	
COAD	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.59	7.99	4.42E-14	Height	
COAD	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.36	4.53	8.96E-6	Height	
COAD	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.66	9.6	6.79E-19	Diastolic blood pressure	
COAD	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.66	9.49	1.5E-18	Diastolic blood pressure	
COAD	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.66	9.49	1.5E-18	Diastolic blood pressure	
COAD	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.58	8.32	5.01E-15	Height	
COAD	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.29	-4.77	3.11E-6	Longevity	
COAD	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.65	9.73	2.68E-19	Height	
COAD	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.37	4.9	1.69E-6	Height	
COAD	cis	1	rs67747005	chr6:163150845	PACRG	chr6:163148164-163736523:+	0.47	5.5	8.98E-8	Body mass index	
COAD	cis	1	rs67766926	chr2:61163581	C2orf74	chr2:61372243-61391964:+	0.24	3.95	9.92E-5	Inflammatory skin disease	
COAD	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.29	-4.84	2.26E-6	Longevity	
COAD	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.35	-4.13	4.97E-5	Schizophrenia (negative symptoms)	
COAD	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.6	-8.42	2.53E-15	Height	
COAD	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.34	-4.41	1.54E-5	Height	
COAD	cis	1	rs6783003	chr3:49524778	WDR6	chr3:49044637-49053386:+	0.33	4.39	1.66E-5	Menarche (age at onset)	
COAD	cis	1	rs67840803	chr6:163049048	PACRG	chr6:163148164-163736523:+	0.49	4.82	2.45E-6	Body mass index	
COAD	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.3	-5	1.08E-6	Longevity	
COAD	cis	1	rs6784615	chr3:52506426	SFMBT1	chr3:52938628-53080070:-	-0.62	-4.51	9.96E-6	Waist-hip ratio	
COAD	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.6	-9.25	8.09E-18	Height	
COAD	cis	1	rs6785045	chr3:49435243	WDR6	chr3:49044637-49053386:+	0.31	4.29	2.47E-5	Menarche (age at onset)	
COAD	cis	1	rs67865942	chr8:89596642	MMP16	chr8:89049462-89339717:-	0.17	3.89	0.000125	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.59	8.75	2.68E-16	Height	
COAD	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.29	3.9	0.000122	Height	
COAD	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.44	-4.99	1.09E-6	Bone mineral density	
COAD	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.57	7.52	9.06E-13	Diastolic blood pressure	
COAD	cis	1	rs67900830	chr21:44615872	TFF3	chr21:43732164-43735706:-	-0.37	-3.99	8.76E-5	Schizophrenia	
COAD	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.65	9.64	5.03E-19	Height	
COAD	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.36	4.81	2.59E-6	Height	
COAD	cis	1	rs67912009	chr11:495057	PTDSS2	chr11:450280-491386:+	-0.47	-5.02	9.56E-7	Body mass index	
COAD	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.29	5.7	3.29E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.6	-8.42	2.53E-15	Height	
COAD	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.34	-4.41	1.54E-5	Height	
COAD	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.27	-4.32	2.18E-5	Longevity	
COAD	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.6	9.14	1.79E-17	Height	
COAD	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.31	4.22	3.43E-5	Height	
COAD	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.58	8.67	4.75E-16	Height	
COAD	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.3	4.04	7.16E-5	Height	
COAD	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs68045643	chr6:163029709	PACRG	chr6:163148164-163736523:+	0.41	4.59	6.85E-6	Body mass index	
COAD	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs6805609	chr3:49471522	WDR6	chr3:49044637-49053386:+	0.36	5.03	9.32E-7	Menarche (age at onset)	
COAD	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.66	9.49	1.5E-18	Diastolic blood pressure	
COAD	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.6	-9.18	1.38E-17	Height	
COAD	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.3	-4.07	6.29E-5	Height	
COAD	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.29	-4.77	3.11E-6	Longevity	
COAD	cis	1	rs6811520	chr4:56315178	SRD5A3	chr4:56212409-56237866:+	0.26	4.25	2.99E-5	Personality dimensions	
COAD	cis	1	rs6812042	chr4:56396079	SRD5A3	chr4:56212409-56237866:+	0.27	4.64	5.62E-6	Personality dimensions	
COAD	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.62	-8.65	5.35E-16	Response to antipsychotic treatment	
COAD	cis	1	rs6819660	chr4:56374577	SRD5A3	chr4:56212409-56237866:+	0.27	4.84	2.23E-6	Personality dimensions	
COAD	cis	1	rs6820475	chr4:171884326	MFAP3L	chr4:170907750-170947429:-	0.31	3.91	0.000118	Lupus nephritis in systemic lupus erythematosus	
COAD	cis	1	rs6824057	chr4:56367278	SRD5A3	chr4:56212409-56237866:+	0.25	4.1	5.47E-5	Personality dimensions	
COAD	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.34	-4.73	3.76E-6	Longevity	
COAD	cis	1	rs6832769	chr4:56298194	SRD5A3	chr4:56212409-56237866:+	0.26	4.49	1.08E-5	Personality dimensions	
COAD	cis	1	rs6834676	chr4:56298414	SRD5A3	chr4:56212409-56237866:+	0.29	4.88	1.89E-6	Personality dimensions	
COAD	cis	1	rs6837710	chr4:56374455	SRD5A3	chr4:56212409-56237866:+	0.25	4.18	3.99E-5	Personality dimensions	
COAD	cis	1	rs6837898	chr4:120179154	FABP2	chr4:120238406-120243316:-	0.39	5.92	1.01E-8	Corneal astigmatism	
COAD	cis	1	rs6849889	chr4:120186348	FABP2	chr4:120238406-120243316:-	0.37	5.67	3.84E-8	Corneal astigmatism	
COAD	cis	1	rs6851838	chr4:56420747	SRD5A3	chr4:56212409-56237866:+	-0.26	-4.65	5.22E-6	Personality dimensions	
COAD	cis	1	rs6853192	chr4:56409254	SRD5A3	chr4:56212409-56237866:+	-0.27	-4.85	2.09E-6	Personality dimensions	
COAD	cis	1	rs6862125	chr5:90724598	LOC100129716	chr5:90676164-90716531:+	0.35	4.21	3.53E-5	Smoking behavior	
COAD	cis	1	rs6862569	chr5:156466548	HAVCR1	chr5:156456531-156486130:-	-0.38	-5.15	5.1E-7	Hypertriglyceridemia	
COAD	cis	1	rs6862569	chr5:156466548	TIMD4	chr5:156346293-156390266:-	-0.29	-4.08	5.95E-5	Hypertriglyceridemia	
COAD	cis	1	rs6865495	chr5:90746424	LOC100129716	chr5:90676164-90716531:+	0.35	4.35	1.96E-5	Smoking behavior	
COAD	cis	1	rs6866191	chr5:90746852	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs6867482	chr5:74280980	GFM2	chr5:74017031-74063042:-	-0.29	-4.7	4.16E-6	C-reactive protein levels or total cholesterol levels (pleiotropy);C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs6874560	chr5:150182713	LOC134466	chr5:150310000-150326146:-	0.49	5.88	1.22E-8	Crohn's disease	
COAD	cis	1	rs6875011	chr5:150182710	LOC134466	chr5:150310000-150326146:-	0.35	4.66	5.07E-6	Crohn's disease	
COAD	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.58	11.88	2.71E-26	Crohn's disease	
COAD	cis	1	rs687672	chr11:65649984	FIBP	chr11:65651212-65656010:-	-0.29	-4.17	4.1E-5	Crohn's disease	
COAD	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.99	12.91	7.95E-30	Type 2 diabetes	
COAD	cis	1	rs6886255	chr5:176718361	PRELID1	chr5:176730835-176733949:+	0.22	4.23	3.27E-5	Migraine without aura	
COAD	cis	1	rs6901250	chr6:117114025	FAM162B	chr6:117073360-117086886:-	-0.25	-4.08	6.01E-5	C-reactive protein levels	
COAD	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.39	-7.2	6.52E-12	Homocysteine levels	
COAD	cis	1	rs6904601	chr6:170131905	C6orf70	chr6:170151721-170181617:+	0.35	4.12	5.11E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs6904991	chr6:33732262	HLA-DOB	chr6:32780541-32784825:-	0.24	4.38	1.7E-5	Crohn's disease	
COAD	cis	1	rs6905391	chr6:28262686	ZSCAN23	chr6:28393287-28411279:-	0.32	3.85	0.000146	Depression	
COAD	cis	1	rs6912959	chr6:170126224	C6orf70	chr6:170151721-170181617:+	0.39	4.55	8.24E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.64	-9.93	6.32E-20	Response to antipsychotic treatment	
COAD	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.39	-7.38	2.08E-12	Homocysteine levels	
COAD	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.38	-7.11	1.13E-11	Homocysteine levels	
COAD	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.39	-7.26	4.31E-12	Homocysteine levels	
COAD	cis	1	rs6920075	chr6:33731797	HLA-DOB	chr6:32780541-32784825:-	0.24	4.4	1.55E-5	Crohn's disease	
COAD	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.54	9.44	2.22E-18	Folate pathway vitamin levels	
COAD	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.63	9.73	2.75E-19	Response to antipsychotic treatment	
COAD	cis	1	rs6923339	chr6:170128033	C6orf70	chr6:170151721-170181617:+	0.39	4.55	8.24E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs6924002	chr6:117114223	FAM162B	chr6:117073360-117086886:-	0.26	4.05	6.8E-5	C-reactive protein levels	
COAD	cis	1	rs6925273	chr6:33732448	HLA-DOB	chr6:32780541-32784825:-	0.22	4.02	7.62E-5	Crohn's disease	
COAD	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.45	5.31	2.31E-7	Diabetic kidney disease	
COAD	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.69	-8.09	2.3E-14	Diabetic kidney disease	
COAD	cis	1	rs6932590	chr6:27248931	C6orf41	chr6:26924772-26991752:+	0.47	5.6	5.55E-8	Schizophrenia	
COAD	cis	1	rs6932590	chr6:27248931	LOC100270746	chr6:26987146-26988085:-	0.46	5.33	2.09E-7	Schizophrenia	
COAD	cis	1	rs6933130	chr6:88902490	PM20D2	chr6:89855769-89875283:+	0.26	3.86	0.000142	Gut microbiota (functional units)	
COAD	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.48	7.07	1.4E-11	Response to antipsychotic treatment	
COAD	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.57	-8.12	1.85E-14	Response to antipsychotic treatment	
COAD	cis	1	rs6937779	chr6:160184156	PNLDC1	chr6:160221301-160241735:+	0.56	4.02	7.71E-5	Iron status biomarkers	
COAD	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.58	-11.88	2.71E-26	Crohn's disease	
COAD	cis	1	rs693824	chr11:65654783	FIBP	chr11:65651212-65656010:-	0.29	4.17	4.1E-5	Crohn's disease	
COAD	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.57	-8.43	2.37E-15	Response to antipsychotic treatment	
COAD	cis	1	rs6940729	chr6:47552920	GPR111	chr6:47624222-47663805:+	0.35	4.96	1.24E-6	Plasma homocysteine levels	
COAD	cis	1	rs6941766	chr6:170131653	C6orf70	chr6:170151721-170181617:+	0.37	4.3	2.42E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs6942332	chr6:170131934	C6orf70	chr6:170151721-170181617:+	0.34	4.01	8.01E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs6948775	chr7:98945480	CYP3A5	chr7:99245818-99332821:-	0.62	7.51	9.69E-13	Blood metabolite levels	
COAD	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.57	-12.19	2.29E-27	Crohn's disease	
COAD	cis	1	rs696092	chr2:188210214	CALCRL	chr2:188207851-188313021:-	-0.13	-4.02	7.71E-5	Coronary heart disease	
COAD	cis	1	rs6983056	chr8:120446127	NOV	chr8:120428552-120436678:+	0.29	3.94	0.000105	Blood pressure	
COAD	cis	1	rs6983795	chr8:124185296	FAM83A	chr8:124191287-124222317:+	-0.5	-4.45	1.27E-5	Urinary uromodulin levels	
COAD	cis	1	rs6984009	chr8:96289091	C8orf37	chr8:96258235-96281437:-	0.44	3.89	0.000126	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
COAD	cis	1	rs698588	chr2:188214924	CALCRL	chr2:188207851-188313021:-	0.13	4.1	5.62E-5	Coronary heart disease	
COAD	cis	1	rs698590	chr2:188214823	CALCRL	chr2:188207851-188313021:-	-0.14	-4.29	2.53E-5	Coronary heart disease	
COAD	cis	1	rs698592	chr2:188214239	CALCRL	chr2:188207851-188313021:-	0.13	3.96	9.85E-5	Coronary heart disease	
COAD	cis	1	rs698593	chr2:188213235	CALCRL	chr2:188207851-188313021:-	0.13	4.11	5.41E-5	Coronary heart disease	
COAD	cis	1	rs6988636	chr8:124185970	FAM83A	chr8:124191287-124222317:+	-0.5	-4.45	1.27E-5	Urinary uromodulin levels	
COAD	cis	1	rs6990760	chr8:120444628	NOV	chr8:120428552-120436678:+	0.29	3.91	0.000118	Blood pressure	
COAD	cis	1	rs7002021	chr8:124185250	FAM83A	chr8:124191287-124222317:+	-0.5	-4.45	1.27E-5	Urinary uromodulin levels	
COAD	cis	1	rs7002332	chr8:124185442	FAM83A	chr8:124191287-124222317:+	-0.5	-4.45	1.27E-5	Urinary uromodulin levels	
COAD	cis	1	rs7004438	chr8:8574379	FLJ10661	chr8:8086092-8102386:+	0.38	4.34	2.02E-5	Obesity-related traits	
COAD	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.74	15.31	3.48E-38	Bone mineral density	
COAD	cis	1	rs7014927	chr8:120431049	NOV	chr8:120428552-120436678:+	0.3	4.05	6.69E-5	Blood pressure	
COAD	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.74	15.19	9.05E-38	Bone mineral density	
COAD	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.41	-5.63	4.63E-8	Hematology traits	
COAD	cis	1	rs7022999	chr9:102694400	STX17	chr9:102668915-102736817:+	-0.28	-3.89	0.000127	Alopecia areata	
COAD	cis	1	rs7027619	chr9:102719728	STX17	chr9:102668915-102736817:+	-0.28	-3.88	0.00013	Alopecia areata	
COAD	cis	1	rs7027813	chr9:102675372	STX17	chr9:102668915-102736817:+	-0.29	-3.98	8.8E-5	Alopecia areata	
COAD	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.4	-5.83	1.66E-8	Rheumatoid arthritis	
COAD	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.53	-7.08	1.37E-11	Multiple sclerosis	
COAD	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.35	5.97	7.52E-9	Multiple sclerosis	
COAD	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.41	-5.63	4.63E-8	Hematology traits	
COAD	cis	1	rs7039716	chr9:102670215	STX17	chr9:102668915-102736817:+	-0.29	-4.06	6.57E-5	Alopecia areata	
COAD	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.56	7.51	9.53E-13	Cognitive function	
COAD	cis	1	rs706201	chr7:134251041	AKR1B15	chr7:134233849-134264300:+	-0.26	-3.84	0.000157	Longevity	
COAD	cis	1	rs706202	chr7:134250704	AKR1B15	chr7:134233849-134264300:+	-0.26	-3.82	0.000168	Longevity	
COAD	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.7	10.74	1.57E-22	Metabolite levels	
COAD	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.17	-3.92	0.000114	Palmitoleic acid (16:1n-7) plasma levels	
COAD	cis	1	rs7078219	chr10:101274365	NKX2-3	chr10:101292690-101296278:+	0.21	4.5	1.03E-5	Dental caries	
COAD	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.17	-3.82	0.000167	Palmitoleic acid (16:1n-7) plasma levels	
COAD	cis	1	rs7081330	chr10:101274465	NKX2-3	chr10:101292690-101296278:+	-0.22	-4.67	4.72E-6	Dental caries	
COAD	cis	1	rs7084928	chr10:88122516	GRID1	chr10:87359312-88126250:-	-0.19	-4.37	1.8E-5	Barrett's esophagus	
COAD	cis	1	rs7085948	chr10:12075344	CAMK1D	chr10:12391583-12871731:+	0.25	3.92	0.000111	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs7093736	chr10:12057225	CAMK1D	chr10:12391583-12871731:+	0.26	4.03	7.43E-5	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs7099	chr20:43997646	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.38	-4.23	3.23E-5	Psoriasis	
COAD	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.54	-8.57	9.14E-16	Forced vital capacity	
COAD	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.22	3.61E-7	Subjective well-being	
COAD	cis	1	rs7122375	chr11:111171071	C11orf53	chr11:111126707-111156970:+	0.31	4.13	4.79E-5	Colorectal cancer	
COAD	cis	1	rs7122375	chr11:111171071	C11orf93	chr11:111169976-111179353:+	0.33	4.62	5.94E-6	Colorectal cancer	
COAD	cis	1	rs71299622	chr3:52917038	SFMBT1	chr3:52938628-53080070:-	-0.7	-5.48	9.97E-8	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71299622	chr3:52917038	TMEM110	chr3:52867139-52931547:-	0.54	4.32	2.25E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71301804	chr3:53073314	SFMBT1	chr3:52938628-53080070:-	-0.61	-5.33	2.17E-7	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71301808	chr3:53085577	SFMBT1	chr3:52938628-53080070:-	-0.55	-4.45	1.28E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71301808	chr3:53085577	TMEM110	chr3:52867139-52931547:-	0.54	4.44	1.35E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71301809	chr3:53090312	SFMBT1	chr3:52938628-53080070:-	-0.54	-4.28	2.64E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71301809	chr3:53090312	TMEM110	chr3:52867139-52931547:-	0.52	4.26	2.88E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71301814	chr3:53117663	SFMBT1	chr3:52938628-53080070:-	-0.59	-4.73	3.71E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71301814	chr3:53117663	TMEM110	chr3:52867139-52931547:-	0.48	3.95	0.000101	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs7131696	chr12:121459344	OASL	chr12:121458095-121476780:-	0.29	3.96	9.66E-5	Type 2 diabetes	
COAD	cis	1	rs7131696	chr12:121459344	WDR66	chr12:122356480-122441830:+	0.38	3.82	0.000164	Type 2 diabetes	
COAD	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.8	8.51	1.36E-15	Metabolite levels (HVA/5-HIAA ratio)	
COAD	cis	1	rs7142235	chr14:75559963	MLH3	chr14:75480467-75518235:-	0.27	4.61	6.35E-6	Height	
COAD	cis	1	rs7143682	chr14:104413455	TDRD9	chr14:104394817-104519002:+	0.34	5.03	9.04E-7	Bipolar disorder	
COAD	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.4	4.65	5.31E-6	Atopic dermatitis	
COAD	cis	1	rs7145159	chr14:75583268	MLH3	chr14:75480467-75518235:-	0.27	4.61	6.38E-6	Height	
COAD	cis	1	rs7147118	chr14:75610170	MLH3	chr14:75480467-75518235:-	0.28	4.8	2.67E-6	Height	
COAD	cis	1	rs7147996	chr14:90396574	TDP1	chr14:90421283-90511106:+	0.37	6.72	1.11E-10	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs71487292	chr11:486076	PTDSS2	chr11:450280-491386:+	-0.51	-4.61	6.36E-6	Body mass index	
COAD	cis	1	rs71487296	chr11:500282	PTDSS2	chr11:450280-491386:+	-0.5	-4.73	3.74E-6	Body mass index	
COAD	cis	1	rs71526949	chr8:89582882	MMP16	chr8:89049462-89339717:-	0.18	4.08	6.06E-5	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs71526953	chr8:89595818	MMP16	chr8:89049462-89339717:-	0.17	3.89	0.000126	Body mass index and cholesterol (psychopharmacological treatment)	
COAD	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.34	5.35	1.96E-7	Common traits (Other)	
COAD	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.42	7.14	9.02E-12	Common traits (Other)	
COAD	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.38	4.77	3.07E-6	Atopic dermatitis	
COAD	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.29	-5.54	7.56E-8	Menarche (age at onset)	
COAD	cis	1	rs7156105	chr14:75541954	MLH3	chr14:75480467-75518235:-	0.27	4.61	6.38E-6	Height	
COAD	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.38	4.65	5.24E-6	Atopic dermatitis	
COAD	cis	1	rs7156328	chr14:75532941	MLH3	chr14:75480467-75518235:-	0.27	4.57	7.42E-6	Height	
COAD	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.3	-5.66	3.91E-8	Menarche (age at onset)	
COAD	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.29	-5.55	6.84E-8	Menarche (age at onset)	
COAD	cis	1	rs71567659	chr6:163001736	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.4	-6.6	2.28E-10	Common traits (Other)	
COAD	cis	1	rs7157940	chr14:94563193	IFI27L1	chr14:94547639-94569059:+	0.31	5.32	2.27E-7	Anthropometric traits	
COAD	cis	1	rs7160196	chr14:68265744	MPP5	chr14:67708021-67802535:+	-0.2	-3.83	0.00016	Amyotrophic lateral sclerosis (sporadic)	
COAD	cis	1	rs71617204	chr3:53042951	SFMBT1	chr3:52938628-53080070:-	-0.6	-4.86	2.07E-6	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs71617204	chr3:53042951	TMEM110	chr3:52867139-52931547:-	0.5	4.1	5.53E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs7162435	chr15:56121334	PRTG	chr15:55903748-56035177:-	-0.21	-3.91	0.000118	Keloid	
COAD	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.33	4.21	3.45E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs7163482	chr15:65739683	DENND4A	chr15:65952959-66084631:-	-0.22	-4.29	2.54E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.32	3.98	8.97E-5	Heschl's gyrus morphology	
COAD	cis	1	rs7165102	chr15:65888359	DENND4A	chr15:65952959-66084631:-	-0.23	-4.38	1.75E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs7166453	chr15:66013143	DENND4A	chr15:65952959-66084631:-	-0.2	-3.98	9.0E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.3	3.94	0.000105	Heschl's gyrus morphology	
COAD	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.33	4.21	3.45E-5	Blood trace element (Zn levels)	
COAD	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.35	4.56	8.03E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.32	3.9	0.000124	Heschl's gyrus morphology	
COAD	cis	1	rs7172335	chr15:65977204	DENND4A	chr15:65952959-66084631:-	-0.21	-3.94	0.000103	Mean corpuscular hemoglobin	
COAD	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.35	4.54	8.46E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.37	-4.67	4.81E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs7176225	chr15:56126857	PRTG	chr15:55903748-56035177:-	0.21	3.84	0.000153	Keloid	
COAD	cis	1	rs7178584	chr15:65795200	DENND4A	chr15:65952959-66084631:-	0.21	4.06	6.55E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs7181333	chr15:66039826	DENND4A	chr15:65952959-66084631:-	0.2	3.83	0.00016	Mean corpuscular hemoglobin	
COAD	cis	1	rs718433	chr14:22235890	RNASE6	chr14:21249210-21250624:+	0.21	3.86	0.000142	Intraocular pressure	
COAD	cis	1	rs7186084	chr16:68816260	TMED6	chr16:69377160-69385689:-	-0.32	-4.12	5.14E-5	Colorectal cancer	
COAD	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.31	-5.39	1.62E-7	Testicular germ cell tumor	
COAD	cis	1	rs719909	chr10:91345696	PANK1	chr10:91342749-91405215:-	0.34	4.07	6.2E-5	Metabolic traits	
COAD	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.31	-5.39	1.55E-7	Testicular germ cell tumor	
COAD	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.42	-4.91	1.58E-6	Breast cancer	
COAD	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.35	4.89	1.78E-6	Height	
COAD	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.54	8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.52	-9.37	3.56E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs7211213	chr17:61769456	FTSJ3	chr17:61896795-61905031:-	0.28	4	8.41E-5	Body mass index	
COAD	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.92	0.000113	Coffee consumption (cups per day)	
COAD	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.54	8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs7214921	chr17:40294025	DHX58	chr17:40253422-40264751:-	-0.31	-4.75	3.32E-6	Fibrinogen levels	
COAD	cis	1	rs7216798	chr17:61740963	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs7218362	chr17:56888299	RAD51C	chr17:56769963-56811690:+	0.29	4.51	9.87E-6	Cognitive test performance	
COAD	cis	1	rs7219014	chr17:37624790	PGAP3	chr17:37827376-37844310:-	-0.26	-4.14	4.68E-5	Urinary metabolites	
COAD	cis	1	rs7219220	chr17:40294280	DHX58	chr17:40253422-40264751:-	-0.31	-4.75	3.32E-6	Fibrinogen levels	
COAD	cis	1	rs7219874	chr17:53065807	STXBP4	chr17:53046126-53241449:+	-0.28	-3.93	0.000108	Breast cancer	
COAD	cis	1	rs7220821	chr17:61704147	FTSJ3	chr17:61896795-61905031:-	0.27	3.86	0.000141	Body mass index	
COAD	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.53	8.14	1.6E-14	Eye color traits	
COAD	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.28	3.89	0.000128	Coffee consumption (cups per day)	
COAD	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.54	-8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.92	0.000113	Coffee consumption (cups per day)	
COAD	cis	1	rs7224737	chr17:40289364	DHX58	chr17:40253422-40264751:-	0.32	4.95	1.32E-6	Fibrinogen levels	
COAD	cis	1	rs7247672	chr19:37743928	ZFP30	chr19:38123389-38146368:-	-0.34	-4.42	1.47E-5	Coronary artery calcification	
COAD	cis	1	rs724868	chr6:118795152	C6orf204	chr6:118786239-119031238:-	-0.26	-4.22	3.38E-5	Renal cell carcinoma	
COAD	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.26	4.38	1.7E-5	Longevity	
COAD	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.28	4.67	4.88E-6	Longevity	
COAD	cis	1	rs7254349	chr19:24230343	ZNF254	chr19:24216247-24312652:+	0.33	4.07	6.3E-5	Response to taxane treatment (placlitaxel)	
COAD	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.63	8.68	4.21E-16	Schizophrenia	
COAD	cis	1	rs725788	chr8:27265371	PTK2B	chr8:27168999-27316903:+	-0.28	-4.27	2.7E-5	Neuroticism	
COAD	cis	1	rs7260598	chr19:24222786	ZNF254	chr19:24216247-24312652:+	-0.33	-4.14	4.79E-5	Response to taxane treatment (placlitaxel)	
COAD	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	0.73	6.07	4.52E-9	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs72649163	chr1:20900592	CDA	chr1:20915444-20945398:+	-0.27	-3.95	0.0001	Age-related hearing impairment (interaction)	
COAD	cis	1	rs726967	chr4:56421713	SRD5A3	chr4:56212409-56237866:+	-0.26	-4.25	3.02E-5	Personality dimensions	
COAD	cis	1	rs727005	chr1:36281336	C1orf216	chr1:36179477-36184790:-	-0.41	-5.68	3.62E-8	Schizophrenia	
COAD	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.51	-5.05	8.13E-7	Abdominal aortic aneurysm	
COAD	cis	1	rs7271729	chr20:33610992	PROCR	chr20:33758727-33765164:+	-0.57	-4.57	7.56E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs72722365	chr8:131190914	ASAP1	chr8:131064353-131414216:-	0.22	3.88	0.000132	Tuberculosis	
COAD	cis	1	rs7274866	chr20:33608616	PROCR	chr20:33758727-33765164:+	-0.38	-3.83	0.000161	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs727563	chr22:41867377	POLR3H	chr22:41921803-41940479:-	0.28	4.2	3.63E-5	Crohn's disease;Inflammatory bowel disease	
COAD	cis	1	rs72782294	chr2:28953390	PPP1CB	chr2:28974612-29025805:+	-0.28	-4.67	4.83E-6	Body mass index	
COAD	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.34	5.49	9.51E-8	Body mass index	
COAD	cis	1	rs7278605	chr21:40292946	ETS2	chr21:40177231-40196876:+	0.36	5.58	5.89E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs7279192	chr21:40293084	ETS2	chr21:40177231-40196876:+	0.36	5.58	5.94E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs7279422	chr21:40292700	ETS2	chr21:40177231-40196876:+	0.36	5.58	5.94E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs7279866	chr21:40292922	ETS2	chr21:40177231-40196876:+	0.36	5.58	5.89E-8	Body mass index;Crohn's disease	
COAD	cis	1	rs72818709	chr10:91371446	PANK1	chr10:91342749-91405215:-	0.33	3.94	0.000103	Metabolic traits	
COAD	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.45	-5.71	3.01E-8	Esophageal cancer (squamous cell)	
COAD	cis	1	rs72823592	chr17:46123004	C17orf57	chr17:45401142-45518675:+	0.33	3.97	9.31E-5	Epilepsy (generalized)	
COAD	cis	1	rs72825704	chr2:99239164	UNC50	chr2:99225042-99234975:+	-0.33	-4.14	4.63E-5	Bipolar disorder	
COAD	cis	1	rs72825710	chr2:99239497	UNC50	chr2:99225042-99234975:+	-0.33	-4.14	4.63E-5	Bipolar disorder	
COAD	cis	1	rs72825718	chr2:99247152	UNC50	chr2:99225042-99234975:+	-0.35	-4.28	2.61E-5	Bipolar disorder	
COAD	cis	1	rs72825719	chr2:99247465	UNC50	chr2:99225042-99234975:+	-0.38	-4.53	9.13E-6	Bipolar disorder	
COAD	cis	1	rs72825720	chr2:99247508	UNC50	chr2:99225042-99234975:+	-0.42	-4.88	1.86E-6	Bipolar disorder	
COAD	cis	1	rs72825725	chr2:99251259	UNC50	chr2:99225042-99234975:+	-0.36	-4.36	1.86E-5	Bipolar disorder	
COAD	cis	1	rs72825727	chr2:99252750	UNC50	chr2:99225042-99234975:+	-0.34	-4.2	3.71E-5	Bipolar disorder	
COAD	cis	1	rs72825732	chr2:99259778	UNC50	chr2:99225042-99234975:+	-0.35	-4.27	2.73E-5	Bipolar disorder	
COAD	cis	1	rs72840063	chr2:85550396	TGOLN2	chr2:85545147-85555374:-	-0.25	-5.12	5.98E-7	Ear protrusion	
COAD	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.45	-4.37	1.78E-5	Response to cytadine analogues (cytosine arabinoside)	
COAD	cis	1	rs72848797	chr17:61934664	FTSJ3	chr17:61896795-61905031:-	0.31	4.11	5.32E-5	Body mass index	
COAD	cis	1	rs7289577	chr22:39042214	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs7289577	chr22:39042214	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs72896770	chr2:188139930	CALCRL	chr2:188207851-188313021:-	0.15	4.24	3.09E-5	Coronary heart disease	
COAD	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.53	-5.09	6.71E-7	Rheumatoid arthritis	
COAD	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.59	-5.12	5.97E-7	Rheumatoid arthritis	
COAD	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.59	-5.09	6.71E-7	Rheumatoid arthritis	
COAD	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.57	-5.12	5.9E-7	Rheumatoid arthritis	
COAD	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.57	-5.12	5.9E-7	Rheumatoid arthritis	
COAD	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.55	-4.92	1.52E-6	Rheumatoid arthritis	
COAD	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.53	-4.74	3.45E-6	Rheumatoid arthritis	
COAD	cis	1	rs72939192	chr11:65433319	RNASEH2C	chr11:65485146-65488409:-	0.56	4.63	5.76E-6	Inflammatory bowel disease	
COAD	cis	1	rs72939200	chr11:65441282	RNASEH2C	chr11:65485146-65488409:-	0.56	4.63	5.67E-6	Inflammatory bowel disease	
COAD	cis	1	rs72941018	chr11:65460087	RNASEH2C	chr11:65485146-65488409:-	0.54	4.51	9.65E-6	Inflammatory bowel disease	
COAD	cis	1	rs72941051	chr11:65478893	RNASEH2C	chr11:65485146-65488409:-	0.45	4.01	7.78E-5	Inflammatory bowel disease	
COAD	cis	1	rs72952733	chr6:118834452	C6orf204	chr6:118786239-119031238:-	-0.28	-4.63	5.8E-6	Renal cell carcinoma	
COAD	cis	1	rs72952761	chr6:118866758	C6orf204	chr6:118786239-119031238:-	-0.28	-4.81	2.51E-6	Renal cell carcinoma	
COAD	cis	1	rs72952793	chr6:118892979	C6orf204	chr6:118786239-119031238:-	-0.27	-4.29	2.47E-5	Renal cell carcinoma	
COAD	cis	1	rs72954221	chr2:99899445	REV1	chr2:100016939-100106480:-	0.32	4.37	1.77E-5	IgG glycosylation	
COAD	cis	1	rs72954806	chr6:118899965	C6orf204	chr6:118786239-119031238:-	-0.29	-4.69	4.32E-6	Renal cell carcinoma	
COAD	cis	1	rs72961173	chr2:99886868	REV1	chr2:100016939-100106480:-	0.32	4.36	1.88E-5	IgG glycosylation	
COAD	cis	1	rs72969531	chr6:118729974	C6orf204	chr6:118786239-119031238:-	-0.27	-4.58	7.25E-6	Renal cell carcinoma	
COAD	cis	1	rs73008453	chr6:163013384	PACRG	chr6:163148164-163736523:+	0.49	5.31	2.39E-7	Body mass index	
COAD	cis	1	rs73015649	chr3:158450298	RARRES1	chr3:158414899-158450275:-	0.51	7.03	1.78E-11	Tetralogy of Fallot	
COAD	cis	1	rs73015651	chr3:158450922	RARRES1	chr3:158414899-158450275:-	0.52	7.09	1.24E-11	Tetralogy of Fallot	
COAD	cis	1	rs73015652	chr3:158451383	RARRES1	chr3:158414899-158450275:-	0.36	4.93	1.45E-6	Tetralogy of Fallot	
COAD	cis	1	rs73015654	chr3:158451654	RARRES1	chr3:158414899-158450275:-	0.51	7.03	1.78E-11	Tetralogy of Fallot	
COAD	cis	1	rs73015655	chr3:158451882	RARRES1	chr3:158414899-158450275:-	0.35	4.71	4.09E-6	Tetralogy of Fallot	
COAD	cis	1	rs73016459	chr6:163066323	PACRG	chr6:163148164-163736523:+	0.52	5.14	5.4E-7	Body mass index	
COAD	cis	1	rs73035012	chr6:162997279	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs73035021	chr6:163000716	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs73035023	chr6:163000927	PACRG	chr6:163148164-163736523:+	0.51	5.53	7.89E-8	Body mass index	
COAD	cis	1	rs73035025	chr6:163000988	PACRG	chr6:163148164-163736523:+	0.48	5.25	3.21E-7	Body mass index	
COAD	cis	1	rs7303	chr14:75520065	MLH3	chr14:75480467-75518235:-	0.24	4.01	7.98E-5	Height	
COAD	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.56	7.65	3.96E-13	Diastolic blood pressure	
COAD	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.74	11.16	6.92E-24	Diastolic blood pressure	
COAD	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.73	11.38	1.24E-24	Diastolic blood pressure	
COAD	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.59	8.06	2.71E-14	Diastolic blood pressure	
COAD	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.66	9.61	6.66E-19	Diastolic blood pressure	
COAD	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.61	8.22	9.62E-15	Diastolic blood pressure	
COAD	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.61	8.22	9.62E-15	Diastolic blood pressure	
COAD	cis	1	rs73088137	chr3:49448423	WDR6	chr3:49044637-49053386:+	0.31	4.1	5.41E-5	Menarche (age at onset)	
COAD	cis	1	rs7309209	chr12:62767728	FAM19A2	chr12:62102043-62653925:-	0.32	3.85	0.00015	Pyoderma gangrenosum in inflammatory bowel disease	
COAD	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.43	-4.58	7.2E-6	Colorectal cancer	
COAD	cis	1	rs731152	chr17:40279680	DHX58	chr17:40253422-40264751:-	-0.32	-4.84	2.2E-6	Fibrinogen levels	
COAD	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	0.6	5.95	8.78E-9	Chronic lymphocytic leukemia	
COAD	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	0.61	6.14	3.11E-9	Chronic lymphocytic leukemia	
COAD	cis	1	rs73128528	chr20:44582187	WFDC3	chr20:44402847-44420547:-	-0.5	-4.29	2.56E-5	Abdominal aortic aneurysm	
COAD	cis	1	rs73168721	chr22:32793641	C22orf28	chr22:32783562-32808274:-	-0.37	-4	8.29E-5	IgG glycosylation	
COAD	cis	1	rs73168729	chr22:32796718	C22orf28	chr22:32783562-32808274:-	-0.37	-3.93	0.000108	IgG glycosylation	
COAD	cis	1	rs7318	chr5:38935682	OSMR	chr5:38846128-38934402:+	-0.12	-3.96	9.51E-5	Obesity-related traits	
COAD	cis	1	rs73197056	chr12:91473658	KERA	chr12:91444273-91452131:-	0.29	4.65	5.23E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs73197065	chr12:91477437	KERA	chr12:91444273-91452131:-	0.28	4.62	6.06E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs73197078	chr12:91481558	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs732072	chr11:65427568	RNASEH2C	chr11:65485146-65488409:-	0.55	4.61	6.31E-6	Inflammatory bowel disease	
COAD	cis	1	rs73217796	chr12:122611600	MLXIP	chr12:122516760-122628965:+	0.21	4.2	3.6E-5	Urate levels	
COAD	cis	1	rs73242910	chr6:170114670	C6orf70	chr6:170151721-170181617:+	0.42	4.77	3.13E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs73242927	chr6:170129573	C6orf70	chr6:170151721-170181617:+	0.39	4.55	8.24E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs7324557	chr13:24296862	PCOTH	chr13:24463028-24466241:+	0.33	4.45	1.29E-5	Visceral adipose tissue adjusted for BMI	
COAD	cis	1	rs73276406	chr8:96021760	C8orf38	chr8:95908040-96088396:+	-0.28	-3.82	0.000167	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs73276444	chr8:96039247	C8orf38	chr8:95908040-96088396:+	-0.29	-3.95	0.000101	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs73282209	chr5:150174959	LOC134466	chr5:150310000-150326146:-	0.34	4.72	3.79E-6	Crohn's disease	
COAD	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.35	4.66	5.03E-6	Crohn's disease	
COAD	cis	1	rs73301712	chr14:59898245	C14orf149	chr14:59939406-59951126:-	-0.41	-4.27	2.69E-5	Schizophrenia	
COAD	cis	1	rs73301725	chr14:59902159	C14orf149	chr14:59939406-59951126:-	-0.41	-4.31	2.31E-5	Schizophrenia	
COAD	cis	1	rs73301741	chr14:59908444	C14orf149	chr14:59939406-59951126:-	-0.42	-4.29	2.47E-5	Schizophrenia	
COAD	cis	1	rs73301746	chr14:59908485	C14orf149	chr14:59939406-59951126:-	-0.42	-4.29	2.47E-5	Schizophrenia	
COAD	cis	1	rs73302152	chr17:37952351	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs73321563	chr12:62756049	FAM19A2	chr12:62102043-62653925:-	0.33	3.9	0.000124	Pyoderma gangrenosum in inflammatory bowel disease	
COAD	cis	1	rs73395547	chr7:98922746	CYP3A5	chr7:99245818-99332821:-	0.62	7.59	5.57E-13	Blood metabolite levels	
COAD	cis	1	rs73395557	chr7:98934424	CYP3A5	chr7:99245818-99332821:-	0.62	7.51	9.69E-13	Blood metabolite levels	
COAD	cis	1	rs734809	chr22:32808998	C22orf28	chr22:32783562-32808274:-	-0.36	-3.84	0.000154	IgG glycosylation	
COAD	cis	1	rs73552468	chr19:21772097	ZNF738	chr19:21541735-21571383:+	0.29	4.03	7.26E-5	Colorectal or endometrial cancer	
COAD	cis	1	rs73559130	chr19:52022169	FPR2	chr19:52264453-52273777:+	0.37	3.84	0.000154	Carotid intima media thickness	
COAD	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.6	8.89	1.04E-16	Height	
COAD	cis	1	rs7356947	chr6:118767920	C6orf204	chr6:118786239-119031238:-	-0.27	-4.57	7.5E-6	Renal cell carcinoma	
COAD	cis	1	rs73586989	chr16:67234741	LRRC29	chr16:67241043-67260901:-	-0.44	-5.43	1.28E-7	HDL cholesterol	
COAD	cis	1	rs73588903	chr16:67241450	LRRC29	chr16:67241043-67260901:-	-0.47	-4.81	2.51E-6	HDL cholesterol	
COAD	cis	1	rs73601308	chr6:160157057	PNLDC1	chr6:160221301-160241735:+	0.53	3.83	0.00016	Iron status biomarkers	
COAD	cis	1	rs737008	chr16:11374866	C16orf75	chr16:11343506-11445617:+	0.28	3.98	9.03E-5	Obesity-related traits	
COAD	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.6	8.93	7.9E-17	Height	
COAD	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000111	Height	
COAD	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.59	8.52	1.31E-15	Height	
COAD	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.29	3.85	0.000146	Height	
COAD	cis	1	rs738665	chr22:47529157	GRAMD4	chr22:47022658-47075687:+	0.27	4	8.29E-5	Longevity	
COAD	cis	1	rs73903009	chr20:33678732	EDEM2	chr20:33703160-33865928:-	0.35	4.09	5.75E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs7395213	chr11:87869579	RAB38	chr11:87846431-87908599:-	-0.38	-4.86	2.0E-6	Frontotemporal dementia	
COAD	cis	1	rs739637	chr17:40280944	DHX58	chr17:40253422-40264751:-	-0.32	-4.84	2.2E-6	Fibrinogen levels	
COAD	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.53	7.96	5.13E-14	Eye color traits	
COAD	cis	1	rs7419837	chr2:70146625	GMCL1	chr2:70056818-70106727:+	0.21	3.9	0.000124	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.68	-6.04	5.22E-9	Plasma clusterin levels	
COAD	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.94	7.29E-17	Height	
COAD	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.35	-4.53	9.09E-6	Height	
COAD	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.34	5.19	4.29E-7	Cognitive performance	
COAD	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.6	8.89	1.04E-16	Height	
COAD	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs7428	chr2:85545490	TGOLN2	chr2:85545147-85555374:-	0.25	5.18	4.43E-7	Ear protrusion	
COAD	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.98	5.36E-17	Height	
COAD	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.34	-4.5	1.02E-5	Height	
COAD	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.59	8.52	1.31E-15	Height	
COAD	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.29	3.85	0.000146	Height	
COAD	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.58	8.28	6.43E-15	Height	
COAD	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.29	3.82	0.00017	Height	
COAD	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs74347384	chr7:1072440	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.32	-4.47	1.18E-5	Longevity	
COAD	cis	1	rs74363821	chr6:26189524	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-3.95	9.9E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs74366004	chr7:1088630	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.15	4.55E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs74369356	chr7:1071711	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs74372131	chr10:81787214	LOC219347	chr10:81805991-81838949:-	0.69	5.8	1.92E-8	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs7444	chr22:21976934	CCDC116	chr22:21987086-21991615:+	-0.34	-4.32	2.17E-5	Systemic lupus erythematosus	
COAD	cis	1	rs74471041	chr3:49542543	WDR6	chr3:49044637-49053386:+	0.33	4.53	8.84E-6	Menarche (age at onset)	
COAD	cis	1	rs745109	chr2:86841069	VPS24	chr2:86730554-86948245:-	0.35	4.68	4.59E-6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
COAD	cis	1	rs74543591	chr20:33658658	PROCR	chr20:33758727-33765164:+	-0.46	-3.88	0.000133	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-0.98	-8.7	3.91E-16	Epithelial ovarian cancer;Ovarian cancer	
COAD	cis	1	rs74562182	chr19:10835612	RAVER1	chr19:10426891-10444314:-	0.47	3.87	0.000136	LDL cholesterol	
COAD	cis	1	rs74652290	chr7:1090109	ZFAND2A	chr7:1192544-1199855:-	-0.41	-4.55	8.31E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7468800	chr9:117592005	AMBP	chr9:116822410-116840752:-	0.51	4.11	5.31E-5	Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.34	-4.22	3.41E-5	Response to temozolomide	
COAD	cis	1	rs74758321	chr8:82667320	CHMP4C	chr8:82644688-82671746:+	-0.98	-8.44	2.15E-15	Epithelial ovarian cancer;Ovarian cancer	
COAD	cis	1	rs747695	chr6:33736672	HLA-DOB	chr6:32780541-32784825:-	0.23	4.2	3.68E-5	Crohn's disease	
COAD	cis	1	rs74785791	chr7:1088494	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.15	4.55E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7484733	chr12:122612598	MLXIP	chr12:122516760-122628965:+	0.21	4.2	3.66E-5	Urate levels	
COAD	cis	1	rs7485054	chr12:122611100	MLXIP	chr12:122516760-122628965:+	0.21	4.21	3.51E-5	Urate levels	
COAD	cis	1	rs7485421	chr12:122611099	MLXIP	chr12:122516760-122628965:+	0.22	4.47	1.19E-5	Urate levels	
COAD	cis	1	rs7485447	chr12:122611200	MLXIP	chr12:122516760-122628965:+	0.21	4.21	3.47E-5	Urate levels	
COAD	cis	1	rs7486198	chr12:122612350	MLXIP	chr12:122516760-122628965:+	0.21	4.2	3.66E-5	Urate levels	
COAD	cis	1	rs7488268	chr12:122614909	MLXIP	chr12:122516760-122628965:+	0.22	4.42	1.43E-5	Urate levels	
COAD	cis	1	rs7488394	chr12:91480002	KERA	chr12:91444273-91452131:-	0.28	4.63	5.81E-6	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs74887741	chr7:1110658	ZFAND2A	chr7:1192544-1199855:-	-0.43	-4.5	1.05E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs74900588	chr6:170102180	C6orf70	chr6:170151721-170181617:+	0.42	4.7	4.24E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.18	4.36	1.87E-5	Blood metabolite levels	
COAD	cis	1	rs74955473	chr5:150174558	LOC134466	chr5:150310000-150326146:-	0.48	5.92	1.03E-8	Crohn's disease	
COAD	cis	1	rs75012727	chr14:97093815	BDKRB1	chr14:96722559-96735303:+	-0.4	-4.06	6.45E-5	Tanning	
COAD	cis	1	rs75012727	chr14:97093815	BDKRB2	chr14:96671135-96710666:+	-0.37	-3.91	0.000119	Tanning	
COAD	cis	1	rs75016635	chr7:1094121	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.69	4.42E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs75024979	chr10:81729853	LOC219347	chr10:81805991-81838949:-	0.7	4.19	3.87E-5	Rheumatoid arthritis	
COAD	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.54	8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs750474	chr3:53085280	SFMBT1	chr3:52938628-53080070:-	-0.52	-6.07	4.44E-9	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs750474	chr3:53085280	TMEM110	chr3:52867139-52931547:-	0.35	4.11	5.27E-5	Immune reponse to smallpox (secreted IL-2)	
COAD	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.33	-4.1	5.59E-5	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs751728	chr6:33764033	HLA-DOB	chr6:32780541-32784825:-	0.21	3.98	9.06E-5	Crohn's disease	
COAD	cis	1	rs751728	chr6:33764033	LEMD2	chr6:33738991-33756906:-	-0.21	-3.93	0.00011	Crohn's disease	
COAD	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.8	-6.98	2.45E-11	Plasma clusterin levels	
COAD	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.33	-4.1	5.59E-5	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.5	7.32	3.04E-12	Homocysteine levels	
COAD	cis	1	rs7525145	chr1:47693814	TAL1	chr1:47681963-47779819:-	-0.18	-4.21	3.46E-5	Body mass index	
COAD	cis	1	rs752621	chr17:61901880	FTSJ3	chr17:61896795-61905031:-	0.3	3.95	0.000102	Body mass index	
COAD	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.32	3.9	0.000124	Heschl's gyrus morphology	
COAD	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.2	4.34	2.08E-5	Type 1 diabetes autoantibodies	
COAD	cis	1	rs75294883	chr5:150196503	LOC134466	chr5:150310000-150326146:-	0.5	5.87	1.29E-8	Crohn's disease	
COAD	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.8	-6.97	2.58E-11	Plasma clusterin levels	
COAD	cis	1	rs7534271	chr1:47693981	TAL1	chr1:47681963-47779819:-	0.19	4.32	2.19E-5	Body mass index	
COAD	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.63	-9.59	7.52E-19	Homocysteine levels	
COAD	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.47	-6.98	2.43E-11	Homocysteine levels	
COAD	cis	1	rs75488469	chr7:1102122	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.68	4.52E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.32	-3.94	0.000105	Response to taxane treatment (docetaxel)	
COAD	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.33	5	1.06E-6	Height	
COAD	cis	1	rs75535620	chr20:33601498	PROCR	chr20:33758727-33765164:+	-0.48	-4.06	6.61E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs755496	chr6:33734376	HLA-DOB	chr6:32780541-32784825:-	0.26	4.7	4.25E-6	Crohn's disease	
COAD	cis	1	rs7560357	chr2:99247820	UNC50	chr2:99225042-99234975:+	0.36	4.53	8.87E-6	Bipolar disorder	
COAD	cis	1	rs7562170	chr2:28943516	PPP1CB	chr2:28974612-29025805:+	-0.28	-4.62	6.12E-6	Body mass index	
COAD	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.33	5.25	3.12E-7	Body mass index	
COAD	cis	1	rs75635914	chr20:33555815	PROCR	chr20:33758727-33765164:+	-0.47	-3.89	0.000128	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs7566277	chr2:99916242	REV1	chr2:100016939-100106480:-	0.36	4.79	2.77E-6	IgG glycosylation	
COAD	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.72	-13.06	2.43E-30	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs756920	chr11:2310870	C11orf21	chr11:2317507-2323143:-	0.4	5.07	7.58E-7	Obesity-related traits	
COAD	cis	1	rs756920	chr11:2310870	TSPAN32	chr11:2323243-2339430:+	0.34	3.96	9.57E-5	Obesity-related traits	
COAD	cis	1	rs7573442	chr2:70154037	GMCL1	chr2:70056818-70106727:+	0.21	3.95	0.000101	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs7574434	chr2:135704656	ACMSD	chr2:135596186-135659600:+	0.42	3.94	0.000106	Obesity-related traits	
COAD	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.31	4.66	5.0E-6	Crohn's disease	
COAD	cis	1	rs7579277	chr2:28996295	PPP1CB	chr2:28974612-29025805:+	0.3	4.97	1.23E-6	Body mass index	
COAD	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.38	-6.11	3.61E-9	Body mass index	
COAD	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	0.6	5.99	6.87E-9	Chronic lymphocytic leukemia	
COAD	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.31	4.18	4.02E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
COAD	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.42	7.09	1.28E-11	Common traits (Other)	
COAD	cis	1	rs7584535	chr2:232106857	ARMC9	chr2:232063342-232238606:+	0.31	4.78	2.96E-6	Food antigen IgG levels	
COAD	cis	1	rs7585004	chr2:73666645	ALMS1	chr2:73612886-73837046:+	0.25	4.08	6.08E-5	Metabolite levels	
COAD	cis	1	rs75866240	chr20:33558839	PROCR	chr20:33758727-33765164:+	-0.47	-3.89	0.000128	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.38	4.69	4.34E-6	Atopic dermatitis	
COAD	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.76	-6.59	2.38E-10	Plasma clusterin levels	
COAD	cis	1	rs7590261	chr2:135608377	ACMSD	chr2:135596186-135659600:+	0.4	4.11	5.32E-5	Obesity-related traits	
COAD	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.72	5.82	1.74E-8	Chronic obstructive pulmonary disease-related biomarkers	
COAD	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.41	-5.57	6.42E-8	Triptolide cytotoxicity	
COAD	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.72	-10.26	5.64E-21	Triptolide cytotoxicity	
COAD	cis	1	rs75921373	chr6:26191843	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-3.96	9.68E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.73	-13.47	9.39E-32	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs7596362	chr2:61204688	AHSA2	chr2:61404553-61414058:+	-0.15	-3.93	0.000109	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.28	5.43	1.29E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs7598283	chr2:70128717	GMCL1	chr2:70056818-70106727:+	0.21	3.95	0.000101	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs7598759	chr2:232321956	C2orf52	chr2:232373137-232379050:-	-0.3	-4.22	3.39E-5	Noise-induced hearing loss	
COAD	cis	1	rs7598876	chr2:28974466	PPP1CB	chr2:28974612-29025805:+	0.29	4.73	3.61E-6	Body mass index	
COAD	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.34	-5.41	1.43E-7	Body mass index	
COAD	cis	1	rs7601738	chr2:242375813	SEPT2	chr2:242254723-242293439:+	-0.59	-5.95	8.76E-9	Chronic lymphocytic leukemia	
COAD	cis	1	rs7603984	chr2:243047294	THAP4	chr2:242523821-242576655:-	0.37	4.48	1.09E-5	Obesity-related traits	
COAD	cis	1	rs7604682	chr2:73788026	ALMS1	chr2:73612886-73837046:+	0.24	3.91	0.000117	Metabolite levels	
COAD	cis	1	rs7604790	chr2:39995782	TMEM178	chr2:39893093-39945101:+	-0.4	-3.84	0.000155	Erectile dysfunction and prostate cancer treatment	
COAD	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.72	13.33	2.83E-31	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs7608623	chr2:23948953	C2orf84	chr2:24397531-24414566:+	-0.27	-4.28	2.61E-5	Obesity-related traits	
COAD	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.27	5.43	1.31E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.25	-4.93	1.43E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.37	-4.32	2.25E-5	Bone mineral density	
COAD	cis	1	rs7611238	chr3:195072918	C3orf21	chr3:194789015-194991895:-	0.33	4.56	7.7E-6	Body mass index	
COAD	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs7611694	chr3:113275624	SIDT1	chr3:113251218-113348421:+	0.23	4.01	7.85E-5	Prostate cancer	
COAD	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs76129108	chr7:1089159	ZFAND2A	chr7:1192544-1199855:-	-0.41	-4.25	2.96E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7613491	chr3:49508976	WDR6	chr3:49044637-49053386:+	0.33	4.39	1.66E-5	Menarche (age at onset)	
COAD	cis	1	rs7615952	chr3:125649403	ALG1L	chr3:125648118-125655882:-	0.35	4.65	5.17E-6	Blood pressure (smoking interaction)	
COAD	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.62	-8.1	2.16E-14	Blood pressure (smoking interaction)	
COAD	cis	1	rs7616044	chr3:125649354	ALG1L	chr3:125648118-125655882:-	-0.38	-4.93	1.49E-6	Blood pressure (smoking interaction)	
COAD	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.63	8.12	1.91E-14	Blood pressure (smoking interaction)	
COAD	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.46	-4.93	1.45E-6	Bone mineral density	
COAD	cis	1	rs76191812	chr20:33563911	PROCR	chr20:33758727-33765164:+	-0.47	-3.87	0.00014	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.58	7.94	5.87E-14	Height	
COAD	cis	1	rs7619451	chr3:134233238	CEP63	chr3:134204575-134293852:+	0.34	4.28	2.67E-5	Height	
COAD	cis	1	rs7619789	chr3:49476263	ARIH2	chr3:48956281-49022969:+	-0.3	-3.84	0.000153	Menarche (age at onset)	
COAD	cis	1	rs7619789	chr3:49476263	WDR6	chr3:49044637-49053386:+	-0.37	-5.51	8.63E-8	Menarche (age at onset)	
COAD	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.44	-4.99	1.09E-6	Bone mineral density	
COAD	cis	1	rs76214082	chr7:1102097	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.74	3.45E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs762676	chr22:51017794	CPT1B	chr22:51007291-51017096:-	-0.47	-4.69	4.38E-6	Narcolepsy	
COAD	cis	1	rs762677	chr22:51017713	CPT1B	chr22:51007291-51017096:-	-0.47	-4.69	4.38E-6	Narcolepsy	
COAD	cis	1	rs76291634	chr19:10836545	RAVER1	chr19:10426891-10444314:-	0.5	4.37	1.83E-5	LDL cholesterol	
COAD	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.42	5.84	1.53E-8	Height	
COAD	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.29	-4.83	2.28E-6	Longevity	
COAD	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.62	-8.85	1.35E-16	Height	
COAD	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.35	-4.52	9.2E-6	Height	
COAD	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.68	10.35	2.85E-21	Diastolic blood pressure	
COAD	cis	1	rs7633265	chr3:195048814	C3orf21	chr3:194789015-194991895:-	0.36	5.03	8.93E-7	Body mass index	
COAD	cis	1	rs7634345	chr3:195073403	C3orf21	chr3:194789015-194991895:-	0.36	4.93	1.49E-6	Body mass index	
COAD	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.3	-4.99	1.12E-6	Longevity	
COAD	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.29	-4.73	3.72E-6	Longevity	
COAD	cis	1	rs7635547	chr3:73539192	FLJ10213	chr3:73110810-73112469:+	0.19	3.85	0.000151	QT interval	
COAD	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.3	-4.95	1.31E-6	Longevity	
COAD	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.3	-4.96	1.28E-6	Longevity	
COAD	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.58	8.07	2.58E-14	Height	
COAD	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.74	3.45E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.4	-4.68	4.69E-6	Bone mineral density	
COAD	cis	1	rs7641070	chr3:135698129	PPP2R3A	chr3:135684567-135866733:+	0.24	3.89	0.000125	Schizophrenia	
COAD	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.52	7.23	5.26E-12	Crohn's disease	
COAD	cis	1	rs7644148	chr3:49545241	WDR6	chr3:49044637-49053386:+	0.33	4.53	8.84E-6	Menarche (age at onset)	
COAD	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.6	8.58	8.35E-16	Height	
COAD	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.33	4.24	3.12E-5	Height	
COAD	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.68	10.35	2.85E-21	Diastolic blood pressure	
COAD	cis	1	rs7646881	chr3:158453279	RARRES1	chr3:158414899-158450275:-	0.48	6.67	1.52E-10	Tetralogy of Fallot	
COAD	cis	1	rs7646987	chr3:158453442	RARRES1	chr3:158414899-158450275:-	-0.49	-6.79	7.39E-11	Tetralogy of Fallot	
COAD	cis	1	rs76472382	chr14:59954385	C14orf149	chr14:59939406-59951126:-	-0.47	-4.23	3.26E-5	Schizophrenia	
COAD	cis	1	rs7647973	chr3:49510931	WDR6	chr3:49044637-49053386:+	0.33	4.39	1.66E-5	Menarche (age at onset)	
COAD	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.75	11.51	4.45E-25	Diastolic blood pressure	
COAD	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs7648995	chr3:49438803	WDR6	chr3:49044637-49053386:+	0.31	4.29	2.47E-5	Menarche (age at onset)	
COAD	cis	1	rs76494403	chr10:81729731	LOC219347	chr10:81805991-81838949:-	0.61	3.95	9.9E-5	Rheumatoid arthritis	
COAD	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.28	-4.64	5.64E-6	Longevity	
COAD	cis	1	rs7651757	chr3:195077305	C3orf21	chr3:194789015-194991895:-	0.35	4.77	3.01E-6	Body mass index	
COAD	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.27	4.5	1.01E-5	Longevity	
COAD	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.57	-5.97	7.79E-9	Tumor biomarkers	
COAD	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.43	-5.44	1.2E-7	Tumor biomarkers	
COAD	cis	1	rs76542740	chr15:43891512	LCMT2	chr15:43619976-43622891:-	-0.38	-3.94	0.000106	Tumor biomarkers	
COAD	cis	1	rs765527	chr19:22129555	ZNF257	chr19:22235266-22273901:+	-0.34	-4.33	2.08E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.37	-5.15	5.16E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
COAD	cis	1	rs76579763	chr14:59935971	C14orf149	chr14:59939406-59951126:-	-0.44	-4.17	4.19E-5	Schizophrenia	
COAD	cis	1	rs7659194	chr4:120207147	FABP2	chr4:120238406-120243316:-	0.39	5.92	1.02E-8	Corneal astigmatism	
COAD	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.36	-4.98	1.17E-6	Plasma amyloid beta peptide concentrations (ABx-40)	
COAD	cis	1	rs7665590	chr4:99796784	ADH4	chr4:100044835-100065449:-	0.35	5.2	4.07E-7	Primary biliary cirrhosis	
COAD	cis	1	rs7667849	chr4:56388199	SRD5A3	chr4:56212409-56237866:+	-0.26	-4.47	1.16E-5	Personality dimensions	
COAD	cis	1	rs7668147	chr4:56339384	SRD5A3	chr4:56212409-56237866:+	0.28	4.92	1.51E-6	Personality dimensions	
COAD	cis	1	rs7670225	chr4:56368018	SRD5A3	chr4:56212409-56237866:+	0.27	4.55	8.26E-6	Personality dimensions	
COAD	cis	1	rs7673321	chr4:17957688	NCAPG	chr4:17812525-17846485:+	0.24	3.82	0.000167	Height	
COAD	cis	1	rs7673908	chr4:56394819	SRD5A3	chr4:56212409-56237866:+	-0.29	-5.25	3.19E-7	Personality dimensions	
COAD	cis	1	rs767391	chr12:62745268	FAM19A2	chr12:62102043-62653925:-	0.33	3.9	0.000124	Pyoderma gangrenosum in inflammatory bowel disease	
COAD	cis	1	rs7677526	chr4:56349908	SRD5A3	chr4:56212409-56237866:+	0.27	4.8	2.63E-6	Personality dimensions	
COAD	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.38	-3.97	9.2E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.86	5.25	3.11E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs7682402	chr4:1743343	FAM53A	chr4:1641609-1685854:-	-0.45	-6.41	6.59E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs7683315	chr4:88773095	SPP1	chr4:88896802-88904562:+	0.29	5.39	1.59E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs76833820	chr7:1070278	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs76837345	chr8:82668818	CHMP4C	chr8:82644688-82671746:+	-0.96	-8.21	1.05E-14	Epithelial ovarian cancer;Ovarian cancer	
COAD	cis	1	rs76872831	chr5:150171559	LOC134466	chr5:150310000-150326146:-	0.47	5.85	1.5E-8	Crohn's disease	
COAD	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.38	-5.31	2.35E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
COAD	cis	1	rs76964550	chr10:81729733	LOC219347	chr10:81805991-81838949:-	0.61	3.95	9.9E-5	Rheumatoid arthritis	
COAD	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.12	26.83	5.51E-77	Birdshot chorioretinopathy	
COAD	cis	1	rs77083167	chr7:1071823	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.28	4.2	3.62E-5	Crohn's disease	
COAD	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.9	5.38	1.66E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs7719994	chr5:156430076	HAVCR1	chr5:156456531-156486130:-	-0.35	-4.36	1.88E-5	Hypertriglyceridemia	
COAD	cis	1	rs7719994	chr5:156430076	TIMD4	chr5:156346293-156390266:-	-0.35	-4.56	8.03E-6	Hypertriglyceridemia	
COAD	cis	1	rs7720132	chr5:90745105	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs77232433	chr17:37962846	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.33	-4.3	2.38E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs7727038	chr5:131590257	PDLIM4	chr5:131593351-131609145:+	-0.15	-4.35	1.94E-5	Blood metabolite levels	
COAD	cis	1	rs7727544	chr5:131590534	PDLIM4	chr5:131593351-131609145:+	-0.15	-4.35	1.94E-5	Blood metabolite levels	
COAD	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.74	3.45E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs77346188	chr7:1114023	GPER	chr7:1121844-1133451:+	0.49	4.13	4.92E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs77346188	chr7:1114023	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.76	3.28E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7742626	chr6:136132496	PDE7B	chr6:136172834-136516708:+	-0.23	-4.86	2.06E-6	Phosphorus levels	
COAD	cis	1	rs77435770	chr6:118819467	C6orf204	chr6:118786239-119031238:-	-0.28	-4.78	2.89E-6	Renal cell carcinoma	
COAD	cis	1	rs77437249	chr20:33564738	PROCR	chr20:33758727-33765164:+	-0.47	-3.87	0.00014	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs7746598	chr6:170084933	C6orf70	chr6:170151721-170181617:+	0.38	4.24	3.16E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs7747645	chr6:170070291	C6orf70	chr6:170151721-170181617:+	0.35	3.94	0.000105	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.34	4.4	1.56E-5	Atopic dermatitis	
COAD	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.63	-9.79	1.73E-19	Response to antipsychotic treatment	
COAD	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.53	9.1	2.45E-17	Folate pathway vitamin levels	
COAD	cis	1	rs7755323	chr6:33761159	LEMD2	chr6:33738991-33756906:-	0.23	3.91	0.000115	Body mass index	
COAD	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.58	-8.44	2.23E-15	Response to antipsychotic treatment	
COAD	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.38	-6.99	2.35E-11	Homocysteine levels	
COAD	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.61	-9.18	1.4E-17	Response to antipsychotic treatment	
COAD	cis	1	rs7762018	chr6:170113244	C6orf70	chr6:170151721-170181617:+	0.41	4.81	2.53E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
COAD	cis	1	rs7764785	chr6:163009967	PACRG	chr6:163148164-163736523:+	0.49	5.31	2.39E-7	Body mass index	
COAD	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.64	-9.86	1.1E-19	Response to antipsychotic treatment	
COAD	cis	1	rs7769686	chr6:163199467	PACRG	chr6:163148164-163736523:+	0.49	5.01	1.0E-6	Body mass index	
COAD	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.26	3.83	0.000162	Crohn's disease	
COAD	cis	1	rs77702926	chr7:1088838	ZFAND2A	chr7:1192544-1199855:-	-0.4	-4.15	4.55E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.58	-8.44	2.23E-15	Response to antipsychotic treatment	
COAD	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.38	-7.09	1.25E-11	Homocysteine levels	
COAD	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.38	-3.97	9.2E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs77789667	chr14:59940418	C14orf149	chr14:59939406-59951126:-	-0.43	-4.16	4.4E-5	Schizophrenia	
COAD	cis	1	rs77790737	chr8:96037156	C8orf38	chr8:95908040-96088396:+	-0.29	-3.95	0.000101	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs77868187	chr7:1093968	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.69	4.42E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.21	-5.93	9.36E-9	Tuberculosis	
COAD	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.33	6.63	1.93E-10	Tuberculosis	
COAD	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.21	-5.86	1.38E-8	Tuberculosis	
COAD	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.33	6.56	2.87E-10	Tuberculosis	
COAD	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.21	-5.95	8.73E-9	Tuberculosis	
COAD	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.33	6.53	3.4E-10	Tuberculosis	
COAD	cis	1	rs78012445	chr6:26195080	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-3.96	9.68E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs78032828	chr2:86309032	LOC90784	chr2:86247339-86250991:-	-0.71	-5.6	5.53E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
COAD	cis	1	rs78055011	chr20:33618606	PROCR	chr20:33758727-33765164:+	-0.49	-4.05	6.66E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs78075821	chr1:171724645	VAMP4	chr1:171669298-171711214:-	0.31	4.32	2.18E-5	Hippocampal atrophy	
COAD	cis	1	rs7808022	chr7:99220083	CYP3A5	chr7:99245818-99332821:-	0.5	7.34	2.71E-12	Blood metabolite levels	
COAD	cis	1	rs78143408	chr7:1096846	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.64	5.62E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs78158942	chr7:1090440	ZFAND2A	chr7:1192544-1199855:-	-0.41	-4.37	1.78E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs78162577	chr19:10839195	RAVER1	chr19:10426891-10444314:-	0.47	4.1	5.46E-5	LDL cholesterol	
COAD	cis	1	rs78172786	chr17:61847114	FTSJ3	chr17:61896795-61905031:-	0.31	3.99	8.5E-5	Body mass index	
COAD	cis	1	rs78177356	chr14:60008967	C14orf149	chr14:59939406-59951126:-	-0.54	-4.42	1.47E-5	Schizophrenia	
COAD	cis	1	rs78177356	chr14:60008967	JKAMP	chr14:59951161-59972080:+	0.51	4.23	3.28E-5	Schizophrenia	
COAD	cis	1	rs78185558	chr7:1090183	ZFAND2A	chr7:1192544-1199855:-	-0.41	-4.61	6.41E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs78185801	chr7:1096367	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.64	5.62E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7819570	chr8:89588626	MMP16	chr8:89049462-89339717:-	0.17	3.93	0.000109	Schizophrenia	
COAD	cis	1	rs78202808	chr20:33667424	EDEM2	chr20:33703160-33865928:-	0.34	4.01	8.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.38	4.68	4.63E-6	Atopic dermatitis	
COAD	cis	1	rs78213404	chr1:171685491	VAMP4	chr1:171669298-171711214:-	0.34	4.65	5.29E-6	Hippocampal atrophy	
COAD	cis	1	rs782590	chr2:55843413	PNPT1	chr2:55861198-55921011:-	-0.21	-4.63	5.65E-6	Metabolic syndrome	
COAD	cis	1	rs782594	chr2:55844445	PNPT1	chr2:55861198-55921011:-	-0.2	-4.57	7.56E-6	Metabolic syndrome	
COAD	cis	1	rs782876	chr7:134240770	AKR1B15	chr7:134233849-134264300:+	0.31	4.39	1.63E-5	Longevity	
COAD	cis	1	rs78308415	chr7:1072634	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.9	0.000121	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7847271	chr9:117830812	TNC	chr9:117782806-117880486:-	-0.23	-4.19	3.85E-5	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs78520676	chr11:517173	PTDSS2	chr11:450280-491386:+	-0.49	-4.69	4.39E-6	Body mass index	
COAD	cis	1	rs78523927	chr7:1089458	ZFAND2A	chr7:1192544-1199855:-	-0.41	-4.25	2.96E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs78580914	chr9:117831881	TNC	chr9:117782806-117880486:-	-0.23	-4.1	5.48E-5	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.32	3.9	0.000124	Heschl's gyrus morphology	
COAD	cis	1	rs78628466	chr7:1068453	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.93	0.000111	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7872350	chr9:117594017	AMBP	chr9:116822410-116840752:-	0.45	3.97	9.17E-5	Ulcerative colitis;Inflammatory bowel disease	
COAD	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-0.98	-8.85	1.37E-16	Epithelial ovarian cancer;Ovarian cancer	
COAD	cis	1	rs78740005	chr8:82659306	CHMP4C	chr8:82644688-82671746:+	-0.98	-8.71	3.59E-16	Epithelial ovarian cancer;Ovarian cancer	
COAD	cis	1	rs78861357	chr7:1095418	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.64	5.62E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs78896566	chr7:1080182	ZFAND2A	chr7:1192544-1199855:-	-0.38	-3.97	9.2E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs789237	chr3:128636961	ACAD9	chr3:128598333-128634910:+	-0.32	-3.97	9.4E-5	IgG glycosylation	
COAD	cis	1	rs79021324	chr14:59941424	C14orf149	chr14:59939406-59951126:-	-0.43	-4.16	4.4E-5	Schizophrenia	
COAD	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.32	3.9	0.000124	Heschl's gyrus morphology	
COAD	cis	1	rs7904985	chr10:88116479	GRID1	chr10:87359312-88126250:-	0.2	4.49	1.07E-5	Barrett's esophagus	
COAD	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.17	-3.84	0.000153	Palmitoleic acid (16:1n-7) plasma levels	
COAD	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.17	4.05	6.7E-5	Blood metabolite levels	
COAD	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.63	9.96	5.15E-20	Response to antipsychotic treatment	
COAD	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.39	4.83	2.38E-6	Atopic dermatitis	
COAD	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.3	-4.26	2.87E-5	Schizophrenia	
COAD	cis	1	rs79327308	chr7:1108141	GPER	chr7:1121844-1133451:+	0.47	3.99	8.53E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.69	4.43E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs79396265	chr8:96071272	C8orf38	chr8:95908040-96088396:+	-0.44	-5.39	1.54E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs79422648	chr7:1080241	ZFAND2A	chr7:1192544-1199855:-	-0.38	-3.97	9.2E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7943121	chr11:18656062	SPTY2D1	chr11:18627949-18656020:-	-0.4	-6.35	9.36E-10	Cholesterol, total	
COAD	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.39	4.74	3.55E-6	Atopic dermatitis	
COAD	cis	1	rs79440439	chr11:478147	PTDSS2	chr11:450280-491386:+	-0.51	-4.61	6.36E-6	Body mass index	
COAD	cis	1	rs79443843	chr7:1075245	ZFAND2A	chr7:1192544-1199855:-	-0.38	-4.01	7.95E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.39	5.96	8.12E-9	Pancreatic cancer	
COAD	cis	1	rs79475579	chr11:58295900	CNTF	chr11:58390146-58393203:+	0.4	3.87	0.00014	Lymphoma	
COAD	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs7954638	chr12:96314795	AMDHD1	chr12:96337071-96362369:+	0.41	5.56	6.8E-8	Metabolite levels (small molecules and protein measures)	
COAD	cis	1	rs7955571	chr12:122616759	MLXIP	chr12:122516760-122628965:+	-0.22	-4.49	1.07E-5	Urate levels	
COAD	cis	1	rs7955575	chr12:122616766	MLXIP	chr12:122516760-122628965:+	-0.22	-4.49	1.07E-5	Urate levels	
COAD	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.9	5.42	1.38E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs79617366	chr7:1111958	GPER	chr7:1121844-1133451:+	0.48	4.08	6.09E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs79617366	chr7:1111958	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.67	4.74E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs7961894	chr12:122365583	WDR66	chr12:122356480-122441830:+	-0.52	-3.82	0.000164	Platelet count;Mean platelet volume	
COAD	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.95	5.66	4.0E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs7964148	chr12:122619261	MLXIP	chr12:122516760-122628965:+	-0.2	-4.13	4.88E-5	Urate levels	
COAD	cis	1	rs79683221	chr7:1096139	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.64	5.62E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.38	4.7	4.28E-6	Atopic dermatitis	
COAD	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.73	-13.51	6.98E-32	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.36	5.31	2.33E-7	IgG glycosylation	
COAD	cis	1	rs79765398	chr7:1073764	ZFAND2A	chr7:1192544-1199855:-	-0.37	-3.94	0.000106	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs79780973	chr5:150174810	LOC134466	chr5:150310000-150326146:-	0.48	5.92	1.03E-8	Crohn's disease	
COAD	cis	1	rs7979545	chr12:112790648	ALDH2	chr12:112204346-112247782:+	-0.25	-3.83	0.000163	Oral cavity and pharyngeal cancer	
COAD	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.36	-5.23	3.42E-7	Educational attainment;Height;Head circumference (infant)	
COAD	cis	1	rs79808876	chr11:465763	PTDSS2	chr11:450280-491386:+	-0.46	-4.57	7.41E-6	Body mass index	
COAD	cis	1	rs79854439	chr10:81730092	LOC219347	chr10:81805991-81838949:-	0.61	3.95	9.9E-5	Rheumatoid arthritis	
COAD	cis	1	rs79868973	chr6:26189312	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-4.22	3.41E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs798719	chr4:1698183	FAM53A	chr4:1641609-1685854:-	-0.45	-6.49	4.38E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798724	chr4:1704643	FAM53A	chr4:1641609-1685854:-	-0.45	-6.69	1.38E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798741	chr4:1712413	FAM53A	chr4:1641609-1685854:-	-0.43	-6.43	6.17E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798744	chr4:1714684	FAM53A	chr4:1641609-1685854:-	-0.45	-6.48	4.52E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798754	chr4:1720757	FAM53A	chr4:1641609-1685854:-	-0.37	-5.46	1.12E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798755	chr4:1720824	FAM53A	chr4:1641609-1685854:-	-0.39	-5.64	4.43E-8	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798756	chr4:1707447	FAM53A	chr4:1641609-1685854:-	-0.47	-6.74	1.03E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798762	chr4:1731150	FAM53A	chr4:1641609-1685854:-	-0.37	-5.41	1.44E-7	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798766	chr4:1734239	FAM53A	chr4:1641609-1685854:-	0.45	6.55	3.0E-10	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs798767	chr4:1734281	FAM53A	chr4:1641609-1685854:-	-0.44	-6.29	1.3E-9	Urinary bladder cancer;Bladder cancer	
COAD	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.38	4.8	2.73E-6	Atopic dermatitis	
COAD	cis	1	rs79947284	chr10:81714579	LOC219347	chr10:81805991-81838949:-	0.7	4.17	4.22E-5	Rheumatoid arthritis	
COAD	cis	1	rs79989390	chr17:37962845	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs80031817	chr7:1096793	ZFAND2A	chr7:1192544-1199855:-	-0.44	-4.64	5.62E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.24	-4.05	6.66E-5	Height	
COAD	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	0.57	5.51	8.63E-8	Chronic lymphocytic leukemia	
COAD	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.78	2.99E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.47	-9.83	1.36E-19	IgG glycosylation	
COAD	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.38	4.76	3.15E-6	Atopic dermatitis	
COAD	cis	1	rs8017642	chr14:75590822	MLH3	chr14:75480467-75518235:-	0.24	4.07	6.12E-5	Height	
COAD	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.29	-3.99	8.46E-5	Blood metabolite ratios	
COAD	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.93	5.53	7.66E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs80212261	chr7:1114012	GPER	chr7:1121844-1133451:+	0.49	4.13	4.92E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs80212261	chr7:1114012	ZFAND2A	chr7:1192544-1199855:-	-0.45	-4.76	3.28E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
COAD	cis	1	rs8021692	chr14:104428576	TDRD9	chr14:104394817-104519002:+	0.34	5.05	8.39E-7	Bipolar disorder	
COAD	cis	1	rs8023716	chr15:65744861	DENND4A	chr15:65952959-66084631:-	-0.21	-4.14	4.68E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs8024944	chr15:56125135	PRTG	chr15:55903748-56035177:-	0.21	3.84	0.000153	Keloid	
COAD	cis	1	rs80259160	chr6:26190199	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-3.96	9.68E-5	Renal underexcretion gout;Gout	
COAD	cis	1	rs8026172	chr15:56125182	PRTG	chr15:55903748-56035177:-	0.21	3.84	0.000153	Keloid	
COAD	cis	1	rs8027260	chr15:65955172	DENND4A	chr15:65952959-66084631:-	0.23	4.3	2.39E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.86	5.04	8.91E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.88	4.99	1.08E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
COAD	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.37	4.58	7.28E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs8035639	chr15:65944548	DENND4A	chr15:65952959-66084631:-	-0.21	-3.9	0.000123	Mean corpuscular hemoglobin	
COAD	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.35	4.56	8.03E-6	Blood trace element (Zn levels)	
COAD	cis	1	rs8042366	chr15:66012443	DENND4A	chr15:65952959-66084631:-	-0.2	-3.97	9.46E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs8042807	chr15:66012444	DENND4A	chr15:65952959-66084631:-	-0.21	-4.04	7.02E-5	Mean corpuscular hemoglobin	
COAD	cis	1	rs8046998	chr16:58825013	GOT2	chr16:58741035-58768246:-	-0.3	-4.91	1.59E-6	Blood metabolite ratios	
COAD	cis	1	rs8047014	chr16:69135049	TMED6	chr16:69377160-69385689:-	-0.38	-5.21	3.83E-7	Attention deficit hyperactivity disorder	
COAD	cis	1	rs8057892	chr16:58832759	GOT2	chr16:58741035-58768246:-	-0.32	-5.23	3.47E-7	Blood metabolite ratios	
COAD	cis	1	rs8057939	chr16:49394276	N4BP1	chr16:48572639-48644120:-	-0.28	-3.92	0.000113	Prostate cancer (gene x gene interaction)	
COAD	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.31	5.36	1.82E-7	Testicular germ cell tumor	
COAD	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.51	8.82	1.62E-16	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.5	8.85	1.32E-16	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs8067431	chr17:61817048	FTSJ3	chr17:61896795-61905031:-	0.3	3.96	9.59E-5	Body mass index	
COAD	cis	1	rs8068603	chr17:61755211	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs8070446	chr17:40285879	DHX58	chr17:40253422-40264751:-	-0.32	-4.84	2.2E-6	Fibrinogen levels	
COAD	cis	1	rs8071789	chr17:38006333	GSDMB	chr17:38060850-38074903:-	-0.31	-5.45	1.15E-7	Selective IgA deficiency	
COAD	cis	1	rs8071789	chr17:38006333	PGAP3	chr17:37827376-37844310:-	-0.27	-4.47	1.19E-5	Selective IgA deficiency	
COAD	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.52	-9.26	7.87E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
COAD	cis	1	rs8073373	chr17:61703320	FTSJ3	chr17:61896795-61905031:-	0.27	3.86	0.000141	Body mass index	
COAD	cis	1	rs8074708	chr17:40286354	DHX58	chr17:40253422-40264751:-	0.32	4.88	1.89E-6	Fibrinogen levels	
COAD	cis	1	rs8075422	chr17:61804686	FTSJ3	chr17:61896795-61905031:-	0.29	4.23	3.23E-5	Body mass index	
COAD	cis	1	rs8076336	chr17:18212614	SHMT1	chr17:18231195-18266856:-	-0.25	-3.94	0.000105	Parental longevity (combined parental age at death)	
COAD	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.33	-5.47	1.08E-7	Metabolite levels	
COAD	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.27	-4.85	2.13E-6	Metabolite levels	
COAD	cis	1	rs8076717	chr17:61850301	FTSJ3	chr17:61896795-61905031:-	-0.3	-4.07	6.28E-5	Body mass index	
COAD	cis	1	rs8077265	chr17:61732727	FTSJ3	chr17:61896795-61905031:-	0.27	3.89	0.000128	Body mass index	
COAD	cis	1	rs8080491	chr17:53049869	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs8081612	chr17:61724695	FTSJ3	chr17:61896795-61905031:-	-0.29	-4.18	4.06E-5	Body mass index	
COAD	cis	1	rs8082471	chr17:53067993	STXBP4	chr17:53046126-53241449:+	-0.28	-3.93	0.000108	Breast cancer	
COAD	cis	1	rs809367	chr10:89741806	PAPSS2	chr10:89419476-89507460:+	0.34	3.82	0.000169	Parental extreme longevity (95 years and older)	
COAD	cis	1	rs8098848	chr18:60857793	TNFRSF11A	chr18:59992548-60053502:+	0.23	3.96	9.79E-5	Cardiac Troponin-T levels	
COAD	cis	1	rs8105833	chr19:41896145	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.46	1.2E-5	Height	
COAD	cis	1	rs8110011	chr19:37745813	ZFP30	chr19:38123389-38146368:-	-0.34	-4.42	1.47E-5	Coronary artery calcification	
COAD	cis	1	rs8110727	chr19:24230916	ZNF254	chr19:24216247-24312652:+	0.35	4.14	4.76E-5	Response to taxane treatment (placlitaxel)	
COAD	cis	1	rs8112837	chr19:10837030	RAVER1	chr19:10426891-10444314:-	0.51	4.36	1.87E-5	LDL cholesterol	
COAD	cis	1	rs8117847	chr20:33642480	EDEM2	chr20:33703160-33865928:-	0.31	3.97	9.48E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs8118005	chr20:33636219	EDEM2	chr20:33703160-33865928:-	0.33	3.83	0.000161	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs8118005	chr20:33636219	PROCR	chr20:33758727-33765164:+	-0.38	-3.87	0.000139	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs8121957	chr20:33676109	EDEM2	chr20:33703160-33865928:-	0.34	4.06	6.54E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs8123978	chr20:33598789	PROCR	chr20:33758727-33765164:+	-0.48	-4.06	6.61E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs8124662	chr20:33639256	EDEM2	chr20:33703160-33865928:-	0.33	3.83	0.000161	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs8124662	chr20:33639256	PROCR	chr20:33758727-33765164:+	-0.38	-3.87	0.000139	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs8131214	chr21:30483386	N6AMT1	chr21:30244513-30257693:-	-0.32	-4.63	5.66E-6	Dental caries	
COAD	cis	1	rs8137478	chr22:51017296	CPT1B	chr22:51007291-51017096:-	-0.47	-4.69	4.38E-6	Narcolepsy	
COAD	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.6	6.47	4.92E-10	Amyotrophic lateral sclerosis	
COAD	cis	1	rs8138996	chr22:39047435	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs8138996	chr22:39047435	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs8140617	chr22:38970439	CBY1	chr22:39052658-39069853:+	-0.39	-6.16	2.72E-9	Resting heart rate	
COAD	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.51	-5.9	1.13E-8	Amyotrophic lateral sclerosis	
COAD	cis	1	rs8142098	chr22:39058757	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs8142098	chr22:39058757	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.52	6.59	2.47E-10	Multiple sclerosis	
COAD	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.38	-6.12	3.47E-9	Multiple sclerosis	
COAD	cis	1	rs8192917	chr14:25102160	GZMB	chr14:25100161-25103432:-	0.36	4.87	1.9E-6	Vitiligo	
COAD	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.29	4.06	6.56E-5	Parkinson's disease	
COAD	cis	1	rs823301	chr3:195123495	C3orf21	chr3:194789015-194991895:-	-0.35	-4.74	3.45E-6	Body mass index	
COAD	cis	1	rs823302	chr3:195104741	C3orf21	chr3:194789015-194991895:-	-0.33	-4.68	4.67E-6	Body mass index	
COAD	cis	1	rs823306	chr3:195108320	C3orf21	chr3:194789015-194991895:-	-0.34	-4.76	3.15E-6	Body mass index	
COAD	cis	1	rs823310	chr3:195127093	C3orf21	chr3:194789015-194991895:-	-0.34	-4.76	3.15E-6	Body mass index	
COAD	cis	1	rs823311	chr3:195141029	C3orf21	chr3:194789015-194991895:-	-0.35	-4.74	3.45E-6	Body mass index	
COAD	cis	1	rs823314	chr3:195132402	C3orf21	chr3:194789015-194991895:-	-0.34	-4.76	3.15E-6	Body mass index	
COAD	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	1.01	12.86	1.18E-29	Type 2 diabetes	
COAD	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.96	12.57	1.2E-28	Type 2 diabetes	
COAD	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.96	12.33	8.13E-28	Type 2 diabetes	
COAD	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	1.01	13.35	2.51E-31	Type 2 diabetes	
COAD	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	1.01	13.38	1.93E-31	Type 2 diabetes	
COAD	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	1.01	13.38	1.93E-31	Type 2 diabetes	
COAD	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.97	12.5	2.02E-28	Type 2 diabetes	
COAD	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	1.01	12.86	1.18E-29	Type 2 diabetes	
COAD	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	1.01	12.86	1.18E-29	Type 2 diabetes	
COAD	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.97	-13.38	1.98E-31	Type 2 diabetes	
COAD	cis	1	rs840567	chr2:188174433	CALCRL	chr2:188207851-188313021:-	-0.14	-4.37	1.81E-5	Coronary heart disease	
COAD	cis	1	rs840569	chr2:188173125	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs840570	chr2:188172677	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs840571	chr2:188171676	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs840572	chr2:188171253	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs840574	chr2:188171068	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs840576	chr2:188168350	CALCRL	chr2:188207851-188313021:-	-0.15	-4.4	1.6E-5	Coronary heart disease	
COAD	cis	1	rs840577	chr2:188168059	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs840578	chr2:188167105	CALCRL	chr2:188207851-188313021:-	-0.14	-4.22	3.35E-5	Coronary heart disease	
COAD	cis	1	rs840581	chr2:188190584	CALCRL	chr2:188207851-188313021:-	-0.14	-4.33	2.14E-5	Coronary heart disease	
COAD	cis	1	rs840583	chr2:188186320	CALCRL	chr2:188207851-188313021:-	-0.13	-4.15	4.52E-5	Coronary heart disease	
COAD	cis	1	rs840584	chr2:188186079	CALCRL	chr2:188207851-188313021:-	-0.13	-4.15	4.52E-5	Coronary heart disease	
COAD	cis	1	rs840586	chr2:188183918	CALCRL	chr2:188207851-188313021:-	-0.14	-4.35	1.97E-5	Coronary heart disease	
COAD	cis	1	rs840587	chr2:188183805	CALCRL	chr2:188207851-188313021:-	-0.15	-4.38	1.74E-5	Coronary heart disease	
COAD	cis	1	rs840589	chr2:188182527	CALCRL	chr2:188207851-188313021:-	-0.14	-4.25	3.03E-5	Coronary heart disease	
COAD	cis	1	rs840590	chr2:188181914	CALCRL	chr2:188207851-188313021:-	-0.14	-4.25	3.03E-5	Coronary heart disease	
COAD	cis	1	rs840593	chr2:188181341	CALCRL	chr2:188207851-188313021:-	-0.14	-4.25	3.03E-5	Coronary heart disease	
COAD	cis	1	rs840595	chr2:188179494	CALCRL	chr2:188207851-188313021:-	-0.14	-4.32	2.27E-5	Coronary heart disease	
COAD	cis	1	rs840596	chr2:188178524	CALCRL	chr2:188207851-188313021:-	-0.15	-4.55	8.3E-6	Coronary heart disease	
COAD	cis	1	rs840597	chr2:188178480	CALCRL	chr2:188207851-188313021:-	-0.15	-4.4	1.6E-5	Coronary heart disease	
COAD	cis	1	rs840600	chr2:188159750	CALCRL	chr2:188207851-188313021:-	0.13	3.93	0.000108	Coronary heart disease	
COAD	cis	1	rs840603	chr2:188160901	CALCRL	chr2:188207851-188313021:-	-0.14	-4.09	5.79E-5	Coronary heart disease	
COAD	cis	1	rs840609	chr2:188199583	CALCRL	chr2:188207851-188313021:-	-0.14	-4.29	2.47E-5	Coronary heart disease	
COAD	cis	1	rs840611	chr2:188198446	CALCRL	chr2:188207851-188313021:-	-0.15	-4.63	5.88E-6	Coronary heart disease	
COAD	cis	1	rs840616	chr2:188196469	CALCRL	chr2:188207851-188313021:-	-0.14	-4.55	8.23E-6	Coronary heart disease	
COAD	cis	1	rs844479	chr2:188159178	CALCRL	chr2:188207851-188313021:-	0.13	3.9	0.000121	Coronary heart disease	
COAD	cis	1	rs847058	chr20:45232757	SLC13A3	chr20:45186463-45313107:-	-0.26	-4.06	6.5E-5	Gout	
COAD	cis	1	rs853676	chr6:28299687	ZSCAN23	chr6:28393287-28411279:-	0.35	4.05	6.71E-5	Depression	
COAD	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.39	-7.25	4.65E-12	Homocysteine levels	
COAD	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.96	-12.74	3.21E-29	Type 2 diabetes	
COAD	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	1.01	12.86	1.18E-29	Type 2 diabetes	
COAD	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.92	12.34	7.28E-28	Type 2 diabetes	
COAD	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	1.01	12.86	1.18E-29	Type 2 diabetes	
COAD	cis	1	rs868213	chr16:67220457	LRRC29	chr16:67241043-67260901:-	-0.44	-5.87	1.32E-8	HDL cholesterol	
COAD	cis	1	rs868530	chr5:156430916	HAVCR1	chr5:156456531-156486130:-	-0.35	-4.3	2.45E-5	Hypertriglyceridemia	
COAD	cis	1	rs868530	chr5:156430916	TIMD4	chr5:156346293-156390266:-	-0.35	-4.62	6.13E-6	Hypertriglyceridemia	
COAD	cis	1	rs873063	chr8:8572447	FLJ10661	chr8:8086092-8102386:+	0.38	4.24	3.08E-5	Obesity-related traits	
COAD	cis	1	rs873064	chr8:8572380	FLJ10661	chr8:8086092-8102386:+	0.37	4.19	3.81E-5	Obesity-related traits	
COAD	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.46	9.07	2.98E-17	Kawasaki disease	
COAD	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.17	3.98	9.09E-5	Blood metabolite levels	
COAD	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.28	-4.76	3.23E-6	Height	
COAD	cis	1	rs876403	chr14:75602834	MLH3	chr14:75480467-75518235:-	0.28	4.83	2.33E-6	Height	
COAD	cis	1	rs876755	chr3:128627933	ACAD9	chr3:128598333-128634910:+	-0.33	-4.06	6.57E-5	IgG glycosylation	
COAD	cis	1	rs876756	chr3:128627623	ACAD9	chr3:128598333-128634910:+	-0.34	-4.15	4.43E-5	IgG glycosylation	
COAD	cis	1	rs878082	chr19:41897674	B3GNT8	chr19:41931265-41934635:-	-0.27	-4.51	9.71E-6	Height	
COAD	cis	1	rs878083	chr19:41897688	B3GNT8	chr19:41931265-41934635:-	-0.3	-5	1.03E-6	Height	
COAD	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.38	-5.5	9.15E-8	Rheumatoid arthritis	
COAD	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.49	-7.21	5.97E-12	Homocysteine levels	
COAD	cis	1	rs883648	chr8:8569521	FLJ10661	chr8:8086092-8102386:+	0.4	4.57	7.38E-6	Obesity-related traits	
COAD	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.57	-8.54	1.14E-15	Response to antipsychotic treatment	
COAD	cis	1	rs885000	chr8:8568875	FLJ10661	chr8:8086092-8102386:+	0.42	4.86	1.99E-6	Obesity-related traits	
COAD	cis	1	rs8897	chr3:49460407	WDR6	chr3:49044637-49053386:+	-0.27	-3.91	0.000117	Menarche (age at onset)	
COAD	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.27	-4.02	7.58E-5	Height	
COAD	cis	1	rs892974	chr3:49398514	WDR6	chr3:49044637-49053386:+	-0.31	-4.16	4.36E-5	Menarche (age at onset)	
COAD	cis	1	rs897119	chr2:70160658	GMCL1	chr2:70056818-70106727:+	0.22	4.29	2.57E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs897120	chr2:70160982	GMCL1	chr2:70056818-70106727:+	-0.22	-4.34	2.0E-5	Carotid plaque burden (smoking interaction)	
COAD	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.28	4.75	3.33E-6	Longevity	
COAD	cis	1	rs903552	chr15:101997991	ALDH1A3	chr15:101420009-101456828:+	-0.22	-3.94	0.000103	Diabetic kidney disease	
COAD	cis	1	rs907463	chr2:188185287	CALCRL	chr2:188207851-188313021:-	0.14	4.23	3.18E-5	Coronary heart disease	
COAD	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.3	5.05	8.12E-7	Height	
COAD	cis	1	rs916134	chr12:54069803	ATP5G2	chr12:54058945-54070512:-	0.27	4.85	2.12E-6	Height	
COAD	cis	1	rs917665	chr4:17668504	MED28	chr4:17616273-17629791:+	-0.26	-3.83	0.000158	Parasitemia in Tripanosoma cruzi seropositivity	
COAD	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.22	4.06	6.47E-5	Type 1 diabetes	
COAD	cis	1	rs918814	chr2:23948466	C2orf84	chr2:24397531-24414566:+	-0.27	-4.1	5.52E-5	Obesity-related traits	
COAD	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.71	-12.71	3.87E-29	Spherical equivalent (joint main effects and education interaction)	
COAD	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.26	4.2	3.67E-5	Longevity	
COAD	cis	1	rs926299	chr22:39095698	CBY1	chr22:39052658-39069853:+	0.33	5.78	2.14E-8	Resting heart rate	
COAD	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	1.01	13.29	4.05E-31	Type 2 diabetes	
COAD	cis	1	rs9289275	chr3:125648659	ALG1L	chr3:125648118-125655882:-	-0.34	-4.28	2.6E-5	Blood pressure (smoking interaction)	
COAD	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.63	7.77	1.85E-13	Blood pressure (smoking interaction)	
COAD	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.61	9.5	1.45E-18	Height	
COAD	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.3	4.07	6.11E-5	Height	
COAD	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.58	8.28	6.43E-15	Height	
COAD	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.29	3.82	0.00017	Height	
COAD	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.6	8.88	1.11E-16	Height	
COAD	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.32	4.28	2.68E-5	Height	
COAD	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.58	8.67	4.75E-16	Height	
COAD	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.3	4.04	7.16E-5	Height	
COAD	cis	1	rs9293568	chr5:90737845	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.42	-5.87	1.33E-8	Plasma homocysteine levels (post-methionine load test)	
COAD	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.83	13.55	4.98E-32	Plasma homocysteine levels (post-methionine load test)	
COAD	cis	1	rs9296504	chr6:46629505	TDRD6	chr6:46655866-46670149:+	-0.3	-5.21	3.89E-7	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs9296505	chr6:46629841	SLC25A27	chr6:46620679-46645925:+	0.15	4.29	2.53E-5	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs9296505	chr6:46629841	TDRD6	chr6:46655866-46670149:+	-0.29	-5.02	9.62E-7	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.53	9.07	3.02E-17	Folate pathway vitamin levels	
COAD	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.54	9.38	3.36E-18	Folate pathway vitamin levels	
COAD	cis	1	rs9297950	chr8:96025659	C8orf38	chr8:95908040-96088396:+	-0.28	-3.82	0.000167	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs9297951	chr8:96041437	C8orf38	chr8:95908040-96088396:+	-0.29	-4.02	7.63E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
COAD	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.47	-5.36	1.85E-7	Menarche (age at onset)	
COAD	cis	1	rs9299335	chr9:102691446	STX17	chr9:102668915-102736817:+	-0.28	-3.89	0.000128	Alopecia areata	
COAD	cis	1	rs9303401	chr17:56847945	RAD51C	chr17:56769963-56811690:+	0.29	4.64	5.64E-6	Cognitive test performance	
COAD	cis	1	rs930421	chr2:42981239	HAAO	chr2:42994230-43019751:-	-0.4	-5.4	1.5E-7	Attention deficit hyperactivity disorder	
COAD	cis	1	rs930421	chr2:42981239	OXER1	chr2:42989641-42991401:-	-0.41	-5.36	1.83E-7	Attention deficit hyperactivity disorder	
COAD	cis	1	rs9304742	chr19:53451291	ZNF702P	chr19:53471505-53496784:-	0.32	3.81	0.000171	Psoriasis	
COAD	cis	1	rs9306329	chr22:39072454	CBY1	chr22:39052658-39069853:+	0.37	6.29	1.31E-9	Resting heart rate	
COAD	cis	1	rs9306329	chr22:39072454	JOSD1	chr22:39081549-39096459:-	-0.27	-4.45	1.26E-5	Resting heart rate	
COAD	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.32	-4.47	1.18E-5	Longevity	
COAD	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.27	4.43	1.4E-5	Inflammatory skin disease	
COAD	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.5	6.65	1.68E-10	Crohn's disease	
COAD	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.3	-4.99	1.12E-6	Longevity	
COAD	cis	1	rs9312662	chr4:56386371	SRD5A3	chr4:56212409-56237866:+	-0.31	-5.06	7.96E-7	Personality dimensions	
COAD	cis	1	rs9318086	chr13:24432467	PCOTH	chr13:24463028-24466241:+	0.31	4.31	2.33E-5	Myopia (pathological)	
COAD	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.31	5.11	6.33E-7	Height	
COAD	cis	1	rs9320656	chr6:118894468	C6orf204	chr6:118786239-119031238:-	0.29	4.88	1.81E-6	Renal cell carcinoma	
COAD	cis	1	rs9320660	chr6:118956827	C6orf204	chr6:118786239-119031238:-	-0.28	-4.58	7.27E-6	Renal cell carcinoma	
COAD	cis	1	rs9329165	chr8:8576642	FLJ10661	chr8:8086092-8102386:+	-0.37	-4.34	2.02E-5	Obesity-related traits	
COAD	cis	1	rs9329166	chr8:8576655	FLJ10661	chr8:8086092-8102386:+	0.46	5.1	6.39E-7	Obesity-related traits	
COAD	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.63	9.57	8.42E-19	Height	
COAD	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.3	4.01	7.81E-5	Height	
COAD	cis	1	rs9344759	chr6:88903937	PM20D2	chr6:89855769-89875283:+	0.27	4.04	6.9E-5	Gut microbiota (functional units)	
COAD	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.38	-7.11	1.13E-11	Homocysteine levels	
COAD	cis	1	rs9380378	chr6:33765479	HLA-DOB	chr6:32780541-32784825:-	0.21	3.97	9.2E-5	Crohn's disease	
COAD	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.15	-4.35	1.95E-5	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs9381469	chr6:46630068	TDRD6	chr6:46655866-46670149:+	0.3	5.18	4.45E-7	QRS complex (Sokolow-Lyon)	
COAD	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.33	5.35	1.89E-7	Homocysteine levels	
COAD	cis	1	rs9394166	chr6:33751122	HLA-DOB	chr6:32780541-32784825:-	0.2	3.85	0.000146	Crohn's disease	
COAD	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.36	-4.51	9.81E-6	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
COAD	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.38	-7.15	8.64E-12	Homocysteine levels	
COAD	cis	1	rs940045	chr3:49449638	WDR6	chr3:49044637-49053386:+	-0.34	-5.06	8.1E-7	Menarche (age at onset)	
COAD	cis	1	rs940174	chr3:136309710	PCCB	chr3:135969167-136056737:+	0.26	4.47	1.16E-5	Schizophrenia	
COAD	cis	1	rs9416684	chr10:59994722	IPMK	chr10:59955618-60027694:-	0.25	4.18	4.06E-5	Inflammatory bowel disease	
COAD	cis	1	rs9420	chr11:57510294	TMX2	chr11:57480042-57508444:+	-0.29	-4.28	2.62E-5	Schizophrenia	
COAD	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.31	4.18	3.96E-5	Life satisfaction	
COAD	cis	1	rs943477	chr6:33750931	HLA-DOB	chr6:32780541-32784825:-	0.23	4.36	1.86E-5	Crohn's disease	
COAD	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.2	4.33	2.14E-5	Type 1 diabetes autoantibodies	
COAD	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.55	9.63	5.47E-19	Folate pathway vitamin levels	
COAD	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.55	9.63	5.47E-19	Folate pathway vitamin levels	
COAD	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.55	-9.65	4.8E-19	Folate pathway vitamin levels	
COAD	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.54	9.51	1.33E-18	Folate pathway vitamin levels	
COAD	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.38	-7	2.18E-11	Homocysteine levels	
COAD	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.54	9.51	1.33E-18	Folate pathway vitamin levels	
COAD	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.54	9.47	1.71E-18	Folate pathway vitamin levels	
COAD	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.3	4.21	3.54E-5	Parkinson's disease	
COAD	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.54	9.2	1.19E-17	Folate pathway vitamin levels	
COAD	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.38	-7.02	1.93E-11	Homocysteine levels	
COAD	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.54	9.51	1.33E-18	Folate pathway vitamin levels	
COAD	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.54	9.51	1.33E-18	Folate pathway vitamin levels	
COAD	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.54	9.4	2.86E-18	Folate pathway vitamin levels	
COAD	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.54	9.38	3.36E-18	Folate pathway vitamin levels	
COAD	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.53	9.22	1.06E-17	Folate pathway vitamin levels	
COAD	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.53	8.91	9.1E-17	Folate pathway vitamin levels	
COAD	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.28	-5.99	7.09E-9	Menarche (age at onset)	
COAD	cis	1	rs947583	chr6:136133659	PDE7B	chr6:136172834-136516708:+	0.23	4.72	3.84E-6	Phosphorus levels	
COAD	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.28	4.54	8.7E-6	Height	
COAD	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.29	4.78	2.9E-6	Height	
COAD	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.31	5.11	6.33E-7	Height	
COAD	cis	1	rs9481808	chr6:118784571	C6orf204	chr6:118786239-119031238:-	-0.26	-4.33	2.12E-5	Renal cell carcinoma	
COAD	cis	1	rs9481821	chr6:118846022	C6orf204	chr6:118786239-119031238:-	-0.27	-4.61	6.29E-6	Renal cell carcinoma	
COAD	cis	1	rs9481825	chr6:118876092	C6orf204	chr6:118786239-119031238:-	-0.27	-4.66	5.1E-6	Renal cell carcinoma	
COAD	cis	1	rs9481833	chr6:118919631	C6orf204	chr6:118786239-119031238:-	-0.26	-4.32	2.26E-5	Renal cell carcinoma	
COAD	cis	1	rs9482736	chr6:98900621	SFRS18	chr6:99846535-99873207:-	-0.31	-3.85	0.000148	Brain imaging in schizophrenia (interaction)	
COAD	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.29	4.78	2.9E-6	Height	
COAD	cis	1	rs9487605	chr6:111582885	KIAA1919	chr6:111580482-111590259:+	-0.44	-6	6.4E-9	Inflammatory skin disease	
COAD	cis	1	rs9489394	chr6:118758234	C6orf204	chr6:118786239-119031238:-	-0.27	-4.57	7.5E-6	Renal cell carcinoma	
COAD	cis	1	rs9489395	chr6:118758884	C6orf204	chr6:118786239-119031238:-	-0.27	-4.57	7.5E-6	Renal cell carcinoma	
COAD	cis	1	rs9489399	chr6:118767147	C6orf204	chr6:118786239-119031238:-	-0.27	-4.57	7.5E-6	Renal cell carcinoma	
COAD	cis	1	rs9489407	chr6:118792337	C6orf204	chr6:118786239-119031238:-	0.27	4.66	5.03E-6	Renal cell carcinoma	
COAD	cis	1	rs9489409	chr6:118802721	C6orf204	chr6:118786239-119031238:-	-0.24	-4.11	5.38E-5	Renal cell carcinoma	
COAD	cis	1	rs9489428	chr6:118852935	C6orf204	chr6:118786239-119031238:-	-0.28	-4.78	2.89E-6	Renal cell carcinoma	
COAD	cis	1	rs9489433	chr6:118867006	C6orf204	chr6:118786239-119031238:-	-0.28	-4.81	2.51E-6	Renal cell carcinoma	
COAD	cis	1	rs9489436	chr6:118873817	C6orf204	chr6:118786239-119031238:-	-0.28	-4.81	2.51E-6	Renal cell carcinoma	
COAD	cis	1	rs9489442	chr6:118885950	C6orf204	chr6:118786239-119031238:-	-0.28	-4.81	2.51E-6	Renal cell carcinoma	
COAD	cis	1	rs9489447	chr6:118900846	C6orf204	chr6:118786239-119031238:-	-0.28	-4.7	4.26E-6	Renal cell carcinoma	
COAD	cis	1	rs9489450	chr6:118904385	C6orf204	chr6:118786239-119031238:-	-0.26	-4.32	2.26E-5	Renal cell carcinoma	
COAD	cis	1	rs9489452	chr6:118910868	C6orf204	chr6:118786239-119031238:-	-0.28	-4.7	4.26E-6	Renal cell carcinoma	
COAD	cis	1	rs9489457	chr6:118920285	C6orf204	chr6:118786239-119031238:-	-0.26	-4.32	2.26E-5	Renal cell carcinoma	
COAD	cis	1	rs9489458	chr6:118920503	C6orf204	chr6:118786239-119031238:-	-0.26	-4.32	2.26E-5	Renal cell carcinoma	
COAD	cis	1	rs9489460	chr6:118925754	C6orf204	chr6:118786239-119031238:-	-0.26	-4.29	2.56E-5	Renal cell carcinoma	
COAD	cis	1	rs9489467	chr6:118935206	C6orf204	chr6:118786239-119031238:-	-0.28	-4.58	7.27E-6	Renal cell carcinoma	
COAD	cis	1	rs9489477	chr6:118946192	C6orf204	chr6:118786239-119031238:-	-0.28	-4.58	7.27E-6	Renal cell carcinoma	
COAD	cis	1	rs9491140	chr6:124691237	NKAIN2	chr6:124125069-125146784:+	0.46	6.21	2.07E-9	Neuroticism	
COAD	cis	1	rs9491142	chr6:124693017	NKAIN2	chr6:124125069-125146784:+	0.48	6.18	2.46E-9	Neuroticism	
COAD	cis	1	rs9500256	chr6:58308955	GUSBL2	chr6:58246159-58287724:-	-0.35	-5.29	2.53E-7	Eosinophilic esophagitis (pediatric)	
COAD	cis	1	rs950027	chr15:45801035	GATM	chr15:45653324-45670980:-	0.3	3.97	9.47E-5	Response to fenofibrate (adiponectin levels)	
COAD	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.32	-4.52	9.2E-6	Schizophrenia	
COAD	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.56	-6.74	1.01E-10	Arsenic metabolism	
COAD	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.61	8.62	6.51E-16	Response to antipsychotic treatment	
COAD	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.62	-8.65	5.35E-16	Response to antipsychotic treatment	
COAD	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.62	-8.32	4.99E-15	Response to antipsychotic treatment	
COAD	cis	1	rs957644	chr1:165616157	MGST3	chr1:165600450-165624853:+	0.39	5.51	8.82E-8	Total ventricular volume	
COAD	cis	1	rs959617	chr1:165616881	MGST3	chr1:165600450-165624853:+	0.39	5.62	4.95E-8	Total ventricular volume	
COAD	cis	1	rs9606947	chr22:32795285	C22orf28	chr22:32783562-32808274:-	-0.37	-3.93	0.000108	IgG glycosylation	
COAD	cis	1	rs9607566	chr22:39075434	CBY1	chr22:39052658-39069853:+	0.38	6.49	4.34E-10	Resting heart rate	
COAD	cis	1	rs9607566	chr22:39075434	JOSD1	chr22:39081549-39096459:-	-0.25	-4.23	3.28E-5	Resting heart rate	
COAD	cis	1	rs9609527	chr22:32795751	C22orf28	chr22:32783562-32808274:-	0.37	4.03	7.33E-5	IgG glycosylation	
COAD	cis	1	rs9610986	chr22:39025277	CBY1	chr22:39052658-39069853:+	0.33	5.7	3.3E-8	Resting heart rate	
COAD	cis	1	rs9610986	chr22:39025277	JOSD1	chr22:39081549-39096459:-	-0.27	-4.69	4.47E-6	Resting heart rate	
COAD	cis	1	rs9610993	chr22:39042818	CBY1	chr22:39052658-39069853:+	0.36	6.13	3.26E-9	Resting heart rate	
COAD	cis	1	rs9610993	chr22:39042818	JOSD1	chr22:39081549-39096459:-	-0.28	-4.81	2.52E-6	Resting heart rate	
COAD	cis	1	rs9622833	chr22:39000397	CBY1	chr22:39052658-39069853:+	0.33	5.4	1.51E-7	Resting heart rate	
COAD	cis	1	rs9622833	chr22:39000397	JOSD1	chr22:39081549-39096459:-	-0.25	-4.08	5.88E-5	Resting heart rate	
COAD	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.27	-4.67	4.79E-6	Gut microbiome composition (summer)	
COAD	cis	1	rs9635324	chr15:40703211	DISP2	chr15:40650434-40663256:+	0.29	4.21	3.48E-5	Blood metabolite levels;Blood metabolite ratios	
COAD	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.64	-9.86	1.1E-19	Response to antipsychotic treatment	
COAD	cis	1	rs9651447	chr10:81736754	LOC219347	chr10:81805991-81838949:-	0.67	4.13	4.85E-5	Rheumatoid arthritis	
COAD	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.54	8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs9677476	chr2:232126290	ARMC9	chr2:232063342-232238606:+	-0.26	-4.12	5.0E-5	Food antigen IgG levels	
COAD	cis	1	rs9684708	chr4:56430381	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.79	2.86E-6	Personality dimensions	
COAD	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	1.02	9.68	3.98E-19	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
COAD	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.44	6.85	5.33E-11	Erythrocyte sedimentation rate	
COAD	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.49	-7.48	1.13E-12	Erythrocyte sedimentation rate	
COAD	cis	1	rs9689	chr1:25688276	TMEM50A	chr1:25664811-25688850:+	0.22	3.87	0.00014	Erythrocyte sedimentation rate	
COAD	cis	1	rs974495	chr3:49400482	WDR6	chr3:49044637-49053386:+	-0.35	-5.14	5.47E-7	Menarche (age at onset)	
COAD	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.54	8.29	6.01E-15	Eye color traits	
COAD	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.54	8.26	7.22E-15	Eye color traits	
COAD	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.54	8.44	2.22E-15	Forced vital capacity	
COAD	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.31	4.67	4.93E-6	Pancreatic cancer	
COAD	cis	1	rs9783386	chr11:18386625	GTF2H1	chr11:18343816-18388590:+	0.39	5.77	2.18E-8	Pancreatic cancer	
COAD	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.43	4.71	3.97E-6	Colorectal cancer	
COAD	cis	1	rs9805979	chr14:75566209	MLH3	chr14:75480467-75518235:-	0.25	4.31	2.28E-5	Height	
COAD	cis	1	rs9807825	chr19:52019947	FPR2	chr19:52264453-52273777:+	0.37	3.84	0.000154	Carotid intima media thickness	
COAD	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.59	8.66	4.84E-16	Height	
COAD	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs9810077	chr3:195005422	C3orf21	chr3:194789015-194991895:-	0.39	5.6	5.45E-8	Body mass index	
COAD	cis	1	rs9810089	chr3:135807609	PCCB	chr3:135969167-136056737:+	-0.27	-4.6	6.62E-6	Gestational age at birth (child effect)	
COAD	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.29	4.77	3.12E-6	Longevity	
COAD	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.61	9.42	2.52E-18	Height	
COAD	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.29	3.93	0.000108	Height	
COAD	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.27	7.38E-18	Height	
COAD	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.33	-4.31	2.29E-5	Height	
COAD	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.3	-5.06	7.76E-7	Longevity	
COAD	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.61	8.2	1.13E-14	Diastolic blood pressure	
COAD	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.29	-4.93	1.45E-6	Longevity	
COAD	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.66	9.51	1.37E-18	Diastolic blood pressure	
COAD	cis	1	rs9818982	chr3:45812514	ZDHHC3	chr3:44956754-45017674:-	-0.37	-3.94	0.000106	Blood metabolite levels	
COAD	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.6	8.81	1.83E-16	Height	
COAD	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.29	3.84	0.000156	Height	
COAD	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.62	8.28	6.28E-15	Diastolic blood pressure	
COAD	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.62	8.28	6.28E-15	Diastolic blood pressure	
COAD	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.29	-4.74	3.47E-6	Longevity	
COAD	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.61	9.49	1.53E-18	Height	
COAD	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.29	4.01	8.03E-5	Height	
COAD	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.59	8.52	1.31E-15	Height	
COAD	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.29	3.85	0.000146	Height	
COAD	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.63	9.37	3.6E-18	Height	
COAD	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.33	4.38	1.73E-5	Height	
COAD	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.59	8.85	1.35E-16	Height	
COAD	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.74	11.45	7.49E-25	Diastolic blood pressure	
COAD	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.61	9.21	1.13E-17	Height	
COAD	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.3	4.03	7.38E-5	Height	
COAD	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs9837383	chr3:71552366	FOXP1	chr3:71004737-71633140:-	-0.21	-4.06	6.48E-5	Educational attainment (years of education)	
COAD	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.3	-5.09	6.81E-7	Longevity	
COAD	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.74	11.39	1.14E-24	Diastolic blood pressure	
COAD	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.6	8.51	1.34E-15	Height	
COAD	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.34	4.39	1.64E-5	Height	
COAD	cis	1	rs9842132	chr3:49427933	WDR6	chr3:49044637-49053386:+	0.31	4.29	2.47E-5	Menarche (age at onset)	
COAD	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.38	-6.15	2.88E-9	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
COAD	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.68	-9.99	4.24E-20	Diastolic blood pressure	
COAD	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.62	8.28	6.28E-15	Diastolic blood pressure	
COAD	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.56	7.38	2.15E-12	Diastolic blood pressure	
COAD	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.52	6.72	1.17E-10	Diastolic blood pressure	
COAD	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.3	-4.95	1.31E-6	Longevity	
COAD	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.6	8.89	1.04E-16	Height	
COAD	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.62	9.13	1.88E-17	Height	
COAD	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.31	4.1	5.46E-5	Height	
COAD	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.63	9.68	4.05E-19	Height	
COAD	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.3	4.12	5.05E-5	Height	
COAD	cis	1	rs985434	chr5:90744509	LOC100129716	chr5:90676164-90716531:+	0.33	3.96	9.58E-5	Smoking behavior	
COAD	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.58	7.62	4.61E-13	Diastolic blood pressure	
COAD	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.66	9.51	1.37E-18	Diastolic blood pressure	
COAD	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.66	9.51	1.37E-18	Diastolic blood pressure	
COAD	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.74	11.23	3.97E-24	Diastolic blood pressure	
COAD	cis	1	rs9860055	chr3:49506900	WDR6	chr3:49044637-49053386:+	0.33	4.53	8.84E-6	Menarche (age at onset)	
COAD	cis	1	rs9862534	chr3:49598064	WDR6	chr3:49044637-49053386:+	-0.33	-4.78	2.9E-6	Menarche (age at onset)	
COAD	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.59	8.8	1.96E-16	Height	
COAD	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.29	3.83	0.000163	Height	
COAD	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.54	7.16	8.29E-12	Diastolic blood pressure	
COAD	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.59	8.74	2.96E-16	Height	
COAD	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.31	4.12	5.19E-5	Height	
COAD	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.28	-4.68	4.69E-6	Longevity	
COAD	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.6	8.6	7.71E-16	Height	
COAD	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.33	4.31	2.34E-5	Height	
COAD	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.65	-9.51	1.35E-18	Diastolic blood pressure	
COAD	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.59	8.73	3.2E-16	Height	
COAD	cis	1	rs9871024	chr3:49554241	WDR6	chr3:49044637-49053386:+	0.31	4.28	2.6E-5	Menarche (age at onset)	
COAD	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.63	9.37	3.6E-18	Height	
COAD	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.33	4.38	1.73E-5	Height	
COAD	cis	1	rs9872999	chr3:133457514	TF	chr3:133419211-133497635:+	-0.27	-3.87	0.000138	Iron status biomarkers	
COAD	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.59	8.06	2.71E-14	Diastolic blood pressure	
COAD	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.61	8.22	9.62E-15	Diastolic blood pressure	
COAD	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.58	7.62	4.61E-13	Diastolic blood pressure	
COAD	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.74	11.23	3.97E-24	Diastolic blood pressure	
COAD	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.52	-7.62	4.65E-13	Height	
COAD	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.31	-5.06	7.76E-7	Longevity	
COAD	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.3	-4.87	1.94E-6	Longevity	
COAD	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.58	8.67	4.75E-16	Height	
COAD	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.3	4.04	7.16E-5	Height	
COAD	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.29	-4.75	3.41E-6	Longevity	
COAD	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.29	-4.84	2.22E-6	Longevity	
COAD	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.58	8.6	7.36E-16	Height	
COAD	cis	1	rs9889618	chr17:40293467	DHX58	chr17:40253422-40264751:-	-0.31	-4.75	3.32E-6	Fibrinogen levels	
COAD	cis	1	rs9889640	chr17:40293497	DHX58	chr17:40253422-40264751:-	-0.31	-4.75	3.32E-6	Fibrinogen levels	
COAD	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.92	0.000113	Coffee consumption (cups per day)	
COAD	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.92	0.000113	Coffee consumption (cups per day)	
COAD	cis	1	rs9891018	chr17:61827856	FTSJ3	chr17:61896795-61905031:-	0.29	4.07	6.2E-5	Body mass index	
COAD	cis	1	rs9891865	chr17:53060033	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.97	9.45E-5	Coffee consumption (cups per day)	
COAD	cis	1	rs9892173	chr17:53060214	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs9892976	chr17:53060329	STXBP4	chr17:53046126-53241449:+	-0.29	-4.03	7.23E-5	Breast cancer	
COAD	cis	1	rs9893306	chr17:53054749	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs9893348	chr17:61676534	FTSJ3	chr17:61896795-61905031:-	0.31	4.06	6.57E-5	Body mass index	
COAD	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.53	7.96	5.13E-14	Eye color traits	
COAD	cis	1	rs9894529	chr17:53055246	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs9894680	chr17:37962237	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs9895920	chr17:61852719	FTSJ3	chr17:61896795-61905031:-	0.28	4.2	3.72E-5	Body mass index	
COAD	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.95	0.000102	Coffee consumption (cups per day)	
COAD	cis	1	rs9897206	chr17:28406108	EFCAB5	chr17:28256874-28435469:+	-0.27	-3.82	0.000167	Coffee consumption (cups per day)	
COAD	cis	1	rs9899788	chr17:61756384	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs9901507	chr17:61765524	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs9901617	chr17:37964176	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.27	-3.82	0.00017	Coffee consumption (cups per day)	
COAD	cis	1	rs9902621	chr17:37973011	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs9902718	chr17:53061622	STXBP4	chr17:53046126-53241449:+	-0.27	-3.85	0.000148	Breast cancer	
COAD	cis	1	rs9903146	chr17:53057747	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs9903204	chr17:40288062	DHX58	chr17:40253422-40264751:-	-0.32	-4.91	1.58E-6	Fibrinogen levels	
COAD	cis	1	rs9903220	chr17:53057865	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs9903444	chr17:53057893	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs9903825	chr17:53057914	STXBP4	chr17:53046126-53241449:+	-0.28	-3.91	0.000119	Breast cancer	
COAD	cis	1	rs9903903	chr17:61762044	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs9904277	chr17:37976599	IKZF3	chr17:37921201-38020441:-	0.34	3.86	0.000141	Systemic lupus erythematosus	
COAD	cis	1	rs9904677	chr17:56873025	RAD51C	chr17:56769963-56811690:+	0.29	4.64	5.64E-6	Cognitive test performance	
COAD	cis	1	rs9908044	chr17:61747032	FTSJ3	chr17:61896795-61905031:-	0.28	4.03	7.19E-5	Body mass index	
COAD	cis	1	rs9908983	chr17:37976927	IKZF3	chr17:37921201-38020441:-	0.34	3.86	0.000141	Systemic lupus erythematosus	
COAD	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.46	-6.37	8.68E-10	Glycated hemoglobin levels	
COAD	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.39	-5.27	2.85E-7	Subjective well-being	
COAD	cis	1	rs9911069	chr17:37976602	IKZF3	chr17:37921201-38020441:-	0.34	3.86	0.000141	Systemic lupus erythematosus	
COAD	cis	1	rs9911669	chr17:37943767	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs9912088	chr17:40288278	DHX58	chr17:40253422-40264751:-	-0.32	-4.91	1.58E-6	Fibrinogen levels	
COAD	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.28	-3.92	0.000113	Coffee consumption (cups per day)	
COAD	cis	1	rs991427	chr12:91474422	KERA	chr12:91444273-91452131:-	0.27	4.43	1.38E-5	Systolic blood pressure (alcohol consumption interaction)	
COAD	cis	1	rs9914302	chr17:37962408	IKZF3	chr17:37921201-38020441:-	0.34	3.95	0.000101	Systemic lupus erythematosus	
COAD	cis	1	rs9914732	chr17:53054367	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs9915255	chr17:40284191	DHX58	chr17:40253422-40264751:-	-0.28	-4.25	2.96E-5	Fibrinogen levels	
COAD	cis	1	rs991561	chr3:66760593	MAGI1	chr3:65339907-66024509:-	0.27	3.84	0.000152	Carotid intima media thickness	
COAD	cis	1	rs9915832	chr17:53054697	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs9916642	chr17:53054497	STXBP4	chr17:53046126-53241449:+	-0.27	-3.83	0.000162	Breast cancer	
COAD	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.31	-5.37	1.72E-7	Testicular germ cell tumor	
COAD	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.31	-5.33	2.13E-7	Testicular germ cell tumor	
COAD	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.31	-5.34	1.98E-7	Testicular germ cell tumor	
COAD	cis	1	rs993394	chr6:117117143	FAM162B	chr6:117073360-117086886:-	0.26	4.07	6.11E-5	C-reactive protein levels	
COAD	cis	1	rs9939768	chr16:67219107	LRRC29	chr16:67241043-67260901:-	-0.47	-6.11	3.69E-9	HDL cholesterol	
COAD	cis	1	rs9940665	chr16:67289841	LRRC29	chr16:67241043-67260901:-	-0.35	-4.42	1.45E-5	HDL cholesterol	
COAD	cis	1	rs9941751	chr20:33645709	EDEM2	chr20:33703160-33865928:-	0.33	3.9	0.000122	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
COAD	cis	1	rs9955622	chr18:47203955	ACAA2	chr18:47309875-47340283:-	0.26	3.87	0.000138	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	
COAD	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.62	-9.26	7.69E-18	Height	
COAD	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.33	-4.35	1.97E-5	Height	
COAD	cis	1	rs9978611	chr21:37807318	CLDN14	chr21:37832920-37948867:-	-0.4	-4.8	2.72E-6	Myopia (pathological)	
COAD	cis	1	rs9979408	chr21:37807345	CLDN14	chr21:37832920-37948867:-	-0.4	-4.59	6.8E-6	Myopia (pathological)	
COAD	cis	1	rs9981599	chr21:37807927	CLDN14	chr21:37832920-37948867:-	-0.4	-4.83	2.36E-6	Myopia (pathological)	
COAD	cis	1	rs9981659	chr21:37807852	CLDN14	chr21:37832920-37948867:-	-0.41	-4.94	1.43E-6	Myopia (pathological)	
COAD	cis	1	rs9983229	chr21:30137674	N6AMT1	chr21:30244513-30257693:-	0.42	5.04	8.85E-7	Cognitive test performance	
COAD	cis	1	rs9984793	chr21:30486471	N6AMT1	chr21:30244513-30257693:-	-0.32	-4.63	5.82E-6	Dental caries	
COAD	cis	1	rs9984974	chr21:37809377	CLDN14	chr21:37832920-37948867:-	0.45	5.44	1.23E-7	Myopia (pathological)	
COAD	cis	1	rs9985126	chr21:37809408	CLDN14	chr21:37832920-37948867:-	-0.39	-4.74	3.54E-6	Myopia (pathological)	
COAD	cis	1	rs9985341	chr3:134232840	ANAPC13	chr3:134196547-134204865:-	0.5	6.54	3.16E-10	Height	
COAD	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.33	4.69E-15	Height	
COAD	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.35	-4.64	5.41E-6	Height	
COAD	cis	1	rs9987357	chr8:124187620	FAM83A	chr8:124191287-124222317:+	-0.5	-4.38	1.76E-5	Urinary uromodulin levels	
COAD	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.29	4.4	1.58E-5	Pancreatic cancer	
COAD	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.58	8.67	4.75E-16	Height	
COAD	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.3	4.04	7.16E-5	Height	
COAD	cis	1	rs9990333	chr3:195827205	SDHAP1	chr3:195686792-195717150:-	-0.24	-4.21	3.54E-5	Iron status biomarkers (transferrin saturation);Iron status biomarkers (transferrin levels)	
COAD	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.58	-8.2	1.11E-14	Height	
COAD	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.32	-4.2	3.6E-5	Height	
COAD	cis	1	rs9990702	chr4:88772316	SPP1	chr4:88896802-88904562:+	-0.28	-5.18	4.41E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.32	-4.53	9.14E-6	Longevity	
COAD	cis	1	rs9997288	chr4:56347227	SRD5A3	chr4:56212409-56237866:+	0.27	4.35	1.99E-5	Personality dimensions	
COAD	cis	1	rs9998146	chr4:56397977	SRD5A3	chr4:56212409-56237866:+	-0.25	-4.25	3.01E-5	Personality dimensions	
COAD	cis	1	rs9998898	chr4:88772189	SPP1	chr4:88896802-88904562:+	-0.28	-5.18	4.41E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	cis	1	rs9998975	chr4:88772233	SPP1	chr4:88896802-88904562:+	-0.28	-5.18	4.41E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
COAD	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.68	-11.63	1.82E-25	Migraine without aura	
COAD	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.08E-17	Educational attainment	
COAD	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.6	9.07	2.92E-17	Educational attainment	
COAD	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.27E-17	Educational attainment	
COAD	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.6	9.09	2.49E-17	Educational attainment	
COAD	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.6	9.09	2.49E-17	Educational attainment	
COAD	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.6	9.09	2.49E-17	Educational attainment	
COAD	trans	1	rs11843405	chr13:60236037	VCY	chrY:16168102-16168837:+;chrY	0.4	6.57	2.78E-10	Trans fatty acid levels	
COAD	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.59	8.93	7.6E-17	Educational attainment	
COAD	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.59	-8.78	2.17E-16	Educational attainment	
COAD	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.6	9.03	3.88E-17	Educational attainment	
COAD	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.22E-17	Educational attainment	
COAD	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.59	8.98	5.51E-17	Educational attainment	
COAD	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.82	-9.4	2.83E-18	Total ventricular volume (Alzheimer's disease interaction)	
COAD	trans	1	rs2084386	chr3:196554020	LOC646214	chr15:21932514-21940739:-	-0.88	-8.99	5.22E-17	Total ventricular volume (Alzheimer's disease interaction)	
COAD	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.27E-17	Educational attainment	
COAD	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.6	9.07	2.92E-17	Educational attainment	
COAD	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.61	9.2	1.17E-17	Educational attainment	
COAD	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.21E-17	Educational attainment	
COAD	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.6	9.09	2.49E-17	Educational attainment	
COAD	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.27E-17	Educational attainment	
COAD	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.27E-17	Educational attainment	
COAD	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.61	9.13	1.88E-17	Educational attainment	
COAD	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.22E-17	Educational attainment	
COAD	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.59	8.98	5.51E-17	Educational attainment	
COAD	trans	1	rs492042	chr4:75084804	C21orf56	chr21:47581063-47604373:-	1.02	6.43	6.13E-10	Immune reponse to smallpox (secreted IL-1beta)	
COAD	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.67	11.82	4.32E-26	Migraine without aura	
COAD	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.6	8.94	7.24E-17	Educational attainment	
COAD	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.61	9.13	1.92E-17	Educational attainment	
COAD	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.6	-9.01	4.45E-17	Educational attainment	
COAD	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.61	9.13	1.88E-17	Educational attainment	
COAD	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.6	8.9	9.68E-17	Educational attainment	
COAD	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.61	9.16	1.53E-17	Educational attainment	
COAD	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.6	9.07	2.92E-17	Educational attainment	
COAD	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.22E-17	Educational attainment	
COAD	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.6	9.07	2.92E-17	Educational attainment	
COAD	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.6	9.05	3.48E-17	Educational attainment	
COAD	trans	1	rs73206686	chr13:60234779	VCY	chrY:16168102-16168837:+;chrY	0.4	6.57	2.78E-10	Trans fatty acid levels	
COAD	trans	1	rs73206689	chr13:60235610	VCY	chrY:16168102-16168837:+;chrY	0.39	6.41	6.86E-10	Trans fatty acid levels	
COAD	trans	1	rs7602568	chr2:28584315	GAGE4	chrX:49216634-49294597:+	-0.31	-6.23	1.9E-9	Soluble interleukin-2 receptor subunit alpha	
COAD	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.6	9.07	2.92E-17	Educational attainment	
COAD	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.6	-8.88	1.12E-16	Educational attainment	
COAD	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.63	9.61	6.44E-19	Educational attainment	
COAD	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.27E-17	Educational attainment	
COAD	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.61	9.13	1.92E-17	Educational attainment	
COAD	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.6	9.09	2.49E-17	Educational attainment	
COAD	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.6	9.09	2.49E-17	Educational attainment	
COAD	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.27E-17	Educational attainment	
COAD	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.6	9.07	2.92E-17	Educational attainment	
COAD	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.61	9.16	1.53E-17	Educational attainment	
COAD	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.27E-17	Educational attainment	
COAD	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.6	9.09	2.49E-17	Educational attainment	
COAD	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.61	-9.28	6.96E-18	Educational attainment	
COAD	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.59	8.98	5.51E-17	Educational attainment	
COAD	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.6	8.9	9.72E-17	Educational attainment	
COAD	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.6	9.07	2.92E-17	Educational attainment	
COAD	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.59	-8.82	1.62E-16	Educational attainment	
COAD	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.6	9.02	4.26E-17	Educational attainment	
COAD	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.6	8.96	6.14E-17	Educational attainment	
